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SUMMARY 
 
Helicobacter pylori is a well-characterizDe human pathogen that colonizes the stomach 
of more than half of the world’s population. It is a Gram-negative, microaerophilic, 
flagellated, spiral shaped bacterium able to establish a life‐long chronic infection in the 
gastric mucosa. Infection with H. pylori is generally acquired early in childhood, with a 
higher prevalence in developing countries, and typically persists for life. As in many 
chronic infections, most individuals remain asymptomatic with only a small proportion 
developing clinical disease. H. pylori is considered a pathogen as it universally causes 
progressive inflammation and gastric mucosal damage; in 1994 it was declared a class I 
human carcinogen by the World Health Organization (WHO). The clinical outcomes 
associated to H. pylori infection include severe gastroduodenal diseases, such as peptic 
and duodenal ulcers, noncardia gastric adenocarcinoma, and gastric mucosa-associated 
lymphoid tissue (MALT) lymphoma. For more than 100 years it has been recognized that 
atrophic gastritis was tightly associated with gastric cancer. The discovery of H. pylori in 
1983 identified the cause of chronic gastric mucosal inflammation and thus the underlying 
cause of gastric cancer. As consequence, since its culture from a gastric biopsy, H. pylori 
has been the subject of intense investigations and provoked the interest of many 
scientists, such as bacteriologists, molecular biologist, gastroenterologists, infectious 
disease specialists, cancer biologists, epidemiologists, pathologists, and pharmaceutical 
scientists.  
H. pylori has developed a surprising molecular machinery to survive in the unfriendly 
environment and achieve a successful colonization of the stomach. Since H. pylori is not 
an acidophilus bacterium, it has evolved several specialized mechanisms to survive 
gastric acid. The pathogen has to resist in the gastric lumen for a short period, enough to 
enter into the highly viscous mucosa, reach the gastric epithelium, find nutrients and 
multiply. Some acid-adaptive mechanisms include an acid-activated inner membrane 
urea channel, UreI, a neutral pH-optimum intrabacterial urease, and periplasmic and 
cytoplasmic carbonic anhydrases. This acid acclimation system allows to regulate the pH 
of the periplasm and of the surrounding liquid in acidic medium at levels compatible with 
survival and growth. A key factor essential for survival and successful colonization is the 
bacterial motility, mediated by its sheathed unipolar flagella, allowing H. pylori to swim in 
response to a gradient of pH and to stay within the mucus layer, where the pH is generally 
higher with respect to the lumen. Approximately only 20% of H. pylori bacteria in the 
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stomach adhere to the surface of the gastric epithelial cells; bacterial adhesion involves 
specialized molecular interactions mediated by adhesins and surface components, which 
are able to evade the host immune recognition by displaying a high antigenic variation. 
H. pylori is characterized by high genetic variability, not only in gene sequence but also 
in gene content, evidenced by the availability of complete genome sequences. One of the 
most striking differences in H. pylori strains is the presence or absence of a 40‐kb DNA 
region named cag Pathogenicity Island, that encodes a Type IV Secretion System, 
causing the translocation of CagA toxin, one of the most relevant virulence factor of H. 
pylori.  Upon injection into epithelial gastric cells, CagA induces cellular modifications, 
including alteration of cell structure, motility, cell scattering and proliferation, and tight 
junctions. A further relevant virulence factor is the vacuolating cytotoxin VacA, which is a 
secreted, pore-forming toxin able to induce vacuolization in gastric epithelial cells. Almost 
all H. pylori strains contain a vacA gene, but the gene sequence is highly variable, causing 
changes in VacA virulence activity. Therefore, H. pylori strains can be classified in 
subtypes associated with different levels of pathogenic offense during colonization, on 
the basis of the variability of the virulence factors. However, the various and divergent 
clinical outcomes deriving from the H. pylori infection are dictated by a complex balance 
between host genetic factors, bacterial virulence determinants, and environmental 
components. Therefore, understand in detail the host-pathogen relationship is a complex 
challenge, still incomplete. Despite that the bacterial genome has been completely 
sequenced, several pathogenic mechanisms have not yet been defined. Moreover, 
currently H. pylori can be eradicated by a triple therapy combining a protonic pump 
inhibitor and antibiotics; but the increasing antibiotic resistance is the main reason for this 
treatment failure. Therefore, it becomes necessary to identify new pharmacological 
targets against the bacterium, in order to overcome the serious problem of the drug-
resistance and to develop new antibiotic treatments. 
The main purpose of this research project is focused on identification and structural 
characterization of new potential pharmacological targets of H. pylori. In this respect, 
proteins responsible for colonization and virulence, as well as secreted proteins mediating 
important pathogen-host interactions, are interesting candidates for structural 
characterization, in order to deepen their putative function. In particular, the investigations 
were focused on the periplasmic α-carbonic anhydrase (HPG27_1129), the cytoplasmic 
β-carbonic anhydrase (HPG27_4), the flagellar protein FliK (HPG27_857), the thiol: 
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disulfide oxidoreductase HPG27_1020, and two secreted “hypothetical proteins”, namely 
HPG27_1030 and HPG27_1117. 
The research described in this thesis was mostly carried out at the Department of 
Biomedical Sciences, University of Padova, and at Venetian Institute of Molecular 
Medicine (VIMM), Padova. The strategy adopted included preliminary bioinformatic 
analyses, PCR-amplification of the selected genes starting from purified H. pylori 
chromosomal DNA (strain G27), cloning in a His-tag-containing vector and expression of 
the protein in E. coli competent cells. The recombinant proteins were then purified using 
two chromatography steps, from soluble or insoluble fractions, and concentrated for 
crystallization trials. The α-carbonic anhydrase was successfully crystallized and the 
structure was determined by x-ray diffraction. Crystals of β-carbonic anhydrase and 
HPG27_1117 were also obtained, nevertheless not suitable to x-ray diffraction 
measurement. To ensure the sample quality, Western blotting, analytical gel-filtration, 
UV-Vis absorption spectrum, circular dichroism analyzes were performed.  
Structural peculiarities and possible functional implications of α-carbonic anhydrase are 
described in Chapter III. This periplasmic protein plays a key role in the complex balance 
of urea and bicarbonate aimed to the survival in the stomach, catalyzing the reversible 
conversion of carbon dioxide to bicarbonate; thus, it is fundamental in buffering the pH of 
the periplasm. H. pylori α-carbonic anhydrase was cloned as recombinant protein lacking 
the N-terminal secretion signal, expressed in E. coli cells and purified; crystals were 
obtained by vapor-diffusion technique and the structure was determined at 1.52 Å by 
molecular replacement, based on a model built from α-carbonic anhydrase from 
Sulfurihydrogenibium yellowstonense (Di Fiore et al., 2013; PDB accession code: 4G7A). 
The protein structure shares many features with other members of the α-carbonic 
anhydrase family, showing a central ten-stranded β-sheet surrounded by three α-helices 
and by the remainder of the protein chain. Structural peculiarities are presented by the 
active site, since the glutamic acid residue (position 127) interacting with three catalytic 
histidine residues is substituted by a serine residue and the absent negative charge is 
replaced by a chloride ion captured from the external medium. The definition of the 
structural details of the protein allows to investigate new specific inhibitors as potential 
antibiotics against H. pylori. Moreover, cocrystallization trials were performed to 
investigate the molecular binding of inhibitor compounds to the active site; but cocrystals 
suitable to x-ray diffraction measurement have not been obtained yet. 
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The pathogen encodes a further carbonic anhydrase, namely the cytoplasmic β-carbonic 
anhydrase, whose investigations are described in Chapter IV. The enzyme is 
hypothesized to catalyze the same conversion for the carbon dioxide molecules that do 
not freely diffuse out of the inner membrane, contributing to buffer the pH of the cytoplasm 
and survival in the gastric acid environment. The β-carbonic anhydrase was cloned as 6-
His-tag recombinant protein and expressed in E. coli competent cells, exhibiting a limited 
yield of soluble protein, the most relevant limit encountered, likely owing to an improper 
folding by E. coli cells. The purification was performed both from the soluble and from the 
insoluble fractions, adopting various chromatographic techniques. Higher quality protein 
sample was obtained via immobilized-metal ion affinity chromatography, although the 
final yield of purified protein was impaired by the low affinity for the Ni-NTA resin. The 
purified protein was concentrated for crystallization trials, but crystals obtained were not 
suitable to x-ray diffraction measurement. 
In Chapter V the investigations on the flagellar protein FliK are reported. As mentioned 
before, bacterial motility mediated by unipolar flagella is an essential factor to minimize 
the exposure to the acid environment and to achieve a successful colonization of the 
gastric mucosa. In H. pylori more than 50 putative proteins are predicted to be involved 
in expression, secretion and assembly of the flagellar apparatus. It is composed of three 
structural elements: a basal body, an external helically shaped filament, and a hook that 
serves as a joint. FliK is responsible for the hook length control and in fliK mutants it has 
been observed that long hooks of unregulated length, named polyhooks, are formed, 
impairing the bacterial motility. Preliminary bioinformatics analyzes have evidenced that 
the flagellar protein exhibits an overall unstructured nature, with a limited folded region 
located at the C-terminal domain. Flik was cloned as 6-His-tag recombinant protein and 
several expression attempts were performed, adopting various E. coli strains and varying 
the conditions. Nevertheless, FliK exhibited an improper production by E. coli cells and 
degradation processes, likely ascribed to the high disorder level of the sequence. 
Strategies to overcome the limits of successful expression could be the cloning as single 
domains, or selecting more sophisticated system of expression, able to properly fold the 
protein. 
Since the formation of disulfide bonds plays a key role also in bacterial virulence, many 
bacteria possess an oxidative protein-folding machinery to properly assemble their 
proteins, including H. pylori. The thiol:disulfide oxidoreductase HPG27_1020, whose 
experimental procedures are reported in Chapter VI, is a thioredoxin-fold protein which 
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plays a role in the cytochrome c maturation, as well as in oxidized protein proper folding. 
Therefore, it provides essential function in H. pylori and represents a possible 
pharmacological target. Since its N-terminal region encode an export signal, the protein 
was cloned as 6-His-tag recombinant protein lacking of 24 N-terminal aminoacids. The 
recombinant HPG27_1020 protein was successfully expressed in E. coli cells, exhibiting 
a significant amount of soluble protein (approximately 60%). The researches were 
forcedly interrupted since meantime the x-ray structure of the thiol:disulfide 
oxidoreductase from H. pylori 26695, namely HP0377, has been determined and 
published. Their aminoacid sequences show a high degree of identity (96%), therefore 
the investigation has not longer been considered innovative. 
In Chapter VII cloning, expression, purification and crystallization trials concerning two 
secreted “hypothetical proteins”, namely HPG27_1030 and HPG27_1117, are described. 
Recently, several secreted proteins were identified by proteomic analysis of H. pylori 
secretome; they represent attractive subjects of structural and functional investigations, 
since they could mediate important pathogen-host interactions and, thus, represent 
potential target for antibiotics and vaccine development. HPG27_1030 was successfully 
cloned as 6-His-tag recombinant protein, expressed in E. coli cells and purified by two 
chromatography steps. A significant amount of soluble purified protein was achieved, but 
the protein exhibited instability in solution and a clear tendency to aggregation, resulting 
in a limited final concentration of purified sample for crystallization trials. HPG27_1117 
was cloned, expressed and purified as before. The most relevant limits encountered were 
the low yield of expression and the tendency to degradation. Nevertheless, purified 
protein was concentrated for crystallization trials and crystals were obtained by vapor-
diffusion technique; but the crystals diffracted at a limited resolution and crystals suitable 
to x-ray diffraction measurement have not been obtained yet. To overcome the common 
problem of instability and degradation of these secreted proteins, changings in the buffer 
composition could improve the stability in solution and enhance the final yield of purified 
product for crystallization trials. 
Concluding, identification of some new bacterial features have made possible to increase 
the overall knowledge about H. pylori and its peculiar mechanisms aimed to survival and 
virulence. On the basis of these findings, new investigations can be approached, in order 
to widely understand the pathophysiological mechanisms of this peculiar pathogen and 
to develop new eradication treatments. 
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SOMMARIO 
 
Helicobacter pylori è un microorganismo patogeno ben caratterizzato, che colonizza lo 
stomaco di più di metà della popolazione mondiale. È un batterio Gram-negativo, 
microaerofilo, flagellato, spiraliforme, in grado di instaurare un’infezione cronica della 
mucosa gastrica, che può durare tutta la vita se non trattata. L’infezione da H. pylori è 
generalmente acquisita in età infantile, con un tasso di prevalenza maggiore nei paesi in 
via di sviluppo, e tipicamente persiste per tutto il corso della vita. Come nel caso di molte 
infezioni croniche, la maggior parte degli individui risulta asintomatica, mentre solo una 
limitata porzione sviluppa patologie correlate. H. pylori è considerato un microorganismo 
patogeno poiché causa universalmente un’infiammazione progressiva e danni tissutali 
alla mucosa gastrica; nello specifico, nel 1994 H. pylori è stato dichiarato un agente 
carcinogeno di classe I per l’uomo da parte della World Health Organization (WHO). Gli 
esiti clinici conseguenti all’infezione da H. pylori comprendono patologie gastrointestinali 
particolarmente severe, quali ulcere peptica e duodenale, adenocarcinoma gastrico non 
cardia e MALT linfoma (mucosa-associated lymphoid tissue lymphoma). Da più di 100 
anni è riconosciuto che la gastrite atrofica è strettamente associata al cancro del tessuto 
gastrico. La scoperta dell’esistenza di H. pylori nel 1983 ha identificato la causa 
dell’infiammazione cronica della mucosa gastrica e quindi la causa fondamentale del 
cancro allo stomaco. Di conseguenza, sin dalla sua scoperta a partire da biopsie di 
tessuto gastrico, H. pylori è al centro di intense investigazioni e suscita l’interesse di molti 
studiosi, quali batteriologi, biologi molecolari, gastroenterologi, infettivologhi, biologi 
specializzati in patologie cancerose, epidemiologi, patologi e farmacologi. 
Per sopravvivere nell’ambiente estremamente inospitale dello stomaco e potervi 
realizzare una colonizzazione efficace, H. pylori ha sviluppato una sorprendente 
macchina molecolare. Poiché non è un batterio acidofilo, H. pylori ha evoluto molti 
espedienti specializzati per sopravvivere all’acidità gastrica. Innanzitutto, il patogeno 
deve resistere alle condizioni estreme del lume gastrico solo per un breve periodo, 
sufficiente per penetrare nella mucosa altamente viscosa, raggiungere l’epitelio gastrico, 
recuperare nutrienti e moltiplicarsi. Alcuni dei meccanismi coinvolti nell’adattamento alle 
condizioni acide prevedono il canale per l’urea, UreI, localizzato nella membrana interna 
e attivato da un pH acido, l’ureasi citoplasmatica, caratterizzata da un optimum di attività 
a pH neutro, e due anidrasi carboniche, localizzate nel citoplasma e nel periplasma. 
Questo sistema di adattamento all’acidità gastrica permette di regolare il pH del 
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periplasma e anche del liquido circostante nonostante l’ambiente acido, a livelli 
compatibili con la sopravvivenza e la crescita. Inoltre, un fattore cruciale per la 
sopravvivenza e una colonizzazione efficace del tessuto gastrico è rappresentato dalla 
motilità del batterio, resa possibile da flagelli unipolari e rivestiti da una guaina di difesa; 
grazie a quali H. pylori è in grado di nuotare in risposta a un gradiente di pH e di rimanere 
all’interno dello strato di muco gastrico, dove il pH è generalmente maggiore rispetto al 
lume dello stomaco. Circa solo il 20% dei microorganismi nello stomaco aderisce alla 
superfice delle cellule epiteliali gastriche; in particolare, l’adesione batterica vede 
coinvolte interazioni molecolari specializzate, mediate da adesine e altre componenti 
della superficie batterica, che sono in grado di eludere il riconoscimento da parte del 
sistema immunitario dell’ospite grazie a una elevata variabilità antigenica. Infatti, H. pylori 
è caratterizzato da una sorprendente variabilità genetica, non solo per quanto riguarda la 
sequenza dei geni, ma anche nel contenuto genico; la disponibilità delle sequenze 
genomiche complete ha reso possibile rilevare questa elevata variabilità in H. pylori. 
Soprattutto, una delle differenze più evidenti tra i ceppi di H. pylori è la presenza o meno 
di un frammento di DNA cromosomico di 40 kb chiamato isola di patogenicità cag, che 
codifica per un sistema di secrezione di tipo IV, responsabile della traslocazione della 
tossina CagA, uno dei più importanti fattori di virulenza di H. pylori. In seguito all’iniezione 
all’interno delle cellule epiteliali gastriche, CagA induce una serie di modificazioni 
cellulari, tra le quali alterazioni della struttura cellulare, della motilità, della proliferazione 
e della migrazione cellulari, della struttura delle giunzioni cellulari occludenti. Un ulteriore 
importante fattore di virulenza è la citotossina vacuolizzante VacA, che consiste in una 
tossina secreta, in grado di formare pori nelle membrane e indurre vacuolizzazione nelle 
cellule epiteliali gastriche. Quasi tutti i ceppi di H. pylori contengono il gene che codifica 
VacA, ma la sequenza genica è altamente variabile, causando perciò cambiamenti 
nell’intensità dell’attività di VacA. Perciò, in base alla variabilità dei fattori di virulenza, i 
ceppi di H. pylori possono essere classificati in sottotipi, ciascuno dei quali è associato a 
differenti livelli di patogenicità in seguito a colonizzazione. Oltre a quanto riportato, gli esiti 
clinici vari e divergenti derivanti dall’infezione da H. pylori dipendono da un intricato 
bilancio tra variabilità genetica dell’ospite, fattori di virulenza batterica e componenti 
ambientali. Perciò, la comprensione dettagliata della relazione tra ospite e patogeno è 
una sfida complessa, ancora da chiarire nella sua interezza. Nonostante che il genoma 
da più ceppi di H. pylori sia stato completamente sequenziato, molti dei meccanismi di 
patogenicità non sono ancora stati definiti. Inoltre, l’attuale trattamento di eradicazione di 
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H. pylori prevede una tripla terapia che combina un inibitore di pompa protonica e due 
antibiotici; ma la crescente diffusione di antibiotico resistenza è il principale motivo del 
fallimento di questa terapia. Perciò si rende necessario identificare nuovi target 
farmacologici contro questo patogeno, al fine di superare il preoccupante problema della 
farmaco resistenza e di sviluppare nuovi trattamenti antibiotici.  
Lo scopo principale di questo progetto di ricerca verte sull’identificazione e la 
caratterizzazione strutturale di nuovi potenziali target farmacologici di H. pylori. A questo 
proposito, proteine responsabili di colonizzazione e virulenza, così come proteine secrete 
che mediano le rilevanti interazioni tra ospite e patogeno, sono ritenute interessanti 
candidati per la caratterizzazione strutturale, allo scopo di approfondire la loro funzione 
presunta. In dettaglio, le indagini di questo progetto di ricerca si sono concentrate sull’α-
anidrasi carbonica (HPG27_1129), con localizzazione periplasmatica, la β-anidrasi 
carbonica (HPG27_4), con localizzazione citoplasmatica, la proteina flagellare FliK 
(HPG27_857), l’ossidoreduttasi HPG27_1020 e infine due “proteine ipotetiche” secrete, 
di funzione sconosciuta, cioè HPG27_1030 e HPG27_1117. 
Il lavoro di ricerca descritto in questa tesi è stato eseguito presso il Dipartimento di 
Scienze Biomediche dell’Università di Padova e presso l’Istituto Veneto di Medicina 
Molecolare (VIMM) di Padova. La strategia adottata prevedeva analisi bioinformatiche 
preliminari, amplificazione del gene di interesse tramite PCR a partire da DNA 
cromosomico purificato di H. pylori (ceppo G27), clonaggio in vettori in fusione con un 6-
His-tag ed espressione in cellule competenti di E. coli.  Di seguito, Le proteine 
ricombinanti sono state purificate tramite procedimenti che prevedono due passaggi 
cromatografici, sia dalla frazione solubile che da quella insolubile, e quindi concentrate 
per le prove di cristallizzazione. α-anidrasi carbonica è stata cristallizzata con successo 
e la struttura è stata determinata tramite diffrazione a raggi X. Inoltre, sono stati ottenuti 
cristalli anche di β-anidrasi carbonica e di HPG27_1117, però non adatti per la misura di 
dati di diffrazione a raggi X di buona risoluzione. Per assicurare la qualità del campione 
di proteina, sono state eseguite analisi quali Western blotting, gel-filtrazione analitica, 
spettro di assorbimento UV-Vis, spettro di dicroismo circolare. 
Le peculiarità strutturali e le possibili implicazioni funzionali di α-anidrasi carbonica sono 
descritte nel Capitolo III. Questa proteina periplasmatica svolge un ruolo chiave 
nell’intricato bilancio di urea e bicarbonato volto alla sopravvivenza del batterio nello 
stomaco, poiché catalizza la conversione reversibile dell’anidride carbonica in 
bicarbonato; perciò, essa è fondamentale nel regolare il pH del periplasma, dove è 
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localizzata. α-anidrasi carbonica da H. pylori è stata clonata come proteina ricombinante 
mancante del segnale N-terminale di secrezione, è stata espressa in cellule di E. coli e 
infine purificata; cristalli sono stati ottenuti mediante il metodo a diffusione di vapore e la 
struttura è stata determinata a 1.52 Å tramite molecular replacement, basandosi su un 
modello costruito a partire da α-anidrasi carbonica di Sulfurihydrogenibium 
yellowstonense (Di Fiore et al., 2013; codice PDB: 4G7A). La struttura della proteina 
condivide molte caratteristiche con altri membri della famiglia delle α-anidrasi carboniche, 
in quanto presenta un β-foglietto centrale costituito da 10 filamenti, circondato da 3 α-
eliche e dalla rimanente catena polipeptidica. Alcune peculiarità strutturali sono 
presentate dal sito attivo, poiché il residuo di acido glutammico (posizione 127) che 
interagisce con i tre residui catalitici di istidina è sostituito da un residuo si serina nella 
stessa posizione e la carica negativa mancante è rimpiazzata da uno ione cloro catturato 
dal mezzo esterno. La determinazione dei dettagli strutturali di questa proteina permette 
di ricercare nuovi specifici inibitori che possano agire come potenziali antibiotici contro H. 
pylori. Inoltre, sono state eseguite delle prove di cocristallizzazione con inibitori 
sulfamidici, per investigare i dettagli strutturali delle interazioni dei composti inibitori col 
sito attivo; ma cocristalli di qualità adatta per la misura dei dati di diffrazione a raggi X non 
sono stati ancora ottenuti. 
Il microorganismo patogeno codifica anche un’ulteriore anidrasi carbonica, cioè β-
anidrasi carbonica localizzata nel citoplasma, le cui indagini sono descritte nel Capitolo 
IV. Si ipotizza che questo enzima catalizzi la stessa conversione per quanto riguarda le 
molecole di anidride carbonica che non diffondono liberamente al di fuori della membrana 
interna; perciò contribuisce alla regolazione del pH del citoplasma e alla sopravvivenza 
nell’ambiente gastrico estremamente acido. β-anidrasi carbonica è stata clonata come 
proteina ricombinante con un 6-His-tag ed espressa in cellule competenti di E. coli; però 
il principale limite incontrato è stato una limitata resa di proteina solubile, probabilmente 
dovuta a un’impropria organizzazione tridimensionale da parte delle cellule di E. coli. La 
purificazione è stata eseguita sia a partire dalla frazione solubile sia da quella insolubile, 
adottando tecniche cromatografiche variegate. Il campione di proteina di migliore qualità 
è stato ottenuto per mezzo della cromatografia di affinità per ioni metallici immobilizzati, 
sebbene la resa finale di proteina purificata sia stata compromessa a causa della 
moderata affinità per la resina Ni-NTA. La proteina purificata è stata concentrata per le 
prove di cristallizzazione, ma i cristalli ottenuti non sono di qualità adatta per la misura 
dei dati di diffrazione a raggi X. 
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Nel Capitolo V è riportato il lavoro di ricerca sulla proteina flagellare FliK. Come 
menzionato in precedenza, la motilità batterica mediata dai flagelli unipolari è un fattore 
essenziale per minimizzare il contatto con l’ambiente acido e realizzare una 
colonizzazione efficiente della mucosa gastrica. In H. pylori si prevede che più di 50 
proteine siano coinvolte nell’espressione, secrezione e assemblaggio dell’apparato 
flagellare. Quest’ultimo è composto di tre elementi strutturali; un corpo basale, un 
filamento esterno a forma elicoidale e un uncino che serve ad unione. FliK è responsabile 
del controllo della lunghezza dell’uncino e si è osservato che in mutanti mancanti del 
gene di FliK si formano lunghi uncini di lunghezza incontrollata, chiamati “polyhooks”, che 
compromettono la motilità batterica. Analisi bioinformatiche preliminari hanno evidenziato 
come questa proteina flagellare presenti una struttura globale altamente disordinata, con 
una limitata regione strutturata localizzata a livello del dominio C-terminale. FliK è stata 
clonata come proteina ricombinante con un 6-His-tag e numerosi tentativi di espressione 
sono stati eseguiti, facendo uso di differenti ceppi di E. coli e variando le condizioni. 
Nonostante ciò, si sono riscontrati un’impropria produzione di FliK da parte delle cellule 
di E. coli e un’evidente degradazione della proteina, probabilmente entrambi gli eventi 
dovuti all’elevato grado di disordine della sequenza amminoacidica. Alcune strategie per 
risolvere questo limite dell’espressione potrebbero essere il clonaggio dei singoli domini 
oppure l’utilizzo di sistemi di espressione più sofisticati, in grado di strutturare 
correttamente la proteina. 
Poiché la formazione dei ponti disolfuro riveste un ruolo chiave anche nella virulenza 
batterica, molti batteri posseggono sistemi molecolari per l’assemblaggio delle proteine 
nel corretto stato ossidativo, tra cui anche H. pylori. L’ossidoreduttasi HPG27_1020, le 
cui procedure sperimentali sono riportate in Capitolo VI, è una proteina con 
un’organizzazione simile alla tioredoxina che riveste un ruolo cruciale nella maturazione 
del citocromo c, così come nell’assemblaggio corretto di proteine ossidate. Perciò, questa 
proteina fornisce funzioni essenziali per H. pylori e rappresenta un possibile target 
farmacologico. Poiché la regione N-terminale codifica un segnale di secrezione, la 
proteina è stata clonata come proteina ricombinante con un 6-His-tag e mancante dei 24 
amminoacidi N-terminali. HPG27_1020 ricombinante è stata espressa con successo in 
cellule di E. coli, mostrando una quantità significativa di proteina nella frazione solubile 
(circa il 60%). Però le ricerche sono state obbligatoriamente interrotte, in quanto nel 
frattempo è stata determinata e pubblicata la struttura dell’ossidoreduttasi da H. pylori 
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26695, cioè HP0377. Poiché la loro sequenza amminoacidica presenta un elevato grado 
di identità (96%), le indagini sono state considerate non più innovative. 
Nel Capitolo VII sono descritti il clonaggio, l’espressione, la purificazione e le prove di 
cristallizzazione per quanto riguarda due “proteine ipotetiche” secrete, cioè HPG27_1030 
e HPG27_1117. Recentemente numerose proteine secrete sono state identificate tramite 
analisi proteomica del secretoma di H. pylori; queste rappresentano interessanti soggetti 
di indagini strutturali e funzionali, poiché potrebbero mediare importanti interazioni tra 
ospite e patogeno e, quindi, concorrere come potenziali target per lo sviluppo di antibiotici 
e vaccini. HPG27_1030 è stata clonata con successo come proteina ricombinante con 
un 6-His-tag, espressa in cellule di E. coli e purificata tramite due passaggi cromatografici. 
È stato possibile ottenere una quantità molti rilevante di proteina solubile, questa ha 
esibito un’elevata instabilità in soluzione e una chiara tendenza all’aggregazione, 
portando perciò a una limitata concentrazione finale di campione purificato per le prove 
di cristallizzazione. HPG27_1117 è stata clonata, espressa e purificata come riportato 
sopra. I limiti più rilevanti che sono stati incontrati sono una bassa resa di espressione e 
la tendenza alla degradazione del campione. Nonostante ciò, la proteina purificata è stata 
concentrata per le prove di cristallizzazione e sono stati ottenuti cristalli utilizzando il 
metodo di diffusione di vapore; ma questi hanno diffranto ad una risoluzione troppo 
limitata e non è stato possibile ottenere cristalli di qualità adatta per le misure di 
diffrazione a raggi X. Per superare il problema comune dell’instabilità e della 
degradazione di queste proteine secrete, cambiamenti nella composizione dei tamponi 
di purificazione potrebbe migliorare la stabilità in soluzioni e così la resa finale di prodotto 
purificato per le prove di cristallizzazione. 
In conclusione, grazie all’individuazione di alcune nuove peculiarità di questo patogeno è 
stato possibile accrescere la conoscenza in merito a H. pylori e i suoi meccanismi 
peculiari volti alla sopravvivenza e alla virulenza. Questi primi risultati costituiscono la 
base per nuove investigazioni, al fine di apprendere nel modo più completo possibile i 
meccanismi patofisiologici di questo peculiare microorganismo e di sviluppare nuovi 
trattamenti per l’eradicazione. 
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1.1 HELICOBACTER PYLORI 
 
 
Helicobacter pylori is an important and one of the most common and successful human 
pathogens. It affects approximately half of the world’s population and is responsible for 
severe gastric diseases (Fig. 1.1; Rothenbacher and Brenner 2003). It is a Gram-negative 
spiral bacterium (2.4-4 µm long and 0.5-1 µm wide) able to colonize the human stomach, 
a unique ecological niche. H. pylori has adapted itself to surviving in this unfriendly 
environment; after the first settlement that usually occurs early in life, it is able to establish 
a life-long chronic infection. 
The presence of spiral microorganisms in the human stomach was observed for the first 
time over one hundred years ago by Walery Jaworski and then was confirmed in animals 
by Giulio Bizzozero, but was 
not really taken seriously until 
the discoveries of two 
Australian scientists in the 
late XX century (Konturek 
2003). In 1983 Barry Marshall 
and Robin Warren isolated a 
curved bacillus from the 
stomach epithelium of 
patients with gastritis and 
ulcer diseases and were able 
to demonstrate a strong 
association between the 
presence of this microorganism and the finding of inflammation in gastric biopsies 
(Marshall and Warren 1984). The flagellated, spiral-shaped bacterium was initially 
classified as Campilobacter pylori, due to its curved morphology; then the name was 
changed to Helicobacter pylori, considering its structural and genetic features. Since the 
description of this bacterium and its association with gastritis and peptic ulceration shown 
by Marshall and Warren, the interest in this microorganism has continued to grow. Its 
association with the development of gastric cancer and mucosa-associated lymphoid 
tissue (MALT) lymphoma has served only to increase the interest in this area (Taylor 
1999). Moreover, the importance of relationship between H. pylori and gastric diseases 
Fig. 1.1 H. pylori bacteria and gastric cancer tissue. Adapted from National 
Geographic web site. 
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has been supported by Nobel Prize in Physiology or Medicine (Marshall and Warren, 
2005 award). 
The infection shows appreciable differences between countries and racial or ethnic 
groups, with a stronger incidence in the developing regions and a tendency to disappear 
in industrialized ones. Risk factors for H. pylori contagion include household crowding, 
low socio-economic status, country of origin and ethnicity. The family is the core unit of 
H. pylori transmission and it is usually acquired within the first few years of childhood 
(Covacci et al. 1999). The infection occurs most likely by fecal-oral, gastric-oral or 
waterborne transmission or by improperly cleaned endoscopic equipment. Indeed H. 
pylori has been found in vomitus, saliva and diarrheal stools. Colonization by H. pylori is 
specific to the stomach of humans and primates; no other natural reservoir has been 
demonstrated (De Reuse and Bereswill 2007). Once the stomach is colonized, the 
microorganism persists chronically if untreated. Subsequent infections by other H. pylori 
strains appear to be rare among European and North American population, but they are 
more common in developing countries (Frenck and Clemens 2003). However, transiently 
infecting H pylori strains, although unable to colonize, provide genetic material to the 
resident strain. Bacteria isolated from the same patient at intervals of several years have 
identical DNA fingerprints; however, continuous evolution occurs within the stomach of 
the infected person, owing to nucleotide mutations, excision of the cag-pathogenicity 
island (cagPAI), transposition of insertion elements, recombination with DNA from 
incoming strains that do not establish a chronic infection and horizontal transfer of new 
genes. 
According to several phylogeographical studies and thanks to genetic comparisons 
between human and H. 
pylori populations, it has 
been revealed that humans 
have been colonized by H. 
pylori since their migration 
out of Africa, about 100,000 
years ago (Fig. 1.2; 
Covacci et al., 1999). 
Subsequent spread of the 
bacterium all over the world can be attributed to human migratory fluxes, such as the 
prehistoric colonization of Polynesia and the Americas, the Neolithic introduction of 
Fig. 1.2 World map indicating the direction of human migrations (arrows) and time 
range (years since migrations happened). Adapted from Covacci et al., 1999. 
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farming to Europe, the Bantu expansion within Africa, and the slave trade (Falush et al. 
2003). Especially, H. pylori can be divided into seven populations and subpopulations 
with distinct geographical distributions (Tab. 1.1); they derived their gene pools from 
ancestral populations arising in Africa, Central Asia and East Asia (De Reuse and 
Bereswill 2007). Close associations between H. pylori subtypes and human 
subpopulations in one continent or even ethnic subgroups within small geographic 
regions have been detected. Therefore, studies of the population genetics of the 
microorganism can provide information about the prehistoric and modern migrations of 
human populations (Yamaoka 2009). Since H. pylori is present in populations as an 
ancestral host, this long-standing relationship suggests that the parasite could provide 
also beneficial effects. Its infection appears protective in case of esophageal diseases, 
childhood-onset asthma or rhinitis or atopic dermatitis, and other commensals 
proliferation; thus there is no advantage to eradicate H. pylori, because of development 
of drug-resistance and alteration of the balance of microbiota (Malnick et al. 2014). 
Moreover, the long permanence of each strain within the same person and the family-
linked mode of transmission suggest that the evolution of H. pylori is linked to the social 
behavior of humans. For most of history, humans have been socially organized and, 
consequently, their genetic traits segregated in the communities. It is likely that during the 
social evolution, while mutations accumulated and segregated in the human genes, a co-
segregation of the genes of H. pylori occurred (Covacci et al. 1999). A deeper 
understanding of the human-bacterium relationship is required to elucidate the role of H. 
pylori in human life and to formulate efficient preventive and therapeutic strategies.  
 
 
Tab. 1.1 An overview of H. pylori populations. Adapted from Bridge and Scott, 2013. 
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1.2 GENETIC VARIABILITY 
 
 
1.2.1 GENOME COMPARISON 
The scientific investigation of H. pylori and infection-related diseases was greatly 
promoted by the release of the genome sequences and the genetic analysis (De Reuse 
and Bereswill 2007). Complete genome sequence provides information for biological 
mechanisms, evolution, drug discovery, vaccine development. H. pylori is the first 
bacterium to have more completely sequenced genomes from unrelated strains, of which 
the first two identified were 26695 and J99. H. pylori 26695 was isolated in the mid-1980s 
in the United Kingdom from a patient with gastritis; whereas strain J99 was isolated in 
1994 in the United States from a duodenal ulcer patient. The comparison of these two 
genomes have provided a framework for understanding the level and mechanisms of 
genetic variability in this gastroduodenal pathogen (Alm and Trust 1999). Both genomes 
were sequenced using a random shotgun approach from libraries of cloned chromosomal 
fragments of ~2.5 kb. 
 
1.2.1.1 HELICOBACTER PYLORI 26695 
H. pylori 26695 genome was the first to be sequenced, in August 1997. It consists of a 
circular chromosome of 1,667,867 bp and includes 1590 predicted coding sequences 
(Fig. 1.3); these predicted genes have an average size of 945 bp, similar to that observed 
in other prokaryote, and 1091 among them were assigned biological roles. More than 
70% of the predicted proteins in H. pylori have a calculated isoelectric point (pI) greater 
than 7.0, compared to ~40% in Haemophilus influenzae and Escherichia coli. The basic 
aminoacids, arginine and lysine, occur twice as frequently in H. pylori proteins, perhaps 
reflecting an adaptation to the very acid environment of the stomach. The average content 
of G+C is 39% and five regions within the genome have a significantly different G+C 
composition. Two of them contain one or more copies of the insertion sequence IS605 
and are flanked by a 5S ribosomal RNA sequence at one end and a 521 bp repeat near 
the other. These two regions are also notable because they contain genes involved in 
DNA processing. Two distinct insertion sequence (IS) elements have been discovered. 
An insertion sequence is the simplest autonomous transposable elements and 
transposition is responsible of several consequences, among which the transfer of  
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antibiotic resistance genes. There are five full-length copies of the IS605 and two of a 
newly identified element designated IS606. In addition, there are eight partial copies of 
IS605 and two partial copies of IS606 (Tomb et al. 1997). These elements have some 
peculiar hallmarks, compared to the insertion sequences belonging to other bacteria. 
Both elements have two open reading frames (orfA and orfB) and encode two divergently 
transcribed transposases, named TnpA and TnpB. IS606 has less than 50% nucleotide 
identity with IS605 and the IS606 transposases have 29% aminoacid identity with their 
IS605 counterpart (Ronning et al. 2005). The typical eubacterial block of replication 
genes, dnaA-dnaN-recF-gyrB, hasn’t been recognized in 26695 genome sequence. The 
dnaA gene is located ~600 kb away from the dnaN-gyrB genes, while the recF gene is 
missing. The dnaC gene encoding DnaC protein, which delivers the DnaB helicase to the 
prepriming complex, is absent. Moreover, an origin of DNA replication, oriC, has not been 
precisely identified from the genome sequence. In many eubacterial chromosomes oriC 
is located close to the dnaA gene. In 26695 genome it was detected by protein-DNA 
interaction techniques and supposed to be located 1.4 Kb upstream of the dnaA gene. 
The presence of typical repeated sequences confirms the location of oriC and dnaA gene. 
Bacterial oriC consists of repeated DnaA binding motifs, named DnaA boxes, and AT-
rich regions. Five DnaA boxes have been found next to the start of the dnaA gene. 
Fig.1.3 Circular      
representation of 
the H. pylori 26695 
chromosome. Outer 
concentric circle: 
predicted coding 
regions on the plus 
strand; second 
concentric circle: 
predicted coding 
regions on the 
minus strand; third 
and fourth 
concentric circles: 
IS elements (red) 
and other repeats 
(green) on the plus 
and minus strand, 
respectively; fifth 
and sixth concentric 
circles: tRNAs 
(blue), rRNAs (red), 
and sRNAs (green) 
on the plus and 
minus strand, 
respectively. 
Adapted from Tomb 
et al., 1997. 
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Comparison of these five DnaA boxes from the putative H.pylori oriC region allowed to 
propose the consensus sequence: TT/CATTCACA (Zawilak et al. 2001). Surprisingly, in 
silico analysis allowed to identify an additional replication origin region (oriC2), separated 
from the original one (oriC1) by the dnaA gene, therefore downstream of the gene. Both 
regions are required for the initiation of H. pylori chromosome replication, which indicates 
a bipartite structure of H. pylori oriC, being the first such origin discovered in a Gram-
negative bacterium. oriC2 is bound exclusively as a supercoiled DNA, indicating the 
importance of the DNA topology in the replication initiation (Donczew et al. 2012). 
 
1.2.1.2 HELICOBACTER PYLORI J99 
H. pylori J99 genome is 24,036 bp 
smaller and contains 57 fewer 
predicted open reading frames 
(91% of the genome) than strain 
26695 (Tab. 1.2; Alm and Trust 
1999). Common features are the 
average content of G+C (both 
39%), the hard identifiable origin of 
replication, the average length of 
coding sequence, the relative 
frequency of the different initiation 
codons, the location of the strain-
specific genes. Both genomes 
present genes encoding for two 
16S and two 23S-5S ribosomal 
RNA copies in the same relative 
locations, but strain 26695 has a further, orphan gene for 5S rRNA and one structural 
RNA gene (Alm et al. 1998). Each strain contains a set of specific genes, about 6-7% of 
the entire coding capacity, which are absent from the other (89 in J99 and 117 in 26695) 
and represent a variable gene pool. In both strains almost half of these specific genes 
are clustered into one locus called hypervariable plasticity zone, which has a G+C content 
of 35%, indicating that this region contains fragments that have been acquired by 
horizontal gene transfer. This is supported by the finding that in H. pylori 26695 genome 
the plasticity region contains DNA that had previously been characterized as part of a 
General comparative features of the H. pylori genomes
Tab. 1. 2 General comparative features of the H. pylori genomes. Adapted 
from Alm et al., 1998 
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plasmid, pHPM186 (Suerbaum 2000). This region is continuous in strain J99, but is split 
into two regions in 26695. The majority (approximately 60%) of the strain-specific genes 
are also H. pylori specific. To relatively few of these strain-specific genes can be attributed 
a function (25 and 26 for J99 and 26695, respectively) with the majority (approximately 
60%) encoding DNA restriction/modification enzymes in both strains. It has been 
demonstrated that restriction/modification systems reduce the efficiency of DNA 
exchange between bacterial strains belonging to different clonal lineages. Therefore, they 
help to stabilize clonal groupings by reducing the efficiency of intraspecific transformation 
(Suerbaum 2000). Several strain-specific genes encode products that are likely to be able 
to alter the complexion of the bacterial cell envelope and subsequently may alter the 
interaction with the host immune system. 1406 genes in J99 genome have orthologues 
in 26695 genome and the extent of gene order conservation was determined by 
comparing each of the J99 genes to its orthologous 26695 partner (if present) with respect 
to its immediate neighboring gene flanking each side. Two genomes have 84.7% of their 
genes (1267 genes) preserved in the same genetic order, on both sides. There are 161 
genes (10.8%) where the gene order is disrupted on one side by the insertion/deletion of 
a strain-specific gene while maintaining the gene order on the other side. 40 genes (2.7%) 
are flanked by strain-specific genes on both sides, although only one (JHP1295) even 
possesses an orthologue in strain 26695 at all. Surprisingly, only 27 genes (1.8%) have 
the same neighboring gene on one side and are flanked on the other side by a gene 
common to both strains that is out of order due to an organizational rearrangement such 
as a translocation and/or inversion. In addition, one of the 23S-5S rRNA loci is associated 
with the plasticity zone, and is flanked by strain-specific genes in both strains. The 
average nucleotide identity for all orthologues is 92.6%. However, the average nucleotide 
identity for the orthologues with a predicted function is higher, 94.0%. Within the genes 
that have been assigned a predicted function, the genes (and corresponding proteins) 
predicted to be involved in DNA restriction and modification display the highest level of 
divergence with only 90.6% identity. Therefore, the H. pylori specific genes have the 
lowest level of identity. There were nine strings of conserved genes over 50 genes in 
length, representing 46% of the total number of common genes, with the longest being 
133 genes. The limited gene shuffling observed is consistent with a low level of 
evolutionary divergence within H. pylori. J99 genome has 14 NotI sites, compared to 7 in 
26695. All 7 of the 26695 NotI sites are also found in the corresponding orthologues in 
strain J99. Nucleotide changes in orthologous genes, which fail to affect the sequence of 
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the encoded protein, are responsible for 6 of the additional 7 NotI sites in J99 genome, 
whereas the last difference is due to a single aminoacid change (Alm and Trust 1999). 
Both genomes present more than 25 homopolymeric tracts and dinucleotide repeats, that 
can be subjected to frequent length changes due to slipped-strand mispairing. These 
repeats are identified in a subset of genes, named contingency genes, that are 
hypermutable because of slippage within DNA repeats. This mechanism results in 
frequent shifting into and out of frame (relative to the translational start), leading to an on–
off switching of the associated gene products (Saunders et al. 1998). Repeat lengths in 
some J99 genes differ from those in 26695 genes, indicating that such genes may be 
differently expressed in the two strains. This variation in gene expression facilitates 
adaptation to changing host environments (Alm et al. 1998). 
 
 
1.2.2 CORE GENOME 
Inter-strain diversity is common to many other 
bacterial species. It has been defined that a particular 
bacterial species presents a core set of genes, named 
core genome, and some auxiliary genes. The core 
genome contains genes that are common to all or 
nearly all of the strains. It determines the properties 
that are characteristic of that species. The auxiliary 
genes are present in some strains; they are 
determinants of the biological properties unique to 
some of the strains. The core genome of H. pylori was 
firstly investigated by Nina Salama in 2000 and was found to be composed by 1281 genes 
(Salama et al. 2000). Since a limited number of H. pylori strains was considered and they 
were only isolated from Western individuals, the core set of genes was again examined 
by Helga Gressmann in 2005 and it consist of 1111 genes, based on 56 representative 
H. pylori strains. In 2011 data were revised by Edgard Eduardo Lara-Ramírez, using new 
bioinformatics tools, and the core genome was found to be composed by 1186 genes 
(Fig. 1.4; Lara-Ramírez et al. 2011). By sequence analysis it has been detected that core 
genes are located in potential genome rearrangement sites, in the hypervariable plasticity 
zone and in the cagPAI. The auxiliary set of genes in H. pylori amounts to 22%-27% of 
the genome and they encode for functionally unknown proteins, cag proteins, outer 
Fig. 1.4 Sketch map of core genome for 
protein-coding genes. Adapted from Lara-
Ramírez et al., 2011. 
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membrane proteins and proteins of DNA metabolism (Dong et al. 2009). Furthermore, in 
H. pylori genome species-specific genes can be detected. H. pylori is classified into the 
Epsilon subdivision of Proteobacteria, as well as Helicobacter hepaticus, Campylobacter 
jejuni, Wolinella succinogenes. The availability of the sequenced genomes has led to 
define species-specific genes as well as genes exchanged and shared by members of 
this bacterial group. Whole genome clustering of H. pylori and C. jejuni demonstrated that 
648 H. pylori genes are species-specific. The fact that most of the strain-specific genes 
are species-specific supports the assumption that genes of the flexible gene pool are 
exchanged among Helicobacter species, but are not transferred to bacteria of other genus 
(De Reuse and Bereswill 2007).   
 
 
1.2.3 MECHANISMS GENERATING GENETIC VARIABILITY 
Concluding, H. pylori appears unique among bacteria regarding the diversity between 
strains. Nowadays several H. pylori genomes have been sequenced and have revealed 
significant differences each other in size, nucleotide sequence, protein and gene 
arrangement. The most unusual feature of this diversity is the very high number of unique 
nucleotide sequences for every gene. Most of these heterogeneities are clustered in the 
hypervariable plasticity zone. This heterogeneity can be analyzed at two different levels: 
genotypic variation among strains and variations in H. pylori populations within an 
individual host. Corresponding alleles in different H. pylori strains typically present an 
average identity in nucleotide sequence of 92 to 99%, but several genes exhibit a much 
higher level of genetic diversity. In addition, there is considerable variation among strains 
in gene content (McClain et al. 2009). Strain-specific genetic diversity is involved in 
adaptation to the changing microenvironment and to the individual hosts, 
microorganism’s ability to establish a lifelong chronical infection and to cause different 
diseases. Despite this diversity, there is a great deal of conservation of proteins; the 
presence of such a great degree of homology among open reading frames present in 
different strains suggests that the key cellular processes, including DNA replication, are 
conserved among these strains (Nitharwal et al. 2011). The high level of genetic diversity 
in H. pylori strains is probably the consequence of multiple factors, including a high rate 
of mutation, a high rate of intra-species genetic recombination, a long evolutionary history. 
Vertical genetic transfer mechanisms are the most frequent. Point mutations, DNA 
rearrangement, as insertions, deletions or inversions of genes and intergenic regions, 
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provide mechanisms to adapt to unfavorable conditions. Genetic diversity can arise also 
by acquisition of heterologous DNA from other species. There are several areas of H. 
pylori genome, including the plasticity zones, the cagPAI and several DNA 
restriction/modification genes, which significantly differ in G+C content from the 
remainder of the genome (Alm and Trust 1999) and attest events of horizontal transfer of 
genetic materials. The inter-strain diversity of H. pylori is extended by plasmids, that are 
involved in the same phenomenon of horizontal transfer, by sequence changes affecting 
phase-variable genes, in which mutations can modulate gene expression, and by 
insertion sequences, that act as small transposable elements. 
 
 
1.2.3.1 MUTAGENESIS 
Owing to their haploid genotype and mode of replication, bacteria are by default clonal; 
genetic diversity firstly occurs by sequential acquisition of mutations. The spontaneous 
mutation rate of the majority of H. pylori strains lies between 10-5 and 10-7 (Björkholm et 
al. 2001); thus, it is several orders of magnitude higher than the average mutation rate of 
E. coli. The bacterial chromosome is exposed to mutagenic effects at all times, such as 
alkylation or oxidation of single nucleotides resulting in mispairing. These damaged 
nucleotide bases can be removed by a number of repair mechanisms, involving different 
glycosylases and endonucleases. Most of the information about DNA repair mechanisms 
in H. pylori is deduced from the two completely sequenced genomes of strains 26695 and 
J99. Damaged bases can be repaired by glycosylases that belong to the base excision 
repair pathway. All glycosylases can excise a damaged base resulting in an 
apurinic/apyrimidinic site, while some of them additionally nick the DNA 
deoxyribosephosphate backbone through an apurinic/apyrimidinic lyase activity. Finally, 
the gap is refilled by the action of RecJ, polymerase I and ligase (Krokan, Standal, and 
Slupphaug 1997). The H. pylori chromosome contains orthologues of the glycosylase 
genes ung, nth, mutY and magIII, whereas several other genes that protect the 
chromosome of E. coli from mutational influences appear to be absent (some examples 
are tag, alkA and mutM). H. pylori nth gene encodes the endonuclease III enzyme, which 
removes oxidized pyrimidine bases and also displays apurinic/apyrimidinic lyase activity. 
Initially magIII gene was also annotated as an endonuclease III, but later shown to encode 
an unusual 3-methyladenineDNA glycosylase that protects H. pylori from the effect of 
alkylating agents, but lacks apurinic/apyrimidinic lyase activity. Repair pathways 
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recognizing mismatches in the double-helix structure (such as mutH, mutS, mutL, 
belonging to the methyl-directed mismatch repair system) were absent from the H. pylori 
genome (Alm et al. 1998). This evidence suggests that H. pylori has a less stringent 
control of replicative errors and explains the higher mutation rate. However, the H. pylori 
genome contains a gene with weak homology to the E. coli mutS gene, but it was 
demonstrated that it belongs to the mutS2 subfamily, that usually have no function in 
methyl-directed mismatch repair system; its major role is to repair oxidative DNA lesions, 
particularly 8-oxoguanine (Wang et al. 2005). Furthermore, H. pylori, like other bacterial 
species that include Campylobacter jejuni and Helicobacter hepaticus, uses 
hypermutable homopolymeric or dinucleotide repeat sequences to control gene 
expression. Such mutations which occur at a very high frequency can switch genes on 
and off, if the repeats are located within coding regions, or affect gene regulation by 
changing promoter activity. Many repeats are located in genes important for survival, such 
as the flagellar gene fliP, or for adaptation to the individual human host, such as 
lipopolysaccharide biosynthesis genes, restriction/modification systems, composition of 
the antigenic structure of outer cell surface (Kraft and Suerbaum 2005). The best studied 
examples of the phase-variation phenomenon are the fucosyltransferase genes, involved 
in the final stages of lipopolysaccharide biosynthesis. The two copies of the α-1,3 
fucosyltransferase genes and the single copy of the α-1,2 fucosyltransferase gene in H. 
pylori are involved in the synthesis of Lewis X and Y antigens of lipopolysaccharide, and 
may contribute to antigenic mimicry and autoimmune disease. There is a long 
homopolymeric C tract in the 5’ coding region of each of the four H. pylori α-1,3 
fucosyltransferase genes and in the central domain of the α-1,2 fucosyltransferase gene. 
The serotype of lipopolysaccharide-phase variants is correlated with the varying length of 
the homopolymeric tract (Alm and Trust 1999). Phase-variation provides a fast and 
effective possibility to react to environmental changes and to alter the appearance of the 
micro-organism to the host immune system. Finally, the H. pylori genome contains 
numerous repetitive sequences of different lengths that permit intra-genomic deletions or 
rearrangements. It was demonstrated that the deletion of fragments between repeats of 
up to 100 bp was RecA-independent and that deletion frequencies increased with the 
increasing length of the repeats; exemplificative genes include cagY and cagA, located 
on the cagPAI, as well as aimA, encoding an amidase involved in peptidoglycan 
biosynthesis, and genes involved in the fucosylation of lipopolysaccharide (Suerbaum 
and Josenhans 2007). Another mechanism to generate genetic variability in H. pylori is 
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provided by the insertion sequences (IS), as result of their translocation. They are 
segments of DNA that can move from one position on a chromosome to a different 
position on the same chromosome or on a different chromosome; they encode proteins 
implicated in the transposition activity, such as transposase and regulatory proteins. In 
bacteria transposition is a relevant phenomenon, because is also responsible for the 
emergence of antibiotic resistance; as can be evidenced, transposable elements can 
carry antibiotic resistance genes. In H. pylori more insertion sequences have been 
discovered; the first two identified are IS605 and IS606, which are present in one-third of 
tested strains (Kersulyte et al. 1998). Insertion sequences can be classified into families 
based on the general features of their DNA sequences and associated transposases; 
IS605 and IS606 belong to the widespread IS200/IS605 bacterial family. This group 
differs from classical insertion sequences, because its members transpose using 
obligatory single-strand DNA intermediates, instead of double-strand ones, and because 
they carry subterminal palindromic structures, instead of inverted repeats, and insert 3’-
end to specific AT-rich tetra- or penta-nucleotide sequences, without duplicating (or 
deleting) the target site (He et al. 2015). Other members of this family identified in H. 
pylori are also IS607, IS608 and IS609. Another peculiarity of these IS elements is their 
chimeric feature, because they contain two transposition-related genes (orfA and orfB, 
with orfA upstream of orfB), which encode for two transposase (TnpA and TnpB, 
respectively). Exception is IS609, which encode for two additional open reading frames 
(orf1 and orf2, besides orfA and orfB,), whose function is unknown. The IS200/IS605 
family elements can be divided into two subfamilies, based on orfA homologies. In one 
subfamily, including IS607, orfA encodes a putative serine recombinase; in the other 
subfamily, including IS605, IS606 and IS608, orfA encodes a transposase homologous 
to that encoded by IS200 in E. coli, whose product is distinct from serine recombinase 
proteins (Kersulyte et al. 2004). On the other side, orfB shows strong homology with the 
putative gene of IS1341, that is evidenced in Gram-positive species. Transposition plays 
an important role in genomic evolution and facilitates the horizontal transfer of genetic 
material. It is also responsible for gain of advantages by bacteria; emergence of antibiotic 
resistance is the most common. 
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1.2.3.2 RECOMBINATION 
Additionally, recombination after natural transformation plays a key role in generating 
allelic diversity in H. pylori populations. This microorganism presents a natural 
transformation competence for uptake of exogenous chromosomal or plasmid DNA. H. 
pylori is able to differentiate between homologous and heterologous DNA and will not 
integrate DNA from other Helicobacter species, or other genera into its chromosome. The 
only known exception is the successful transformation with DNA from the related species 
Helicobacter acinonychis, the phylogenetically closest relative of H. pylori. Uptake of 
genomic DNA from the same strain was one to two logs more efficient than uptake of 
DNA from an unrelated H. pylori strain (Kraft and Suerbaum 2005). Chromosomal DNA 
uptake is mediated by a transport system related to the type 4 secretion system (T4SS), 
named the ComB system. This conjugative apparatus consists of a  nearly complete  set  
of  T4SS  components  with  a  similar  gene cluster organization, which were named 
according to their orthologous proteins of the Agrobacterium tumefaciens VirB/VirD4 
system, considered the prototype for type 4 secretion. The ComB system presents all 
T4SS core components, except for the homologues to VirB1, VirD4, VirB5 factors, as well 
as VirB11 ATPase (Karnholz et al. 2006). Also the uptake of plasmid DNA, by a 
conjugative mechanism, contributes to the genetic variability. Many H. pylori strains carry 
cryptic plasmids, that differ in size (from 2 to 100 Kb) and in gene content. The smaller H. 
pylori plasmids encode for an origin of replication, replication genes (repA or repB) and, 
occasionally, a small open reading frame, with unknown function. The larger ones carry 
a number of additional ORFs with unknown function (Fernandez-Gonzalez and Backert 
2014). The uptake of plasmid DNA is restricted by an inter-strain transformation barrier. 
In fact, most strains of H. pylori contain a large number of restriction/modification systems 
(RM systems), described as a defense strategy against invasion by foreign DNA. Many 
of these are pseudogenes and predicted to be inactive. Most restriction/modification 
genes predicted to be functional are only found in selected H. pylori strains. According to 
the variable number of these genes, H. pylori chromosomal DNA shows highly variable 
restriction patterns when digested with methylation-sensitive restriction endonucleases. 
The large number of RM genes homologous to those in other bacterial species and their 
strain-specificity suggest that H. pylori may have horizontally acquired these genes. 
Furthermore, the large amount of these genes (approximately 3% of the genome), their 
maintenance in the genome, and their association with genomic rearrangements are 
consistent with the proposal that these systems can act as selfish genetic elements (Alm 
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and Trust 1999). The barrier to transformation with heterologous plasmid DNA is related 
to the number and activity of the RM systems present in the H. pylori strain. HpyII, a type 
IIs RM system, has been demonstrated to present a barrier to uptake of chromosomal 
DNA fragments > 1 Kb from unrelated donor strains (Aras 2002). Additional genes that 
have been shown to be involved in transformation competence of H. pylori include dprA, 
comE3, comH, the nuclease nucT, a VirB4 homolog, HP0017, and genes HP0015, 
HP1089, HP1424 and HP1473, which were identified in a large-scale transposon shuttle 
mutagenesis screen, but their function is still unknown (Kraft and Suerbaum 2005). 
Exogenous DNA must be integrated into H. pylori chromosome by homologous (or site-
specific) recombination or replicated as plasmid. Thus, homologous recombination is 
essential for bacterial evolution and genome plasticity and, at the same time, it helps to 
maintain genetic barriers between species by selecting for DNA with sufficient homology 
(Fischer, Hofreuter, and Haas 2001). The unusually short length of imported fragments 
of foreign DNA together with the high frequency of recombination leads to mosaic 
structures and finally to unique alleles of each gene and therefore to unique strains 
isolated from every patient (Kraft and Suerbaum 2005). The mechanisms of 
recombination repair have been intensively studied in E. coli. Two homologous 
recombination initiation pathways coexist in E. coli: the RecBCD pathway is essential for 
the repair of double-stranded DNA breaks and for resolving regressed forks; the RecFOR 
pathway is needed for post-replication gap repair and for replication restart after UV 
damage (Kuzminov 1999). These initiation pathways metabolize the DNA break to 
generate single-stranded DNA on which the recombinase RecA is loaded and 
cooperatively forms a nucleoprotein filament. The filament is then aligned with a 
homologous duplex and promotes strand exchange. The product of this reaction is a 
branched DNA molecule, named the Holliday junction, that is processed by the RuvABC 
complex (Orillard et al. 2011). From the sequenced H. pylori genomes it has been 
possible to detect only a limited amount of genes related to recombinational repair, 
including a RecA homologue. This H. pylori recombination enzyme is required for DNA 
pairing and homologous strand exchange; it plays a key role because a recA-negative 
mutant is almost deficient in recombination and recombinational repair and exhibits 
reduced acid tolerance, resistance to UV radiation, and increased susceptibility to 
metronidazole. Moreover, RecA is subjected to posttranslational modifications; mutants 
that produce unmodified RecA maintain transformation competence and resistance to UV 
light and acid, but show an increased susceptibility to metronidazole(Kraft and Suerbaum 
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2005). Despite the limited number of genes related to recombinational repair, both 
pathways can be identified in H. pylori. An AddAB class of helicase-nuclease enzymes, 
related to the E. coli RecBCD, was demonstrated to be functional in H. pylori. By 
bioinformatics analysis a novel RecO orthologue was identified (Marsin et al. 2008), 
suggesting the presence of the RecRO pathway in H. pylori. Whereas the RecO protein 
can displace ssDNA-binding protein and bind to ssDNA, RecR is the key component for 
loading RecA onto ssDNA (Wang, Leja, and Maier 2011). Even genes coding for 
homologs of ruvABC, involved in the Holliday junctions formation, are present in H. pylori; 
it was demonstrated that a ruvC mutant lacking the Holliday junction resolvase was 
unable to establish chronical infection in a mouse model (Robinson et al. 2005). This 
finding remarks the role of genetic variation on bacterial fitness and adaptation. 
 
 
1.2.4 HELICOBACTER PYLORI AS A “QUASI SPECIES” 
A large study comparing mutation and recombination rates between different pathogenic 
bacteria confirmed that H. pylori stands out as the bacterial species with the highest 
population recombination rate (Suerbaum and Josenhans 2007). Moreover, genetic 
evolution occurs even during the colonization of the host, a phenomenon named 
microevolution. H. pylori exhibits substantial genetic diversity among bacteria that 
colonize human tissues. Genetic rearrangement and recombination events may occur 
among H. pylori strains during chronic infections in different parts of the gastric tissue. 
These genetic variations, mainly recombination between different superinfecting strains, 
can lead to development of diverse H. pylori strains in a single host. Several studies 
indicated that mixed H. pylori infections may occur in single individual (Farzi et al. 2015). 
Thanks to its high genetic variability, H. pylori was recognized as a “quasi species”, that 
is a well-defined distribution of mutants that is generated by a mutation-selection process 
(Nowak 1992). Its population structure appears to be clonal only over a short period of 
time after infection, due to frequent recombination; thus, it has a quasi-panmictic feature. 
A Bayesian mathematical model predicted that up to 50% of the genome of an H. pylori 
strain could be exchanged by recombination over four decades of infection. Furthermore, 
the large amount of hypermutable genes leads to differ each large H. pylori population in 
many subpopulation, with a specific combination of active and inactive phase-variable 
genes; the term “quasi species” explains also this phenomenon (Suerbaum and 
Josenhans 2007). Genetic variation of H. pylori during chronic colonization has been 
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extensively investigated, using either sequential strains, isolated from patients during 
repeated endoscopies, or multiple isolates taken from one or multiple locations in the 
same stomach (Suerbaum and Achtman 2004). Dangeruta Kersulyte in 1999 was the first 
to demonstrate the presence of recombinant exchanges between two H. pylori strains 
during mixed infection in the stomach of a single patient from Lithuania. Some strains 
from the patient possessed the cag pathogenicity island, while others lacked it; this 
evidence resulted from transfer of DNA from a cag- strain and following homologous 
recombination (Dangeruta Kersulyte, Chalkauskas, and Berg 1999). H. pylori genetic 
diversity is investigated by several methodologies; some of them are genotyping (Chiurillo 
et al. 2013), plasmid profiling (S. I. Smith et al. 2002), Repetitive Extragenic Palindromic 
PCR (rep-PCR; Kidd et al. 2001), Amplified Fragment Length Polymorphism analysis 
(AFLP; Kuipers et al. 2000), Random Amplification of Polymorphic DNA (RAPD; Farzi et 
al. 2015), microarray analysis (Salama et al. 2000), Multilocus Sequence Typing (MLST; 
Gunaletchumy et al. 2014). These researches confirm the high recombination rate in vivo 
and the exchange of genetic material with transient superinfecting H. pylori or other 
bacteria. Furthermore, frequent genetic variations have important implications in 
pathogenesis; the high variety in clinical outcomes of H. pylori infection in different 
individuals suggests a correlation between strain specific properties and their pathogenic 
effects. Genotyping based on important H. pylori virulence factors, such as cagA, vacA 
(s1/2, m1/2), iceA (A1, A2), recA, provides information on pathogenic diversities and clinical 
outcomes (Farzi et al. 2015). 
 
 
1.2.5 CLASSIFICATION OF HELICOBACTER PYLORI STRAINS 
On the basis of the variability of the virulence factors, H. pylori strains have been grouped 
on two broad families: type I and type II strains; this classification permit to distinguish 
more virulent population from less virulent ones. In fact, type I strains are characterized 
by expression of cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA) 
aggressive variant and by vacuolating activity; instead type II strains lack cagA gene and 
vacuolating activity, although VacA non toxic variants have been found in the 
chromosome (Covacci et al. 1997). Other discriminative feature is the presence of the 
cag-pathogenicity island (cagPAI), which encodes for virulence factors unique to H. Pylori 
strains, including CagA, and is found only in type I strains. The virulence associated with 
this chromosomic region can vary because of the splitting of cagPAI, in cagI and cagII, 
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by insertion of an IS605 sequence (Fig. 1.5; Orodovsky, Appuoli, and Ovacci 1996). Type 
II strains lack cagPAI and IS605 sequences. As evidence, only type I strains have been 
observed to be involved in severe gastroduodenal diseases. Clearly, pathogenicity of H. 
pylori cannot be due 
only to VacA and 
cagPAI genes, among 
which CagA gene; other 
functions and relative 
differences in both type 
strains have been 
investigated, such as 
mechanisms of 
adherence (Su et al. 
1998), interactions 
between pathogen and 
immune response of 
the host (Maria et al. 2011), effects on gastric cells (Kawahara et al. 2001). Moreover, 
allelic polymorphism of the most important virulence factors, that are VacA and CagA, is 
evaluated to classify H. pylori strains and expect the pathogenic consequences of a 
population; vacA+ and cagA+ strains are the most virulent and cause severe diseases. A 
further level of polymorphism of vacA and cagA lies on multiple alleles of these genes, 
which show differences in the sequence and can be present or not. This variety results in 
toxins with varying degrees of virulence (Bridge and Scott Merrell 2013).  
  
Fig. 1. 5 Evolutionary tree that describes the hypothetical emergence of H. pylori type 
I as a result of an event of gene conversin (PAI acquisition). Presumably, it is only after 
the integration of an IS605 that subpopulations of intermediate strains with attenuated 
virulence are differentiated. cag retention is indicated by arrows. Type II strains are 
distinguishable from type I strains with a complete cag deletion by the absence of 
IS605. Adapted from Orodovsky et al., 1996. 
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1.3 EPIDEMIOLOGY 
 
 
Bacteria are diffused everywhere on Earth, in soil, water, air and also in bodies of humans 
and animals. Every mucosal and cutaneous surface of the human body is colonized by 
microbes, overall named microbiota. Most of these microorganisms are not harmful for 
the host; on the contrary, they also perform useful functions and participate to maintain 
health of the human. A classical exemplification is the intestinal flora, which is the largest 
bacterial ecosystem of the human body and consists in a wide variety of microorganisms. 
Instead, the stomach is inhabited by a little amount of microbes (mainly Streptococcus, 
Staphylococcus, Lactobacillus, Peptostreptococcus and types of yeast; Willey et al. 
2011), usually transient, due to the very acidic environment; only H. pylori is able to 
establish a chronic colonization and, when present, is numerically predominant on other 
microorganisms. H. pylori is one of the most common human pathogens and 
approximately 50% of the world’s population is infected, reaching up to 90% in developing 
countries. The prevalence of infection varies widely, depending on geographic area, age, 
race, ethnicity and socio-economic status; as can be demonstrated, it is higher in 
developing countries, because of poor socio-economic conditions, crowding and lack of 
hygienic practices. The infection is acquired early in childhood and transmission probably 
occurs by person-to-person passage; also unclean water sources seem to be implicated 
in infection transmission. Humans are the main reservoir; but H. pylori has been found to 
colonize also the stomach of some animals, particularly those living in a human 
environment, for example cows, sheep, goats (Momtaz et al. 2014). However, the 
possibility of zoonotic transmission has to be further investigated. 
 
 
1.3.1 INCIDENCE AND PREVALENCE OF HELICOBACTER PYLORI INFECTION 
H. pylori infection is ubiquitous and infects both males and females. The role of gender 
as risk factor is still debated, although some studies demonstrate a male predominance 
in H. pylori infection and occurrence of related diseases in adults; such predominance is 
not confirmed in children (de Martel and Parsonnet 2006). The infection occurs worldwide, 
but there are significant differences in the prevalence of infection between countries and 
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also between different regions of the same country (Fig. 1.6). In general, the prevalence 
 
Fig. 1. 6 Mean prevalence of infection with H. pylori in adults. Adapted from Parkin, 2006 
of the infection is higher in developing countries than in developed ones, because of the 
poor socio-economic status and overcrowded conditions (Bardhan 1997). The prevalence 
of H. pylori infection in a community is related to three factors: firstly, the rate of acquisition 
of infection with H. pylori (that is the incidence); secondly, the rate of loss of the infection; 
thirdly, the prolonged persistence of the bacterium in the gastroduodenal mucosa 
between infection and eradication. Variation in the prevalence of H. pylori is mainly 
attributed to the great differences between communities in the rate of acquisition of H. 
pylori in childhood, under the age of 10 years (Pounder and Ng 1995). Over this age, 
however, the rate of acquisition of infection in both countries is similar, in the order of 
0.5% to 2% per annum (Mitchell 1999). The pattern of infection is an early childhood 
acquisition of H. pylori (30%-50%, by the age of 5 years), that reaches over 90% during 
adulthood in developing countries. On the contrary, the infection in developed countries 
is less common in young children (10%-20%)  and reaches up to 60% in older ages (Fig. 
1.7; Salih 2009). This different trend and the observation of the decreasing of the infection 
rate in the developed countries during the past few decades suggest that H. pylori 
acquisition and related diseases are a birth cohort-related phenomenon (Sipponen 1995). 
All individuals are infected in childhood and the decreased levels of H. pylori infection 
associated with younger age groups, particularly in developed countries, are due to 
gradual improvements in medical care, sanitation, alimentation and living conditions; 
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older individuals may have been born in periods 
when risk of infection was greater. 
Nevertheless, the acquisition of H. pylori is 
decreasing in developing countries at a slower 
rate than in developed ones and  the 
prevalence of the infection remains still high; 
the risk of acquisition can be minimized by 
implementation of household hygiene, boiling 
water for drinking purposes and proper cleaning of vegetables (Salih 2009). 
The rate of H. pylori infection depends not only on socio-economic status or hygienic 
practice. Marked differences in the prevalence were observed and reported among 
various ethnic and racial groups. For example, in Malaysia, the increased risk of H. pylori 
infection in Chinese and Indians was suggested as an inherent ethnic genetic 
predisposition (Goh 1997). In New Zealand, ethnicity was suggested as a risk factor 
among different groups in the populations. H. pylori infection was most prevalent in Pacific 
Islanders, intermediate in Maori, and least prevalent in Europeans (Fraser et al. 1996). 
On the contrary, in a study conducted in USA, the prevalence of H. pylori infection was 
almost identical between Hispanic and African Americans, but significantly higher than 
that among Caucasians. However, ethnicity was ruled out as a major factor and the 
observed variance was attributed to socioeconomic conditions. Additionally, a study of 
monozygotic and dizygotic twins (Malaty et al. 1994) suggested also that genetic factors 
might have some influence on the incidence of H. pylori infection (Khalifa, Sharaf, and 
Aziz 2010). Therefore, also ethnic and genetic predispositions have a relevant role in the 
occurrence of H. pylori infection.  
 
 
1.3.2 SOURCE AND TRANSMISSION 
The sources and the mode of transmission of H. pylori is one of the most controversial 
topics in the investigation about this pathogen. Transmission mainly occurs by person-to-
person passage and the failure to consistently isolate from reservoirs other than humans 
confirms this hypothesis. Besides the well-known reservoir of H. pylori, the human 
stomach, several other potential sources of infection have been highlighted (Mégraud and 
Broutet 2000). The possibility that H. pylori may be a zoonosis first arose following 
seroepidemiological studies that showed the significantly increasing prevalence of H. 
Fig. 1.7 Prevalence of H. pylori by age in developing 
and developed countries. Adapted from Logan and 
Walker, 2012. 
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pylori infection in abattoir and meat workers increased, as compared with that in subjects 
not involved in handling animals or animal products (Vaira et al. 1988). These evidences 
have subsequently been debated, because the increased prevalence in these workers 
may have resulted from cross-reactivity between H. pylori and antibodies to other 
gastrointestinal microorganisms, such as Campylobacter jejuni (Vaira et al. 1988). 
Historically pigs were the first animal from which at the beginning of 1990s H. pylori were 
detected, from the stomach of a laboratory pig. But all the subsequent studies of this 
bacterium in pigs failed and the microorganism described the first time was probably 
Helicobacter suis (Grasso et al. 1996). A high prevalence of H. pylori was evidenced in 
Sardinian shepherds (M. Dore et al. 1999), a prevalence significantly higher than that in 
their family members, who did not have regular contact with sheep and blood donors. 
Subsequently H. pylori was isolated from the milk of sheep, suggesting sheep as 
ancestral host (M. P. Dore et al. 1999). Houseflies can act as vector to transmit pathogens 
from feces to food. In 1997 caged houseflies were exposed to freshly grown H. pylori o 
agar plate; it was possible to isolate the bacterium from the external surfaces of the flies 
and from gut and excreta (Grübel et al. 1997). But the evidence that H. pylori couldn’t be 
recovered from houseflies fed human feces infected with the bacterium, suggests that the 
domestic housefly is neither a vector for transmission nor a reservoir for H. pylori (Osato 
MS, Ayub K, Le HH, Reddy R 1998). Furthermore, H. pylori was identified also in pets, 
but the relationship between pet owner and the prevalence of the infection is not 
adequately demonstrated. In particular, in 1994 the bacterium was isolated from the 
stomach of laboratory cats (Handt et al. 1994). These data suggest felines as reservoir 
of H. pylori; but the reliability of this hypothesis is questionable, because these cats were 
commercially bred and were maintained in isolation. Additionally, H. pylori can be isolated 
also from rhesus monkeys (Handt et al. 1997); but, given the rare contact between 
humans and monkeys, they can’t represent an important reservoir for H. pylori. In 
conclusion, any animal reservoir was confirmed and supported by convincing results; 
therefore, human stomach remains the unique proven source. 
Another potential reservoir for H. pylori is the water and objects in contact with it, such as 
food, vegetables, bathing (Hopkins et al. 1993). Studies employing microbiological 
techniques have demonstrated that H. pylori is able to survive when introduced into water 
and that it is present in water and other environmental samples all over the world. 
Epidemiological studies have shown that water source and exposures related to water 
supply represent risk factors for infection (Bellack et al. 2006). In 1984 Barry Marshall 
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himself drank a culture of H. pylori, to prove water as source of infection and to 
demonstrate that the bacterium is able to infect a healthy person and cause gastritis. As 
evidences in favor of water as source of infection, some epidemiological studies were 
carried out in developing countries. As first example, Peruvian children, whose homes 
had an external water supply, were found to be three times more likely to be infected with 
H. pylori than children whose homes had an internal water source (Klein et al. 1991). In 
a second study, in Colombia, acquisition of H. pylori in children was evidenced to be 
associated with swimming more than one time per year in rivers, streams and ponds and 
drinking stream water (Goodman et al. 1996). Nevertheless, in Southern China, despite 
the practice to boiling water prior to consumption in the majority of subjects, the 
prevalence of H. pylori infection still remains high (Mitchell et al. 1992). Findings as the 
last and the unsuccessful attempts to culture H. pylori from the water samples lead to a 
controversial survival of the bacterium in the environment, especially in water. It was 
supposed that H. pylori, when exposed to adverse environmental stimuli (such as also 
increased oxygen tension, extended incubation, exposure to antibiotics), takes a viable 
but not-culturable coccoid form (Bode, Mauch, and Malfertheiner 1993). Specifically, the 
coccoid form of H. pylori can be classified in two types: the first one is a degenerative 
form, pyknotic, not-culturable, as result of cell death of H. pylori, in which the cell 
membrane is disintegrated, but gene material can be detected by PCR in water supplies; 
the second one is a viable but in any case not-culturable form, potentially virulent (it 
preserves some virulence factors, such as cagA gene, flagellum-mediated motility, 
adhesion property, urease activity; She et al. 2003), likely able to colonize and induce 
inflammation in experimental animals (Andersen and Rasmussen 2009). But the 
possibility of the transformation of the coccoid form in the virulent and infective spiral one 
in human stomach is not confirmed; therefore, the feasibility of the infection through the 
coccoid form is debated (Duś et al. 2013) and more probably this shape represents an 
early stage of bacterial death. In conclusion, therefore, despite extensive studies about 
potential environmental sources of H. pylori, no significant reservoir was identified 
besides the human stomach, the unique proven source. This evidence is supported by 
analysis of the genome sequence of H. pylori, which shows that this bacterium does not 
possess the full complement of enzymes required for an exclusive aerobic or anaerobic 
metabolism (Tomb et al. 1997) and consequently its ability to survive in natural 
environments appear less likely. 
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Given the unsuccessful attempts to isolate the bacterium from other reservoirs, the direct 
person-to-person contact appears to be the most likely route of transmission. Ingestion 
of bacteria is the main mean of acquisition and it occurs by one or a combination of three 
modes: oral-oral, gastro-oral or fecal-oral, but the determination of a dominant route is 
complex. Close personal contact is fundamental for the spread of the bacterium. This 
evidence explains the acquisition of the bacterium early in childhood, especially between 
family members (Kivi et al. 2005). The latter is favored by overcrowded conditions in the 
developing countries, where the infection rate in children is higher than in the developed 
ones. In familial transmission, the mother plays the key role. As evidenced in a Japanese 
investigation, mother-to-child transmission is suggested as the most probable route of 
transmission of H. pylori; the fingerprint patterns were found to be identical to those of at 
least one family member in 76% of the children, with an higher rate of identity in the case 
of the mother’s patterns, compared with those of father (Konno et al. 2008). Furthermore, 
the prevalence of H. pylori infection is significantly increased in family members of 
children infected by H. pylori, compared with that in family members of not infected 
children (Miyaji et al. 2000). Intra-familial or vertical transmission occurs more commonly, 
but also horizontal transmission is evidenced, mainly in the case of institutionalized 
populations. Several studies were carried out about the infection rate in these 
populations. One of the first was performed in Austrian patients to evaluate the 
prevalence of H. pylori antibodies in mentally and physically handicapped adults living 
together in a long-term care facility; as could be evidenced, institutionalized patients 
showed a higher prevalence (75%) of H. pylori, compared with controls from the general 
population (Lambert et al. 1995). Given the location of H. pylori infection and the basic 
requirement of this bacterium for in vivo proliferation, ingestion appears to be the most 
likely means to acquiring the bacterium. H. pylori reaches the oral cavity via the oral-oral, 
gastro-oral or fecal-oral route; it was evidenced that it was possible to isolate and cultivate 
the microorganism from saliva (Goosen et al. 2002), vomitus (Leung et al. 1999) and 
feces (Mapstone et al. 1993). But, especially in the case of attempts to culturing H. pylori 
from feces and oral cavity, the results are hard to be clearly evidenced, because of the 
presence in these sites of the resident microbiota. These bacteria, due to its abundance, 
tend to grow more rapidly than H. pylori and, even if H. pylori is present, they will often 
mask its presence. 
A further source for H. pylori is the contamination of medical tools for endoscopies. They 
are common medical procedure used to diagnose and manage gastrointestinal disease. 
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Because of the complex structure of the endoscope and difficulty in disinfecting it, the 
possibility of iatrogenic infection in patients following endoscopy is a potential risk factor, 
not only for H. pylori but also for other infectious diseases (Brown 2000). Epidemiological 
studies of the iatrogenic transmission were carried out; they suggest that rate of iatrogenic 
infection may approximate to 4 per 1,000 endoscopies (0.4%) when the prevalence of H. 
pylori in the endoscoped population is around 60% (Tytgat 1995). This rate may be 
higher, reaching 1%, in areas of the world in which improper disinfection techniques are 
used. Proper cleaning and disinfection of the endoscopic tools reduce the contribution of 
this source to the spread of H. pylori infection. 
Despite several investigations, the current knowledge about the dominant route of 
transmission is still controversial and further epidemiological and microbiological studies 
are required. 
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1.4 ADAPTATION AND GASTRIC COLONIZATION 
 
 
H. pylori infection is implicated in a wide range of disorders of the upper gastrointestinal 
tract, as well as associated organs. It leads to a chronic and progressive gastric mucosal 
inflammation and it is responsible of severe disorders, such as gastric inflammation-
associated diseases, non-ulcer dyspepsia, peptic and duodenal ulceration, gastric 
cancer, mucosal-associated lymphoid tissue (MALT) lymphoma. As evidence, H. pylori is 
recognized as the main etiological agent of peptic ulcer. Despite of the high prevalence, 
most of the infected individuals are asymptomatic and the bacterium inhabits the human 
stomach for many decades without adverse consequences; fewer than 10% of individuals 
colonized by H. pylori develop peptic ulcer disease, gastric cancer or further associated 
diseases (Dunn, Cohen, and Blaser 1997). Specific outcomes depend on the interplay 
among host-, bacterial- and environmental-related factors. The ability of H. pylori to 
survive to acidic conditions and colonize the stomach is essential for the development of 
virulence and the onset and progress of gastrointestinal disorders. Therefore, the 
mechanisms of acid resistance and gastric colonization have been greatly investigated. 
Following transmission, H. pylori faces 
a new set of challenges in establishing 
colonization. H. pylori exhibits both host 
tropism, colonizing only primates, and 
tissue tropism, adhering specifically to 
gastric mucosal tissue in the stomach 
or the duodenum, but not to intestinal 
or squamous-type epithelium. One 
possible reason for this specific 
association, between H. pylori and 
gastric epithelium, is that this bacterium 
takes advantage of specific 
components of gastric mucus or other 
factors released by gastric epithelial 
cells as nutritional sources (Johnson, 
Gaddy, and Cover 2012). Within the 
stomach, H. pylori can inhabit a range 
Fig. 1.8 Schematic representation of gastric structure; H. pylori 
colonization is largely confined to the antrum, which lacks acid-
secreting parietal cells. Adapted from Mobley et al., 2001. 
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of different microenvironments. The bacteria are typically more abundant within the 
gastric antrum, less acid, but they can also be found within the corpus, under conditions 
of low acid secretion, such as when patients are on long-term acid suppression. 
Specifically, H. pylori mainly adheres to the gastric epithelial lining of the antrum 
(preferring the mucus-secreting gastric epithelial cells of the upper half of the gastric pits) 
or stays in the gastric mucus layer; approximately 80% of the bacteria remain in the 
mucus layer (pH approximately 4.5), with the smaller proportion colonizing the gastric 
surface (pH close to neutrality). Within the mucus layer, the microorganisms can be found 
relatively close to the gastric lumen or deep within gastric glands; furthermore, they can 
be either free-swimming or attached to gastric epithelial cells (Fig. 1.8; Schreiber et al. 
2004). Instead, H. pylori doesn’t adhere to chief cells, parietal cells or endocrine cells in 
the gastric pit. Moreover, only occasionally H. pylori can be internalized by gastric 
epithelial cells, because of its invasive nature (Dubois and Borén 2007). 
 
The process of bacterial colonization consists of four steps (Mobley, Mendz, and Hazell 
2001): 
- transmission to a new host; 
- bacterial adherence to a specific niche within the host; 
- avoidance, subversion or exploitation of host defense mechanisms; 
- acquisition of nutrients resulting in successful replication. 
 
Each event is closely related to the others and directed to a successful persistence of the 
bacterium in its niche. Even in the case of the colonization by H. pylori, the mechanisms 
involved in each event have been extensively investigated. H. pylori adhesion to gastric 
epithelial cells is evidenced to be necessary for the establishment of a successful 
infection, but many other factors also influence the persistence of H. pylori in the gastric 
mucosa, such as epithelial cell turnover, host immune response, impact of gastric 
contents. Bacterial factors critical for the colonization of the gastric mucosa include 
urease, helicoidal shape, flagella, adhesins, δ-glutamyltranspeptidase. 
Lipopolysaccharide, urease and vacuolating cytotoxin A (VacA) are among the factors 
that allow H. pylori to persist for decades and invoke an intense inflammatory response 
(McGee and Mobley 2000). Once a chronic infection is established, a considerable 
amount of bacteria is present in the gastric mucosa, with an infection density estimated 
between 105 and 107 H. pylori CFU per gram of gastric mucus gel (Atherton et al. 1996). 
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The bacterial density is higher in the antrum respect to the corpus and plays a key role in 
the pathogenesis. Higher levels of H. pylori density are associated with the development 
of more severe diseases. 
Some bacterial factors involved in H. Pylori acid adaptation and colonization are 
described in the following. 
 
 
1.4.1 ACID ADAPTATION 
 
Fig. 1.9 Periplasmic buffering by H. pylori. Adapted from Krulwich et al., 2011. 
The human stomach is a peculiar ecological niche, characterized by a very acid pH of the 
gastric juice (1.5-3.5), representing the first line of defense against most gastrointestinal 
pathogens. It has been estimated that exposure to gastric acid kills more than 99.9% of 
ingested Salmonella species and Vibrio cholerae (Gorden and Small 1993). H. pylori is 
the only neutralophile able to survive and to colonize this hostile environment. Since this 
bacterium is not an acidophile, it has evolved several specialized mechanisms to survive 
gastric acid. The pathogen has to resist in the gastric lumen (pH ≤2) for a short period, 
enough to enter into the highly viscous mucosa (average pH ≥5.5), reach the gastric 
epithelium, find nutrients and multiply (Suerbaum and Josenhans 1999). Some acid-
adaptive mechanisms, involved in the gastric juice buffering, include an acid-activated 
inner membrane urea channel, UreI, a neutral pH-optimum intrabacterial urease, a 
membrane-anchored periplasmic carbonic anhydrase (Fig. 1.9). This acid acclimation 
system allows to regulate the pH of the periplasm and of  the surrounding liquid in acidic 
medium at levels where both the cytoplasmic pH and membrane potential are compatible 
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with survival and growth (Sachs 2005). On the contrary, other neutralophiles cannot 
maintain a constant intracellular pH and consequently only transit the human stomach. 
Therefore, H. pylori can be classified as an acid tolerant neutralophile, because it grows 
best at neutral pH, but it is able to survive and  grow  in  acid conditions  and  to  increase  
its periplasmic pH in the presence of acid by specialized  mechanisms (Scott et al. 1998). 
Urease, also named urea amidohydrolase, was the first colonization factor identified in H. 
pylori. This neutral pH-optimum enzyme is expressed by H. pylori at higher levels than 
any other known bacteria, accounting for as much as 8% of the total protein. It represents 
one of the most prominent antigenic components, since it induces a strong 
immunoglobulin response of both IgG and IgA and helps to recruit neutrophils and 
monocytes in the inflamed mucosa and to activate production of proinflammatory 
cytokines (Mobley, Island, and Hausinger 1995; Montecucco and Rappuoli 2001). For 
these reasons it is used as a taxonomic and diagnostic marker for gastritis and peptic 
ulcer diseases in humans and it has been tested as a vaccine candidate (Suerbaum and 
Josenhans 1999). Urease-negative mutants retain only 0.4% of the urease activity of the 
parent strain and, consequently, are unable to colonize animal models, showing that this 
enzyme is essential for gastric habitation (Eaton et al. 1991). The urease plays a key role 
regarding the bacterial ability to overcome the acidic conditions of the gastric lumen. It 
catalyzes the hydrolysis of urea into ammonia and carbamate; the latter compound 
spontaneously decomposes to yield another molecule of ammonia and carbon dioxide. 
Ammonia scavenges protons, to mitigate the acidity and increase the pH; carbon dioxide 
is converted to bicarbonate by a pair of carbonic anhydrases and it buffers the periplasmic 
space. Therefore, the generation of ammonia and carbon dioxide provides both acid-
neutralizing and acid-buffering capacity, enabling H. pylori to raise the pH in its 
microenvironment and periplasm. Besides the neutralization of the intracellular pH, 
urease activity leads H. pylori also to maintain a normal proton motive force (PMF), an 
electrochemical gradient for protons across the bacterial cell membrane, by adjustment 
of the transmembrane potential, despite the acid condition, allowing the growth in the 
gastric environment (Meyer-Rosberg et al. 1996). H. pylori survives at a pH range 
between 4.0 and 8.0 in the absence of urea (Meyer-Rosberg et al. 1996); however, in the 
presence of urea this microorganism can survive at a pH as low as 2.5. The Km value of 
the H. pylori urease for urea is 0.8 mmol/L (Dunn et al. 1990); accordingly, H. pylori 
displays a much higher affinity for its substrate than that of ureases produced by other 
bacterial species. This high affinity allows the utilization of the limited amount of urea 
   Introduction 
 
51 
 
(between 1.7 and 3.4 mM) present in the gastric juice (Dunne 2014). H. pylori urease has 
a cytoplasmic localization, but a significant fraction has been evidenced to be even 
associated with the bacterial surface. The mechanism whereby urease becomes 
associated with the surface of the microorganism is unique. This process is defined 
"altruistic autolysis" and involves release of urease (and other cytoplasmic proteins) by 
genetically programmed autolysis with subsequent adsorption of the released urease 
onto the surface of neighboring intact bacteria (Dunn and Phadnis 1998). Therefore, the 
enzyme is able to maintain a physiological pH value of cytoplasm and periplasm and the 
membrane potential, and also to develop a protective buffered layer surrounding the 
bacterial outer membrane. However, the protective role of the surface-associated urease 
has been challenged because the isolated pure enzyme has a pH optimum of 7.0–8.0 
and is rapidly inactivated by short-term exposure to a buffered pH <5, even in the 
presence of urea (Ha et al. 2001). The urease synthesis and regulation is a complex 
process, which requires the participation of several gene products. The biosynthesis of 
urease is controlled by a gene cluster, ureABIEFGH, composed by seven genes: an 
upstream promoter, ureA and ureB, the two structural subunits of the enzyme, ureI, 
encoding for an urea-specific channel in the cytoplasmic membrane, ureE, ureF, ureG 
and ureH, encoding accessory proteins that 
interact with the apo-enzyme and deliver nickel 
ions to the active site in an energy-dependent 
process (Mobley et al. 1995). All of the genes 
except ureI show considerable homology with 
urease cluster genes of other bacterial 
species, including Klebsiella aerogenes (Lee 
et al. 1992), Proteus mirabilis (Jones and 
Mobley 1988), Yersinia enterocolitica (de 
Koning-Ward, Ward, and Robins-Browne 
1994). The H. pylori urease core enzyme is a 
huge complex, whose molecular mass has 
been estimated to be approximately 600 KDa 
(Evans et al. 1991). The X-ray structure revealed that H. pylori urease has a spherical 
dodecameric assembly, composed of six heterodimers of UreA (26.5 KDa) and UreB 
(60.3 KDa) subunits (Fig. 1.10; Ha et al. 2001; PDB accession codes: 1E9Z and 1E9Y). 
Fig. 1.10 The figure evidences the three-fold symmetry 
of the dodecameric assembly of UreA/UreB complex 
and the central huge hallow. Adapted from Nam-Chul 
Ha et al., 2001. 
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The supramolecular distribution is organized 
in four (UreA/UreB)3 units (Fig. 1.11), related 
by the crystallographic two- and three-fold 
symmetry axis of a cubic cell. The resulting 
complex has an outer diameter of the protein 
shell of approximately 130 Å and a huge 
central hallow, as observed with transmission 
electron microscopy (TEM). The urease is 
originally produced as an immature apo-
enzyme and requires Ni2+ ions insertion for its 
catalytic activity. Activation takes place when 
four chaperone proteins, organized as two 
complexes, UreE/UreG and UreF/UreH, 
mediate the Ni2+ insertion and assemble the 
catalytic site of the protein (Mobley et al. 1995). The insertion of two Ni2+ ions into each 
active site is essential for complete activation of the protein, as well as the carbon dioxide, 
which probably reacts with a Lysine side chain to produce Lysine-carbamate, participating 
as a ligand in the metal binding, and the GTP hydrolysis, necessary for the Nickel-
dependent activation (Ha et al. 2001). Hence urease activity is essential for gastric 
colonization by H. pylori and regulation of urease occurs at several levels: biosynthesis 
of the structural genes, insertion of Ni2+ ions into the apo-enzyme, regulation of urea 
access to the urease itself (Sachs, Wen, and Scott 2009). The genes encoding UreA and 
UreB are located in one operon, ureAB, while ureIEFGH represents another operon 
(Akada et al. 2000).  Recent studies have evidenced that the ureAB operon can yield a 
2.7 kb full-length transcript that produces a functional enzyme and also a 1.4 kb truncated 
transcript, the product of which exhibits much lower urease activity and is generated by 
cleavage of the 3’ ureB region. Acid pH results in a significant increase in transcription of 
ureAB, while neutral pH increases the truncated transcript. The expression of this smaller 
transcript was shown to be influenced by pH, the presence of the histidine kinase ArsS 
and the phosphorylation state of the response regulator ArsR, illustrating the influence 
that pH has on the expression of an active urease (Wen et al. 2011). ArsR and ArsS 
belong to a two-component signal transduction system, named ArsRS system, that 
regulates the transcription of the seven genes of the urease gene cluster and even of 
other proteins involved in important H. pylori pH-sensitive metabolic processes, such as 
Fig. 1.11 Ribbon diagram of the trimeric unit. One unit is 
represented with wider ribbons, and the others are 
differently colored. Each unit consists of the UreA (α-
subunit; blue) and two physically distinct domains of the 
UreB (β-subunit, the N-terminal domain, red, and the C-
terminal domain, magenta). Adapted from Nam-Chul Ha 
et al., 2001. 
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acid resistance (amidase), acetone metabolism (acetone carboxylase), resistance to 
oxidative stress (thioredoxin reductase), quorum sensing (enzyme Pfs) (Fig. 1.9; Loh et 
al. 2010).  UreA and UreB are present largely as apo-enzymes; therefore, regulation of 
Ni2+ concentration inside the organism plays a vital role in acid survival. NixA is a specific 
high-affinity Ni2+ transporter with eight transmembrane segments that exists in the inner 
membrane of H. pylori and functions as a monomer (Fulkerson and Mobley 2000). 
Deletion of nixA reduces, but does not prevent, infection of the mouse stomach (Nolan et 
al. 2002), but many other genes may also be implicated in uptake and storage of this 
essential cation. HypA and HypB are involved in the insertion of nickel into hydrogenase. 
Deletion of these nickel assembly genes not only affected hydrogenase activity, but 
sharply reduced urease activity by 200-fold (Olson, Mehta, and Maier 2001). This finding 
is attributed to a role of these genes in nickel incorporation into urease. H. pylori also 
expresses nikR, which functions as a global regulator of several genes, including ureA 
and ureB, in the presence of high Ni2+ concentrations (Contreras et al. 2003). Finally, the 
uptake of urea from the gastric environment is regulated by an acid-activated 
transmembrane channel, UreI. This transporter is activated by acid pH, when the 
periplasmic pH falls below approximately 6.2 (Sachs et al. 2003); therefore, it doesn’t 
allow for the transport of urea into the bacterial cell at neutral pH, thus preventing lethal 
alkalinization of the cytoplasm. At neutral pH little urease activity is measurable in intact 
organisms, in contrast to lysed bacteria. But as the pH in the medium is reduced from pH 
6.5 to 5.5 and down to pH 2.5, carbon dioxide release sharply increases in intact bacteria. 
The simplest explanation for these observations is that acid pH activates the urea 
transporter in the inner membrane, increasing urea access to cytoplasmic urease, for a 
maximal production of ammonia and carbon dioxide. The stable activity down to pH 2.5 
also shows that even down to this environmental pH, cytoplasmic pH does not fall (Scott 
et al. 2000). UreI is a six-transmembrane segment polytopic membrane protein, localized 
into the inner membrane of the microorganism. UreI shares features of a pH-gated urea 
channel (non-saturable, voltage independent), having low open probability at neutral pH 
and high open probability at pH 5.0 and below, with half maximal opening at pH 5.9. It is 
very selective for urea, with even thiourea being impermeant (Weeks et al. 2000). The 
ureI gene appears to be uniquely expressed by gastric Helicobacter species and its 
absence impairs acid survival. Moreover, ureI gene shows homology to the amiS gene of 
the amidase gene cluster (Scott et al. 2000); not coincidentally urea is an amide 
compound. 
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Although urease and UreI play a significant role in the acid acclimation processes of H. 
pylori, it would be extremely unlikely that these proteins would be the only means of 
combating the stress of gastric habitation. Acid-induced gene regulation has been 
extensively investigated, in absence or presence of urea. Besides urease, several gene 
products, which might be considered as pH homeostatic genes, are able to produce NH3, 
such as acylamide amidohydrolase or amidase (AmiE), formamide amidohydrolase or 
formamidase (AmiF), two asparaginases (AnsA, AnsB), γ-glutamyltranspeptidase or 
glutamase (Ggt), glutaminaseaspartate-ammonia lyase or aspartase (AspA). The 
periplasmic and cytoplasmic carbonic anhydrases are able to produce HCO3- as buffer. 
Also, three hydrogenase expression/formation genes, hypA, hypB and hypC, are up 
regulated; the first two, as previously described, have a role in nickel uptake and 
sequestration, essential for adequate 
urease enzyme activity (Sachs et al. 
2009). 
Although the NH3 produced by urease 
activity is able to neutralize entering 
protons, the pKa of NH4+ is 9.2 and 
the NH4+/NH3 couple would not 
effectively buffer the periplasm to a 
relatively neutral pH. Therefore, NH3 
alone would not account for the 
finding that the periplasmic pH is 
relatively constant at 6.1 in the 
presence of urea. On the other hand, 
pH 6.1 is the effective pKa of HCO3-. 
Hence, both NH3 and CO2 production 
from intrabacterial urease activity 
enable acid acclimation by H. pylori, 
the NH3 to neutralize entering protons 
and the HCO3- to buffer the periplasm 
(Sachs et al. 2009). H. pylori carbonic 
anhydrases closely cooperate with 
urease, since the latter produces 
2NH3 + CO2 from urea, and these 
Fig. 1.12 H. pylori pH-buffering mechanisms. The outer membrane 
contains porins permeable to urea and protons. With acidification, UreI 
opens and urea moves into the cytoplasm, increasing intrabacterial urease 
activity. This produces 2NH3 and CO2, gases that readi H. pylori pH-
buffering mechanisms. The outer membrane contains porins permeable to 
urea and protons. With acidification, UreI opens and urea moves into the 
cytoplasm, increasing intrabacterial urease activity. This produces 2NH3 
and CO2, gases that readily exit the cell into the periplasm. Protons 
entering the cytoplasm are neutralized by NH3, forming NH4
+, whereas 
cytoplasmic β-carbonic anhydrase generates HCO3
–, which is a stronger 
buffer at neutral pH than NH3. Similarly, the NH3 that effluxes into the 
periplasm can neutralize entering acidity and the CO2 due to periplasmic 
α-carbonic anhydrase activity, producing H+ and HCO3
–. A second NH4
+ is 
formed along with HCO3
–, the latter providing buffering in the range of pH 
6.1. Adapted from Sachs et al., 2005. 
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enzymes together establish the main pH-buffering mechanism; therefore, carbonic 
anhydrases have been investigated in detail. Carbonic anhydrases are metalloenzymes 
which catalyze the reversible carbon dioxide hydration into bicarbonate and protons. H. 
pylori genome encodes two different classes of carbonic anhydrase with different 
subcellular localization: a periplasmic enzyme belonging to the α-family and a cytoplasmic 
enzyme belonging to the β-family (Nishimori et al. 2008). Carbonic anhydrases are 
involved in pH homeostasis, as well as CO2 transport or trapping. The mechanism of 
periplasmic pH-buffering is explained in detail in Fig 1.12. This acid acclimation feature 
of H. pylori, maintaining an intracellular neutral pH while the pH of the environment is 
acid, is unique to this microorganism and is critical to survival of the pathogen in the 
stomach. When the periplasmic carbonic anhydrase gene is deleted, many of the 
properties of the wild type are lost, similar to ureI deletion. Furthermore, acid survival is 
impaired, either with deletion of the enzyme or by addition of acetazolamide, a specific 
inhibitor for α-carbonic anhydrase, although UreI and urease remain fully functional. 
There is a 3-log decrease in survival in the knockout mutants or after the addition of 
acetazolamide at pH 2.0 in the presence of urea (Marcus et al. 2005b). These evidences 
confirm the crucial role of carbonic anhydrase for the survival of H. pylori in the gastric 
environment.   
In addition to urease, H. pylori also possesses other NH3-producing enzymes, including 
two paralogous amidases, the acylamide amidohydrolase or amidase (AmiE) and the 
formamide amidohydrolase or formamidase (AmiF). These enzymes are aliphatic 
amidases that catalyzes the hydrolysis of short-chain amides to produce ammonia and 
the corresponding organic acid (Skouloubris, Labigne, and De Reuse 2001). Firstly, in 
1997, AmiE was identified in H. pylori genome, showing high homology to the aminoacid 
sequence of the aliphatic amidases from other bacterial species, such as Pseudomonas 
aeruginosa or Rhodococcus sp. R312 (Skouloubris, Labigne, and De Reuse 1997). Later, 
analysis of the complete genome sequence has revealed a second aliphatic amidase, 
belonging to the nitrilase superfamily and named AmiF, whose aminoacid sequence is 
34% identical to AmiE. Therefore, AmiE and AmiF are classified as paralogous proteins, 
presumably generated by a duplication event of an ancestral gene. This evidence 
suggests some enzymatic specialization: while AmiE hydrolyzes propionamide, 
acetamide and acrylamide in vitro, AmiF presents an unexpected substrate specificity, 
since it only hydrolyzes formamide (Skouloubris et al. 2001). Interestingly, H. pylori is the 
first pathogenic microorganism in which two amidases belonging to the aliphatic amidase 
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family have been found; these enzymes were previously reported only in bacteria present 
in the environment, like P. aeuruginosa (Bury-Moné et al. 2003). The presence of these 
protein underlines the essential role played by ammonia metabolism in the H. pylori 
survival, as a major nitrogen source, as a compound involved in the acid resistance, and 
as a cytotoxic molecule. Genes encoding these amidases are up-regulated in response 
to moderately acid conditions (pH approximately 5.5) encountered at its colonization site, 
the gastric mucus layer (Bury-Moné et al. 2004). This observation confirms the 
importance of the buffering role of the ammonia in the protection against the acidity. 
Furthermore, AmiE and AmiF expression is dependent on the activity of other enzymes 
involved in the nitrogen metabolism of H. pylori, urease and arginase respectively; the 
production of these amidases is stimulated in H. pylori mutants deficient in urease and 
arginase (Skouloubris et al. 2001). As suggested by these findings, H. pylori presents a 
complex regulatory network that includes several effectors and allows to maintain an 
appropriate nitrogen balance. 
Another enzyme involved in this regulatory network is the above-mentioned arginase 
(RocF). This protein catalyzes the conversion of L-arginine to L-ornithine and urea, 
providing endogenously the substrate for the urease. In addition to producing 
endogenous urea, H. pylori also obtains some of its urea exogenously from the host, as 
urea is present in the gastric mucosa through host arginase activity. Exogenous substrate 
is imported into H. pylori cytoplasm through the UreI transporter, under acid conditions; 
but this system may be inoperable in vivo under neutral pH conditions. Thus, arginase 
may be important for providing endogenous urea in vivo under conditions in which the 
exogenous one is limited (McGee et al. 2004). RocF in H. pylori is metabolically upstream 
of urease and the latter is known to be required for colonization of animal models by the 
bacterium. On the contrary, H. pylori RocF is required for arginase activity and is crucial 
for acid protection in vitro, but is not essential for in vivo colonization of mice or for urease 
activity (McGee et al. 1999). H. pylori arginase is specifically involved in acid resistance; 
but it also inhibits host nitric oxide production, evading the immune response and thus 
contributing to persistent infection. Moreover, it plays a role in inhibiting T cell proliferation. 
These evidences confirm that H. pylori arginase is largely involved in pathogenesis. 
Additionally, two asparaginases (AnsA, AnsB), glutaminase (Ggt) and aspartase (AspA), 
previously mentioned, participate to the ammonia metabolism of H. pylori, since they 
produce NH3 from aminoacid catabolism. Especially, asparaginase converts L-
asparagine to L-aspartic acid and NH3; glutaminase is responsible for conversion of L-
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glutamine to L-glutamic acid and NH3; finally, aspartase catalyzes the reversible 
conversion of L-aspartic acid to fumarate and NH3. Besides the roles in the aminoacid 
metabolism and in the acid acclimation, asparaginase and glutaminase are also involved 
in the host cell cytotoxicity and in the suppression of the host immune response (Miller 
and Maier 2014): asparaginase inhibits either the cell-cycle, particularly the G1 phase, of 
gastric and non-gastric cells (fibroblasts and epithelial cells) or the normal lymphocyte 
function at the gastric niche, allowing H. pylori to evade the host immune response (Scotti 
et al. 2010; Shibayama et al. 2011); on the other hand glutaminase induces apoptosis in 
gastric epithelial cells via a mitochondria-mediated pathway (K.-M. Kim et al. 2007). 
Nevertheless, the major ammonia-producing pathway, central to the acid resistance of H. 
pylori, includes urease, amidase, formamidase and arginase. In this complex metabolic 
network ammonia and also urea could serve as sensors for the regulation of the nitrogen 
balance, avoiding toxic intracellular accumulation of ammonium and ensuring sufficient 
nitrogen supply in environmental conditions riches in urea, aminoacids or amides 
(Skouloubris et al. 2001). Compared to many other bacteria, H. pylori possesses relatively 
few transcriptional regulatory systems; thus it is possible that the few regulatory proteins 
present control multiple responses and metabolic processes (Alm and Trust 1999). 
Consistent with this, many genes involved in the H. pylori acid resistance, including 
members of urease genes cluster, amidases and arginase, have been demonstrated to 
be regulated in the same way by the previously mentioned ArsRS two‐component system 
in response to low pH conditions (Fig. 1.13). It consists of a histidine kinase sensor 
element ArsS, which phosphorylates itself in response to low pH and transfers the 
phosphoryl group, and 
an OmpR-like 
response regulator 
ArsR that, by accepting 
the phosphoryl group, 
functions as an 
activator or repressor of 
gene promoters (Pflock 
et al. 2006). The 
influence on the 
transcription of the pH-
sensitive genes by this 
Fig. 1. 13 A model of ArsRS two-component system regulation of periplasmic pH of H. 
pylori. Adapted from Sachs et al., 2009. 
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two-component system leads to the upregulation of the product in response to low pH. 
ArsS, in addition to its role in urease gene cluster transcription, is also involved in the 
recruitment of urease proteins to the inner membrane, precisely to the UreI channel, in 
order to augment acid acclimation during acute acid exposure (Marcus et al. 2012); this 
second ArsS function is phosphorylation-independent. Deletion of ArsS renders H. pylori 
unable to colonize the stomach of mouse models, suggesting an essential role of the 
ArsRS system in the regulation of important virulence properties of the pathogen (Panthel 
et al. 2003). On the other hand, ArsR has proved to be essential for cell growth (Schär, 
Sickmann, and Beier 2005). These evidences suggest that this regulatory system and the 
related target genes are likely essential for the gastric colonization. Besides the genes 
involved in the acid resistance, several others are regulated by the ArsRS two-component 
system in a similar mode, including outer membrane proteins, Ni2+ storage proteins, 
detoxifying enzymes involved in the oxidative stress resistance and H. pylori specific 
proteins of unknown function (Pflock et al. 2006). Several of these genes are also under 
the control of the metal-dependent regulators NikR and Fur. The ferric uptake regulator 
(Fur) is a well characterized iron-binding transcriptional factor that controls intracellular 
iron homeostasis via concerted expression of iron-uptake and iron-storage genes in 
response to changes in iron availability (Van Vliet et al. 2002). Binding of ferrous iron to 
Fur triggers a conformational change that activates the protein for binding to specific DNA 
sequences named Fur boxes (Dian et al. 2011); it acts as transcriptional repressor that 
decreases iron uptake in the presence of a high-iron environment. Iron is required as a 
cofactor by several enzymes and as a catalyst in the electron transport processes. 
However, iron overload stimulates the formation of reactive oxygen species via the 
Fenton reaction. The resulting species damage DNA, proteins and membrane lipids 
(Touati 2000). In addition to genes directly related to iron homeostasis, Fur also regulates 
expression of several enzymes that play a central role in metabolism and energy 
production, as well as in response to low pH, oxidative stress, salt. Therefore, in H. pylori 
Fur is negatively auto-regulated and is required for the adaptation of the bacterium to two 
conditions known to oscillate within the gastric mucosa: iron limitation and low pH. 
Specifically, by DNA array-based transcriptional profiling it has been shown that 16 genes 
encoding proteins involved in metal metabolism, nitrogen metabolism, motility, cell wall 
synthesis and cofactor synthesis have displayed iron-dependent Fur-repressed 
expression; conversely, 16 genes encoding proteins involved in iron storage, respiration, 
energy metabolism, chemotaxis, and oxygen scavenging have displayed iron-induced 
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Fur-dependent 
expression (Ernst et al. 
2005). Thus, this iron-
sensing protein is 
actually a global 
regulator of gene 
expression in H. pylori 
that contributes 
significantly to the 
unique plasticity that is 
characteristic of this 
bacterium. 
Consequently, the Fur 
regulon includes genes involved in acid acclimation, resistance to oxygen reactive 
species and nitrogen metabolism. Therefore, collectively, Fur plays a key role in the 
adaptation of H. pylori to the hostile conditions that exist in the stomach (Pich and Merrell 
2013). The most widespread group of genes under the control of this metalloregulator is 
that of the iron uptake systems, including the high-affinity iron transporters FecA1, FecA2, 
FrpB1 and FeoB (Fig. 1.14; Delany et al. 2001; Danielli et al. 2009). When the intracellular 
concentration of ferrous iron is low, Fur is unable to bind to the Fur box sequences within 
the promoters of these genes, transcription is derepressed and the capacity of H. pylori 
to acquire extracellular iron increases drastically. Furthermore Fur activity is also 
regulated at low pH, because its transcription is repressed in response to low pH (Bury-
Moné et al. 2004); this regulation is mediated by the previously mentioned NikR (Van 
Vliet, Ernst, and Kusters 2004). NikR is a nickel-binding transcription factor that directly 
controls urease expression and regulates the uptake and storage of nickel, and is also 
able to regulate the expression of other regulatory proteins, such as Fur. Nickel is a 
required co-factor for several enzymes, including the fundamental urease; however, 
because of its potential toxicity, nickel import and homeostasis must be tightly controlled. 
NikR utilizes allostery and coordination geometry to sense nickel ions and regulate 
transcription of genes involved in nickel import and processing (Dosanjh and Michel 
2006). This regulatory protein acts as both a repressor and an activator within an acid 
adaptation cascade, which enables the optimal use of the nickel ions under acid 
conditions, thereby preventing the emergence of toxic nickel concentrations. It has been 
Fig. 1.14 The iron sources available in the stomach and the ferric uptake regulator-
mediated responses aimed at maintaining the intracellular iron balance in H. pylori. 
Yellow color indicates that expression is inactivated by iron-bound ferric uptake regulator (Fur). 
Green color indicates that expression is inactivated by apo-Fur. Red color indicates that 
expression is activated by iron-bound Fur. Adapted from Pich and Merrell, 2013. 
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hypothesized that H. pylori uses a repressor cascade to 
respond to low pH conditions, with NikR initiating the response 
directly via the urease operon and indirectly via the members 
of the Fur regulon. The NikR and Fur proteins generally 
function as transcriptional repressor proteins through binding 
of operators in their target promoters, blocking access of RNA 
polymerase, and subsequent transcription. The regulatory 
cascade utilizes these two repressors, each only allowing 
on/off regulation but, by varying the levels of Fur protein in 
cells, NikR not only regulates expression of its own regulon but 
also mediates changes in all members of the Fur regulon 
indirectly via regulation of fur transcription (Fig. 1.15; Van Vliet, Kuipers, et al. 2004a). 
This regulatory system demonstrates the close link between metal metabolism and acid 
resistance in H. pylori and may allow the bacterium to mount protective responses to a 
multitude of different stresses despite a paucity of regulatory systems. 
 
 
1.4.2 MOTILITY AND CHEMIOTAXIS 
Since H. Pylori is not an acidophile, the bacterium has evolved several strategies to 
minimize the exposure to the acid conditions in the stomach lumen by remaining in very 
close proximity to the surface of the epithelium, where the pH is approximately neutral 
(Amieva and El-Omar 2008). Therefore, a key factor essential for survival and successful 
colonization is the bacterial motility. H. pylori is considered a “good swimmer”, able to 
remain within a narrow band of the protective mucus layer that is constantly being 
secreted by epithelial cells of the stomach. The bacterium moves in the mucus gel via a 
cork-screwing mechanism thanks to its helicoidal shape and to a group of four to eight 
flagella arranged at one of its poles (Fig. 1.16). The helicoidal shape is crucial for bacterial 
motility and a prerequisite for successful colonization. The turning helical cell body is 
thought to interact with large polymers to generate torque that enhances translational 
movement and reduces circumferential slip, promoting the penetration of the mucus layer. 
The helicoidal shape improves propulsion efficiency in the form of speed in viscous 
polymer solutions, such as the gastric mucus gel composed by polymerized mucins, and 
H. pylori has been shown to swim faster at higher viscosities respect to certain rod-
shaped bacteria (Magariyama and Kudo 2002). Most bacteria, including H. pylori, present 
Fig. 1.15 Relationship of NikR, 
Fur, amidase, formamidase and 
urease in H. pylori. Adapted from 
Van Vliet et al., 2004. 
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a peptidoglycan  (murein) 
sacculus, surrounding the 
cytoplasmic membrane and 
essential to maintain osmotic 
stability and cell shape. It 
consists in a meshwork of 
glycan strands joined by 
peptide crosslinks (Sycuro et 
al. 2010). A number of H. 
pylori genes that induce 
modifications in 
peptidoglycan cross-linking of 
the bacterial cell wall or lead to trimming of peptidoglycan muropeptides have been 
identified. These include several genes that encode peptidases and determine the helical 
shape of H. pylori, namely, csd1, csd2, csd3/hdpA, ccmA, csd4, csd5 and csd6 (Sgouras, 
Trang, and Yamaoka 2015). Quantitative morphological analyses of multiple-gene 
deletion mutants have revealed different impairments in shape and motility and each 
protein uniquely and coordinately contributes to the shape-generating pathway. These 
findings suggest that the coordinated action of multiple proteins relaxes peptidoglycan 
crosslinking, enabling helicoidal cell curvature and twist (Sycuro et al. 2010; Sycuro et al. 
2012). In addition to the influence of peptidases on bacterial cell shape, recent research 
has revealed that the shape of H. pylori may be dictated by coiled-coil-rich proteins 
(Ccrps). The bacterium contains four Ccrps (Ccrp58, Ccrp59, Ccrp1143, and Ccrp1142), 
and all four ccrp deletion mutants significantly exhibit impaired motility, despite unaltered 
flagella morphology (Sgouras et al. 2015). 
Motility is essential for successful in vivo colonization by H. pylori and is provided by its 
sheathed unipolar flagella, which are considered as one of the most important 
colonization and virulence factors of this pathogen, since non-motile mutants lacking 
flagella are unable to establish persistent infection in animal models (Montecucco and 
Rappuoli 2001). These propulsive elements allow H. pylori to swim in the gastric juice, 
guided by chemical stimulant, especially urea and bicarbonate ions, till crossing the thick 
mucus layer protecting the epithelium. In this way the bacterium gets nutrients and avoids 
to be discharged in the intestinal tract by peristalsis. H. pylori possesses two to eight 
flagella; the filaments extend 3-5 μm from the bacterial surface and exhibit a typical bulb-
Fig. 1.16 H. pylori has unipolar flagella and a spiral shape that enable the 
bacterium to be motile. Electron micrograph; source: Yutaka Tsutsumi, M.D. 
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like structure at its distal end that represents a dilation of the flagellar sheath (Geis et al. 
1989). The sheath itself consists of both proteins and lipopolysaccharide, and is thought 
to be an extension of the bacterial outer membrane that protects the flagellar filaments 
from acid in the stomach (Geis et al. 1993). 
The H. pylori flagella, as those 
of enteric bacteria, are 
composed of three structural 
elements: a basal body, which 
is embedded in the cell wall 
and contains the proteins 
required for rotation and 
chemotaxis and usually the 
flagellar export proteins; an 
external helically shaped 
filament that works as a 
propeller when rotated at its 
base; a hook that serves as a 
joint between the basal body 
and the flagellar filament (Fig. 
1.17; Chevance and Hughes 
2008). In H. pylori more than 
50 putative proteins are 
predicted to be involved in expression, secretion and assembly of this complex flagellar 
apparatus; at least 20 of these proteins constitute the structural components of the basal 
body, hook and filament (Tomb et al. 1997; Alm et al. 1998). The filament is a copolymer 
constituted by two subunits, the predominant flagellin FlaA and the minor one FlaB, 
localized close to the basis of the flagellum (Kostrzynska et al. 1991). Both flagellins have 
similar molecular mass (approximately 53 KDa), present an acid pI of 5.2 and share 
considerable aminoacid homology (58% identity), but the respective genes are unlinked 
in the chromosome (Mobley et al. 2001). They are are necessary for full motility 
(Josenhans, Labigne, and Suerbaum 1995) and for the establishment of a persistent 
infection in the gnotobiotic piglet model (Eaton et al. 1996). The hook is composed of 
FlgE structural subunit (78 KDa); whereas FliD is a hook-associated protein, which is 
localized at the tip of the flagellar filament and promotes the incorporation of the flagellin 
Fig. 1.17 Structural elements of H. pylori flagella. Adapted from Chevance and 
Hughes, 2008. 
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monomers into the growing flagellar filament (Mobley et al. 2001). Mutants in flgE, 
defective in hook production generated by allele replacement, are non-motile and devoid 
of flagellar filaments but produce both flagellin subunits (O’Toole, Kostrzynska, and Trust 
1994). Mutants in fliD produce truncated flagella and are severely impaired in motility and 
their ability to colonize the gastric mucosa of mice (Kim et al. 1999). Several other genes 
involved in the flagellar architecture and function have been identified by sequence 
homologies studies. The fliF gene encodes the subunits of the MS ring, the first complex 
to be assembled during flagellar morphogenesis (Jones, Homma, and Macnab 1989). 
This complex is formed on the cytoplasmic side of the inner membrane, where it provides 
a construction base for the flagellar rod made of the FlgB, FlgC and FlgG proteins and 
functions as an anchor for the motor switch proteins FliM, FliN and FliG and the motor 
rotation proteins MotA and MotB. On the other hand, flgI and flgH genes encode the 
subunits of the P and L rings (Jones et al. 1989), which anchor to the flagellum in the 
periplasmic space and to the outer membrane, respectively (Mobley et al. 2001). 
Additionally, many other putative proteins seem to be implicated in biosynthesis, 
assembly and function of the flagellar apparatus, but little is known about them (O′Toole, 
Lane, and Porwollik 2000). 
Since most of the flagellar apparatus is localized beyond the cytoplasmic membrane, 
many of the flagellar proteins have to cross the membrane to reach their final destination. 
The proteins constituting the P and L rings are secreted via the conventional signal-
peptide–dependent Sec pathway, whereas the axial components of the flagellar 
apparatus, including the structural proteins of filament, hook and rod, which connects the 
hook to the basal body, are believed to be secreted by a specialized flagellum-specific 
pathway. This process is constituted of biosynthetic proteins that assemble into a 
structure at the MS ring of the flagellum that binds the flagellar proteins and transfers 
them actively into the growing flagellum. The members of this system share homology to 
components of the widely distributed contact-dependent type III secretion systems 
(Mobley et al. 2001). 
Another ability that plays a crucial role in the gastric colonization by H. pylori is the control 
of the direction of the movement, which is achieved by means of chemotactic response 
to various chemical stimuli. It has been proved that chemotaxis is responsible of four main 
events in H. pylori mouse infections: establishing infection, achieving high-level infection, 
maintaining an infection when there are competing H. pylori present and colonizing all 
regions of the stomach (Terry et al. 2005). Most flagellated bacteria perform chemotactic 
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motility by the recognition of environmental conditions, such as solute concentration, 
coupled with regulation of swimming behavior (Falke and Hazelbauer 2001); H. pylori 
exhibits attractant chemotactic activity toward various compounds, including the 
aminoacids glutamine, histidine, lysine and alanine (Abdollahi and Tadjrobehkar 2012), 
as well as mucin, urea, sodium bicarbonate and sodium chloride (Mizote, Yoshiyama, 
and Nakazawa 1997), and it is repelled as response to low pH. From the gastric lumen to 
the apical surface of the gastric mucosa a large pH gradient generated by a different 
permeability of the mucus to different compound has been postulated (Montecucco and 
Rappuoli 2001). H. pylori can lose motility rapidly when it encounters acid conditions 
(Schreiber et al. 2005); therefore, it penetrates the gastric mucus quickly and establish 
persistent colonization in an area close to the epithelium, where the pH is approximately 
neutral. H. pylori increases its swimming speed when placed within an acid gradient; it 
can also change its swimming route to favor movement away from the acid environment 
and toward the gastric epithelium. Like other bacteria, H. pylori uses four different 
chemoreceptors, also named transducer-like proteins (Tlps), to phosphorylate the 
flagellar rotational response regulator and modulate the flagellar rotational direction. This 
chemoreceptors (specifically TlpA, TlpB, TlpC and TlpD), located in the bacterial 
membrane or in the cytoplasm, are molecule that sense the extracellular chemical signals 
and, following interaction with their respective ligands, initiate a molecular signal 
transduction cascade, which causes a change in the direction of rotation of the flagellar 
motors (Sgouras et al. 2015). Positive taxis to arginine and bicarbonate have been 
observed to be dependent on TlpA function. Whereas negative taxis to acid pH is 
dependent on the sensor protein TlpB. TlpC has been hypothesized to modulate the TlpB-
mediated acid behavior by an as-yet-unknown mechanism. On the other hand, TlpD is a 
receptor for energy taxis (Cerda et al. 2011). The relevant role of these chemoreceptors 
has been demonstrated by deletion experiments; an H. pylori mutant in the tlpB gene can 
swim but do not move away from acid regions. These H. pylori mutant are defective in 
their ability to colonize mice stomach (Croxen et al. 2006). Therefore, the structure of 
flagella, the chemotactic movement and its regulation underline the pivotal role of motility 
and flagella in H. pylori colonization. 
Additionally, H. pylori has been shown to possess the enzymatic ability to disrupt the 
oligomeric structure of mucins, enabling the pathogen to move freely in the mucus layer, 
assisted by its highly active flagellum and its ability to down-regulate mucin synthesis 
(Byrd et al. 2000). A thioredoxin system has been identified to be responsible of the 
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alteration of the mucus structure; it specifically reduces interchain disulphide bonds of 
mucins (Windle et al. 2000). This event reduces the gel-forming capabilities of mucins 
and therefore the viscoelastic properties of mucus aiding movement of the bacterium 
through mucus. 
 
 
1.4.3 ADHESION 
Approximately only 20% of H. pylori 
bacteria in the stomach adhere to 
the surface of the gastric epithelial 
cells, with a majority exhibiting a 
tropism for intercellular junctions 
and, occasionally, for deeper 
intercellular spaces (Fig. 1.18); 
whereas most of the infecting 
bacterial cells are found living in the 
mucus layer (Hessey et al. 1990). 
H. pylori has been shown to disrupt 
tight junction function, possibly through intraepithelial injection of cytotoxin-associated 
antigen A (CagA) protein or through the ammonia produced by urease; this change might 
open the paracellular route for bacterial penetration deep into the mucosa (Amieva et al. 
2003). Although H. pylori has generally been considered an extracellular pathogen, a 
number of evidences have shown that a subset of microorganisms is capable of 
occasionally invading gastric mucosa and entering epithelial cells (Petersen and Krogfelt 
2003). H. pylori invasion of and survival within epithelial cells is not merely a passive 
event, but requires active participation of the microorganism. A study on bacterial entry 
have demonstrated that H. pylori enters into gastric epithelial cells through a zipper-like 
phagocytic mechanism, that requires protein kinase C and phosphatidylinositol 3-kinase 
(Kwok et al. 2002). Moreover, it has been proposed that VacA toxin promotes bacterial 
intracellular survival in gastric epithelial cells and contributes to the persistence of 
infection (Terebiznik et al. 2006); indeed, one possible explanation for the persistence of 
H. pylori infection despite vigorous host immunological defenses and antibiotic therapy is 
the existence of an intracellular bacterial reservoir. Additionally, electron microscopy 
studies of gastric biopsy specimens obtained from infected humans have demonstrated 
Fig. 1.18 Electron microscopy shows H. pylori attached to remaining 
microvilli (arrowheads). Adapted from Warren, 2010. 
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extensive areas of adhesion to the host cells and the presence of H. pylori within epithelial 
cells (Wyle et al. 1990). However, significant controversy still remains regarding the ability 
of H. pylori to invade epithelial cells and the mechanisms involved.  
H. pylori bacteria which infect mucosal surface share two main goals to achieve a 
successful colonization: firstly to overcome the mucus barrier, and secondly to interact 
with the underlying epithelial cells that results in disease (Naughton et al. 2014). H. pylori 
is highly adaptable, as evidenced by the fact that it can occupy a single host for decades, 
and it is its able to physically interact with various types of gastric host cells and also with 
host mucins and extracellular matrix proteins using a number of different adhesins 
displaying a variety of unique receptor specificities (Fig. 1.19; Evans and Evans 2000). 
Bacterial adhesion involves specialized molecular interactions with the gastric mucosa 
that may trigger cellular changes including signal transduction cascades and lead to 
intimate attachment and modification of the cell surface and the underlying cytoskeleton. 
It is widely accepted that the microorganisms in contact with the epithelial cells cause 
disease. Moreover, it is considered unlikely that chronic infection with H. pylori could 
occur in the absence of adhesin-host cell interactions. Therefore, adherence of the 
bacteria to the gastric mucosa is one of the initial steps of H. pylori infection and is an 
important virulence factor; it renders H. 
pylori 100 to 1,000 times more resistant 
to antibiotics than non-adherent 
bacteria (Megraud et al. 1991). 
More than 30 genes that encode 
bacterial outer membrane proteins have 
been identified as possible candidate 
involved in the adhesion (Odenbreit et 
al. 2009); several of these have been 
recognized as adhesins, suggesting 
multiple and perhaps redundant 
variable modes of attachment to the 
gastric cell surface (Amieva and El-
Omar 2008). Moreover, different H. 
pylori strains express different adhesins 
sets, contributing to the strain variability 
in H. pylori and to the adaptation to 
Fig. 1.19 Interaction of H. pylori adhesins with host cell receptors. 
(A) Interaction of H. pylori adhesins to gastric epithelial cell 
receptors. (B) Interaction of H. pylori adhesins to the basement 
membrane protein laminin. Adapted from Mobley, 2001. 
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changes in mucosal glycosylation at different anatomic locations and over time; adhesin 
expression can also change within a single strain over time, thus suggesting an 
evolutional meaning in the redundancy of mechanisms of adhesion. No individual 
molecule has been shown to be essential for adhesion, further corroborating the 
multifactorial nature of the adhesin-mediated colonization and the redundancy of 
adhesive mechanisms. Additionally, to bacterial variability in the adhesin sets, host 
factors may also influence the adhesion, such as the varying expression of host cell 
receptors within a single host and the genetic variability in receptor expression in different 
hosts. Therefore, the cell adhesion mechanism and the role of individual adhesins are 
very difficult to dissect at the molecular level because of several bacterial and host factors 
involved.  
Particularly, molecular effectors that mediate the interaction between the bacterium and 
the host cell surface include bacterial proteins, glycoconjugates and lipids. H. pylori 
adheres strongly to the human gastric epithelial cells using fucosylated glycoproteins and 
sialylated glycolipids as host receptors, highly expressed in the gastrointestinal tract 
(Boren et al. 1993). The successful adhesion is mediated by several adhesins, including 
proteins and glycolipids, which play an essential role in the development of the diseases. 
The primary colonization may occur in the oral cavity, as H. pylori has been shown to 
adhere to MG2 in the human salivary mucin (Andersen 2007). Mucins are a family of high 
molecular weight oligomeric proteins that are sulfated and heavily glycosylated, 
containing a wide array of structurally distinct carbohydrate side chains, such as sulfated 
or non-sulfated sugar moieties, Lewis a, b, X, and/or Y moieties, and sialic acid residues 
(Carraway and Hull 1991). Adherence to the sialic acid in the mucin seems to be a 
common feature in most H. pylori strains. Several sialic acid-containing glycoconjugates 
have been shown to exist, such as on the surface of gastric epithelial cells and on human 
neutrophils; these sialic acid-containing glycoconjugates are up-regulated upon contact 
of H. pylori with the host cell (Miller-Podraza et al. 1999). H. pylori possesses at least six 
adhesins able to bind sialic acid; some of them have been identified, especially HpaA, 
Nap, SapA, SabA (Fig. 1.19). HpaA has been the first sialic acid-binding adhesion of H. 
pylori to be characterized (Evans et al. 1988). It is a surface-located lipoprotein that binds 
to sialoconjugates, specifically to the N-acetylneuraminyllactose (Evans et al. 1993), 
mainly in an α-2,3-specific manner. It has been revealed to be essential to establish a 
successful colonization in mice (Carlsohn et al. 2006). HpaA has also been observed as 
a component of the extracellular flagellar sheath (Jones et al. 1997). 
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The sialic acid-binding adhesin (SabA, also known as HopP because it belongs to the 
Helicobacter outer membrane porin (hop) superfamily) is one of the best characterized 
H. pylori adhesins, along with the Lewis b antigen binding adhesin (BabA, also known as 
HopS). SabA binds to sialylated structures present on gastric mucin and on epithelial 
cells. This adhesin also binds to sialylated receptors on neutrophils, which leads to non-
opsonic activation of the neutrophils, phagocytosis of the bacteria and induction of the 
oxidative burst response. Furthermore, the adhesin exhibits haemagglutinating activity, 
binding to gangliosides on erythrocytes in mucosal blood vessels (Dunne 2014). SabA 
interacts with sialyl-Lewis X antigen (LeX), an important blood group antigen that is rarely 
expressed in healthy gastric epithelium but is present in abundance in inflamed and 
cancerous gastric epithelium (Mahdavi et al. 2002). The SabA-sialyl-LeX interaction is 
therefore likely to play a pivotal role in H. pylori colonization during chronic infection, 
almost always associated with chronic active gastritis (Pang et al. 2014). SabA adhesion 
has also been shown to mediate binding to the structurally related sialyl-Lewis a antigen 
(Lea). This glycoconjugate is an established tumor antigen and marker of gastric 
dysplasia, which may further illustrate H. pylori capacity to exploit a full range of host 
responses to epithelial damage (Mahdavi et al. 2002). SabA-mediated binding of H. pylori 
to sialyl glycoconjugates and sialyl gangliosides requires NeuAcα2–3Gal disaccharide as 
the minimal binding epitope and is favored by extended and flexible glycan core chains 
(Aspholm et al. 2006). Furthermore, SabA variants in different H. pylori strains exhibit 
different affinities and specificities for the sialylated glycans, sialyl dimeric Lewis X 
antigen, sialyl-Lewis a antigen, dialyllactosamine and extracellular matrix protein laminin 
(Aspholm et al. 2006). Such variable SabA binding specificity might be a host adaptation 
mechanism by which H. pylori rapidly modulates its adhesion properties to achieve 
optimal colonization and concomitantly evade host immune responses (Pang et al. 2014). 
BabA is the second best characterized H. pylori adhesin, together with SabA, and it 
belongs to the hop superfamily too. Moreover, BabA shares with SabA the structural 
organization; it contains two domains: a N-terminal extracellular host-binding domain and 
a C-terminal outer membrane–spanning domain forming an 8 stranded β-barrel structure 
(Fig. 1.20; Hage et al. 2015). BabA mediates the binding of H. pylori to fucosylated 
structures, including the H type 1 antigen and Lewis b blood group antigen (generating 
by addition of a fucose residue to the precursor H type 1 by transferase activity), 
presented by the surface of gastric epithelial cells and the gastric secretory mucins (Ilver 
et al. 1998). BabA is also centrally involved in H. pylori binding to the mucins MUC5AC 
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and MUC5B, even in non-secreting individuals that either lack an α(1,2)-
fucosyltransferase (and are therefore not able to express Leb in high amounts) or lack 
Leb, and thereby acts as an important factor for initial colonization (Van de Bovenkamp 
et al. 2003). This adhesin is expressed by most disease-causing H. pylori strains and its 
presence on the bacterium correlates with enhanced colonization and virulence (Prinz et 
al. 2001). A high level of heterogeneity is found in the BabA protein amongst strains, with 
various polymorphisms being identified, and different levels of Lewis b binding observed. 
 
Fig. 1.20 Comparison of the BabA and SabA extracellular domain crystal structures. (A) Crystal structure of the BabA 
extracellular domain. Indicated are the handle (blue) and head regions (dark magenta) and the crown b-strand unit (gold). The four 
disulfide bridge are represented as green sticks. (B) Superimposition of the extracellular domains of BabA and SabA (gray). Adapted 
from Hage, 2015. 
Similarly to SabA, BabA also presents a high degree of genetic variability due to phase 
variation events; their gene includes homopolymeric tracts in the promoter region and 
dinucleotide repeats in the coding region and phase-variation can occur at these sites via 
slipped-strand mispairing. This high level of sequence flexibility helps H. pylori to rapidly 
adapt to the stomach environment and contributes to differing clinical outcomes among 
H. pylori-infected humans (Hennig et al. 2004; Kao et al. 2012). There is also a high level 
of allelic variation in bab genes. H. pylori possesses a closely related gene to babA, 
named babB, and both proteins are highly similar in their N- and C-terminus regions, but 
vary quite significantly in their central region. The paralogous BabB protein does not bind 
Lewis b antigen, indicating that the central region of the two proteins confers unique 
functions (Dunne 2014). Despite its specific function is yet unknown, an experimental 
rhesus macaque model of infection has revealed that BabB, closely related to BabA, 
could be involved in conversion events where babA gene is deleted and babB gene is 
duplicated and replaces the first one (Solnick et al. 2004).  
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Other adhesins of H. pylori include the outer membrane proteins AlpA and AlpB, that are 
known to mediate the attachment to epithelial cells by defining a macromolecular complex 
on the bacterial surface with other outer membrane proteins belonging to this family 
(Odenbreit et al. 1999). AlpA and AlpB are two closely related proteins carried on the 
same operon in the H. pylori genome. The C-terminal portion of both proteins is predicted 
to form a porin-like β-barrel in the outer membrane, consisting of 14 transmembrane 
amphipathic beta-strands, similarly to SabA and BabA. Adhesion experiments with 
defined isogenic mutants indicate that both proteins are necessary for specific adhesion 
of H. pylori to human gastric tissue; loss of these proteins was found to influence the 
ability of H. pylori to colonize the guinea pig stomach (De Jonge et al. 2004) and to bind 
to gastric tissue (Odenbreit, Faller, and Haas 2002). Virtually all strains express AlpA and 
AlpB, indicating they have an essential function. Recently, these two proteins have been 
shown to contribute to the ability of H. pylori to bind host laminin (Senkovich et al. 2011). 
Additionally to its influence on adhesion, the alpAB locus has been shown to influence 
host cell signaling and cytokine production (Odenbreit et al. 2002). 
HopZ was identified as a further outer membrane protein of H. pylori that plays a role in 
colonization. It is regulated by a phase-variable CT repeat and two allelic variants of the 
hopZ gene were identified, with a 20 aminoacid region present in only one allele 
(Kennemann et al. 2012). The role of HopZ in infection has been largely unexplored; 
HopZ also mediates adherence, since a hopZ isogenic mutant has reduced adherence 
(Peck et al. 1999). There is strong selection in vivo for HopZ expression, as hopZ on 
variants have been recovered from volunteers challenged with a hopZ off strain. 
Transmission of H. pylori within families has also been associated with a status change 
of hopZ (Dunne 2014). 
Recently, OipA, also named outer inflammatory protein or HopH, has been identified as 
a phase-variable outer membrane protein characterizing more virulent strains. Its gene is 
located on the H. pylori chromosome approximately 100 kb from the cagPAI and its 
presence is associated with enhanced interleukin-8 secretion, peptic ulcer and increased 
inflammation (Dabiri et al. 2009). Mutagenesis of oipA gene results in reduced bacterial 
adherence to gastric epithelial cells, but does not alter IL-8 secretion in vitro, probably 
due to the presence of cag Pathogenicity Island (Yamaoka, Kwon, and Graham 2000). 
OipA may be linked to gastroduodenal diseases owing to its association with other 
virulence factors or increased bacterial adhesion and colonization. Expression of oipA is 
regulated by the slipped-strand repair mechanism based on the number of CT 
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dinucleotide repeats in the 5’ region of the oipA gene in a way such that its switch on 
would be functional and its switch off would be nonfunctional. This is consistent with the 
observation that an OipA-positive status has been significantly associated with the 
presence of duodenal ulceration and gastric cancer, high H. pylori density and severe 
neutrophil infiltration (Yamaoka 2006). OipA on genotype is linked to bacterial virulent 
determinants, such as functional vacA, babA and, most strongly, cagA genotypes 
(Dossumbekova et al. 2006). 
The biological role of the adhesion process is still controversial. On one hand, adhesive 
interactions contribute to inflammation, with concomitant expression of sialylated glycans 
such as sialyl-Lea and sialyl-LeX, and seem to be involved in disease progression. In 
particular, when transgenic mice expressing the Lewis b antigen have been infected with 
H. pylori, the mice have showed increased bacterial attachment, more severe chronic 
gastritis and parietal cell loss (Guruge et al. 1998). The delivery of the major H. pylori 
virulence factors CagA and VacA are intimately related to adhesion as well, suggesting a 
role of adhesion in the delivery of toxins (Amieva and El-Omar 2008). Attachment of H. 
pylori to the gastric mucosa activates the type IV secretion system which results in the 
translocation of CagA protein into the host cells and triggers inflammation (Odenbreit et 
al. 2000). Some investigators have speculated that inflammation could have an adaptive 
role, since it promotes the release of nutrients into the gastric lumen. On the other hand, 
adhesion seems necessary to avoid mechanical clearance, such as liquid flow, peristaltic 
movements or shedding of the mucous layer, and to allow the bacterium to hold firmly to 
its environment. 
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1.5 PATHOGENESIS AND VIRULENCE FACTORS 
 
 
After stomach colonization, H. pylori is able to persist for many decades and invoke an 
intense inflammatory response, leading to damaged host cells. In most of the time its 
presence is asymptomatic; but it is sometime associated with an increased risk of 
developing various gastrointestinal diseases, including non-ulcer dyspepsia, peptic and 
duodenal ulceration, gastric cancer, mucosal-associated lymphoid tissue (MALT) 
lymphoma (Kusters, van Vliet, and Kuipers 2006). The ability of H. pylori to survive the 
acid conditions and colonize the stomach is essential for the development of virulence, 
defined as the degree of pathogenicity of a microorganism; but the latter does not 
necessarily occur. The pathogenesis of H. Pylori infection in humans can be divided into 
three steps (McGee and Mobley 2000): 
- entry to, adherence to, and colonization of the human gastric mucosa; 
- avoidance, subversion, or exploitation of the human immune system; 
- multiplication, tissue damage, and transmission to a new susceptible host or 
spread to adjacent tissues. 
The success of H. pylori in 
causing such a wide spectrum of 
diseases depends on host, 
bacterial, and environmental 
factors. A complex and 
fascinating balance between 
these factors takes part in the 
gastric niche, allowing H. pylori to 
switch between commensalism 
and pathogenicity. On one hand 
this network allows the majority of 
infected individuals to be without 
any symptom during their entire 
life; on the other hand it 
determines the different clinical 
outcomes (D’Elios and Andersen 
2007; Larussa et al. 2015). 
Fig. 1.21 Schematic representation of the stomach mucosa colonized by H. 
pylori, showing the main virulence factors involved in colonization and 
disease. Adapted from Montecucco and Rappuoli, 2001. 
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The host immune response during H. pylori infection plays an important role in the 
persistence of infection and the pathogenesis. The bacterium is able to escape host 
defence mechanisms involving both the innate and adaptive immune systems of the host, 
reducing the inflammatory response in its favor; consequently, it establishes a chronic 
infection by achieving a delicate balance between inducing immune responses and 
surviving in the inflammatory condition by using an array of important virulence factors. 
Both the bacterium and the host adapt to the other in the form of a long-standing dynamic 
equilibrium. One of the mechanisms employed by H. pylori for immune evasion and 
immune modulation is the ability to adapt to changing environmental conditions, in the 
gastric epithelium, acidity and nutrient availability, during long-term colonization, made 
possible by an unusual genetic variability. Particularly, the high prevalence and wide 
distribution of clusters of strain-specific genes, namely hypervariable plasticity zones, in 
the genomic sequence throughout several H. pylori isolates might favor the emergence 
of variants after selective pressure and provide a fitness benefit to their hosts for 
increased persistence (Fischer et al. 2014). H. pylori bacteria are also highly competent 
for uptake of DNA from other H. pylori strains. The analysis of genomic sequences shows 
strong evidence of recombination between strains, to the degree that clonal lineages are 
largely obscured (Falush et al. 2001). Substantial intragenomic recombination occurs, 
based largely on the presence of repetitive DNA sequences; their presence allows high-
frequency deletion and duplication, including slipped-strand mispairing (Aras et al. 2003). 
The local selection within an individual stomach also may promote the genetic variability; 
separate gastric microniches are likely colonized by H. pylori subpopulations that have 
particular attributes to maximize fitness, for example, ligand specificity for local receptors 
(Ilver et al. 1998). 
Following H. pylori acquisition, there is a rapid host recognition in the form of both innate 
and adaptive immune responses; it results in strong specific local and systemic antibody 
production, cell-mediated immunity as well as an inflammatory infiltrate of neutrophils, 
lymphocytes, plasma cells, macrophages and eosinophils in the gastric mucosa (Akhiani 
et al. 2002). Once chronicity is established, the immune stimulation appears remarkably 
constant, consistent with a model of dynamic equilibrium. The ubiquity and duration of 
host recognition of H. pylori and yet the lifelong colonization by the bacterium demonstrate 
the effectiveness of bacterial strategies to evade the host immune system. The important 
first step is to survive without tissue invasion; most of the H. pylori bacteria reside in the 
gastric lumen, beyond the reach of most host immune recognition and effector 
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mechanisms. However, even in this niche, some H. pylori bacteria establish intimate 
contact with the epithelial surface, some H. pylori proteins cross the epithelial barrier, and 
both innate and adaptive immune systems are activated (Blaser and Atherton 2004). 
Innate immune recognition involves Toll-like receptors 
(TLRs), which are present on the surface of gastric 
epithelial cells and belong to a conserved family of 
eukaryotic receptors recognizing invariant regions of 
bacterial molecules termed pathogen-associated 
molecular patterns (PAMPs). Although the bacterial 
ligands for TLRs are distinct, the signaling pathways 
activated by these receptors all result in NF-κB 
activation and pro-inflammatory cytokine expression 
TLR (Fig. 1.22). If bacteria invade and penetrate the 
gastric epithelial barrier, the alternate pathway of 
complement is activated and invading bacteria encounter macrophages and neutrophils. 
Since most of H. pylori microorganisms are localized within the gastric mucus layer and 
do not invade gastric tissue, contact between H. pylori and phagocytic cells probably 
occurs infrequently unless there are disruptions in the gastric epithelial barrier (Algood 
and Cover 2006). Furthermore, H. pylori is able to elude the recognition by the TLRs; to 
avoid the activation of this system the bacterium modulates its surface molecules, 
including lipopolysaccharide (LPS) and flagellin. TLR5 recognizes bacterial flagella such 
as those of Salmonella typhimurium, but it is not stimulated by H. pylori flagella, since H. 
pylori flagellin is not recognized by this receptor. As can be evidenced, H. pylori flagellin, 
especially FlaA, is not released and noninflammatory, since it is unable to induce a pro-
inflammatory state by promoting IL-8 secretion (Gewirtz et al. 2004). TLR9 recognizes 
the largely unmethylated DNA of most bacteria, but the highly methylated H. pylori DNA 
likely minimizes this recognition (Smith 2014). Lipopolysaccharide (LPS) is a surface 
exposed glycolipid found on the outer membrane of Gram-negative bacteria and it acts 
as a potent signal for development of an inflammatory response by interaction with TLR4 
on gastric epithelial cells and macrophages. It has three distinct units: lipid A, which is 
responsible for the toxic effects; a core polysaccharide of five sugars linked through 
ketodeoxyoctulonate to lipid A; and the O-antigen, an outer polysaccharide consisting of 
up to 25 repeating units of three to five sugars (Lina et al. 2014). In comparison to LPS 
from Escherichia coli or other Gram-negative bacteria, H. pylori LPS has approximately 
Fig. 1.22 Toll-like receptors and pathogen 
recognition. Adapted from Peek et al., 2010. 
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500-fold lower endotoxic activity (Muotiala et al. 1992). The low biological activity of H. 
pylori LPS is attributable to modifications of its lipid A component, especially regarding its 
phosphorylation pattern and acylation, in order to mask the negatively charged phosphate 
groups present on the lipid A disaccharide backbone (Cullen et al. 2011). Consequently, 
H. pylori LPS poorly binds to TLR4 and its ability to stimulate macrophage production of 
pro-inflammatory cytokines, nitric oxide and prostaglandins is decreased, preventing the 
contribution to innate immune response. Interestingly, H. pylori LPS has also been shown 
to possess antiphagocytic properties in vitro, since LPS may mediate direct 
bacteria/phagocyte interactions and it may also regulate antibacterial activity of the 
phagocytes (Grebowska et al. 2008). Moreover, H. pylori LPS is important not only for 
the activation of TLR4, but also because the bacterium commonly expresses LPS O-
antigens that are structurally related to Lewis blood group antigens found on human cells. 
Particularly, H. pylori O-antigen is composed of N-acetyl-D-glucosamine, L-fucose and 
D-galactose to form fucosylated oligosaccharide structures that show a clear tendency to 
mimic the structural motif of human antigens Lewis X (LeX) and Y (LeY) and, thus, are 
less immunogenic than those of many other enteric bacteria (Aspinall and Monteiro 1996). 
This similarity in structure between H. pylori LPS and Lewis blood group antigens may 
represent a form of molecular mimicry or immune tolerance that permits H. pylori LPS 
antigens to be shielded from immune recognition because of similarity to “self” antigens 
(Algood and Cover 2006).  
H. pylori also activates 
the adaptive immune 
system, as indicated by 
both humoral (B 
lymphocytes) and cellular 
(T lymphocytes) 
recognition of its 
antigens, although it has 
evolved to substantially 
downregulate and avoid 
acquired immune 
effectors (Fig. 1.23). The 
lines between adaptive and innate immunity are frequently blurred by the close 
interactions between pathways, such that stimulation of antigen-presenting cells (APCs), 
Fig. 1. 23 Inflammatory response to H. pylori. Adapted from Portal-Chelay et al., 2006. 
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such as macrophages and dendritic cells (DCs), leads to activation and recruitment of 
lymphocytes, particularly CD4+ T cells, and the development of T-helper (Th) cell-specific 
responses. Classically, differentiation of Th cells involves clonal expansion that is caused 
by engagement of the T cell receptor. Th cells can differentiate from CD4+ T cells to 2 
major functional classes, namely Th1 cells, which produce a set of cytokines that include 
interferon-γ (IFN-γ) and interleukin IL-2, and Th2 cells, which produce cytokines such as 
IL-4, IL-5, IL-10, and IL-13. Th1 cells generate cell-mediated immunity, which is important 
in protection against intracellular microorganisms; whereas Th2 response is associated 
with humoral immunity and protection against extracellular pathogens (Wilson and 
Crabtree 2007). Based on the fact that H. pylori is non-invasive and that infection is 
accompanied by an exuberant humoral response, one might predict that a Th2 response 
would be predominant within H. pylori colonized gastric mucosa. Paradoxically, the 
majority of H. pylori antigen-specific T cell clones isolated from infected gastric mucosa 
produce higher levels of IFN-γ than IL-4, which is reflective of a Th1 response (Bamford 
et al. 1998). H. pylori also stimulates production of IL-12 in vitro, a cytokine that promotes 
Th1 differentiation. These findings raise the hypothesis that an aberrant host response 
(Th1) to an organism predicted to induce secretory immune responses (Th2) may 
influence and perpetuate gastric inflammation (Fig. 1.23; Portal-Celhay and Perez-Perez 
2006). The reasons for the impaired Th1 immune response could lie in the continuous 
process of virulence factor elaboration implemented by H. pylori over the thousands of 
years of coexistence with the human host (Larussa et al. 2015). A key role has recently 
been ascribed to the natural 
regulatory T cells (Treg); although 
widely acknowledged to play a role in 
the maintenance of self-tolerance, 
recent studies indicate that Treg can 
be activated and expanded against 
bacterial antigens. Recent evidence 
suggests that the activation of 
regulatory T cells might result in 
decreased pathological responses 
and prolonged persistence of infection as a mechanism for the maintenance of pathogen-
specific immunological memory, reducing the activation of IFN-γ-producing CD4+ T cells, 
even at the expense of a higher H. pylori load in the gastric mucosa (Fig. 1.24; Raghavan 
Fig. 1.24 Interplay between H. pylori, the effective T helper 
lymphocytes and the regulatory T cells. Adapted from Larussa et al., 
2015. 
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et al. 2003; Raghavan and Holmgren 2005). H. pylori is able to subvert not only the innate, 
but also the adaptive immune response. Recognition by this immune system requires 
antigen presentation. Particularly, the proliferation of CD4+ T cells is triggered by 
recognition of antigenic epitopes bound to a protein receptor, named major 
histocompatibility complex (MHC) class II, exposed on the surface of antigen-presenting 
cells (APCs); antigen presentation by APCs plays an essential role in the initiation of 
adaptive immune responses. H. pylori interferes with both uptake and processing of 
antigens, partially through an effect induced by the toxin VacA. The latter specifically 
inhibits antigen processing by interfering with late endocytic membrane trafficking by 
antigen-presenting cells (APCs); this in turn decrease the proliferation of autologous 
human CD4+ T cells triggered by recognition of antigenic epitopes bound to MHC class II 
molecules exposed on APC surfaces. Specifically, VacA interferes with  the proteolytic 
processing of antigens and the generation of T cell epitopes loaded on newly synthesized 
MHC class II molecules (the Ii-dependent pathway of antigen presentation), leaving 
unaffected generation and presentation of epitopes by class II molecules that recycle 
through early endosomal compartments (Molinari et al. 1998). Furthermore, the virulence 
factor VacA acts as an immunomodulatory, since it efficiently inhibits signaling and 
proliferation of T cells by inducing a G1/S cell cycle arrest, through the interference with 
the T cell receptor/IL-2 signaling pathway at the level of the Ca2+-calmodulin-dependent 
phosphatase calcineurin. In this way, VacA avoids the nuclear translocation of nuclear 
factor of activated T cells (NFAT), the main regulator of the T cell pathway (Gebert et al. 
2003). A low-molecular-weight protein, distinct from VacA, has been reported to inhibit 
proliferation of T cell by blocking cell cycle progression at the G1 phase through G1 cyclin-
dependent kinase activity modulation. This suppression factor has been identified as the 
γ-glutamyltranspeptidase (Ggt); as can be noticed, this enzyme mediates the extracellular 
cleavage of glutathione, with ROS production and consequently induction of cell cycle 
arrest in lymphocytes (Schmees et al. 2007). Additionally, among the enzymes involved 
in nitrogen metabolism, arginase is involved in immune evasion and, specifically, impairs 
the T cell function. This enzyme is important for urea production by hydrolyzing L-arginine 
to urea and ornithine. L-arginine is required for T cell activation and function; therefore 
arginase has been observed to cause a significant decrease in T cell proliferation by 
depleting L-arginine availability. The results has appeared not to be mediated by 
apoptosis, but rather correlated with a reduced expression of the chief signal transduction 
   Introduction 
 
78 
 
protein CD3ζ-chain of the T cell receptor (TCR), which is required for the initiation of T 
cell activation (Zabaleta et al. 2004). 
The relative contributions of the different host immune modulation and evasion strategies 
to H. pylori persistence are not precisely established, possibly differing in individual hosts; 
but the existence of these various mechanisms implies that immune surveillance of the 
gastric lumen is powerful and that bacterial survival requires its subversion, as 
fundamental requirement for pathogenesis. A strong correlation exists between gastric 
infiltration by neutrophils, mucosal damage and development of gastroduodenal diseases 
in H. pylori infection (D’Elios, Montecucco, and de Bernard 2007). Several virulence 
factors contribute to these outcomes, but the most important and most characterized ones 
include the Vacuolating cytotoxin A (VacA), the cag pathogenicity island (cagPAI) and its 
effector, namely cytotoxin-associated gene A (CagA), and the neutrophil-activating 
protein (HP-NAP). In recent years, more than hundred different toxins produced by 
various bacterial species have been characterized. Their cellular effects lead to 
“intoxication” of the host cell and range from cell death to a variety of non-lethal changes, 
including permeabilization of membranes, blockade of exocytosis, and alterations of 
cellular signal transduction, cellular cytoskeletal properties and cellular proliferation 
(Cover and Blanke 2005). Even H. pylori toxins affect a multitude of host cellular pathways 
and they have also polymorphic nature. These combined evidences can easily contribute 
to differences in disease outcomes and severity. 
 
 
1.5.1 VACUOLATING CYTOTOXIN A 
The vacuolating cytotoxin A (VacA) is one of the most versatile and most characterized 
virulence factors produced by H. pylori. VacA is a secreted, pore-forming toxin, that was 
identified when the supernatants of H. pylori broth cultures have been found to induce 
large intracellular vacuoles in cultured mammalian cells (Fig. 1.25; Leunk et al. 1988). 
VacA is present nearly in all H. pylori strains, defining VacA+ and VacA- populations, and 
its presence is epidemiologically associated with tissue damage and disease (Tomb et 
al. 1997). Particularly, VacA triggers intrinsic apoptosis, increases mitogen-activated 
protein kinases, induces autophagy and cell death, and alters immune cell activity (Cid et 
al. 2013). The aminoacid sequence of VacA does not show a significant similarity to any 
other known bacterial or eukaryotic protein. As most of the H. pylori factors, VacA 
presents an important level of polymorphism and is characterized by a considerable 
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genetic variability. Genetic variation 
at this locus could be under strong 
selection as H. pylori adapts to the 
host immune response, colonizes 
new human hosts, or inhabits 
different host environments. 
Moreover, expression levels, 
cytotoxicity, disease severity are 
linked to this sequence variation in 
different domains of VacA. The toxin 
is firstly expressed as a 140 kDa 
proenzyme that is trimmed at both 
ends during secretion from the 
bacterial cell. It has been supposed 
to be secreted by a type Va secretion 
system (T5aSS) which is SecA-
dependent (Kim et al. 2014). The N-
terminal domain contains a signal 
sequence (“s” region of the gene) 
that shows allelic variability and has 
been classified into different types, 
mainly s1 and s2 variants (Fig. 1.26). 
Strains harboring s1 types of VacA secrete active toxin and are also more highly 
associated with both ulcers and gastric cancer; instead s2 subtype strains are associated 
with less inflammation and lower ulcer prevalence (Atherton et al. 1995). The N-terminal 
signal sequence allows the export of the toxin throughout the bacterial inner membrane 
and it is hydrolyzed during this process. This product is anchored to the outer membrane 
by its C-terminal region; it could undergo a subsequent translocation out of the external 
H. pylori envelope and be consequently removed by the mature toxin (Fig. 1.26). The 
middle region of the VacA gene is classified as the “m” region, which also shows allelic 
variation, with m1 types having stronger vacuolating activity (Amieva and El-Omar 2008). 
Among the allowed combinations of these alleles, s1/m1 VacA protein is the most 
interactive and toxigenic product, while s2/m2 the mildest one. Because nearly all strains 
are positive for VacA, genotypes of vacA are documented as the critical determinant of 
Fig. 1.25 Vacuolating cytotoxin A; a: oligomeric structure of VacA 
deduced by electron microscopy; b: current model of the cellular 
alterations induced by VacA cyototxin. Adapted from Montecucco and 
Rappuoli, 2001. 
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pathogenesis, rather than its presence or absence, and s1/m1 genotypes are associated 
to an increased risk of acquiring peptic and duodenal ulcer. Further allelic variation is 
attributable to other two region, particularly the intermediate or “i” region, between the “s” 
region and the “m” region (González-Rivera et al. 2012), and the deletion or “d” region, 
between the “i” region and the “m” region (Ogiwara et al. 2009). Despite several attempts 
to relate these subtypes to outcomes or pathogenesis, no truly consistent associations 
have been found so far.  
 
Fig. 1.26 VacA functional domains; a: the amino-terminal signal sequence and carboxy-terminal domain are cleaved from the 140-
kDa VacA protoxin to yield an 88-kDa mature toxin that is secreted into the extracellular space via an autotransporter mechanism. A 
33-kDa C-terminal beta-barrel domain of VacA is predicted to insert into the outer membrane and form a channel, through which the 
mature VacA toxin is secreted. Arrows indicate sites of proteolytic cleavage. b: there is a high level of diversity among vacA alleles 
from different H. pylori strains. Allelic diversity is particularly striking near the 5' terminus of vacA (the s-region) and in the mid-region 
of the gene (the m-region). Two main families of s-region sequences (s1 and s2) and two main families of m-region sequences (m1 
and m2) have been described. Type s1 and s2 VacA proteins differ in the site at which N-terminal signal sequences are cleaved, and 
consequently, the mature, secreted type s2 VacA toxin contains a 12-amino-acid hydrophilic extension at its N-terminus that is absent 
from type s1 VacA toxins. VacA toxins that contain this 12-amino-acid hydrophilic extension fail to induce cell vacuolation in vitro. The 
amino acid sequences of type m1 and m2 VacA proteins are approximately 65% identical within a region comprising 250 aminoacids. 
Subtypes of vacA alleles (for example, s1a, s1b, s1c, m1a, m1b, m2a and m2b) have been described, and certain subtypes have a 
geographically restricted distribution. Mosaic forms of vacA are thought to arise via homologous recombination among vacA alleles 
from different strains. Adapted from Cover and Blanke, 2005. 
 
The mature VacA protein has a molecular mass of 88 kDa, but it can be further nicked 
into 2 smaller peptides that remain non-covalently associated (Cover et al. 1994). Upon 
secretion, approximately 50% of the toxin remains associated with the bacterial cell 
surface, and the rest is released and processed again by unidentified proteases, to give 
the mature enzyme (Dundon et al. 2000). Interestingly, the surface-associated VacA 
molecules are still biologically functional and are delivered to the host cells by direct 
contact between adhered bacteria and the epithelial cell membrane, followed by uptake 
and intoxication (Ilver et al. 2004). On the other hand, the secreted protein in the 
supernatant has a strong tendency to oligomerize into water-soluble molecular 
complexes resembling flowers with six-fold or seven-fold radial symmetry (Figs. 1.25 and 
1.27; Lupetti et al. 1996; Reyrat et al. 1999). It is not clear whether these secreted VacA 
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complexes are toxigenic 
because they have little 
vacuolating activity unless 
they are dissociated by high 
or low pH into the monomeric 
forms that can be taken up by 
cell membranes. This pH-
mediated disassembly is 
associated with a marked 
increase in VacA cytotoxic 
activity. Specifically, an acid 
pH is necessary for release of 
the toxin in the environment, 
dissociation into monomers 
and activation; but studies in 
vitro have proved that even 
alkaline pH values could 
activate VacA toxin. 
Furthermore, this protein 
presents unusual structural 
resistance to extremely acid pH, pepsin digestion at pH 2, and thermal treatments (de 
Bernard et al. 1995). Following exposure to either acid or alkaline conditions, the 
oligomeric complexes dissociate in the monomeric components, up to 12 teardrop-
shaped subunits, demonstrating that the oligomer consists of 12 subunits of 88 kDa 
assembled into two interlocked six-membered arrays. VacA monomers are firstly able to 
interact with cells and their subsequent oligomerization contributes to the ability of the 
toxin to form anion-selective membrane channels into planar lipid bilayer. Therefore, 
VacA cytotoxicity requires an initial activation by interaction of the monomeric forms with 
cells and the flower-like ring oligomer is the conformation it adopts when inserted into 
membranes, hence its pore-forming properties (Cover, Hanson, and Heuser 1997). 
Moreover, the VacA monomer of 88 kDa consists of two putative domains and can 
undergo to limited proteolytic cleavage to yield two fragments, namely p33 and p55, that 
are located at the N-terminus and the C-terminus, respectively, and remain non-
covalently associated (Fig. 1.26). Both the p33 and p55 domains contribute to the binding 
Fig. 1.27 The inactive, soluble oligomer can be disrupted by acidic or alkaline 
treatment to release active monomeric VacA. Hydrophobic VacA monomers can 
insert into the plasma membrane, where they associate to form a pore. (NB: non-
specific binding; SB: specific binding; MI: membrane interaction; PM: plasma 
membrane; E: endocytosis; X-: anion; R: receptor. Adapted from Mobley, 2001. 
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and internalization of VacA and that both domains are required for vacuolating cytotoxic 
activity. Especially, aminoacid sequences located within a hydrophobic region near the 
N-terminus of the p33 domain are required for the formation of anion-selective membrane 
channels; on the other hand, p55 domain is the main responsible for VacA binding to host 
cells, requiring also the contribution of p33 fragment (Torres et al. 2005). Analysis of the 
X-ray structure of p55 domain (Gangwer et al. 2007; PDB accession code: 2QV3)  
together with electron microscopy images of the oligomers has led to a model of VacA 
oligomer organization in which the p33 domain occupies the inner core of the complex 
and the p55 domain extends outward from the central core, enabling the formation of a 
stable anionic membrane channel only when both subunits are present (Fig. 1.25; 
Zeevaart et al. 2009). Near the N-terminus of the p33 domain there is the only strongly 
hydrophobic region of VacA containing three tandem GXXXG motifs, which are 
characteristic of transmembrane dimerization sequences. Mutagenesis on several 
residues within the N-terminal unique hydrophobic region abolishes the ability of VacA to 
form membrane channels in planar lipid bilayers and also abolishes vacuolating cytotoxic 
activity. Therefore these results indicate that an intact proline residue and an intact 
GXXXG motif within the N-terminal hydrophobic region of VacA are essential for 
membrane channel formation, and they also provide strong evidence that membrane 
channel formation is required for VacA-induced cell vacuolation (McClain et al. 2003; 
Cover and Blanke 2005). 
The acid-activated VacA binds to the host cells probably by a receptor protein-tyrosine 
phosphatase β (RPTPβ), which regulates intracellular tyrosine phosphorylation; 
subsequently the toxin is internalized into the host cell by receptor-mediated endocytosis 
and it is localized in multiple intracellular sites, including endosomal compartments, the 
large intracellular vacuoles that form as a consequence of VacA intoxication, and the 
inner mitochondrial membrane (Garner 1996; Yahiro et al. 1999). Many of the toxigenic 
effects of VacA, both in epithelial cells and T lymphocytes, can be attributed to the ability 
of this toxin to be inserted into membranes and to form anion-selective channels (Cover 
and Blanke 2005). Among its several effects, VacA forms pores in the host cell 
membranes in order to the release of anions and urea, which are essential for urease 
enzyme activity (Figs. 1.25 and 1.27). The induction of intracellular vacuoles was the first 
characterized action of VacA. It is believed that VacA inserts into the membranes of late 
endosomal vesicles, forms pores with chloride channel activity, alters the composition of 
anions within endosomes, and subsequently leads to osmotic swelling (Amieva and El-
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Omar 2008). Following, VacA induces the formation of large acid vacuoles in the 
cytoplasm of certain lines of host cells, growing from the perinuclear area to fulfill the 
entire cytosol and leading eventually to necrosis of the eukaryotic cell (Figura et al. 1989). 
The formation of VacA-induced vacuoles requires the full activity of the vacuolar-type 
ATPase proton pump (V-ATPase) and the presence of weak bases, suggesting that 
vacuoles are derived from the accumulation of membrane-permeable weak bases within 
acidic compartments followed by water influx and swelling (Cover, Reddy, and Blaser 
1993). Alterations in endosomal function in the gastric mucosa could have many effects 
on the epithelium. A proper function of endosomal trafficking is necessary for antigen 
presentation process, which is shown to be perturbed by VacA in vitro, promoting the host 
immune evasion and contributing to the persistence of H. pylori infection, as previously 
described (Molinari et al. 1998). Moreover, VacA has been observed to impair the 
transport of acidic hydrolases to lysosomes in HeLa cells, resulting in release of these 
enzymes into the extracellular medium and reducing the degradative power of lysosomes 
(Satin et al. 1997). In addition to its effects on endosomes, VacA also induces host-cell 
death through apoptosis, through pore formation in mitochondrial membranes and also 
indirectly through the activation of proapoptotic signaling molecules. A third reported 
effect of VacA is its ability to cause leakage of ions and small molecules, such as iron, 
nickel, sugars, and aminoacids, by disrupting the barrier function of tight junctions, without 
major disruptions in junction integrity. This could be a mechanism by which H. pylori 
acquires nutrients across an intact epithelial barrier (Amieva and El-Omar 2008). VacA 
plays a further role in pathogenesis interfering with the autophagy process, fundamental 
to protect against bacterial infection. Prolonged exposure to the toxin disrupts autophagy, 
by preventing maturation of the autolysosome. It has been observed that VacA-
suppressed autophagy facilitates intracellular survival and persistence of the pathogen, 
since the toxin assists in producing the vacuole where H. pylori can survive intracellularly 
(Raju et al. 2012). 
 
 
1.5.2 CAG PATHOGENICITY ISLAND AND CYTOTOXIN-ASSOCIATED GENE A 
The cytotoxin-associated gene pathogenicity island (cagPAI) is widely known as the most 
important pathogenic factor of H. pylori that carries an increased risk for gastric cancer. 
It consists in a 40-kb region of horizontally acquired DNA inserted into the genome of the 
more virulent H. pylori strains, namely type I strains, and it contains approximately 30 
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genes encoding a type IV secretion system (T4SS) apparatus, capable of delivering its 
 
effector protein cytotoxin-associated gene A (CagA) and a bacterial cell wall component, 
peptidoglycan, into host cells (Fig. 1.28). The H. pylori PAI was originally named cag 
(cytotoxin-associated gene) since the toxin CagA, encoded by the cagPAI, has been 
found to be associated with the vacuolating cytotoxin VacA and their concomitance has 
been thought correlating (Censini et al. 1996). However, it has been later shown that both 
factors, VacA and cagPAI, are independent of each other. On the genetic level, the 
cagPAI carries from 27 to 31 genes and is flanked by 31-bp direct repeat, which contains 
the recombination site and corresponds to the last nucleotides of the glutamate racemase 
gene (glr), within which cagPAI has been integrated (Fig. 1.29; Censini et al. 1996). The 
module also forms the core of the left and right ends of an insertion sequence common 
in H. pylori, the IS605 element, whose highest number of copies is statistically related 
with cagPAI-containing strains. Depending on the isolate, different numbers of insertion 
sequences are associated with cagPAI. More often the module is split into two clusters 
Fig 1.28 cag 
pathogenicity 
island 
(cagPAI); a: 
arrangement 
of cagPAI 
genes in H. 
pylori strain 
26695; b: 
extensive 
sequence 
variation in 
some Cag 
proteins; 
exposure of 
Cag proteins 
to the host 
presumably 
places them 
under strong 
positive 
selection in 
vivo. 
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by a long independent intervening 
genome sequence, flanked by two 
IS605 elements; the subregions are 
named cagI and cagII, located 
downstream and upstream this 
interruption and containing at least 
14 and 16 open reading frames, 
respectively (Fig. 1.29; Bukanov and 
Berg 1994). Since intervening 
genome sequence is present 
between the two insertion sequences, IS605 elements generate H. pylori strains with 
different levels of virulence; especially, strains with many insertions often resemble type 
II strains (less virulent) more than type I strains (more virulent, cagPAI-containing), 
because the integrity of all the components of the T4SS is needed for translocation of the 
virulence effector CagA. Additional genetic instability of cagPAI results from deletions and 
inversions. In some cases, the entire module can even be lost completely due to DNA 
transfer of an empty site from a cagPAI-deficient strain into a type I strain and subsequent 
homologous recombination (D Kersulyte, Chalkauskas, and Berg 1999). H. pylori cagPAI 
is characterized by a different nucleotide composition with respect to the overall bacterial 
genome, showing a lower G+C content, and is flanked by transposable elements, 
suggesting an acquisition by horizontal transfer of genetic material (Censini et al. 1996; 
Tomb et al. 1997). Foreign and rearranged DNA sequences are often responsible for the 
acquisition of genes involved in virulence. It can be hypothesized that early bacteria 
communities originating from crop plants, animals or rodent pests rampant in the vicinity 
of early human societies may have served as donors of some of the virulence cassettes. 
Such an interspecies gene transfer could be explained partly based on the fact that many 
constituent genes of the cagPAI reveal well-established homologies to the type IV 
systems of Agrobacterium tumifaciens and that cagA-like sequences have been reported 
from some Aeromonas isolates, obtained from environmental samples (Ahmed, Tenguria, 
and Nandanwar 2009). After this initial event of horizontal acquisition, the DNA block has 
undergone a series of rearrangements in different strains, defining subpopulations. IS605 
elements might have played a central role in these recombination events (Censini et al. 
1996). The presence or absence of cagPAI, classifying H. pylori populations in cag+ and 
cag- respectively, is one of the most striking differences among H. pylori strains, 
Fig. 1.28 Location and splitting of cag pathogenicity island (cagPAI). 
Adapted from Censini et al., 1996. 
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concurring in making more complex the genetic variability of the pathogen. Diversity 
within cagPAI can also be noted between people belonging to different world’s regions: 
only one-half to two-thirds of the isolates from the Western world carry cagPAI; in 
contrast, nearly all East Asian isolates carry this chromosomal module (Kauser et al. 
2004). 
The pathogenicity island provides H. 
pylori with at least two unique 
properties: an increased 
transmission probability and the 
transformation of what would be an 
almost commensal into a potential 
pathogen (Montecucco and Rappuoli 
2001). There are approximately 30 
open reading frames within the 
cagPAI; one of them encodes the 
immunodominant antigen CagA, 
which is localized to the 3’ end of the 
region and does not present any 
sequence homology to other known 
proteins, while many of the adjacent genes have significant homology to components of 
a type IV secretion system (T4SS; Fig. 1.30). Besides the cag-T4SS, certain H. pylori 
strains can harbour up to other 3 T4SSs in their genome (comB, previously mentioned; 
tfs3; tfs4); but the chapter concerns the description of the cag-T4SS. This secretion 
apparatus consists in a macromolecular structure that functions as a minute needle (also 
named T4SS pilus) for the transfer of bacterial products, both proteins and DNA, from 
pathogenic bacteria into host cells, and is present in several Gram-negative bacteria 
ancestrally related to conjugation systems (Cascales and Christie 2003). The best 
characterized T4SS, namely VirB ⁄D4 machinery, belongs to the plant pathogen 
Agrobacterium tumefaciens and it is regarded as the prototype among that family 
members. This bacterium injects oncogenic nucleoprotein particles (T-DNA) into host 
plant cells to induce the formation of a plant tumor or gall. It was thus hypothesized that 
the cagPAI of H. pylori could serve as a novel transport system for secretion of virulence 
factors. T4SS are multicomponent membrane-spanning transport systems ancestrally 
related to the conjugation processes, which can be responsible for diverse processes 
Fig. 1.29 Assembly and interaction model of the Cag type IV secretion 
system. Adapted from Fischer, 2011. 
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such as DNA transfer, DNA uptake and release, and translocation of proteins that have 
an effector role in the target cell (Cendron and Zanotti 2011). These transporters are 
functionally diverse both with respect to delivered substrates (DNA, proteins or DNA-
protein complexes) and recipients, which can be either a bacterium of the same or other 
species, or organisms from a different kingdom like plants, fungi or mammalian cells 
(Backert and Selbach 2008). T4SS transporters typically are composed of 11 VirB 
proteins (encoded by virB1-virB11 genes) and the so-called coupling protein, the NTPase 
VirD4. The proteins comprising this secretion apparatus can be generally categorized into 
three groups: cytoplasmic or inner membrane proteins, a core complex located in the 
periplasm or membrane, and a pilus or surface structure that projects beyond the outer 
membrane (Busler et al. 2006). The VirB proteins from A. tumefaciens T4SS can be 
grouped into these three categories: the core components or putative channel (VirB6-10), 
the pilus-associated components (VirB2, and possibly VirB3 and VirB5) and the energetic 
components (the NTPases: VirB4 and VirB11). VirB1 is an enzyme with muraminidase 
activity possibly enabling localized lysis of murein to achieve T4SS assembling at a given 
location. In A. tumefaciens, signal peptidase-I removes signal peptides from precursors 
of the main pilus component VirB2 and the minor pilus component VirB5, followed by 
cyclization of VirB2. Processed VirB2 and VirB5 subsequently associate with the 
membranes as stabilized by VirB4 and VirB8. Stabilized and properly oriented VirB5 then 
forms a complex with VirB2, which is a key step in the formation of the T4SS pilus 
assembly subcomplex (Tegtmeyer, Wessler, and Backert 2013). 
Even H. pylori T4SS has been characterized in some components; 11 out of the 29 Cag 
proteins can be ascribed to the secretion machinery itself or have been proposed to 
represent functional homologues of VirB proteins (Cendron and Zanotti 2011), leading to 
a T4SS model similar to that of A. tumefaciens. Particularly, only a few cag genes encode 
proteins with clear sequence similarities to known T4SS proteins. Obvious similarities 
exist only for CagE (to VirB4), CagX (to VirB9), CagY (to VirB10), Cagα (to VirB11) and 
Cagβ (to VirD4). Nevertheless, protein topology predictions and determinations, 
localization studies and functional studies suggested that Cagγ (VirB1), CagC (VirB2), 
CagL (VirB5), CagW (VirB6), CagT (VirB7) and CagV (VirB8) are further VirB homologues 
(Fischer 2011). Moreover, cagPAI encode several auxiliary factors unique to the Cag 
system. Three further gene products are not absolutely necessary, although their 
absence results in a reduced efficiency of secretion; thus, these proteins, named 
supporting components, appear to be involved in properly assembling the secretion 
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apparatus. An additional group of genes has been shown to be required for CagA 
translocation; therefore, the encoded gene products are termed CagA translocation 
factors. Finally, several other cagPAI gene products do not appear to have a function for 
the T4SS assembly and their role has not yet been identified (Fischer 2011). H. pylori 
T4SS powering machinery is composed of three cytoplasmic NTPases, Cagα (VirB11), 
Cagβ (VirD4) and CagE (VirB4 putative homologue), which supply the energy necessary 
to assemble the apparatus and secrete CagA. Cagα and CagE have been shown to have 
ATPase activity, while Cagβ corresponds to the coupling protein VirD4, which binds DNA 
in A. tumifaciens. These enzymes couple NTP hydrolysis to conformational changes; 
these might in turn be coupled to unfolding or transfer of the substrate. The periplasmic 
core, namely translocation pore, spans the entire periplasmic space and forms channels 
in the inner and outer membranes. It is subdivided into two layers: the I layer inserting 
into the inner membrane and the O layer inserting into the outer membrane. The I layer 
consists of the N-terminal region of CagX and CagY; the O is formed by the C-terminal 
domains of CagX and CgaY and the full-length CagT. T4SS pilu is generally composed 
of two proteins, CagC and CagL. The latter, less abundant, decorates the external part of 
the appendage formed by CagC and plays a role in adhesion, acting as an anchor of the 
apparatus to the host cell surface. CagF is a chaperone-like protein crucial for CagA 
translocation. Although T4SS core complexes are able to form autonomously, they are 
unlikely to do so constitutively and without a positional preference. Accordingly, Cagγ, a 
lytic transglycosylase responsible of the peptidoglycan-degrading, and CagV, a bitopic 
inner membrane protein with features similar to a nucleating factor from A. tumifaciens 
T4SS, are essential components assisting in the secretion apparatus assembly (Terradot 
and Waksman 2011; Fischer 2011). 
The only reported effector molecules injected by the H. pylori T4SS are peptidoglycan 
and CagA, although CagA is an effector protein with multiple functions in target cells. A 
functional activation of the T4SS apparatus, by interaction with a specific host cell 
receptor, is required to translocate the effector; host cell integrins have been recently 
shown to directly interact with the CagL protein. The latter contains an Arg-Gly-Asp (RGD) 
motif which mediates binding of the pilus to integrin α5β1 and is required for injection of 
CagA (Kwok et al. 2007). After translocation into host cells, CagA becomes rapidly 
tyrosine phosphorylated (CagAPY) in its C-terminally located Glu-Pro-Ile-Tyr-Ala (EPIYA) 
motifs by a kinase of the host belonging to the Src family, whose members control 
cytoskeletal processes, cell proliferation and differentiation in normal cells, but are also 
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key players in carcinogenesis (Selbach et al. 2002). A second conserved motif found to 
be required for phosphorylation-independent effects is located adjacent to the EPIYA 
motifs and has been termed microtubule affinity-regulating kinase inhibitor motif because 
of its binding to this kinase (Neiši et al. 2010). The C-terminal EPIYA motifs are 
responsible of allelic polymorphism of CagA protein. It has been reported that a number 
of cagA alleles exist and that variation in the C-terminus of the protein is the major 
difference between the different alleles. Polymorphisms in the C-terminus occur in the 
EPIYA motifs and typically involve changes in the aminoacid sequences flanking the five-
amino-acid repeat (Fig. 1.28). Four different EPIYA regions (A, B, C and D) have been 
identified and CagA can be categorized based on the alignment of these different motifs 
on two types: East Asian-type CagA, circulating in Japan, China, and Korea, includes 
EPIYA-A, EPIYA-B, and usually only one EPIYA-D; while Western-type CagA, prevalent 
in Europe, America, Australia, and Africa, includes EPIYA-A, EPIYA-B, and one or 
multiple (up to 5) EPIYA-C motifs (Jones et al. 2009; Sgouras, Trang, and Yamaoka 
2015). This evidence explains the size variability of CagA protein (range, 120–145 kDa). 
Moreover, CagA motifs EPIYA-A and -B have shown to be much weakly susceptible of 
phosphorylation compared to their variant -C and -D. The phosphorylation level is 
proportional to the number of EPIYA-C motifs, and thus, increased motifs numbers 
enhance the pro-inflammatory and carcinogenic potential of the protein, with higher levels 
of CagA antibody, more severe degrees of atrophy, and reduced survival in a low pH. 
Thus, both number and types of the motifs, seem to be related to different level of 
pathogenicity. 
After its tyrosine phosphorylation, CagA remains near the plasma membrane; there, it 
interacts with a number of host proteins, triggering signals that resemble the activation of 
receptor-tyrosine kinase growth factors, such as c-met. The consequent signal 
transduction cascade leads to several alterations in the gastric epithelial cells, including 
activation of Src homology 2 (SH2) domain-containing tyrosine phosphatase 2, alteration 
in cell structure and motility, alteration in cell scattering and proliferation. The cellular 
functions of CagA do not always require its tyrosine phosphorylation. These 
phosphorylation-independent interactions induce activation of β-catenin and NF-κB 
signalling, leading to disruption of tight and adherens junctions, perturbation of epithelial 
cell differentiation and polarity, pro-inflammatory and mitogenic responses (Suzuki et al. 
2009; Cover and Blaser 2009). As result of its cellular functions, CagA is responsible of 
evident morphological changes in the host tissues, leading to cell elongation and 
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formation of filopodia and lamellipodia (“hummingbird” phenotype). According to these 
various morphogenetic changes that lead to malignant transformation, CagA is defined 
as a bacterial oncoprotein (Hatakeyama 2004). Furthermore, early reports have indicated 
that genes encoding components of the T4SS but not CagA itself are required for the 
induction of pro-inflammatory signalling, including activation of NF-kB, AP-1 and the 
proto-oncogenes c-Fos and c-Jun. This has suggested that the T4SS might inject factors 
in addition to CagA (Backert and Selbach 2008). It has been demonstrated that the 
peptidoglycan is injected by the T4SS into the host cells and induce synthesis of 
chemokines that recruit neutrophils, such as interleukin-8 (IL-8), and activation of pro-
inflammatory signalling pathway, acting through the cytoplasmic receptor Nod1, an 
intracellular pathogen recognition molecule with specificity for Gram-negative 
peptidoglycan (Hatakeyama 2004). 
 
 
1.5.3 NEUTROPHIL-ACTIVATING PROTEIN 
The H. pylori neutrophil-activating 
protein (HP-NAP) is a highly 
immunogenic protein, both in humans 
and mice, responsible for the 
attraction of neutrophils and 
monocytes by chemotaxis at the site 
of H. pylori infection; it has been 
shown to induce neutrophil adhesion 
to endothelial cells, to increase the 
adhesion of neutrophils to endothelial 
cells, to induce migration and 
activation of human neutrophils and 
monocytes and to be a potent 
stimulant of mast cells (Choli-
Papadopoulou 2011). The crystallographic structure, which has been determined in our 
laboratory, reveals that HP-NAP consists in a 150 kDa-oligomer composed by four‐helix 
bundle subunits that oligomerize to form a dodecamer with a central internal iron‐
containing negative cavity (Fig. 1.31; Zanotti et al. 2002; PDB accession code: 1JI4). HP-
NAP shows relevant similarities to some bacterial iron-binding and DNA-protecting 
Fig. 1.30 Ribbon representation of Neutrophil activating protein: 
dodecameric structure (PDB accession code:1JI4) 
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proteins, named Dps protein. These proteins protect bacterial DNA from oxidative 
radicals generated by the Fenton reaction and also from various other damaging agents; 
in fact, their expression is induced under stress conditions. The napA gene is highly 
conserved among geographically distinct strains of H. pylori, suggesting a precise 
structurally‐dependent function for HP-NAP; as can be evidenced, the few non-
conservative differences within the aminoacid sequence do not affect its whole structure. 
Interestingly, HP-NAP does not bind to DNA fragments like the other Dps proteins, but it 
is able to storage in its central cavity up to 500 atoms of iron per oligomer (Tonello et al. 
1999). An additional peculiarity of this H. pylori protein resides in its N-terminal region. 
Usually Dps proteins contain a positively charged N‐terminus that promotes the binding 
to DNA and its condensation; HP‐NAP does not possess a positively charged N‐terminus, 
but it is characterized by a positively charged protein surface, due to the presence of a 
large number of positively charged residues. This peculiar surface potential charge 
distribution has been proposed to be responsible for binding and condensing DNA, as 
well as for activating human leukocytes (Zanotti et al. 2002; Ceci et al. 2007). HP-NAP is 
the only protein of the Dps family capable of activating human leukocytes. HP-NAP has 
been found to promote neutrophil adhesion to endothelial cells and to induce neutrophils 
to produce reactive oxygen radicals. Moreover, HP-NAP has been found to activate the 
Toll-like receptor 2 (TLR2) and, thus, stimulate either neutrophils or monocytes to 
increase their expression of interleukin-12 (IL-12), a key cytokine for the differentiation of 
CD4+ T cells into the Th1 phenotype (Trinchieri 2003). HP-NAP is released in the medium, 
probably after cell lysis, and binds to the bacterial surface where it can act as an adhesin, 
mediating binding to mucin or to polymorphonuclear leukocyte sphingomyelin. Therefore, 
HPNAP is able to cross the epithelium efficiently and to promote rapid neutrophil adhesion 
in the infection site. Here, the H. pylori protein induces polymorphonuclear leukocytes to 
synthesize and release several pro‐inflammatory cytokines responsible for the 
inflammation process. Moreover, after crossing epithelial monolayers, HPNAP is also 
able to activate the underlying mast cells to release tumor necrosis factor-α (TNF-α) and 
other pro-inflammatory molecules, and to recruit neutrophils and monocytes from the 
blood, thus amplifying the flogistic process (de Bernard and D’Elios 2010; Choli-
Papadopoulou 2011). This inflammation could promote H. pylori growth by releasing of 
nutrients from the degraded epithelium, for the bacterial survival and colonization; but the 
specific role of HP‐NAP inside the bacterium is still controversial.  
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1.6 HELICOBACTER PYLORI AND GASTRODUODENAL DISEASES 
 
 
Fig. 1.31 Main H. pylori colonization and persistence factors related to gastroduodenal diseases. Adapted from Salama et 
al., 2013. 
H. pylori typically colonizes the human stomach without causing adverse consequences 
for many decades; but its presence is associate with an increased risk of several 
diseases, including peptic ulcers, noncardia gastric adenocarcinoma, and gastric 
mucosa-associated lymphoid tissue (MALT) lymphoma (Cover and Blaser 2009). 
Interestingly, according to the strong association between H. pylori and gastric cancer, 
the World Health Organization (WHO) classified the pathogen as a Class I Carcinogen 
(WHO-IARC 1994), and now it is considered the most common etiologic agent of 
infection-related cancers. Since H. pylori is so well adapted to its environment, in most 
cases the predominant symptom of a prolonged infection is a mild gastritis resulting from 
the inflammation process linked to nutrients acquisition. One salient factor contributing to 
the co-existence of H. pylori in the human stomach is the localization of the bacterium 
within the gastric mucus layer, without any substantial invasion of host tissue. Moreover, 
H. pylori is versed in evading immune recognition by the host, by displaying a phase 
variation and an antigenic variation of its surface components, like outer membrane 
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proteins (OMPs) and lipopolysaccharide (LPS) antigens, as previously described. 
Incorporation of a modified form of cholesterol into H. pylori membranes and the coating 
of the bacterium with host molecules, such as plasminogen, might represent additional 
types of antigenic disguise (Cover and Blaser 2009). Flagellar proteins and many 
bacterial factors also appear to be designed to reduce inflammation or recognition by the 
host immune system. Therefore, H. pylori induces a robust but specific form of chronic 
inflammation that is ineffective in clearing the infection, while avoiding forms of 
inflammation that would eliminate it (Amieva and El-Omar 2008).  
A discrete incidence (approximately 10%) of severe gastrointestinal diseases has been 
correlated with the long‐term stomach colonization by H. pylori. The various and divergent 
clinical outcomes deriving from the H. pylori infection are dictated by a complex balance 
between host genetic factors, bacterial virulence determinants, environmental 
components, such as salt consumption, general alimentary habits, smoking, and living 
conditions (Fig. 1.32; Sgouras et al. 2015). Moreover, recently the gastrointestinal 
microbiota, either at the time of exposure or over the course of infection, has been 
evidenced as another potential determinant in the clinical outcome (Martin and Solnick 
2014). The basic process that mediates H. pylori-induced damage is gastritis with its 
associated humoral and cell-mediated immune mechanisms. The extent and distribution 
of this gastritis ultimately determine the clinical outcome. Three main gastric phenotypes 
have been identified: “simple or benign gastritis”, “duodenal ulcer”, and “gastric cancer” 
phenotypes, respectively (Fig. 1.33). Each phenotype is associated with a set of 
pathophysiologic abnormalities that could explain why a certain outcome occurs (Amieva 
and El-Omar 2008). Therefore, colonization with H. pylori induces a chronic gastritis in all 
infected individuals. Although the majority of infections are asymptomatic, however, as 
result of long-term colonization, 10%-15% of infections lead to the development of peptic 
ulcer disease; especially, H. pylori is associated with 95% of duodenal ulcers and 80% of 
gastric ulcers. Infection with this pathogen is a significant risk factor for the development 
of gastric cancer and 1%-3% of 
infected individuals develop 
the disease. Infection is 
associated in particular with 
intestinal-type (approximately 
90% of patients) rather than 
diffuse-type gastric cancers 
Fig. 1.32 Pathophysiologic and clinical outcomes of chronic H. pylori infection. 
Adapted from Amieva and El-Omar 2008 
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(approximately 32% of patients). The risk of developing gastric cancer is reduced in 
patients with duodenal ulcers. The gastric mucosa does not normally contain any 
mucosa-associated lymphoid tissue (MALT), however the pan-gastric inflammation 
induced by H. pylori infection results in the development of MALT. In < 0.1% of infected 
individuals this develops into B cell MALT lymphoma; however, at early stages the 
lymphoma can be cured by eradication of H. pylori (Dunne 2014).  
First of all, H. pylori polymorphism plays a role crucial in planning the consequences of 
the colonization. Most of polymorphisms associated with various disease risks are 
associated to genes that encode bacterial factors responsible of the interaction with host 
cells. H. pylori strains isolated from unrelated individuals exhibit a high level of genetic 
diversity. Nucleotide sequences of conserved genes are 92%–99% identical among 
different H. pylori strains, but several bacterial genes are more highly diverse in 
sequence; additionally, there is a considerable variation in gene content (Cover and 
Blaser 2009). One of the most striking differences among H. pylori strains is the presence 
or absence of the cag pathogenicity island (cagPAI), which also encodes the virulence 
effector CagA. Several studies have demonstrated that cagPAI positive H. pylori strains, 
particularly in Western populations, are associated to a higher risk of peptic ulcer disease, 
premalignant gastric lesions, and gastric cancer, than the strains lacking cagPAI (Basso 
et al. 2008). 
Moreover, as previously mentioned, a higher number of tyrosine phosphorylation EPIYA-
C motifs in CagA is correlated with a higher risk of gastric cancer. All H. pylori strains 
contain a vacA gene, encoding a further very common virulence factor, the vacuolating 
cytotoxin A. The gene presents a high polymorphism, with variations at several loci; 
consequently, the protein effector shows different levels of vacuolating cytotoxin activity. 
The major variation occurs in the vacA signal region (s1 or s2) and the middle region (m1 
or m2). Type s1/m1 strains are highly toxigenic and s2/m2 strains are nontoxigenic; while 
s1/m2 strains are often intermediate. Few s2/m1 strains have been described, suggesting 
the existence of a strong negative selection toward this allele (Basso et al. 2008). 
Therefore, both s1/m1 and s1/m2 strains are associated with peptic ulcer disease; 
additionally, s1/m1 strains are strongly related to gastric cancer risk (Atherton et al. 1997). 
Similarly, H. pylori strains expressing outer membrane proteins (OMPs), such as BabA, 
SabA, and OipA, are predicted to be highly interactive with the host cells and associated 
with increased gastric epithelial disease risk, respect to strains lacking these adhesion 
factors (Israel and Peek 2001; Cover and Blaser 2009). Therefore, concordant with these 
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evidences, CagA+, s1-VacA+, BabA+ strains are associated with increased gastric 
mucosal inflammatory cell infiltration and increased gastric epithelial injury, compared to 
strains that do not express these factors. In addition, the colonization density of CagA+, 
s1-VacA+, BabA+ strains is typically higher than that of strains that do not express these 
factors (Cover and Blaser 2009).  
The ability of H. pylori to cause disease depends not just on bacterial factors, but also on 
environmental and host factors. A number of host gene polymorphisms have been 
identified which are thought to increase H. pylori colonization and increase susceptibility 
to disease (Dunne 2014). In effect, genetic polymorphisms directly influence 
interindividual variation in the magnitude of cytokine response, and this clearly contributes 
to an individual ultimate clinical outcome (Amieva and El-Omar 2008).  
Especially, the IL-1 gene cluster is composed of three genes which encode the pro-
inflammatory cytokines IL-1α and IL-1β, as well as their endogenous receptor antagonist 
IL-1ra. IL-1β is a potent inhibitor of gastric acid secretion in vivo. H. pylori infection results 
in an upregulation of IL-1β, which plays an important role in initiating and amplifying the 
immune response. Additionally, polymorphisms in IFN-γ are associated with infection by 
cag positive strains and polymorphism in TNF-α are associated with development of 
peptic ulcer disease. While polymorphisms in IL-10 have been demonstrated to favor the 
development of intestinal metaplasia and non-cardia gastric cancer. Therefore, 
polymorphisms which effect cytokine function may explain the highly variable outcomes 
of H. pylori infection (Zambon et al. 2005; Dunne 2014). Moreover, polymorphisms in 
genes involved in the innate and adaptive immune response play a role in host 
susceptibility to infection and disease progression. Particularly, IL-2 plays an important 
role in mediating the T lymphocyte response, including the Th1 phenotype which 
dominates the immune response to H. pylori infection. An increase in IL-2 production as 
a result of a gene polymorphism has been shown to be associated with a decreased risk 
of H. pylori infection in adults (Queiroz et al. 2009). Furthermore, there is an association 
between polymorphisms in the gene encoding the membrane-associated mucin MUC1, 
which result in shorter MUC1 alleles, and H. pylori-related gastritis. Short MUC1 alleles 
have also been linked to the development of gastric adenocarcinoma and intestinal 
metaplasia in patients with chronic gastritis. Moreover, the secretor status of an individual 
is also thought to influence their susceptibility to infection. A Fucα1,2-glycan is expressed 
along the gastro-intestinal tract of individuals with a positive secretor status, which 
express the secretor-(fucosyl)transferase. Studies involving infected secretor and non-
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secretor mice have revealed that the non-secretor mice display reduced adhesion of H. 
pylori to gastric tissue (Magalhaes et al. 2009). A functional polymorphism has been 
described in TLR4 gene, resulting in alteration in the extracellular domain of the receptor. 
TLR4 receptor is responsible of recognition and interaction with lipopolysaccharide (LPS) 
antigen of H. pylori. Defective signaling through the mutant TLR4 receptor are associated 
with an exaggerated and destructive chronic inflammatory phenotype in H. pylori-infected 
subjects. This phenotype is characterized by gastric atrophy and hypochlorhydria, the 
hallmarks of subsequent increased risk of gastric cancer. Therefore, bacterial factors 
alone cannot explain why some individuals develop disease upon H. pylori infection 
whereas others remain asymptomatic. The individual‐specific synergy between bacterial 
and host polymorphisms is crucial in determining disease risk and different clinical 
outcome as result of H. pylori colonization (Amieva and El-Omar 2008; Dunne 2014). 
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1.7 ERADICATION AND POTENTIAL BENEFITS 
 
 
H. pylori has started to colonize humans so long ago that it is not surprising that its 
relationship is that of both a commensal bacterium and a pathogen, causing some 
diseases and possibly protecting against others; a growing body of literature suggests 
that the eradication of H. pylori might also be associated with an increased risk of other 
diseases (Dorer, Talarico, and Salama 2009).  
An absence of H. pylori could indicate that an individual was never colonized, or that the 
microorganism was present earlier in life and subsequently spontaneously eradicated 
(Cover and Blaser 2009). Natural elimination of the bacterium is a rare event, occurring 
mainly soon after acquisition in childhood (Xia and Talley 1997). In order to eradicate H. 
pylori from stomach of adults, and even of children, it is necessary a specific treatment. 
The ideal H. pylori eradication therapy should be safe, effective (eradication rate > 90%), 
simple, and economical (Zhang 2015). The first-line treatment is a triple therapy, 
consisting of a proton pump inhibitor PPI, clarithromycin and amoxicillin or metronidazole, 
in populations with less than 15–20% clarithromycin resistance rate (Malfertheiner et al. 
2007). The eradication rate of this triple therapy is currently less than 80% in most parts 
of the world (B. G. Kim et al. 2007); antibiotic resistance is the main reason for this 
treatment failure. The recourse to antibiotic treatments in the past has dramatically 
increased the resistance of H. pylori and this evidence has always been underestimated. 
Therefore, these observations lead to strong rationale for development of effective 
vaccines against H. pylori, since they could also allow to prevent the colonization. Over 
the last years, several approaches have been devised to generate an efficient vaccine 
against the bacterium. Whole bacterial cell sonicates (first-generation vaccines) and 
individual H. pylori proteins (second-generation vaccines) have been used as antigens to 
stimulate immunity in the host, but they require adjuvants to elicit effective protection 
(Ferrero and Labigne 2001). The results of H. pylori vaccine development efforts, both 
preclinical and early clinical, have so far been disappointing. Sterilizing immunity is rarely 
achieved, even in animal models, and there is no consensus on the delivery route, 
adjuvants and choice of antigen. The most promising preclinical results have generally 
been obtained with vaccination strategies that aim to induce protective T cell-mediated 
immunity rather than humoral immunity, with local gastric T helper 1 (Th1) and Th17 
responses being reasonably good correlates of, and prerequisites for, protection 
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(Salama, Hartung, and Muller 2013). New immunization approaches are going to be 
explored in the near future, including live vector vaccines, DNA vaccines, microsphere 
vaccines, ghost vaccines. Briefly, DNA vaccines carry DNA sequences encoding H. pylori 
antigens and they are known because of their safety and efficacy. Microspheres 
effectively induce humoral and mucosal immunity as well as cell mediated immunity, 
whereas bacterial ghosts are empty cell envelopes without cytoplasmic contents that 
retain their cellular morphology with native antigenic structures. Several questions about 
when and whom to vaccinate will need to be appropriately answered, and a cost-effective 
vaccine production and delivery strategy will have to be useful for developing countries 
(Agarwal and Agarwal 2008). Besides the development of new more efficient vaccine 
against H. pylori, the medical research is also focused on finding new pharmacological 
targets in order to develop new antibiotic treatments, required for a successful eradication 
of the pathogen. The characterization of new potential pharmacological protein targets is 
topic of my research project.  
Conversely, the complete eradication of H. pylori has been suggested to be associated 
with a potentially increased risk of onset of other disorders. Not surprisingly, most of the 
potential benefits (as with the costs) come from cagA+ strains, which are the most 
interactive with their human hosts. Firstly, an inverse association has been observed 
between the presence of H. pylori (especially cagA+ strains) and disorders such as 
gastroesophageal reflux disease, Barrett’s esophagus and esophageal adenocarcinoma. 
One potential mechanism for this effect could be that H. pylori colonization diminishes 
gastric acidity; therefore, during reflux episodes, the acidic refluxate might be less 
damaging to the esophageal epithelium. Another hypothesis is that H. pylori alters the 
expression of multifunctional gastric hormones that have effects on esophageal tissue. 
Furthermore, the incidence of asthma and related disorders, such as allergies, especially 
those that appear during childhood, has been observed to arise as result of the absence 
of H. pylori. This inverse association is specific for childhood-onset asthma, and is most 
pronounced for cagA+ strains. It is possible that the presence of cagA+ H. pylori strain in 
the stomach leads to gastric recruitment of T-cell populations, including regulatory T cells, 
that ultimately affect the activities of T-cells present in other mucosal and cutaneous sites. 
Recently it has been suggested that H. pylori colonization might confer protection against 
various other infectious diseases. Moreover, H. pylori has been proposed to protect 
against diarrheal diseases, although this relationship has not been consistently observed. 
Mechanisms for protection might include production of antibacterial peptides by the 
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pathogen or the host, activating the immune system as an adjuvant, competition for niche, 
or hypergastrinemia leading to maintenance of gastric acidity throughout childhood. 
Finally, H. pylori presence is also associated to benefits on metabolism, since it is 
involved in the regulation of two hormones that control the body weight, namely leptin and 
ghrelin, partially secreted by the stomach. H. pylori-positive persons produce lower 
amounts of ghrelin than do H. pylori-negative persons and the eradication of the 
bacterium is associated with a subsequent increase in ghrelin production, resulting in 
long-term metabolic consequences (Rothenbacher et al. 2000; Blaser, Chen, and 
Reibman 2008; Cover and Blaser 2009). Therefore, if continued studies confirm the 
findings reported above, then the medical approaches to H. pylori infection will need to 
change. 
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RESEARCH PROJECT AND EXPERIMENTAL METHODS 
 
The main purpose of this research thesis is focused on identification and structural 
characterization of new potential pharmacological targets of the pathogen H. pylori. There 
is no effective therapy for eradicating H. pylori infection. Combination therapies employing 
one proton pump inhibitor and two or three antibiotics have been used as preferred 
treatments. However, these therapies have several inherent problems, including the 
appearance of resistance to the antibiotics used and associated adverse effects, the risk 
of re-infection and the high cost of antibiotic therapy. Alternative therapeutic approaches 
are required to control H. pylori infection (Ayala et al. 2014). The determination of the 
three-dimensional structure by x-ray crystallography of H. pylori proteins essential for 
colonization or pathogenesis might allow to develop new potential therapeutic molecules. 
The strategy adopted consists of the following steps: 
- selection of candidates suitable for crystallization; 
- amplification of the corresponding gene by PCR from genomic DNA belonging 
to the G27 strain; 
- cloning into expression vectors and eventual insertion of affinity tags to improve 
the purification steps; 
- small scale expression trials in E. coli and tests of solubility of the recombinant 
constructs in order to identify the most effective protocol of expression; 
- small scale purification trials in order to define the most fruitful and quality 
purification protocol; 
- characterization in solution; 
- crystallization trials adopting various techniques and performing several 
precipitant solution screening; 
- X-ray diffraction tests and optimization of initial crystals; 
- X-ray diffraction data collection at synchrotron facilities; 
- data processing and structure determination; 
- further investigations in order to functionally characterize the candidates. 
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2.1 SELECTION OF CANDIDATES 
 
H. pylori strain G27, which was originally isolated from an endoscopy patient from 
Grosseto Hospital (Tuscany, Italy), has been extensively used in H. pylori research. It is 
readily transformable and therefore amenable to gene disruption. In addition, it efficiently 
delivers the translocated effector protein CagA to cells in culture. The complete genome 
sequence was determined at the Washington University School of Medicine Genome 
Sequencing Center. Genomic DNA from an isolate of strain G27 was purified by CsCl 
gradient centrifugation and used to generate plasmid and fosmid libraries, both of which 
were subjected to whole shotgun Sanger sequencing (4,609 total reads). The G27 
genome consists of a single circular 1,652,983 bp chromosome that is AT rich (61.1%), 
contains 1,515 open reading frames (ORFs), and is similar in size and composition to the 
other published H. pylori genomes of strains 26695, J99, and HPAG. G27 also contains 
one 10,032 bp AT-rich (65.2%) plasmid that encodes 11 genes and resembles the 
plasmid found in strain HPAG. The G27 cag pathogenicity island (cagPAI) contains a 
transposon, but this does not disrupt any of the open reading frames and is not predicted 
to interfere with the type IV secretion system delivery of CagA into host cells. Similar to 
strains J99 and HPAG but in contrast to 26695, G27 has a single plasticity region, which 
contains many H. pylori-specific genes that are variably present between strains. G27 
contains 58 genes that are not found in 26695, J99, or HPAG. The majority of these G27-
specific genes are predicted to encode hypothetical proteins (Baltrus et al. 2009). 
The criterion for selection of protein candidates is based on two main features; the 
possible pathogenic role and the predicted solubility have been evaluated. The soluble 
nature of a protein, in addition to other structural features, is an essential prerequisite for 
achieving a successful crystallization. Literature searches have been conducted to 
evaluate metabolic pathways as new potential targets for therapeutic treatment. In this 
regard, effector proteins involved in H. pylori crucial processes, such as acid adaptation, 
motility, and redox metabolism, have been taken into account. Moreover, G27-specific 
genes encoding hypothetical proteins have been considered an interesting 
pharmacological target since they could play a key role in bacterial survival. Taking into 
account the information from literature, the structural predictions and the functional 
features, 6 candidates have been selected, of both known and unknown function, as 
suitable subjects for recombinant production in E. coli, purification and following 
crystallization. 
   The project 
 
105 
 
2.2 MOLECULAR CLONING 
 
 
The first step toward protein production is the cloning of the gene encoding the protein of 
interest into a proper expression vector. The selected genes have been amplified by PCR 
from a genomic DNA sample extracted from H. pylori strain G27, using specific primers 
designed individually for each open reading frame. Without exception, the candidates 
have been cloned as fusion proteins with an affinity tag, which might help to isolate the 
recombinant fusion protein by affinity chromatography and discard the majority of E. coli 
proteins. The PCR products have been purified by 1% agarose gel and subsequently 
cloned into a pET vector that simultaneously works as either cloning and expression 
vector (Fig. 2.1). These pET vectors are optimized for a rapid cloning of His-tagged 
proteins and are under the control of an inducible promoter (T7 RNA polymerase 
promoter) with tight regulation for high expression as well as plasmid stability. These 
vectors are provided in a pre-processed, linearized format for rapid enzyme-free cloning, 
by homologous recombination. The open reading frames are directionally cloned into the 
pET vector, in frame with a choice of either an N- or C-terminal 6-His affinity tag. This 
approach allows to limit as much as possible the time-consuming procedure of traditional 
cloning methods. In most cases full-length genes have been cloned. For those genes that 
are predicted to encode a secretion signal sequence, only the portion of the gene 
encoding the mature protein has 
been cloned, in order to avoid 
that the signal sequence made 
the product more toxigenic to E. 
coli. Prior to proceed with protein 
expression trials, all the 
constructs have been confirmed 
by DNA sequencing. 
 
 
2.3 PROTEIN EXPRESSION IN E. COLI AND TEST OF SOLUBILITY 
 
Once the gene of interest has been cloned into the selected expression vector, small 
scale trials were performed to control and optimize level and quality of protein expression. 
Fig. 2.1 pETite expression vectors (Lucigen), widely used in this research 
project. 
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Escherichia coli remains the preferred host for heterologous expression of recombinant 
proteins in order to carry out structural studies. This bacterium is the most characterized 
host for protein expression and has numerous advantages over other hosts. These 
advantages include ease of handling, well-known genetics, relatively inexpensive culture 
medium, availability of vectors and fast high-density cultivation and expression (Makrides 
1996; Sørensen and Mortensen 2005a; Sorensen and Mortensen 2005b). Additionally, 
E. coli is a Gram-negative bacterium, like H. pylori, and it can be considered the best 
choice to express H. pylori proteins. The sequenced plasmid vectors have been directly 
transformed into E. coli BL21(DE3) cells (Lucigen), which were used for preliminary small 
scale expression trials. Expression tests have firstly been carried out by growing cultures 
inoculated with single colonies in small scale using 10-100 ml of Luria Bertani media and 
taking aliquots of the cultures prior to and following growth induction by adding isopropyl-
β-D-thiogalactoside (IPTG). Protein expression has been induced with 0.5-1 mM IPTG 
and its duration has depended on the growth temperature, specifically 3 h at 37°C, 5 h at 
30°C, and overnight at 20°C. Whole-cell lysates have been prepared from cultured cells, 
by a French pressure cell press or by sonication, and analyzed by Coomassie-stained 
15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. If the 
protein expression was too low or not detected, further E. coli strains, which can assist in 
case of problematic target, have been tested. BL21 (DE3) pLysS cells (Invitrogen) contain 
a chloramphenicol resistant plasmid, pLysS, which carries the gene encoding T7 
lysozyme that inhibits the background expression level of target genes under the control 
of the T7 promoter, but does not interfere with the level of expression achieved following 
induction by IPTG. C41 (DE3) cells (Lucigen), derived from BL21(DE3), have a mutation 
that reduces the level of T7 RNA polymerase activity, thereby preventing cell death 
associated with overexpression of many recombinant toxic proteins. C43 (DE3) cells 
(Lucigen), derived from C41(DE3), carry at least one additional mutation that provides a 
greater level of tolerance to toxic proteins. SHuffle® Express Competent E. coli cells (New 
England Biolabs) are engineered to form proteins containing disulfide bonds in the 
cytoplasm. Lemo21 (DE3) cells (New England Biolabs) offer the host features of 
BL21(DE3) while also allowing for tunable expression of difficult proteins, achieved by 
varying the level of lysozyme (lysY), the natural inhibitor of T7 RNA polymerase, 
modulated by adding L-rhamnose to the expression culture. Finally, ArcticExpress (DE3) 
cells (Agilent) are engineered to address the common bacterial gene expression hurdle 
of protein insolubility and provide an approach to increasing the yield of soluble protein 
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produced in E. coli at low temperature, since they co-express the cold-adapted 
chaperonins Cpn10 and Cpn60 from the bacterium Oleispira antarctica. 
Besides the determination of the expression conditions, the composition of lysis buffers 
has been evaluated to achieve the highest yield of soluble protein. The protein solubility 
represents one of the most relevant bottleneck for production of protein for X-ray 
crystallography.  Cultured cells have been resuspended in several lysis buffers, which 
differ in pH value (at least 2 units different from the pI, to avoid the protein aggregation), 
salt concentration, and eventual additives, lysed by French pressure cell press or 
sonication, and finally centrifuged; the supernatant and pellet from the centrifugation have 
been analyzed by 15% SDS–polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blotting to compare solubility of the protein in the various lysis buffers. If most of 
the protein was found in the pellet, as inclusion bodies, changes in the expression 
conditions have been made, especially in E. coli strain and growth temperature, to 
decrease the rate of protein translation or enhance protein folding. Despite several trials 
to improve the expression conditions and the yield of the soluble fraction, the proteins 
could remain insoluble or behave poorly. Therefore, in case of high expression level of 
unfortunately insoluble protein, the recovery of the recombinant product has been 
attempted, by denaturation and subsequent refolding, using solubilizing buffers 
supplemented with 8 M urea or 6 M Guanidine hydrochloride.   
 
 
Fig. 2.2 Mechanism of induction of expression by IPTG and T7 promoter. Adapted from Quora web site. 
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2.4 PROTEIN PURIFICATION AND CHARACTERIZATION 
 
Purification should yield a sample of protein containing only one type of molecule; 
crystallization step requires samples characterized by high degree of purity and 
homogeneity. Since every protein have a unique behavior, every purification usually 
requires constant assessments and modifications based upon the peculiar features of the 
target. After having developed the expression conditions on small scale, the protein 
expression has been reproduced on large scale. Purification has generally been 
approached once a relatively high yield of soluble protein has been achieved. The 
cultured cells have been resuspended in selected lysis buffer and lysed by French press 
or sonication. All lysis buffers have also contained protease inhibitors cocktail in order to 
suppress protein degradation. After the lysis cell debris has been removed by vacuum 
centrifugation at 18,000 rpm for 30 min at 4 °C. Protein solubility has been checked on 
15% SDS–PAGE and Western blotting by loading both the pellet and the soluble fraction 
after centrifugation. Proteins can be purified by chromatography, on the basis of such 
characteristics as solubility, size, charge, and binding affinity. The chromatographic 
separations were generally operated on an ÄKTA FPLC instrument (GE Healthcare). 
Firstly, an affinity chromatography has been performed for each protein, based on the 
fused tags, which might help to isolate the recombinant protein and discard the majority 
of the other E. coli proteins. Since all the constructs were 6-His-tagged, the first 
chromatographic step of purification has been a standard immobilized metal affinity 
chromatography (IMAC). After extensive washing the proteins have been eluted applying 
an imidazole gradient (0-500 mM imidazole). If the recombinant fusion protein was not 
enough pure after affinity chromatography, it has been concentrated by ultrafiltration, with 
suitable cut-off, and loaded onto a gel-filtration column, chosen according to the molecular 
weight of the product. Gel-filtration chromatography, also named size-exclusion 
chromatography, allows to separate a mixture of proteins on the basis of their size. The 
affinity tag sometimes may negatively affect the protein purification, since it can interfere 
with folding, oligomerization, protein localization. In case of unsuccessful purification by 
these leader chromatographic techniques, the preparation of pure proteins has been 
performed by a classical method, which includes three steps: fractional precipitation with 
saturated ammonium sulfate solution, ion-exchange chromatography, and finally gel-
filtration chromatography. Since the His-tag may affect the crystallization process due to 
its flexibility and ionic charge, it has been necessary to remove it. In this regard, the 
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proteins of interest have been cloned into the vectors with a protease restriction site 
between the affinity tag and the construct. The most efficient one is the TEV protease, 
from the Tobacco Etch Virus, which shows high specificity, is relatively easy to make in 
large amounts and cleaves in most case leaving a native N-terminus. Specifically, 
recombinant 6-His-tagged TEV proteases have been used, enabling an easy separation 
of the enzyme by means of a new affinity chromatography after the cleavage.  
Subsequently, the purified proteins have been characterized in solution by: 
- analytical gel-filtration chromatography, to evaluate the homogeneity and eventual 
oligomeric form of the samples; 
- circular dichroism (CD) to ensure the correct folding of the protein product and 
estimate the content of secondary structures; 
- UV/Vis spectroscopy; 
- SDS-PAGE and Western blotting; 
- functional essays. 
 
 
2.5 PROTEIN CRYSTALLIZATION 
 
If the protein samples presented high 
degree of purity and homogeneity, they 
have been submitted to crystallization 
trials. The proteins have been 
concentrated by ultrafiltration to 5-20 
mg/ml as starting concentration for 
crystallization trials. Optimal conditions 
for crystallization are very difficult to 
predict, since they depend on a large 
number of variables, such as pH, 
precipitant, salt, protein concentration, additives, buffer, temperature, detergents, organic 
compound, etc. An effective way to search through this large number of parameters that 
may influence crystal growth is to conduct a sparse matrix search of specific 
crystallization conditions (Krauss et al. 2013). First crystallization trials have been 
performed using commercial crystal screening kits, specifically Structure Screen I and II 
(Molecular Dimension), PACT Suite (Qiagen), PEGs Suite (Qiagen), Crystal Screen I and 
Fig. 2.3 Oryx8 Protein Crystallization Device (Douglas 
Instruments, UK) 
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II (Hampton Research), JCSG Suite (Molecular Dimension), AmSO4 Suite (Qiagen). Both 
hanging drop and sitting drop vapor-diffusion methods have been approached; these 
techniques rely on the exchange of either water and/or some volatile agents between a 
micro-drop of mother liquor, containing the protein, and much larger reservoir solution. 
Moreover, microbatch-under-oil method has also been approached; this technique allows 
to regulate the rate of water evaporation through the layer of oil, leading to a concomitant 
increase in the concentrations of both protein and precipitant until the nucleation point is 
reached, as well as preventing complete desiccation of the drops. The crystallization 
experiments have been performed manually and also using an Oryx8 crystallization robot 
(Douglas Instruments). Quantity of reservoir solution, drop size, ratio between protein 
sample and precipitant have been varied in each experiment. Mainly three crystallization 
temperatures were tested: 4 °C, 12 °C, 20 °C. For initial crystallization condition 
screenings have been used 96-well crystal plates (Douglas Instruments); conditions that 
yielded crystals have been optimized with manually prepared condition using 24-wells 
plates (Hampton Research). Moreover, microseeding and co-crystallization experiments 
have been performed, in order to optimize the crystal quality and to further investigate the 
structural features of the protein, respectively. Manual inspection of crystallization 
experiments has been carried out under an optical microscope; furthermore, the nature 
and quality of crystals have been evaluated using a fluorescence microscope. 
 
 
2.6 DATA COLLECTION AND STRUCTURE DETERMINATION 
 
Protein crystals are very often thin and small (microns to millimeters, in a few lucky 
events) and rich in solvent content, between 30 to 70 %. Therefore, it is often a great 
advantage to have access to high brilliance synchrotron sources to collect X-ray data with 
good quality and high resolution. Moreover, the synchrotron radiation is tunable, thus it 
allows the use of any suitable wavelength in the spectral range selected (usually between 
0.9 and 2 Å for proteins). This property is particularly relevant in multiple wavelength 
anomalous dispersion (MAD) technique and when wavelengths shorter than 1 Å are 
necessary. Specifically, X-ray diffraction data have been collected at SLS (Villigen, 
Switzerland) and ESRF (Grenoble, France). Determination of the three-dimensional 
structure of proteins is achieved by several techniques, such as Multiple wavelength 
Anomalous Dispersion (MAD), Multiple Isomorphous Replacement (MIR), Single 
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wavelength Anomalous Dispersion (SAD), Single Isomorphous Replacement (SIR), and 
Molecular Replacement (MR). Since the solved protein structure presented a structural 
homologue, molecular replacement technique has been adopted to determine it. This 
method relies upon the existence of a previously solved protein structure which is 
homologous to the unknown structure and allows to quite easily solve the phase problem. 
The goal is to orient and position the determined model, such that it coincides with the 
position of the unknown protein in the crystal; the model can then provide phase 
information for the unknown structure. 
 
In the following experimental section, each chapter is dedicated to a protein or a group of 
proteins; the experimental procedures, briefly described above, are applied to the specific 
subjects and explained more in detail.  
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3.1 INTRODUCTION 
 
Carbonic anhydrases (carbonate hydro-lyase; EC 4.2.1.1) are Zn2+-containing enzymes 
that catalyze the reversible conversion of carbon dioxide to bicarbonate (Tripp, Smith, 
and Ferry 2001). This process is extremely rapid, with rate constants in the region of 105–
106 s-1 and following a two-step ping-pong mechanism; on the other hand, the reversible 
hydration occurs rather slowly in the absence of a catalyst (Lindskog and Coleman 1973). 
Since carbonic anhydrase is ubiquitous in many tissues and plays several important 
physiological roles in humans, such as bone resorption, gluconeogenesis, production of 
body fluids, acid–base balance, secretion, signal transduction, oncogenesis, transport of 
CO2 and HCO3- (Sly and Hu 1995), it is considered to be an attractive pharmacological 
target. Its inhibitors are clinically used to treat diseases as different as glaucoma, 
convulsions, osteoporosis and obesity; the enzyme is also a tumour marker (Supuran and 
Scozzafava 2007; Gilmour 2010). These seemingly disconnected functions are mediated 
by specific isoforms belonging to the α-carbonic anhydrase family. In humans 16 
members of this family have been identified which have distinct tissue-specific 
expression, kinetic properties, and sensitivity to inhibitors (Becker, Klier, and Deitmer 
2014). The mammalian carbonic anhydrase isoforms have been extensively 
characterized (Lindskog 1997); the catalytic mechanism has been thoroughly described 
(Boone et al. 2014) and structural studies have led to the deposition of 477 crystal 
structures in the Protein Data Bank (http://www.pdb.org), either in the native form or with 
inhibitors or ligands bound. In mammals only one class of carbonic anhydrase is present, 
the α-carbonic anhydrase, whilst five phylogenetically and structurally different classes of 
the enzyme, α-carbonic anhydrase, β-carbonic anhydrase, γ-carbonic anhydrase, δ-
carbonic anhydrase and ζ-carbonic anhydrase, have been found in bacteria, archaea and 
diatoms. Very recently, a new carbonic anhydrase family, named η-carbonic anhydrase, 
has been identified (Del Prete et al. 2014). 
Specifically, bacteria encode for enzymes belonging to the α-, β-, and γ-carbonic 
anhydrase classes; in particular, α-carbonic anhydrases have been detected only in the 
genomes of Gram-negative bacteria (only in six microorganisms, including  H. pylori, as 
well as Neisseria gonorrhoeae, Vibrio cholerae, Sulfurihydrogenibium yellowstonense, 
Sulfurihydrogenibium azorense and Ralstonia eutropha), whereas β-carbonic 
anhydrases and γ-carbonic anhydrases have been identified in both Gram-negative and 
Gram-positive bacteria (Capasso and Supuran 2015).  
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These five different carbonic anhydrase classes are distinct in their secondary, tertiary 
and quaternary structures; specifically, the enzymes belonging to the α-class are usually 
monomeric, β-carbonic anhydrases are oligomeric with 2–8 monomers, and γ-carbonic 
anhydrases are homotrimers; whereas δ- and ζ-carbonic anhydrases are less well 
characterized. Despite the fact that these five classes do not share sequence or structural 
similarity, their active site structure and catalytic mechanism are common, a clear 
example of convergent evolution (Liljas and Laurberg 2000; Tripp et al. 2001). A 
peculiarity that differs these class of enzymes regards the catalytic site; carbonic 
anhydrases are generally Zn2+-containing metalloenzymes, except for the ζ form, which 
uses Cd2+ ion as alternative metal cofactor (Xu et al. 2008), since these enzyme are 
diffuse in marine diatoms, environment characterized by a very low concentration of Zn2+ 
ion (Park, Song, and Morel 2007); additionally, γ-carbonic anhydrases contain Fe2+ ion in 
vivo, at least in anaerobic Archaea (Macauley et al. 2009). Since they are often essential 
for the survival of the organism, bacterial carbonic anhydrases are considered to be 
potential pharmacological targets for antibacterial drugs (Supuran 2011). Carbonic 
anhydrases from bacteria and archaea have been less studied structurally than their 
human counterpart; the crystal structures of carbonic anhydrases of various classes from 
15 different bacteria and 2 archaea have been determined to date (Tab. 3.1). 
More in detail, despite the structural differences and functional variety among carbonic 
anhydrases from various organisms, they exhibit a general catalytic mechanism, that has 
been extensively studied using the human carbonic anhydrase II as a model. The 
catalysis occurs via a two-step ping-pong mechanism, that consists in the nucleophilic 
attack of the hydroxide ion coordinated to the Zn2+ ion on a carbon dioxide molecule 
(Lindskog 1997). 
 
                        Fig. 3.1 General catalytic mechanism of α-carbonic anhydrase. Adapted from Becker et al., 2014. 
In α-carbonic anhydrases, a member of which is examined in this Chapter, the binding of 
CO2 in the hydrophobic region adjacent to the Zn2+ cofactor promotes the nucleophilic 
attack by the Zn-OH- leading to the formation of HCO3- which is later displaced by the 
random diffusion of water in the active site. The transfer of a proton in the second step 
from the bound water molecule at the Zn2+ to an acceptor in the bulk solvent (B) is needed 
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to regenerate the OH- ion for a subsequent round of catalysis via a proton shuttle histidine 
residue. The intramolecular proton transport between the Zn2+-bound solvent and the 
proton shuttle histidine residue occurs via intervening water molecules in the active site. 
From the histidine residue, an intermolecular transfer event delivers the proton to the bulk 
solvent (Fig. 3.1; Becker, Klier, and Deitmer 2014). This transfer occurs on the order of 
106 s-1 for the human carbonic anhydrase II and is the rate-limiting step of the overall 
maximum velocity of catalysis; this kinetic properties are also shared by the bacterial α-
carbonic anhydrases (Chirica, Elleby, and Lindskog 2001; Russo et al. 2013; Vullo et al. 
2013). Additionally, the α-carbonic anhydrases from various organisms share the 
structural organization of the active site, containing a Zn2+ ion coordinated by three 
histidine residues and a H2O molecule/OH- ion. Interestingly, α-carbonic anhydrases can 
also catalyze the hydrolysis of esters (Steiner and Lindskog 1972) and thioesters (Tanc 
et al. 2015); whereas no esterase activity was detected so far for enzymes belonging to 
the other four classes. A peculiar common feature of the bacterial α-carbonic anhydrases 
known to date is a N-terminal signal sequence indicating a periplasmic or extracellular 
location and a possible physiological role in CO2 uptake processes. It can be assumed 
that the N-terminal sequence of a primordial carbonic anhydrase was changed by 
introducing a signal peptide and generating a new carbonic anhydrase class, named 
thereafter α-carbonic anhydrase, localized in a secretory compartment, such as the 
periplasmic space, in order to supply the metabolic needs also in these compartments 
(Capasso and Supuran 2015). 
H. pylori is a microaerophilic microorganism, which 
grows under atmospheres with low O2 partial 
pressures and, as a capnophile, requires a CO2-
enriched atmosphere (5 to 10% CO2). Thus, CO2 
appears to be an important component of the 
physiology of H. pylori, and it may also have a role in 
the pathogenicity of this bacterium (Bury-Moné et al. 
2008). Two different carbonic anhydrases are coded 
by the genome of H. pylori: the periplasmic α-carbonic 
anhydrase and the cytoplasmic β-carbonic anhydrase. 
In H. pylori the role of α-carbonic anhydrase (named 
HP1186 in strain 26695 and HPG27_1129 in strain G27 examined, respectively) is 
fundamental in buffering the pH of the periplasm, since when the ammonia and carbon 
Fig. 3.2 Role of α-carbonic anhydrase and β-
carbonic anhydrase in the maintenance of 
periplasmic pH in H. pylori. Adapted from 
Capasso and Supuran 2015. 
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dioxide produced by urease in the cytoplasm diffuse back, at least partially, into the 
periplasmic space, this catalyzes the conversion of CO2 to HCO3-. It is reasonable to 
assume that β-carbonic anhydrase in the cytoplasm plays the same role for the CO2 
molecules that do not freely diffuse out of the inner membrane (Fig. 3.2). The α-carbonic 
anhydrase expression in H. pylori has been shown to be induced under acidic conditions 
by a two-component (ArsRS) system (Wen et al. 2007). The α-carbonic anhydrase has 
been shown to be essential for acid acclimatization (Marcus et al. 2005a) and some α-
carbonic anhydrase defective H. pylori mutants exhibited only reduced stomach 
colonization in vivo, despite the fact that the enzyme does not seem to have an effect on 
urease activity in vitro (Bury-Moné et al. 2008). Both carbonic anhydrases from H. pylori 
have been proposed as alternative possible therapeutic targets for the treatment of 
patients infected by drug-resistant strains of the bacterium, and several inhibitors have 
been identified (Nishimori, Minakuchi, et al. 2006; Nishimori, Vullo, et al. 2006; Nishimori 
et al. 2007). Sulfonamides and their isosteres (sulfamates/sulfamides) constitute the main 
class of carbonic anhydrase inhibitors, which bind to the metal ion in the enzyme active 
site; an example of sulfonamide inhibitor, specifically acetazolamide (AAZ), bound to the 
catalytic site of α-carbonic anhydrase from H. pylori is reported in Fig. 3.3. Recently the 
dithiocarbamates, possessing a similar mechanism of action, were reported as a new 
class of inhibitors. Additionally, other families of compounds possess a distinct 
mechanism of action: phenols, polyamines, some carboxylates, and sulfocoumarins 
anchor to the Zn2+-coordinated water molecule; coumarins and five/six-membered 
lactones are prodrug inhibitors, binding in hydrolyzed form at the entrance of the active 
site cavity. (Becker et al. 2014). Finally, a strong inhibition has been reported for inorganic 
and complex anions interacting with Zn2+ ion, such as cyanide, cyanate, hydrogen sulfide, 
divanadate, tellurate, perruthenate, selenocyanide, trithiocarbonate, iminodisulfonate. It 
has been observed that α-carbonic anhydrase and β-carbonic anhydrase from H. pylori 
are highly inhibited by many primary sulfonamides, including the clinically used 
acetazolamide, ethoxzolamide, methazolamide, topiramate and sulpiride (Nishimori, 
Minakuchi, et al. 2006; Nishimori et al. 2007). Furthermore, certain carbonic anhydrase 
inhibitors, such as acetazolamide and methazolamide, have been observed to inhibit the 
H. pylori growth in cell cultures (Nishimori et al. 2008). In addition, previous studies have 
shown that treating H. pylori with carbonic anhydrase inhibitors drastically reduces the 
ability of the bacterium to survive within an acid environment, suggesting that carbonic 
anhydrases are essential for gastric colonization (Bury-Moné et al. 2008). 
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In this context, the design of selective inhibitors for α-carbonic anhydrase could help to 
better clarify the effective role played by this enzyme in the control of pH and could 
eventually open the way to improved classes of therapeutics against the bacterium. The 
crystallization of α-carbonic anhydrase with acetazolamide in an orthorhombic crystal 
form has been published (Modak, Revitt-Mills, and Roujeinikova 2013) and its structure 
complexed with the clinically used compound sulfonamide has recently been published 
(Fig. ; Modak et al. 2015; PDB accession codes: 4YGF, 4YHA). In this research project 
the crystal structure of the native form of α-carbonic anhydrase from H. pylori has been 
taken into account and the possible implications for its function have been discussed. 
 
 
Type 
Number of 
structures 
Ligands or variants 
Bacteria 
Escherichia coli β, γ 7 Bicarbonate, MSE 
Chlostridium difficile γ 1  
Halothiobcillus neapolitanus β 1  
Haemophilus influeanzae β 17 Co2+ substituted, 
bicarbonate, Y181F, 
V47A, G41A, D44N, 
W39F, P48S/A49P, 
W39V/G41A, 
W39V/G41A/P48S/A49P 
Micobacterium tubercolosis β 6 Thiocyanate ion 
Neisseria gonorreae α 2  
Pseudomonas aeruginosa β 2 CO2 
Salmonella enterica β 1  
Streptococcus mutans ? 1  
Sulfurihydrogenibium 
azorense 
α 1 AZM 
Sulfurihydrogenibium 
yellostonense 
α 1 AZM 
Thermosynecoccus 
elongatus 
γ 3  
Thermovibrio ammonificans α 3 Sulfanilamide, AZM, B3P 
Thiomicrospira crunogena α 1 Bicarbonate 
Vibrio cholerae β 2 Bicarbonate 
Archea 
Methanobacterium 
thermoautotrophicum 
β 1  
Methanosarcina thermophila γ 12 W19A, W19F, W19N, 
Y200A, Co substituted, 
bicarbonate 
 
 
 
Tab. 3.1 List of bacteria and archaea whose carbonic anhydrase crystal structure is known. The third column refers to 
the number of files present in the PDB. 
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3.2 SEQUENCE ANALYSIS 
 
 
 
Property Value 
Aminoacid 247 
Cysteines 2 
Molecular weight (kDa) 28324.3 
Theoretical pI 9.19 
Abs280nm (C=1mg/mL; b=1cm) 1.056 (all Cys reduced) 
Signal peptide Yes 
 
10 20 30 40 50 60
MKKTFLIALA LTASLIGAEN AKWDYKNKEN GPHRWDKLHK DFEVCKSGKS QSPINIEHYY 
70 80 90 100 110 120
HTQDKADLQF KYAASKPKAV FFTHHTLKAS FEPTNHINYR GHDYVLDNVH FHAPMEFLIN 
130 140 150 160 170 180
NKTRPLSAHF VHKDAKGRLL VLAIGFEEGK ENPNLDPILE GIQKKQNFKE VALDAFLPKS 
190 200 210 220 230 240
INYYHFNGSL TAPPCTEGVA WFVVEEPLEV SAKQLAEIKK RMKNSPNQRP VQPDYNTVII 
KRSAETR 
Fig 3.3 Binding of acetazolamide (AAZ) in the active site of α-carbonic anhydrase from H. pylori; right: 
electron density for AAZ bound to α-carbonic anhydrase is shown in green (Adapted from Modak et 
al., 2015); left: AAZ molecule (N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-acetamide), Ki=21 nM (Nishimori, 
Minakuchi, et al., 2006)  
 
Tab. 3.2 Some properties of α-carbonic anhydrase from H. pylori 
 
  Chapter III 
121 
 
α-carbonic anhydrase from H. pylori G27 is composed of 247 aminoacids, including 2 
cysteine residues, which will be demonstrated to be involved in an intramolecular disulfide 
bond formation. As mentioned before, the N-terminal end encodes a 21 aa secretion 
signal (Fig. 3.5), confirmed by SignalP 4.1 Server prediction (Petersen et al. 2011; 
http://www.cbs.dtu.dk/services/SignalP). The alignment of the aminoacid sequence of H. 
pylori α-carbonic anhydrase shows how the enzyme shares 39% identity with the α-
carbonic anhydrase from Sulfurihydrogenibium yellowstonense, 37% identity with the 
enzyme from Thermovibrio ammonificans, and 36% identity with the enzyme from 
Neisseria gonorrhoeae (Fig. 3.4). Moreover, the sequence alignment reveals that the 
aminoacid residues important for the catalytic mechanism are highly conserved, namely 
three histidine residues (red labelling in Fig. 3.4). 
 
 
 
 
 
Fig. 3.4 Sequence alignment of α-carbonic anhydrase from H. pylori strain G27, S. yellowstonense, T. ammonificans, 
and N. gonorrhoeae; in shades of blue the identity above 50% is shown; red labelling denotes the catalytic histidine 
residues (ClustalW and Jalview ver. 2.9.0b2). 
 
Fig. 3.5 α-carbonic anhydrase from H. pylori 
signal peptide prediction (SignalP 4.1 Server). 
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3.3 MATERIALS AND METHODS 
 
3.3.1 CLONING, EXPRESSION AND PURIFICATION 
The coding sequence for the α-carbonic anhydrase gene (HPG27_1129) was PCR-
amplified from genomic H. pylori DNA (strain G27) using Phusion High-Fidelity DNA 
Polymerase (New England Biolabs) and primers 5'-
CATCATCACCACCATCACGAAAACCTGTATTTTCAGGGAAAATGGGATTATAAAAAT
AAAGAA-3' (fw) and 5'-GTGGCGGCCGCTCTATTAGCGGGTCTCAGCTGA-3' (rv). 
Since the full-length protein is toxic to Escherichia coli, the N-terminal export signal 
sequence was excluded and a N-terminal 6-His-tag and a TEV proteolysis site were 
included. The following sequence corresponds to the final recombinant protein lacking of 
the N-terminal 21 aa export signal and added of the N-terminal 6-His-tag flanked by a 
TEV recognition site. 
 
 
// corresponds to the cleavage site for TEV protease 
 
 
Property Value 
Aminoacid 239 
Cysteines 2 
Molecular weight (kDa) 27840.4 
Theoretical pI 8.98 
Abs280nm (C=1mg/mL; b=1cm) 1.128 (all Cys reduced) 
Signal peptide No 
 
 
10 20 30 40 50 60
HHHHHHENLY FQ//GKWDYKNK ENGPHRWDKL HKDFEVCKSG KSQSPINIEH YYHTQDKADL 
70 80 90 100 110 120
QFKYAASKPK AVFFTHHTLK ASFEPTNHIN YRGHDYVLDN VHFHAPMEFL INNKTRPLSA 
130 140 150 160 170 180
HFVHKDAKGR LLVLAIGFEE GKENPNLDPI LEGIQKKQNF KEVALDAFLP KSINYYHFNG 
190 200 210 220 230
SLTAPPCTEG VAWFVVEEPL EVSAKQLAEI KKRMKNSPNQ RPVQPDYNTV IIKRSAETR 
Tab. 3.3 Some properties of α-carbonic anhydrase referred to the construct lacking of the 
N-terminal export signal and added of N-terminal 6-His-tag and TEV recognition site 
 
  Chapter III 
123 
 
E. coli BL21 (DE3) competent cells (Lucigen), harboring the pETite plasmid encoding for 
the recombinant construct, were grown in Luria–Bertani medium. Expression was 
induced by adding 0.5 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) to the medium 
and was continued for 5 h at 30 °C with constant shaking. The cells were resuspended in 
50 mM Tris–HCl pH 7, 150 mM NaCl, 5 mM imidazole supplemented with protease 
inhibitors (1 mM phenylmethanesulfonyl fluoride (PMSF), 15 mM aprotinin, 1 mM 
leupeptin) and lysed using a One Shot Cell disruption system (Constant Systems Ltd). 
The lysate was centrifuged at 18,000 rpm for 20 min at 4 °C to separate the supernatant 
from the insoluble fraction. The soluble fraction was loaded onto a 1 mL HisTrap HP Ni–
NTA column (GE Healthcare) pre-equilibrated with lysis buffer. The column was 
extensively washed with buffer A and the protein was eluted using a linear gradient from 
350 to 500 mM imidazole. The protein was eluted as a single species (Figg.  ) and was 
further purified by buffer exchange using a PD-10 desalting column (GE Healthcare) 
equilibrated with a buffer consisting of 50 mM Tris–HCl pH 7, 150 mM NaCl. The His-tag 
was removed by incubation with TEV protease (Sigma–Aldrich) in a 1:100 ratio overnight 
at 30 °C. The reaction mixture was buffer-exchanged with buffer consisting of 50 mM 
Tris–HCl pH 8, 500 mM NaCl, 15 mM imidazole, 1% (v/v) glycerol. The cleaved protein 
was isolated as an unbound sample by loading it onto an Ni Sepharose 6 Fast Flow 
column (GE Healthcare) equilibrated with buffer. The protein was buffer-exchanged into 
30 mM Tris–HCl pH 8, concentrated to 20 mg/ml using a Vivaspin 20 5,000 MWCO 
centrifugal concentrator (Sartorius) and stored at -20 °C for crystallization trials. 
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Fig. 3.6 6-His-tagged recombinant α-carbonic anhydrase affinity chromatography; left: absorption profile; right: 
SDS-PAGE analysis of the fractions collected (IND: induced expression; P: lysed pellet; S: supernatant; FT: flow-throw). 
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3.3.2 CRYSTALLIZATION 
The purified protein was concentrated to 20 mg/ml and used in crystallization tests, which 
were partially automated using an Oryx8 crystallization robot (Douglas Instruments, UK). 
The best crystals (Figs. 3.7 and 3.8) were obtained at 4 °C by the sitting-drop vapor-
diffusion technique using a solution consisting of 0.2 M sodium nitrate, 0.1 M bis-tris 
propane pH 8.5, 20% (w/v) PEG 3350 as precipitant (PACT Suite solution n. 89, Qiagen). 
Moreover, soaking and cocrystallization experiments were performed in order to 
investigate the molecular binding of inhibitor compounds to the active site; specifically, 
topiramate and etoxybenzothiazolesulfonamide were selected, since no cocrystal 
structures of bacterial α-carbonic anhydrase with these compounds have been published. 
The protein/inhibitor ratio used was 1:20 and crystallization attempts were performed by 
sitting-drop vapor-diffusion and microbatch-under-oil techniques. Cocrystals suitable to 
x-ray diffraction measurement have not been obtained yet. 
 
       
 
 
 
 
3.3.3 DATA COLLECTION AND PROCESSING 
Diffraction data were measured on the PXIII beamline at the SLS synchrotron (Villigen, 
Switzerland). The crystal was found to belong to the monoclinic space group P21, with 
unit cell parameters a=44.906, b=95.905, c=53.318 Å, β=92.92. Two molecules are 
present in the asymmetric unit, corresponding to a VM of 2.03 Å3/Da and an approximate 
solvent content of 39%. All data sets were indexed and integrated with XDS (Kabsch 
2010) and merged and scaled with SCALA (Evans 2006) as contained in the CCP4 
crystallographic package (Winn et al. 2011; Tab. 3.4). 
Fig. 3.7 Crystals of recombinant α-carbonic 
anhydrase from H. pylori grown at 20 mg/mL protein 
concentration, in 0.2 M sodium nitrate, 0.1 M bis-tris 
propane pH 8.5, 20% (w/v) PEG 3350, at 4 °C. 
Fig. 3.8 Crystal of recombinant α-carbonic anhydrase from 
H. pylori grown in PACT Suite n. 89 mounted on a loop.  
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Data Collection and processing 
Diffraction source  Beamline PXIII, SLS 
Wavelength (Å)  1.00 
Temperature (K)  100 
Detector  Pilatus 2M 
Rotation range per image (°) 0.1 
Total rotation range (°) 180 
Exposure time per image (s) 0.1 
Space group P 21 
Cell parameters (Å, °) a=44.906, b=95.905, c=53.318, β=92.92 
Resolution range (Å) 47.961 – 1.517 (1.60-1.517) 
Total n. of reflections 229967 
N. of unique reflections 69653 (8705) 
Completeness (%) 96.7 (85.8) 
Multiplicity 3.3 (3.0) 
‹I/σ(I)› 18.5 (3.0) 
Rsym 0.037 (0.382) 
Rp.i.m. 0.024 (0.256) 
Overall B factor from Wilson 
plot (Å2) 
16.97 
 
 
 
3.3.4 STRUCTURE SOLUTION AND REFINEMENT 
The structure was solved by molecular replacement using MOLREP (Vagin and 
Teplyakov 2010), starting from a model built using the SWISS-MODEL server (Biasini et 
al. 2014; http://swissmodel.expasy.org/) from PDB accession code 4G7A (Di Fiore et al. 
2013). The rebuilding procedure available in the PHENIX package (Adams et al. 2010) 
was used to rebuild the model, which was subsequently checked and adjusted with Coot 
(Emsley et al. 2010). Refinement was continued with PHENIX (Adams et al. 2010). The 
final statistics of the refinement are summarized in Tab. 3.5. 
 
 
 
 
 
Tab. 3.4 Statistics on data collection and processing relative to recombinant α-
carbonic anhydrase from H. pylori; values in parentheses are for the outer shell. 
 
  Chapter III 
126 
 
Structure solution and refinement 
Resolution range (Å) 47.96–1.52 
Completeness (%) 96.7 
σ Cutoff 0 
N. of reflections, working set 63791 
N. of reflections, test set 3384 
Final Rcryst 0.1696   
Final Rfree 0.1984 
N. of non-H atoms 
total 
protein 
ions 
others 
water 
 
4396 
3721 
4 
8 
662 
R.m.s. deviations 
Bond length (Å) 
Bond angles (°) 
 
0.007 
1.15 
Average B factor (Å2) 22.6 
Ramachandran plot 
Most favored (%) 
Allowed (%) 
  
96.0 
3.6 
Ramachandran outliers (%) 0.4 
Rotamer outliers (%) 1.2 
Overall score 1.65 
 
 
 
 
3.4 RESULTS AND DISCUSSION 
 
3.4.1 OVERALL FOLD OF THE ENZYME 
The asymmetric unit of the α-carbonic anhydrase crystal contains two monomers. Their 
structure is essentially the same (r.m.s.d. of 0.61 Å), with the exception of the long stretch 
from residues 61 to 68. Each monomer includes 226 residues (22–247; Fig. 3.9; the first 
21 amino acids were not included in the gene cloned, since they are predicted to 
correspond to a signal sequence for export into the periplasmic space of the bacterium). 
The entire polypeptide chain is very well defined in the electron-density map, with the 
exception of amino acids 163–167 of monomer B, a stretch that is exposed to the solvent 
and is far away from the active site and from the contact region with the other monomer 
(see below). The fold of the H. pylori α-carbonic anhydrase monomer corresponds to that 
of the classical α-carbonic anhydrase, characterized by a central ten-stranded β-sheet 
Tab. 3.5 Statistics on structure solution and refinement relative to recombinant 
α-carbonic anhydrase from H. pylori. 
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surrounded by three α-helices and by the remainder of the protein chain (Fig. 3.10). One 
layer of the twisted β-sheet along with another portion of the polypeptide chain defines a 
conical-shaped cavity hosting a Zn2+ ion at the bottom. The latter defines the active site 
of the enzyme. The structure of the monomer is stabilized by an intramolecular disulfide 
bond (Cys45–Cys195) that is conserved in most carbonic anhydrase structures(Di Fiore 
et al. 2013). Since this disulfide bond connects the N-terminus to a loop (residues 192–
195) that surrounds the entrance of the catalytic site cavity, it is tempting to speculate that 
its function is to keep the cavity well opened in order to favour entrance of the substrate. 
 
 
 
 
       ….  
 
 
 
 
 
3.4.2 PROTEIN DIMERIZATION 
The two monomers in the asymmetric unit (Fig. 3.11) are related each other by a rotation 
axis of 177°. The dimer is stabilized mostly by hydrophilic interactions, in particular by the 
formation of 18 hydrogen bonds between protein atoms. Other hydrophilic interactions 
Fig. 3.9 Sequence alignment of H. pylori α-carbonic anhydrase (B5Z8IO) with α-carbonic anhydrases from S. 
yellowstonense (B2V8E3), T. ammonificans (E8T502) and N. gonorrhoeae (Q50940). Red, yellow and pale green 
backgrounds denote the residues involved in the binding of Zn2+, in the conical surface of the active-site cavity and in the areas 
of contact in the dimer, respectively. 
Fig. 3.10 Cartoon view of the monomer of 
H. pylori α-carbonic anhydrase, coloured 
according to secondary-structure 
element. The Zn2+ and Cl- ions are shown as 
orange and yellow spheres, respectively. 
 
Fig. 3.11 The H. pylori α-carbonic anhydrase dimer 
present in the asymmetric unit of the crystal. A molecular 
twofold axis runs approximately vertically in the plane of the 
paper. 
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are mediated by solvent molecules. The surface concealed after formation of the dimer 
is 1226 Å2 per monomer, corresponding to about 11% of the total surface of the monomer. 
This value is relatively low and analysis with PISA (Krissinel and Henrick 2007) assigns 
quite a low score (0.123) to the dimer formation, suggesting that this interface may play 
only an auxiliary role in dimer formation. A size-exclusion chromatography experiment 
(Fig. 3.12) confirmed that the enzyme is present as a monomeric species in solution. 
Altogether, these data suggest that the dimer observed is the result of crystal packing 
and that the physiological state of H. pylori α-carbonic anhydrase is monomeric, 
analogously to all mammalian α-carbonic anhydrases. Nevertheless, it is surprising that 
the dimer observed is the same dimer as found in the α-carbonic anhydrases from the 
other bacteria S. yellowstonense (Di Fiore et al. 2013) and N. gonorrhoeae (Huang et al. 
1998) and in the dimer of the tetrameric T. ammonificans α-carbonic anhydrase (James 
et al. 2014). This occurs despite the regions involved in the dimerization surface not being 
particularly conserved. Since the interaction surface between the two monomers is 
essentially hydrophilic, the equilibrium between monomer and dimer possibly depends on 
the environmental conditions (ionic strength, pH), which in the case of the H. pylori 
periplasm can change significantly according to the pH of the host stomach. Moreover, 
the two active sites in the dimer are quite distant and independent, and dimerization does 
not affect the entrance to the two binding sites. 
 
 
 
 
Fig. 3.12 A gel-filtration experiment showing that the apparent molecular mass of H. pylori α-carbonic anhydrase (red 
square) is about 34,000 Da, which is slightly larger than the theoretical calculated mass (26,165.7 Da, referred to the protein 
removed of 6-His-tag) but significantly smaller than that of a dimer. The small grey square close to it corresponds to bovine α-
carbonic anhydrase. 
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3.4.3 THE ACTIVE SITE 
The Zn2+ ion present in the active site of H. pylori carbonic anhydrase presents a slightly 
distorted trigonal bipyramidal coordination: the five ligands are the three N atoms of three 
histidine residues conserved in all other α-carbonic anhydrases for which structures have 
been determined to date and two solvent molecules (Fig. 3.13). Coordination distances 
for the Zn2+ ion range from 2.14 to 2.19 Å in the two monomers, and from 2.12 to 2.30 Å 
for the solvent O atoms. The Zn2+ coordination in other bacterial α-carbonic anhydrases 
involves the same three histidines in all cases and varies from trigonal bipyramidal to 
tetrahedral according to the ligand bound. Another two important residues in the vicinity 
of the active site, His191 and Glu116, are conserved in several α-carbonic anhydrases. 
The former interacts with one of the two solvent molecules that coordinate the Zn2+ ion, 
while the latter does not form any significant interactions with active-site residues in the 
H. pylori α-carbonic anhydrase structure, but its negative charge is possibly fundamental 
to balance the global positive charge of the active site or to orient the substrate (Vullo et 
al. 2013). A significant difference of H. pylori α-carbonic anhydrase with respect to the 
other bacterial α-carbonic anhydrases is represented by the environment of the active 
site. In all of them one of the histidines (corresponding to His129 in H. pylori α-carbonic 
anhydrase) interacts with a conserved glutamic acid (position 127 in H. pylori α-carbonic 
anhydrase), the negative charge of which partially neutralizes the positive charge of the 
histidine–Zn2+ complex and possibly stabilizes it. In the structure of H. pylori α-carbonic 
anhydrase, aminoacid 127 is a serine and an atom heavier than a water molecule is 
present in the position occupied by the glutamate carboxylic group in the other bacterial 
α-carbonic anhydrases. This atom interacts with Nε2 of His129 (at a distance of 3.11 Å) 
and Oγ of Ser127 (at a distance of 3.15–3.16 Å). It is reasonable to assume that this atom 
must be negatively charged to compensate for the absence of the glutamate in this 
position. An anomalous Fourier difference map with data measured at 1.000 Å 
wavelength presents a large peak (about 20σ) corresponding to the Zn2+ position and a 
smaller peak (about 5σ) corresponding to this unknown atomic species (Fig. 3.13). This 
value corresponds to that for the S atoms of methionines and cysteines visible in our map. 
At this wavelength the f’’ values for Zn2+ and S are 2.6 e and 0.265 e, respectively. The 
only monoatomic anion present in solution is Cl-, the f’’ value of which is 0.321 e, a value 
close to that of S. This strongly supports the presence of a Cl- ion at this position. The 
latter would compensate for the absence of the negative charge of the glutamate. 
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3.4.4 COMPARISON WITH OTHER α-CARBONIC ANHYDRASE STRUCTURES 
The overall architecture of H. pylori α-carbonic anhydrase is quite similar to that of α-
carbonic anhydrases from other bacteria: superposition of the corresponding Cα atoms of 
one monomer with those of the enzyme with the most similar amino-acid sequence, that 
from S. yellowstonense (Di Fiore et al. 2013; PDB accession code: 4G7A), which presents 
39% identity to the enzyme of interest, gives an r.m.s.d. of 1.49 Å for 224 residues; on 
superposition with T. ammonificans α-carbonic anhydrase (37% sequence identity; 
James et al. 2014; PDB accession code: 4COQ) the r.m.s.d. is 1.33 Å for 211 amino acids 
and with N. gonorrhoeae α-carbonic anhydrase (36% identity; Huang et al. 1998; PDB 
entry 1KOP) the r.m.s.d. is 1.57 Å for 212 residues. Some structural differences among 
α-carbonic anhydrases from different bacteria are possibly represented by the entrance 
to the active site and by the surface of the conical cavity that gives access to the active 
site (De Simone, Alterio, and Supuran 2013). The residues lining the surface of the cavity 
are highlighted in Fig. 3.9 by a yellow background. In Fig. 3.14a, in which residues are 
coloured according to their potential charge, it is possible to see that half of the entrance 
of the active-site cavity is charged, with a prevalence of positive charges, in particular if 
the histidine is protonated, whilst the other half is neutral and is mostly hydrophobic. 
Fig. 3.13 Stereographic view of the enzyme active site, showing the Zn2+ ion coordinated by three histidine 
residues and two solvent molecules. A Cl- interacting with His129 is shown as a yellow sphere. The cyan grid 
represents the anomalous-difference map, contoured at 5σ contour level. The position of Met222 side chain is also 
shown for comparison. 
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3.4.5 LOCALIZATION 
H. pylori α-carbonic anhydrase has been detected bound to the inner membrane of the 
periplasmic space and was not found in the soluble fraction in a Western blot experiment 
(Marcus et al. 2005a). The crystal structure presented confirms that it is a soluble protein 
and its surface presents several positively and negatively charged residues (Fig. 3.14b). 
A qualitative electrostatic potential calculation indicates that positive electrostatic 
potentials are prevalent on the protein surface, in line with an isoelectric point of 9.1 as 
estimated from the amino-acid sequence (referred to the protein removed of 6-His-tag). 
An analysis of the distribution of these charges shows that positive potential is mostly 
located on the face of the protein containing the opening of the active-site cavity, whilst 
on the rest of the surface positive and negative potentials are more randomly distributed. 
It is possible to hypothesize that the positive surface of H. pylori α-carbonic anhydrase 
serves to interact with the negatively charged phospholipids of the membrane. If this is 
true, then the enzyme would present the active-site entrance roughly oriented towards 
the membrane in such a way that when CO2 diffuses from the cytoplasm the enzyme 
could capture the gas directly as soon as it flows through the membrane. 
  
a b
Fig. 3.14 a: Surface of the H. pylori α-carbonic anhydrase monomer. Potentially charged residues are coloured blue (Arg and 
Lys), red (Glu and Asp) and cyan (His). The bottom of the central cavity in the center appears in cyan owing to the presence of 
the three histidine residues that coordinate the Zn2+. b: Qualitative electrostatic surface of the H. pylori α-carbonic anhydrase 
monomer. On the left it is possible to observe the access to the active site, whilst on the right the molecule is rotated 180° in the 
vertical direction.  
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CLONING, EXPRESSION AND  
PURIFICATION 
OF β-CARBONIC ANHYDRASE 
FROM HELICOBACTER PYLORI 
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4.1 INTRODUCTION 
 
β-carbonic anhydrase, as well as α-carbonic anhydrase, plays a crucial role in H. pylori 
complex and delicate balance of urea and bicarbonate aimed to survival in the extremely 
acid conditions of the stomach. Therefore, even this enzyme can be considered as an 
interesting pharmacological target to develop new potential antibiotic therapies, affecting 
a critical metabolic network in H. pylori survival. Moreover, since the carbonic anhydrases 
belonging to the β-class are present in pathogenic microorganisms (such as fungi, 
bacterial and protozoa), and they lack from mammals, in which α-carbonic anhydrase 
class is physiologically relevant, these enzymes started to be more widely accepted as 
possible drug targets for developing new antibacterial agents, able thus to overcome the 
important resistance problems, which are affecting most classes of antibiotics in clinical 
use (Ceruso et al. 2015). 
The β-carbonic anhydrase class is broadly distributed in nature, including archaea, 
bacteria, algae, plant chloroplasts and invertebrates (Rowlett 2010). Phylogenetic 
analyses indicate that this enzymatic class is far more diverse in sequence than the other 
classes, with only five residues (three forming the Zn2+ ligands plus an aspartate and an 
arginine) being completely conserved (Smith et al. 2000). Based on sequence identity, 
the β-carbonic anhydrase class can be divided into seven clades (A-G), with the plant 
enzymes forming two clades representing 
dicotyledonous and monocotyledonous plants. 
Enzymes within these clades can vary with 
respect to structure and their response to 
inhibitors, suggesting different functional 
mechanisms of action (Smith and Ferry 1999). 
Moreover, although β-carbonic anhydrases 
catalyze the same reaction as α-carbonic 
anhydrases and other forms, important 
structural differences between these classes 
exist. To date, the X-ray crystallographic 
structures of β-carbonic anhydrases deposed in 
the Protein Data Bank (http://www.pdb.org) are 
definitely not as many as those of the well-
characterized α-carbonic anhydrases; crystal 
Fig. 4.1  β-carbonic anhydrase from Escherichia coli, 
tetrameric association. Adapted from Cronk et al., 
2001.  
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structures from Pisum sativum (Kimber & Pai, 2000; PDB accession code: 1EKJ), the red 
alga Porphyridium purpureum (Mitsuhashi et al., 2000; PDB accession code: 1DDZ), 
Methanobacterium thermoautotrophicum (Strop, Smith, Iverson, Ferry, & Rees, 2001; 
PDB accession code: 1G5C), Escherichia coli, the first bacterium in which β-carbonic 
anhydrase structure has been determined (Fig. 4.1; Cronk, Endrizzi, Cronk, & Neill, 2001; 
PDB accession codes: 1I6O, 1I6P; Fig. ), Mycobacterium tuberculosis (Covarrubias et 
al., 2005; PDB accession code: 1YM3), Haemophilus influenzae (Cronk et al., 2006; PDB 
accession code: 2A8D), Halothiobacillus neapolitanus (Sawaya et al., 2006; PDB 
accession code: 2FGY), the green alga Coccomyxa (Huang et al., 2011; PDB accession 
codes: 3UCJ, 3UCK, 3UCM, 3UCN, 3UCO), Sordaria macrospora (Lehneck et al., 2014; 
PDB accession codes: 4O1J, 4O1K), Pseudomonas aeruginosa (Pinard et al., 2015; PDB 
accession code: 4RXY) and Vibrio cholerae (Ferraroni, Del Prete, Vullo, Capasso, & 
Supuran, 2015; PDB accession code: 5CXK) have been published. X-ray crystallographic 
analysis of β-carbonic anhydrases has revealed two distinct subtypes of this enzymatic 
class based on active-site organization, denoting type I and type II β-carbonic 
anhydrases. In the type I enzymes, exemplified by β-carbonic anhydrases from P. 
sativum, M. thermoautotrophicum and M. tuberculosis Rv1284, the active site Zn2+ ion is 
coordinated by one histidine and two cysteine residues (instead of three histidine residues 
present in α-, γ- and δ-classes), with a fourth coordination site occupied by water or a 
substrate analogue, the so-called “open conformation”. In contrast, the other subclass of 
β-carbonic anhydrases, the type II, exemplified by the enzymes from H. influenzae, E. 
coli, P. purpureum and M. tuberculosis Rv3588c, has a unique Zn2+-coordination 
geometry in which the water molecule is replaced by an aspartate side chain, forming a 
non-canonical active site, namely the “closed conformation” (Ferraroni et al. 2015). These 
differences determine the catalytic properties of these enzymes. The type II β-carbonic 
anhydrases are characterized by little or no CO2 hydration activity at pH values less than 
8.0, compared with the type I enzymes that show catalytic activity at pH values from as 
low as 6.5 to greater than 9.0. Moreover, type II β-carbonic anhydrases show highly 
cooperative pH-rate profiles and cooperative inhibition by HCO3-, whereas type I are not 
inhibited by HCO3- (Rowlett 2010). Therefore, it has been hypothesized that the closed 
conformation observed in the structures of type II β-carbonic anhydrases is an allosteric 
form of the enzyme, the so-called T state, that is an inactive form present at pH values 
below 8.0. This conformation is stabilized by the presence of HCO3-. However, at pH 
values >8.3 the closed active site is converted to an open one, with an incoming water 
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molecule replacing the carboxylate moiety of the aspartate residue and thus generating 
the nucleophile used in the catalytic cycle. Indeed, at this pH value the carboxylate of the 
aspartate residue makes a strong interaction with the guanidine/guanidinium moiety of a 
conserved arginine residue present in all β-carbonic anhydrases so far investigated 
(Ferraroni et al. 2015). Moreover, instead of functioning as obligate monomers like most 
of α-forms or trimers like γ-forms, β-carbonic anhydrases are found in many 
oligomerization states; especially, dimeric, tetrameric, hexameric and octameric β-
carbonic anhydrase structures have been reported (Syrjänen et al. 2010). Additionally, in 
contrast to the overall structure of the α-carbonic anhydrases (extended 10-strand twisted 
β-sheet, flanked by six or more α-helices), the β-enzymes have more compact structures: 
a β-sheet core composed of four or five strands, and four or more α-helices surrounding 
this core (Aggarwal et al. 2015). Despite these differences, β-carbonic anhydrase class 
basically shares the same two-step ping-pong molecular mechanism for reversible 
hydration of carbon dioxide into bicarbonate, as α-carbonic anhydrase class, even if the 
mechanism of proton transfer involves different residues between the two enzymatic 
classes (Fig. 4.2). 
Fig. 4. 2 General catalytic mechanism of β-carbonic anhydrase. The essential elements of this mechanism are (a) nucleophilic 
attack of the metal-activated hydroxide ion on carbon dioxide, (b) ligand exchange of the product bicarbonate for a water molecule, 
and (c) regeneration of the zinc hydroxide form of the enzyme. Adapted from Cronk et al., 2001. 
 
In α-carbonic anhydrases, this function is conducted by a well-ordered network of water 
molecules and a histidine proton shuttle residue (Aggarwal et al. 2014). In contrast, as 
previously mentioned, β-class enzymes possess a highly conserved dyad comprising an 
aspartate residue and an arginine one that seem to be crucial for the catalytic mechanism 
since mutation of these residues severely reduces the catalytic activity. Particularly, the 
aspartate makes a hydrogen bond with the Zn2+-coordinated water molecule, activating it 
for nucleophilic attack of the CO2 molecule (Fig. 4.3; K. S. Smith, Ingram-Smith, and Ferry 
2002). 
β-carbonic anhydrases are important accessory enzymes for many CO2 or HCO3--utilizing 
enzymes, such as RuBisCO in chloroplasts, cyanase in E. coli, carboxylases in 
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Corynebacterium glutamicum, and also urease in H. pylori (Zolfaghari Emameh et al. 
2014). Their importance in prokaryotic biology can be deduced from their widespread 
presence in metabolically diverse species. The β-carbonic anhydrases play an essential 
role in facilitating aerobic growth of microbes at low partial pressures of CO2 by providing 
endogenous HCO3- and are involved in multiple roles such as cyanate degradation, host 
colonization, host survival, and growth in different organisms (Aggarwal et al. 2015). In 
plants and photosynthetic bacteria, β-carbonic anhydrases are required for transport and  
maintenance of CO2 and HCO3− concentrations for carbon fixation and photosynthesis; 
they might possess different roles, depending on the location of the enzyme and the type 
of plant. β-carbonic anhydrases are strongly expressed in both roots and green tissues 
and are located in chloroplasts, cytoplasm and mitochondria with isozyme-specific 
patterns (Fabre et al. 2007). The highest carbonic anhydrase activity has been found 
within the chloroplast stroma, but there is also some carbonic anhydrase activity in the 
cytosol of mesophyll cells. Additionally, β-carbonic anhydrases play a role in 
photosynthesis by facilitating diffusion into and across the chloroplast, and by catalyzing 
HCO3- dehydration to supply CO2 for RuBisCO (Zabaleta, Martin, and Braun 2012). The 
Fig. 4.3 Surface representation of (A) hCA II (human α-carbonic anhydrase II) and (B) psCA3 (β-carbonic anhydrase from 
Pseudomonas aeruginosa). Beige and green regions represent hydrophilic and hydrophobic residues of the active site, respectively. 
Stick representations of the active site for (C) hCA II and (D) psCA3. The active site zinc is depicted as a magenta sphere, 
ordered waters depicted as red spheres, H-bonds represented by red dashes, and distances given in angstroms. Adapted from 
Aggarwal et al., 2015. 
 
Chapter IV 
138 
 
presence of β-carbonic anhydrases in the animal kingdom has been controversial or 
ignored due to the paucity and poor quality of the available sequences; but it has been 
reported that β-class is widespread among invertebrates (Syrjänen et al. 2010). However, 
the full physiological role of β-carbonic anhydrases in the biosphere, either in prokaryotes 
or in plants or other organisms, is still to be discovered. 
In H. pylori, as the α-carbonic anhydrase in the periplasm, the β-carbonic anhydrase 
(named HP0004 in strain 26695 and HPG27_4 in strain G27 examined, respectively) 
catalyzes the reversible hydration of the carbon dioxide into bicarbonate in the cytoplasm, 
cooperating to the urease-dependent response to acidity. Urease activity produces 
ammonia and carbon dioxide; the latter readily diffuses across the inner membrane into 
the periplasm, where it becomes substrate of the hydrolysis by the α-carbonic anhydrase 
(the metabolic mechanism has been described in detail in Chapter I). Carbon dioxide 
molecules that still remain in the cytoplasm are hydrolyzed by the β-form, thus 
contributing to buffer the pH of the cytoplasm. Interestingly, it may be observed that the 
H. pylori β-carbonic anhydrase is a catalytically efficient enzyme, possessing an 
enzymatic activity 3.2 times higher than that of the α-form. The β-carbonic anhydrase 
from H. pylori possesses a catalytic activity higher than that of human carbonic 
anhydrases III, VA, XII, and XIV among others. Only the human carbonic anhydrases VB 
and especially II, one of the best catalysts known in nature, show a better activity than H. 
pylori β-enzyme (Nishimori et al. 2007; Morishita et al. 2008). As previously mentioned, 
deletion or inhibition of the α-carbonic anhydrase drastically reduces acid survival of H. 
pylori even in the presence of urea and impairs the gastric colonization (Marcus et al. 
2005b); deletion of both carbonic anhydrases results in a strongly reduced inflammation 
of the gastric mucosa or even prevents infection of animal models, although some 
mutants still show carbonic anhydrase activity, probably due to compensatory changes 
in the activity and/or expression of other enzymes involved in bicarbonate metabolism 
(Bury-Moné et al. 2008). These findings highlight the crucial importance of these enzymes 
in H. pylori survival and virulence, enrolling them as new attractive pharmacological 
targets to overcome the current antibiotic resistance problem. As for the α-carbonic 
anhydrase, also for the β-form many inhibition studies have been reported and several 
low nanomolar inhibitors have been detected; specifically, sulfamide and sulfamate 
compounds and complex anions, such as cyanide, cyanate, and hydrogen sulfide, have 
been observed to effectively inhibit the in vitro and in vivo growth of the pathogen 
(Nishimori et al. 2007; Morishita et al. 2008; Nishimori et al. 2010; Maresca et al. 2013). 
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4.2 SEQUENCE ANALYSIS 
 
 
 
 
Property Value 
Aminoacid 221 
Cysteines 4 
Molecular weight (kDa) 25691.2 
Theoretical pI 5.93 
Abs280nm (c=1mg/mL; b=1cm) 1.164 (all Cys reduced) 
Signal peptide No 
 
 
β-carbonic anhydrase from H. pylori G27 is composed of 221 aminoacids, including 4 
cysteine residues, which are predicted to not form disulfide bonds (DISULFIND; 
http://disulfind.dsi.unifi.it/ ). Its theoretical 
isoelectric point is close to 6, in accordance with 
that of others bacterial β-carbonic anhydrase. The 
alignment of the aminoacid sequences shows that 
H. pylori β-carbonic anhydrase shares 33% 
identity with the β-carbonic anhydrase CynT from 
Escherichia coli, whose crystallographic structure 
is known, 51% identity with the predicted enzyme 
from the related pathogen Helicobacter hepaticus, 
and 25% identity with the enzyme from Neisseria 
gonorrhoeae (Fig. 4.5), confirming the high 
phylogenetic diversity of the β-carbonic anhydrase 
10 20 30 40 50 60
MKAFLGALEF QENEYEELKE LYESLKTKQK PHTLFISCVD SRVVPNLITG TQPGELYVIR 
70 80 90 100 110 120
NMGNVIPPKT SHKESLSTIA SIEYAIVHVG VQNLIICGHS DCGACGSIHL ISDETTKAKT 
130 140 150 160 170 180
PYIANWIQFL EPIKEELKNH PQFSNHFAKR SWLTERLNAR LQLNNLLSYD FIQERVMDNE 
190 200 210 220
LKIFGWHYII ETGRIYNYNF ESHFFEPIEE TIKQRISHEN F 
Tab. 4.1 Some properties of β-carbonic anhydrase from H. pylori. 
 
Fig. 4.4 Folding and hydrophobicity prediction of β-
carbonic anhydrase from H. pylori (FoldIndex©). 
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class. However, the aminoacid residues important for the catalytic mechanism are highly 
conserved, namely cysteine, histidine and the dyad aspartate and arginine (dark blue in 
Fig. 4.5). A folding prediction program, (FoldIndex; http://bip.weizmann.ac.il/fldbin/findex) 
suggests the presence of an unfolded C-terminal region (Fig. 4.4); on the other hand, the 
secondary structure expected include 7 α-helices (47%) and 5 β-strands (15%), in 
accordance to the overall structure of the β-carbonic anhydrases previously mentioned 
(Phyre2; Kelley et al. 2015; http://www.sbg.bio.ic.ac.uk/phyre2/). In order to investigate 
the structural aspect, a putative structure of the β-carbonic anhydrase from H. pylori has 
been predicted, using the bioinformatics homology modelling tool SWISS-MODEL 
(Biasini et al. 2014; http://swissmodel.expasy.org/) and β-carbonic anhydrase CynT from 
E. coli as template (PDB accession code: 1I6P); it confirms a core of β-strands 
surrounded by the α-helices (Fig. 4.6a) and a homo-tetrameric oligomeric status (Fig. 
4.6b), like CynT from E. coli.  
 
Fig. 4.5 Sequence alignment of β-carbonic anhydrase from H. pylori strain G27, E. coli strain K12, N. gonorrhoeae and H. 
hepaticus; in shades of blue the identity above 50% is shown (ClustalW and Jalview ver. 2.9.0b2). 
 
Fig. 4.6 Homology modelling structure of β-carbonic anhydrase from H. pylori, monomer (a) and homo-tetramer (b) predicted 
(SWISS-MODEL; template: β-carbonic anhydrase from E. coli, PDB accession code: 1I6P). 
 
a b
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4.3 MATERIALS AND METHODS 
 
4.3.1 MOLECULAR CLONING 
The coding sequence for the β-carbonic anhydrase gene (HPG27_4) was PCR-amplified 
from genomic DNA of H. pylori strain G27, using Q5® High-Fidelity DNA Polymerase (New 
England Biolabs) and primers 5’-
CATCATCACCACCATCACGAAAACCTGTATTTTCAGGGAAAAGCGTTTTTAGGAGC
GTTA-3’ (fw) and 5’-GTGGCGGCCGCTCTATTAGAAGTTTTCATGACTTATCCTTTG-3’ 
(rv). The forward primer provided a 18 nt-sequence that recognizes the pETite N-His Kan 
vector (Lucigen) and encodes a N-terminal 6-His tag, and a TEV proteolysis site. The 
reverse primer included a Stop anticodon corresponding to the C-terminus. The PCR 
product, purified by 1% agarose gel, was cloned by thermal shock into the pETite N-His 
Kan vector (Lucigen) using E. coli XL1-Blue competent cells (Agilent), grown overnight 
on selective LB medium supplemented with 30 μg/ml of kanamycin. The colonies were 
checked by colony-PCR using EconoTaq DNA Polymerase (Lucigen) and T7 primers. 
Purified plasmid of positive colonies was double-digested by restriction enzymes NdeI 
(New England Biolabs) and NotI (New England Biolabs), for 2 h at 37 °C. Positive 
samples were finally checked by DNA sequencing to evaluate the quality. 
The following sequence corresponds to the final recombinant protein with the addition of 
a N-terminal 6-His tag flanked by a TEV recognition site. 
 
 
// corresponds to the cleavage site for TEV protease 
 
 
 
 
 
10 20 30 40 50 60
HHHHHHENLY FQ//GKAFLGAL EFQENEYEEL KELYESLKTK QKPHTLFISC VDSRVVPNLI 
70 80 90 100 110 120
TGTQPGELYV IRNMGNVIPP KTSHKESLST IASIEYAIVH VGVQNLIICG HSDCGACGSI 
130 140 150 160 170 180
HLISDETTKA KTPYIANWIQ FLEPIKEELK NHPQFSNHFA KRSWLTERLN ARLQLNNLLS 
190 200 210 220 230
YDFIQERVMD NELKIFGWHY IIETGRIYNY NFESHFFEPI EETIKQRISH ENF
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Property Value 
Aminoacid 233 
Cysteines 4 
Molecular weight (kDa) 27234.8 
Theoretical pI 6.14 
Abs280nm (C=1mg/mL; b=1cm) 1.153 (all Cys reduced) 
Signal peptide No 
 
 
 
4.3.2 EXPRESSION 
The pETite plasmid carrying the gene of interest was transformed into E. coli BL21 (DE3) 
pLysS competent cells (Lucigen), since the basal expression of the recombinant protein 
resulted to be toxic for cell growth. The E. coli BL21 (DE3) pLysS harboring the pETite 
plasmid were grown in a selective LB medium supplemented with 30 µg/mL of kanamycin. 
A 2 L culture was grown under mild shaking (180 rpm) at 37 °C until an OD value (optical 
dispersion, at 600 nm) of about 0.6; then 1 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) was added to the medium to induce protein expression and the culture was 
incubated at 20 °C overnight. The cultured cells were harvested and medium eliminated 
by centrifugation at 5,000 rpm for 30 min at 4 °C. The pellet was resuspended in a 
selected lysis buffer, containing a protease inhibitor cocktail (1 mM 
phenylmethanesulfonyl fluoride (PMSF), 15 µM aprotinin, 1 µM leupeptin, 0.5 mM 4-(2-
Aminoethyl)-benzenesulfonylfluoride hydrochloride (AEBSF)). The composition of the 
lysis buffer changed depending on the chromatographic technique adopted for the 
purification, since various attempts of purification were performed in order to achieve the 
highest yield of β-carbonic anhydrase. Expression and purification steps were checked 
on SDS-PAGE and Western blotting, showing good level of expression, but most of the 
protein of interest in the inclusion bodies. Therefore, the purification of β-carbonic 
anhydrase was performed both from the soluble and from the insoluble fractions.  
 
  
Tab. 4.2 Some properties of β-carbonic anhydrase referred to the construct 
added of N-terminal 6-His-tag and TEV recognition site. 
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4.3.3 PURIFICATION VIA AFFINITY CHROMATOGRAPHY  
The cultured pellet was resuspended in a lysis buffer containing 50 mM Tris–HCl pH 8, 
400 mM NaCl, 5 mM imidazole, supplemented with protease inhibitors and lysed by 
mechanical pressure using a One Shot Cell disruption system (Constant Systems Ltd) at 
pressure 1.35 kBar. The lysis procedure was repeated twice to be more effective. The 
lysed cell suspension was cleared of debris by vacuum centrifugation at 18,000 rpm for 
30 min at 4°C. The supernatant was loaded onto a 1 mL His-Trap HP Ni–NTA column 
(GE Healthcare), previously equilibrated with the lysis buffer, at a flow rate of 
approximately 1 mL/min. The column was extensively washed with the lysis buffer and 
subsequently with a buffer supplemented with 4% elution buffer (50 mM Tris–HCl pH 8, 
400 mM NaCl, 500 mM imidazole), in order to eliminate most of contaminants. The 6-His-
tagged protein was eluted at approximately 50 mM imidazole, by applying a linear 
gradient from 4% to 100% elution buffer (Fig. 4.7, left). The recombinant β-carbonic 
anhydrase was eluted at low imidazole concentration, likely because of the low affinity for 
the Ni-NTA resin of the chromatographic column. Moreover, a generous amount of the 
recombinant protein was eluted concurrently with the initial washings, as shown in the 
SDS-PAGE (Fig 4.7, right).  
 
The fractions containing the 6-His-tagged β-carbonic anhydrase were pooled and 
concentrated by ultrafiltration using a Vivaspin 20 5,000 MWCO centrifugal concentrator 
(Sartorius). Subsequently, the concentrated protein was further purified by gel-filtration 
chromatography using a Superose 12 10/300 GL column (GE Healthcare), equilibrated 
with a buffer containing 50 mM Tris-HCl pH 8, 200 mM NaCl. The elution volume (13 mL) 
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Fig. 4.7 6-His-tagged β-carbonic anhydrase affinity chromatography; left: absorption profile; right: SDS-PAGE analysis 
of the fractions collected (S: supernatant; P: lysed pellet; FT: flow-throw; W: wash). 
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showed a probable dimeric oligomerization of β-carbonic anhydrase in solution (Fig. 4.8, 
left). Moreover, the protein of interest was occasionally eluted as double species (Fig. 
4.8, right), which differs each other for few kDa, therefore the gel-filtration column was 
not suitable to efficiently separate them. 
The purified β-carbonic anhydrase was concentrated by ultrafiltration using a Vivaspin 6 
5,000 MWCO centrifugal concentrator (Sartorius) for crystallization trials, despite the 
limited concentrations reached (4-8.8 mg/mL), verified by UV-Vis absorption spectrum 
(250-340 nm; NanoDrop 2000 UV-Vis Spectrophotometer). In accordance with that, it 
was decided not to cleave the 6-His-tag from the recombinant protein because of the risk 
of losing further protein amount performing this step. 
 
     
 
 
 
4.3.4 WESTERN BLOTTING 
Samples from different steps of β-carbonic anhydrase purification were investigated for 
the presence of the His-tag, to ensure the quality of the protein (Fig. 4.9). After loading of 
the sample into a SDS-PAGE, the proteins were transferred on a Hybond-ECL 
nitrocellulose membrane (GE Healthcare) by electrophoresis. After blocking of the 
membrane using BSA 3% solution in TBS for 1 h and incubation of the Anti-polyHistidine 
primary antibody (Sigma-Aldrich) at 4 °C overnight, three washing steps using TTBS and 
a final one with TBS were performed. The peroxidase-conjugated secondary antibody 
(Promega) was incubated for 1 h at room temperature in TBS and washed for three times 
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Fig. 4.8 6-His-tagged β-carbonic anhydrase gel-filtration chromatography (Superose 12 10/300 GL column); left: 
absorption profile; right: SDS-PAGE analysis of the fractions collected, showing the elution as double species (S: sample 
injected). 
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with TTBS and finally with TBS.  Subsequently, the membrane was developed using the 
Pierce ECL Western Blotting Substrate (ThermoFischer) for detection of peroxidase 
activity, at Image Station 4000 MM PRO (Kodak).  
 
 
 
 
4.3.5 PURIFICATION VIA FRACTIONATED PRECIPITATION AND ION-EXCHANGE 
CHROMATOGRAPHY 
Given the low yield of the affinity chromatography, a classic method of purification was 
performed. The cultured pellet was resuspended in a buffer containing 50 mM Tris–HCl 
pH 8, 150 mM NaCl, supplemented with protease inhibitors and lysed by mechanical 
pressure using a One Shot Cell disruption system (Constant Systems Ltd) at pressure 
1.35 kBar. The lysis procedure was repeated twice to be more effective. The lysed cell 
suspension was cleared of debris by vacuum centrifugation at 18,000 rpm for 30 min at 
4°C. A saturated solution of (NH4)2SO4 (4.1 M at 25°C) was added to the supernatant till 
25% (v/v) and the suspension was cleared by vacuum centrifugation at 16,000 rpm for 
20 min at 4°C to separate the precipitated proteins (Fig. 4.11). The clarified supernatant 
was dialyzed 48 h at 4 °C using a CelluSep H1 5,000 Da cut-off membrane (Biosigma), 
to remove the excess of (NH4)2SO4 and to exchange the buffer with another consisting of 
30 mM Tris-HCl pH 8, suitable for the following ion-exchange chromatography step. The 
dialyzed supernatant was loaded at approximately 1 mL/min onto a HiPrep DEAE FF 
16/10 column (GE Healthcare), suitable for a weak anion-exchange, since the 
recombinant β-carbonic anhydrase is negatively charged at pH 8 (theoretical pI 6.14). 
The column was equilibrated with the dialysis buffer and, following loading of the 
supernatant, was extensively washed with 2 CV of the same buffer. The protein was 
25.0
70.0
kDa
1 2
Fig. 4.9 Western blotting analysis of 6-His-tagged 
β-carbonic anhydrase from affinity 
chromatography fractions (1, 2: fractions collected). 
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eluted at 2 mL/min by applying a linear salt gradient in 7 CV from 0 to 70% high salt buffer, 
consisting of 30 mM Tris-HCl pH 8, 1.5 M NaCl (Figs. 4.10). 
 
 
 
 
 
 
 
 
The fractions containing the recombinant β-carbonic anhydrase, verified on SDS-PAGE, 
were pooled and concentrated by ultrafiltration using a Vivaspin 20 5,000 MWCO 
centrifugal concentrator (Sartorius). A fraction of concentrated protein was further purified 
by gel-filtration chromatography using a Superdex 200 Increase 10/300 GL column (GE 
Healthcare), equilibrated with a buffer containing 50 mM Tris pH 8, 200 mM NaCl (Fig. 
4.12, left). The elution profile was not clear and didn’t allow to separate the protein of 
interest, because of too many species in the ion-exchange sample. The low final yield of 
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Fig. 4.10 6-His-tagged β-carbonic anhydrase anion-exchange chromatography: absorption 
profile. 
Fig.4.11 SDS-PAGE analysis of (NH4)2SO4 fractionated precipitation and anion-
exchange chromatography of 6-His-tagged β-carbonic anhydrase (PEL: lysed pellet; 
SUR 25%: supernatant added of 25% saturated solution of (NH4)2SO4; PPT: precipitate; 
DIAL: dialyzed supernatant; FT: flow-throw; FRACT: fractions collected from anion-
exchange chromatography). 
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β-carbonic anhydrase wasn’t considered compatible to the several purification steps (Fig. 
4.12, right) and the protein not suitable for crystallization trials, also because of the 
several subsequent handlings. Therefore, since the largest amount of β-carbonic 
anhydrase was found in the inclusion bodies, the recovery of the recombinant protein 
from the insoluble fraction was attempted.  
 
 
 
 
 
4.3.6 PURIFICATION VIA ON-COLUMN REFOLDING 
The protein purification from the inclusion bodies was performed according to the 
indications of an on-column chemical refolding protocol, adopting several various 
washings (Oganesyan, Kim, and Kim 2004). 
The cultured pellet was resuspended in a buffer containing 30 mM Tris–HCl pH 8, 150 
mM NaCl, supplemented with protease inhibitors and lysed by mechanical pressure using 
a One Shot Cell disruption system (Constant Systems Ltd) at pressure 1.35 kBar. The 
lysis procedure was repeated twice to be more effective. The lysed cell suspension was 
vacuum-centrifuged at 18,000 rpm for 30 min at 4°C to separate supernatant and debris 
pellet. The latter was resuspended in a denaturing buffer consisting of 30 mM Tris-HCl 
pH 8, 150 mM NaCl, 8 M urea, supplemented with protease inhibitors, and incubated at 
4 °C under vigorous shaking overnight, to solubilize the inclusion bodies. Subsequently, 
the denatured suspension was cleared by vacuum centrifugation at 18,000 rpm for 30 
min at 4°C; the solubilized inclusion bodies, added of 5 mM imidazole, were loaded onto 
500 µL of Ni-Sepharose 6 Fast Flow resin (GE Healthcare), previously equilibrated with 
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Fig. 4.12 6-His-tagged β-carbonic anhydrase gel-filtration chromatography (Superdex 200 Increase 10/300 GL 
column); left: absorption profile; right: SDS-PAGE analysis of the fractions collected, showing the low final yield. 
 
6-His-tagged 
β-carbonic anhydrase 
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the denaturing binding buffer (30 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM imidazole, 8 M 
urea), and incubated at 4 °C overnight to enhance the batch-absorption. On-column 
renaturation and purification were performed by several changes of buffers, as listed 
below: 
1) 30 mM Tris-HCl pH 8, 150 mM NaCl, 20 mM imidazole, 8 M urea, 10 mM β-
mercaptoethanol 
2) 30 mM Tris-HCl pH 8, 150 mM NaCl, 0,1 % Triton X-100, 10 mM β-
mercaptoethanol 
3) 30 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM β-cyclodextrin, 10 mM β-
mercaptoethanol 
4) 30 mM Tris-HCl pH 8, 500 mM NaCl, 10 mM β-mercaptoethanol 
 
Every washing step consisted of 10 CV of peculiar buffer, at approximately 1 mL/min. An 
initial washing at low imidazole concentration was performed to remove nonspecific 
bindings. The subsequent detergent buffer allowed to ensure a complete protein 
denaturation. To remove detergent from the protein–detergent complex and to allow the 
protein refolding, β-cyclodextrin was added to the following washing. A high salt 
concentration buffer was finally applied to remove remaining impurities and β-
cyclodextrin. Refolded β-carbonic anhydrase was eluted with an elution buffer consisting 
of 30 mM Tris-HCl pH 8, 150 mM NaCl, 100 mM imidazole. As previously mentioned, β-
carbonic anhydrase showed a low affinity for the Ni-NTA resin, although the overnight 
shaking incubation to enhance the binding. Therefore, a consistent amount of the 
recombinant protein was eluted concurrently with the initial washing at low imidazole, as 
shown in the SDS-PAGE (Fig. 4.13). The eluted fractions containing the β-carbonic 
anhydrase were pooled and concentrated by ultrafiltration using a Vivaspin 20 5,000 
MWCO centrifugal concentrator (Sartorius), in order to perform some characterization 
experiments.   
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kDa kDa Fig. 4.13 On-column refolding of 6-His-tagged 
β-carbonic anhydrase by several changes of 
buffer (PEL: lysed pellet; SURN: supernatant; 
UREA before: inclusion bodies before incubation 
in urea 8M; UREA after: inclusion bodies after 
incubation in urea 8M; PEL UREA: pellet of 
inclusion bodies suspension cleared by 
centrifugation; SURN UREA: supernatant of 
inclusion bodies suspension cleared by 
centrifugation; FT: flow-throw; W IMID: wash 1; W 
TRIT: wash 2; W β-CD: wash 3; W NaCl: wash 4; 
EL 100mM: protein elution at 100 mM imidazole; 
EL 200mM: protein elution at 200 mM imidazole).  
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4.3.7 CHARACTERIZATION 
Firstly, the concentrated refolded sample was submitted to an analytical gel-filtration 
chromatography using a Superdex 200 Increase 10/300 GL column (GE Healthcare), 
equilibrated with a buffer containing 50 mM Tris-HCl pH 8, 200 mM NaCl, to evaluate the 
oligomerization of the protein in solution. The elution profile demonstrated that the 
refolded β-carbonic anhydrase was poly-disperse in solution, suggesting that this sample 
was not suitable for crystallization trials (Fig. 4.14). 
 
 
 
 
In order to evaluate the goodness of the refolding procedure and to estimate the content 
of secondary structure, a circular dichroism spectrum was collected by a JASCO J-715 
Spectropolarimeter (Jasco), in the range 193-250 nm, with a buffer consisting of 30 mM 
Tris-HCl pH 8 and protein concentration 0.1 mg/mL (Fig. 4.15). Circular dichroism 
analysis revealed that β-carbonic anhydrase was not fully refolded, since α-helix signal 
was lacking, despite its predicted prevalence. These evidence confirmed the not suitable 
quality of this sample for crystallization trials and different approaches of protein refolding 
need to be investigated to purify β-carbonic anhydrase from inclusion bodies. 
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Fig. 4.14 6-His-tagged β-carbonic anhydrase analytical gel-filtration 
chromatography (Superdex 200 Increase 10/300 GL column): absorption 
profile, showing the inhomogeneity of the purified protein sample. 
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4.3.8 CRYSTALLIZATION TRIALS 
β-carbonic anhydrase samples from affinity chromatography purification were used for 
crystallization tests, at different concentration (2-8.8 mg/mL). Crystallization trials with 
sitting-drop vapor-diffusion technique were carried out using an Oryx8 crystallization 
robot (Douglas Instruments). Several standard crystal screening kits were explored, 
including Structure Screen I and II (Molecular Dimensions), Crystal Screen I and II 
(Hampton Research), PACT Suite (Qiagen), JCSG Suite (Qiagen), PEGs II (Qiagen), 
AmSO4 (Qiagen). Given the limited protein concentration obtained, crystallization plates 
were performed mainly at 4 °C, to reduce the protein solubility and facilitate the 
crystallization process. Nevertheless, several conditions showed precipitation even 
immediately after drop deposition, most likely owing to the degradation of the purified 
protein. Microcrystalline precipitates were observed only in few crystallization conditions, 
mainly characterized by acid pH and PEG precipitant. Several crystallization attempts 
were performed, but suitable crystals were not obtained. 
 
 
4.4 RESULTS AND DISCUSSION 
 
The yield of soluble fraction was revealed to be the bottleneck of the purification of the β-
carbonic anhydrase. Most likely due to its C-terminal disorder region, the protein of 
interest was not properly folded by E. coli cells, lacking of some abilities of post-
translational modifications, and formed inclusion bodies. First attempt of overexpression 
Fig. 4.15 Circular dichroism of refolded 6-His-tagged β-
carbonic anhydrase (JASCO J-715 Spectropolarimeter, range 
193-250 nm) 
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was performed in E. coli BL21 (DE3) cells, but the basal expression of the recombinant 
protein was observed to be toxic for cell growth. Therefore, E. coli BL21 (DE3) pLysS 
cells were selected, to inhibit the background expression level of the target protein, and 
cells were grown slowly, at low temperature, to facilitate the correct folding. Despite these 
precautions, most of the protein of interest was found in the insoluble fraction, as inclusion 
bodies. In order to overcome this limitation, overexpression of the recombinant β-carbonic 
anhydrase was attempted using further engineered E. coli strain, including C41 (DE3) 
cells, C43 (DE3) cells, SHuffle® cells, Lemo21 (DE3) cells, whose peculiarities were 
previously described. However, despite the high expression level, the yield of soluble 
protein did not clearly improve (data not shown). ArcticExpress (DE3) cells, not yet tested, 
might be useful for this purpose, since they provide an approach to increasing the yield 
of soluble protein produced at low temperature, thanks to two co-expressed chaperonins. 
A further possible solution could be the subcloning as recombinant protein lacking 15 N-
terminal aminoacid residues, as reported in literature (Nishimori, Minakuchi, Kohsaki, 
Onishi, Takeuchi, Vullo, Scozzafava, and Claudiu T. Supuran 2007); but this region 
seems to be relevant for the purpose of structural investigations, since it is predicted to 
be involved in oligomerization. 
An additional limiting step was revealed to be the low affinity of the 6-His-tagged β-
carbonic anhydrase for the NiNTA resin of the affinity chromatography column. Besides 
the various chromatographic purifications previously reported, in order to overcome this 
issue, the target protein was subcloned as C-terminal 6-His-tag fusion protein. But this 
recombinant product was observed to bind to the NiNTA resin even less effectively, 
probably owing to the C-terminal disorder region, prone to degradation (data not shown). 
Moreover, the elution as double species reported in the event of some purifications was 
possibly due to degradation of this protein domain. 
Further investigations are needed to optimize the purification step and the yield of soluble 
and properly folded protein of interest, in order to explore more crystallization conditions 
and to characterize the catalytic activity and the peculiarities compared to homologues 
from other bacterial species.   
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5.1 INTRODUCTION 
 
As previously evidenced, motility is essential for 
successful stomach colonization by H. pylori 
and is provided by its sheathed unipolar flagella, 
considered as one of the most important 
colonization and virulence factors. H. pylori 
flagella, as those of enteric bacteria, are 
composed of three structural elements: a basal 
body, which is embedded in the cell wall and 
contains the proteins required for rotation and 
chemotaxis and usually the flagellar export 
proteins; an external helically shaped filament 
that works as a propeller when rotated at its 
base; a hook that serves as a joint between the 
basal body and the flagellar filament (Fig. 5.1; Chevance and Hughes 2008). Regulation 
of flagellar gene expression and biosynthesis is a complex and well-coordinated process 
in H. pylori; more than 40 proteins are involved in the biosynthesis and operation of 
flagella and their control by the chemotaxis machinery (Niehus et al. 2004). The assembly 
of the flagellar structure is a process initiated by the assembly of the basal body on the 
cell membrane. On the basal body, the flagellar hook forming protein monomers, namely 
FlgE, are assembled exterior to the cell forming the hook-basal body complex. Reached 
this step, FliK is responsible for the hook length control, as reported in other Gram-
negative bacteria, such as Salmonella typhimurium and Escherichia coli (Kawagishi et al. 
1996). When the flagellar hook substructure reaches its optimal length, sensed by the 
“checkpoint control” protein FliK, the export of the anti-σ28 factor, namely FlgM, is 
triggered, releasing σ28 from a σ28-FlgM complex, which in turn allows the subsequent 
expression of σ28-dependent genes. Specifically, σ28, as well as σ54, is a RNA polymerase 
factor responsible for the control of the transcription of genes encoding the flagellar 
filament subunits, namely FlaA and FlaB (Colland et al. 2001). Therefore, the release of 
σ28 from the complex results in a switch of export substrate specificity from rod/hook type 
to filament type, consequently initiating filament assembly (Baidya, Bhattacharya, and 
Chowdhury 2015). Accordingly, FliK acts as a molecular ruler, since it terminates hook 
Fig. 5.1 Structural elements of H. pylori flagella. 
Adapted from Chevance and Hughes, 2008. 
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export and assembly and transmits a signal to begin filament export, the final stage in 
flagellar biosynthesis (Waters, O’Toole, and Ryan 2007). 
Moreover, a cooperating effector is required for hook regulation and assembly, namely 
FlgD, which functions as the hook scaffolding protein and is also considered to be the 
hook-capping protein and the basal body rod-modification protein. In addition, together 
with FliK, FlgD regulates the assembly of the hook cap structure to prevent the leakage 
of hook monomers into the medium and hook monomer polymerization as well playing a 
role in determination of the correct hook length (Luo et al. 2009). Interestingly, in S. 
typhimurium the N-terminal domain of FliK has been observed to bind to the hook-capping 
protein FlgD with high affinity (Moriya et al. 2006). Therefore, according to their 
importance and cooperation in hook regulation and assembly, FliK and FlgD play a critical 
role in H. pylori pathogenesis, becoming the focus of several studies, also performed by 
this research group (data not published yet). 
In fliK mutants it has been observed that the hook to filament transition does not occur, 
and long hooks of unregulated length, named polyhooks, are formed (Muramoto et al. 
1998). Moreover, microarray analysis of a fliK-null mutant has revealed increased 
transcription of genes under the control of the σ54 sigma factor. This factor has been 
shown to be responsible for transcription of several flagellar genes, including flgE and 
flaB, as previously mentioned. No genes higher in the flagellar hierarchy had altered 
expression, suggesting specific and localized FliK-dependent feedback on the σ54 regulon 
(Ryan et al. 2005; Douillard et al. 2009). FliK thus appears to be involved in three main 
processes: hook-length control, export substrate specificity and control of σ54 
transcriptional activity. Interestingly, it has been reported that contact of H. pylori with 
gastric epithelial cells strongly induces expression of the flagellar hook-length control 
protein. Host cell contact also up-regulates expression of the H. pylori major virulence 
factor CagA (Kim et al. 2004). It has been demonstrated that FliK is necessary for cagA 
gene upregulation in gastric cell-associated H. pylori, since FliK has a role in triggering 
dissociation of the alternate sigma factor, σ28, from a nonfunctional σ28-FlgM complex, 
releasing free, functional σ28; consequently, the σ28-RNA polymerase initiates 
transcription of cagA (Baidya et al. 2015). 
The flagellar cytoplasmic protein FliK regulates hook elongation by two successive main 
events: by determining hook length and by stopping the supply of hook protein; but the 
mechanism remains still controversial. It has been hypothesized that these two distinct 
roles are assigned to different regions of FliK: the N-terminal domain determines length 
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and the C-terminal domain switches secretion from the hook protein to the filament protein 
(Mizuno et al. 2011). Flagellar components are exported through a homologue to a type 
III secretion system (T3SS) apparatus, as previously mentioned; FlhB is a membrane-
bound component of the export apparatus and, particularly, represents the switchable 
secretion gate. As result of the interaction between the C-terminal domain of FliK and the 
cytoplasmic domain of FlhB, FliK has been reported to switch substrate specificity of the 
export apparatus from rod/hook-type to filament-type by causing a conformational change 
in the cytoplasmic domain of FlhB upon completion of the hook assembly (Minamino et 
al. 2004). On the other hand, the N-terminal domain of FliK include a secretion signal and 
is  dispensable for length control of the flagellar hook (Hirano et al. 2005). The secreted 
FliK, thanks to  its highly elongated structure, has been hypothesized to interact with the 
hook cap during hook polymerization, as reported in S. typhimurium; thus, when the hook 
polymerized to a proper length, the FliK C-terminal domain would be in proximity to FlhB 
to catalyze the secretion-specificity switch, terminate hook polymerization, and initiate 
filament assembly (Fig. 5.2; 
Minamino and Pugsley 2005).  
Further investigations are needed 
to comprehend in detail the 
functional mechanism of this 
molecular ruler, affecting a proper 
motility and the colonization ability 
of H. pylori. The information 
reported up to now suggests FliK, 
as well as other flagellar proteins, 
to be an attractive target for 
pharmacological studies, since 
abnormalities in the flagella 
assembly impair the H. pylori 
motility and rate of stomach colonization. Structural investigations of FliK homologues are 
very limited; to date in the Protein Data Bank (http://www.pdb.org) only a NMR structure 
of FliK C-terminal domain from Salmonella enterica serovar Typhimurium (Fig. 5.4; 
Mizuno et al. 2011; PDB accession code: 2RRL) has been published. This paucity of 
structural information is probably due to a largely unstructured nature of FliK, mainly at 
the N-terminal domain, which contains an unusual sequence of glycine and proline, which 
Fig. 5.2 Hypothetical model of substrate specificity switching of the type 
III flagellar protein secretion apparatus. The flagellar protein secretion 
apparatus secretes rod-type and hook-type substrates, but does not secrete 
the filament-type substrates until the hook reaches its mature length. Upon 
completion of the hook structure, the completion signal is transmitted to FliK 
and FlhB, shutting off rod/hook-type protein secretion and turning on filament-
type protein secretion. Adapted from Minamino and Pugsley, 2005. 
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are structure-breaking residues. On the contrary, the C-terminal domain, rich in 
glutamine, is a more compact and globular region, and conserved among several species 
(Fig. 5.3). As can be evidenced, FliK aminoacid sequences from various organisms show 
a low level of identity, even among similar species, such as S. typhimurium and E. coli 
(Mizuno et al. 2011); specifically, there are no conserved sequences in the N-terminal 
domain, whereas conserved sequences are found in the C-terminal domain (Fig. 5.3). A 
high level of disordered regions has also been detected in H. pylori FliK, resulting in 
problematic investigations and leading to interrupt trials, as described below. 
 
 
 
 
Fig. 5.3 Alignment of 
the sequences of 
FliK orthologs from 
eight bacteria and 
from YscP, an 
equivalent protein in 
the injectisome 
assembly. The 
locations of the N-
terminal and C-
terminal fragments 
are marked with 
shaded bars on the 
alignment; the 
numbers marked 
correspond to the 
positions for the 
residues in FliK from 
S. Typhimurium. The 
secondary elements 
determined by NMR 
are depicted on the 
alignment by the filled 
bars: two α-helices 
and four β-strands. 
Adapted from Mizuno 
et al., 2001. 
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5.2 SEQUENCE ANALYSIS 
 
 
10 20 30 40 50 60
MPSPINPIHT NASANASTLI NSGAKNKDTK NAPKSASKDF SKILNQKISK DKTAPKENPN 
70 80 90 100 110 120
ALKATPKNTK EDAKVLEKTP TLQPQHAQNP AKDQQAPTLK DLLNHKTTAP HEAQHENHEH 
130 140 150 160 170 180
ETNPKTPNET LNKNEKEPNG VTSNDHQANL TNKNPLTPTN HAIKNPTAPT HNAKEPKTLK 
190 200 210 220 230 240
DIQTLSQKHD LNANNIQAAT IPENKTPLNA SDHLALKTTQ TPINHTLAKN DAKNTANLSS 
250 260 270 280 290 300
VLQSLEKKES HNKEHANPPN NEKKTPPLKE ALQMNAIKRD KTLSKKKSEK TPTKTQTTAP 
310 320 330 340 350 360
SIAPENAPKI PLKTPPLMPL IGANPPNDNP PTPLEKEETT KEASDNKEKT KESSNSAQNA 
370 380 390 400 410 420
QNAQSSDKTS ENKSVTPKET IKHFTQQLKQ EIQEYKPPMS RISMDLFPKE LGKVEVIIQK 
430 440 450 460 470 480
VGKNLKVSVI SHNNSLQTFL DNQQDLKNSL NALGFEGVDL SFSQDSSKEQ PKEQLKEPFK 
490 500 510
EQELTPLKEN ALKSYQENTD HENKETSMQI TLYA 
Fig. 5.4 NMR structure of FliK C-terminal 
domain from Salmonella enterica serovar 
Typhimurium (PDB accession code: 2RRL). 
Chapter V 
160 
 
Property Value 
Aminoacid 514 
Cysteines 0 
Molecular weight (kDa) 56868.5 
Theoretical pI 9.15 
Abs280nm (c=1mg/mL; b=1cm) 0.079 
Signal peptide Yes 
 
 
The flagellar hook-length control protein from H. pylori G27 is composed of 514 
aminoacids, many more than the other bacterial species considered, and exhibits a basic 
theoretical isoelectric point, approximately 9, differently from the very acid one of S. 
typhimurium and E. coli (approximately 4) and similar to that of the related Helicobacter 
hepaticus. As anticipated, the alignment of the aminoacid sequences confirms that H. 
pylori FliK presents a low level of identity compared to orthologues from similar bacterial 
species, except for the C-terminal domain; specifically, H. pylori FliK shares 29% identity 
with FliK from S. typhimurium, whose C-terminal structure is known, 28% identity with 
FliK from E. coli, and 42% identity with FliK from the related pathogen H. hepaticus, and 
the most conserved residues are located at the C-terminal domain (Fig. 5.6). A folding 
prediction program (FoldIndex; http://bip.weizmann.ac.il/fldbin/findex) confirms the 
overall unstructured 
nature of this flagellar 
protein (Fig. 5.5), 
showing the limited 
folded region located 
at the C-terminal 
domain, as predicted; 
this evidence is also 
confirmed by a 
prediction of naturally 
disordered regions (PONDOR®; http://www.pondr.com), that reveals 75.49% of overall 
disorder and 12 disordered regions (Fig. 5.7). Additionally, the presence of the N-terminal 
secretion signal is demonstrated by SignalP 4.1 Server (Fig. 5.8), that is able to predict 
signal peptide/non-signal peptide based on a combination of several artificial neural 
Tab. 5.1 Some properties of FliK from H. pylori 
 
Fig. 5.5 Folding and hydrophobicity prediction of FliK from H. pylori (FoldIndex©). 
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networks (Petersen et al. 2011; http://www.cbs.dtu.dk/services/SignalP). According to the 
structure prediction by Phyre2 (Kelley et al. 2015; http://www.sbg.bio.ic.ac.uk/phyre2/), 
the content of secondary structure expected is limited and include 31% α-helices and 7% 
β-strands. A putative structure of FliK from H. pylori (Fig. 5.9) has been predicted, using 
the SWISS-MODEL (Biasini et al. 2014; http://swissmodel.expasy.org/) and the FliK C-
terminal domain from S. typhimurium as template (PDB accession code: 2RRL). 
 
 
 
 
 
 
 
Fig. 5.6 Sequence alignment of FliK from H. pylori strain G27, S. typhimurium, E. coli and H. hepaticus; in shades of blue 
the identity above 50% is shown (ClustalW and Jalview ver. 2.9.0b2). 
 
Fig. 5.7 Prediction of naturally disordered regions of 
FliK from H. pylori (PONDOR®; PONDR scores 
indicate the propensities for folding; the regions having 
residues with lower PONDR score tend to be part of a 
folded structure, while the regions having a score over 
0.5 are predicted to be disordered). 
 
Fig. 5.8 FliK from H. pylori secretion signal 
prediction (SignalP 4.1 Server) 
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5.3 MATERIALS AND METHODS 
 
5.3.1 MOLECULAR CLONING 
The coding sequence for FliK (HPG27_857) was PCR-amplified from genomic DNA of H. 
pylori strain G27, using Phusion® High-Fidelity DNA Polymerase (New England Biolabs) 
and primers 5’-GAAGGAGATATACATATGCCATCTCCTATTAATCCCATT-3’ (fw) and 
5’-GTGATGGTGGTGATGATGCGCATAAAGAGTGATTTGC-3’ (rv). The reverse primer 
provided a 18 nt-sequence that recognizes the pETite C-His Kan vector (Lucigen) and 
encodes a C-terminal 6-His tag; it did not include a Stop anticodon. The forward primer 
included a Start codon. It was decided to not introduce a TEV proteolysis site between 
the 6-His-tag and the C-terminal end of the target protein. The PCR product, purified by 
1% agarose gel, was cloned by thermal shock into the pETite C-His Kan vector (Lucigen) 
using E. coli 10G competent cells (Lucigen), grown overnight on selective LB medium 
supplemented with 30 μg/ml of kanamycin. The colonies were checked by colony-PCR 
using EconoTaq DNA Polymerase (Lucigen) and T7 primers. Purified plasmid of positive 
colonies was digested by EcoRV restriction enzyme (New England Biolabs), for 1 h at 37 
°C. Positive samples were finally checked by DNA sequencing to evaluate the quality. 
The following sequence corresponds to the final recombinant construct with a C-terminal 
6-His tag. 
 
Fig. 5.9 Homology modelling structure of FliK from H. pylori, monomer predicted 
(SWISS-MODEL; template: C-terminal domain of FliK from S. typhimurium, PDB 
accession code: 2RRL). 
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Property Value 
Aminoacid 520 
Cysteines 0 
Molecular weight (kDa) 57691.4 
Theoretical pI 9.15 
Abs280nm (C=1mg/mL; b=1cm) 0.077 
Signal peptide Yes 
 
 
 
 
5.3.2 EXPRESSION TRIALS 
The pETite plasmid carrying the gene of interest was transformed into E. coli BL21 (DE3) 
competent cells (Lucigen). The E. coli BL21 (DE3) harboring the pETite plasmid were 
grown in small scale in a selective LB medium supplemented with 30 µg/mL of kanamycin, 
in order to control and optimize level and quality of protein expression. Multiple 50 mL 
cultures were grown under mild shaking (180 rpm) at 37 °C until an OD value (optical 
10 20 30 40 50 60
MPSPINPIHT NASANASTLI NSGAKNKDTK NAPKSASKDF SKILNQKISK DKTAPKENPN 
70 80 90 100 110 120
ALKATPKNTK EDAKVLEKTP TLQPQHAQNP AKDQQAPTLK DLLNHKTTAP HEAQHENHEH 
130 140 150 160 170 180
ETNPKTPNET LNKNEKEPNG VTSNDHQANL TNKNPLTPTN HAIKNPTAPT HNAKEPKTLK 
190 200 210 220 230 240
DIQTLSQKHD LNANNIQAAT IPENKTPLNA SDHLALKTTQ TPINHTLAKN DAKNTANLSS 
250 260 270 280 290 300
VLQSLEKKES HNKEHANPPN NEKKTPPLKE ALQMNAIKRD KTLSKKKSEK TPTKTQTTAP 
310 320 330 340 350 360
SIAPENAPKI PLKTPPLMPL IGANPPNDNP PTPLEKEETT KEASDNKEKT KESSNSAQNA 
370 380 390 400 410 420
QNAQSSDKTS ENKSVTPKET IKHFTQQLKQ EIQEYKPPMS RISMDLFPKE LGKVEVIIQK 
430 440 450 460 470 480
VGKNLKVSVI SHNNSLQTFL DNQQDLKNSL NALGFEGVDL SFSQDSSKEQ PKEQLKEPFK 
490 500 510 520
EQELTPLKEN ALKSYQENTD HENKETSMQI TLYAHHHHHH
Tab. 5.2 Some properties of FliK referred to the recombinant 
construct added of C-terminal 6-His-tag. 
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dispersion, at 600 nm) of about 0.6; then 0.5 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) was added to the medium to induce protein expression and the cultures were 
incubated at 37 °C for 3 h, at 30°C overnight, at 20 °C overnight, respectively. The 
cultured cells were harvested from each small scale culture and medium eliminated by 
centrifugation at 5,000 rpm for 30 min at 4 °C. The pellet was resuspended in a lysis 
buffer containing 50 mM Tris-HCl pH 7.2, 150 mM NaCl, supplemented with a protease 
inhibitor cocktail (1 mM phenylmethanesulfonyl fluoride (PMSF), 15 µM aprotinin, 1 µM 
leupeptin, 0.5 mM 4-(2-Aminoethyl)-benzenesulfonylfluoride hydrochloride (AEBSF)), 
and lysed by mechanical pressure using a One Shot Cell disruption system (Constant 
Systems Ltd) at pressure 1.35 kBar. After vacuum centrifugation at 18,000 rpm for 30 min 
at 4°C, pellet and supernatant were loaded on SDS-PAGE and Wester blotting, in order 
to evaluate the propriety of the expression and the solubility of the expressed protein. The 
recombinant FliK expects a molecular weight of 57691.4 kDa; the expressed protein 
revealed a lower molecular weight, approximately 45 kDa, as well as a low expression 
level profile (Fig. 5.10). Moreover, Western blotting analysis to investigate the presence 
of the His-tag could not detect any species.  
  
 
 
 
5.4 RESULTS AND DISCUSSION 
 
These findings are likely ascribed to the high disorder level of H. pylori FliK sequence, 
structural feature shared by orthologous proteins from several organisms. Firstly, E. coli 
competent cells are not able to properly express and fold the recombinant protein, thus it 
undergoes degradation; these evidences may explain the unexpected molecular weight 
C-His-tag FliK 
Fig. 5.10 SDS-PAGE analysis of expression and 
solubilization of 6-His-tagged FliK from H. pylori. 
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on SDS-PAGE, as well as the low expression level. Moreover, the lacking of signal in 
Western blotting analysis for His-tag could indicate that the C-terminal domain is 
degraded, despite its more evident structural organization. It has been chosen to locate 
the 6-His-tag at the C-terminal end just because it is reported to be more compact and 
folded. To confirm this C-terminal degradation, some purification attempts by affinity 
chromatography onto a 1 mL His-Trap HP Ni–NTA column (GE Healthcare) were 
performed, but the purified fractions were not clearly identified, since the corresponding 
molecular weight is not attributable neither to expected recombinant FliK nor to evidenced 
expressed protein of 45 kDa (Fig. 5.11). Therefore, the degradation of the 6-His-tagged 
C-terminal region is supported, since the expressed protein is not able to bind to the Ni-
NTA resin of the column. Alternatively, the recombinant FliK undergoes further 
degradation during the purification and can not be detected. To be sure of the 
recombinant construct, FliK gene was PCR-amplified and cloned in pETite C-His Kan 
vector (Lucigen) for a second time. The plasmid carrying the gene of interest was again 
sequenced, confirming the correctness of the recombinant construct. Therefore, the 
overall unstructured organization seems to be limiting factor for the purification of H. pylori 
Flik, as well as for the structural characterization of flagellar hook-length control proteins 
from other organisms. As previously reported, literature data on structural investigations 
are very limited. Adoptable strategies to overcome the reported problems could be the 
cloning and purification of single domains, or selecting more sophisticated system of 
expression, or co-expressing with FlgD demonstrating to bind to FliK during flagellar hook 
assembly and thus stabilizing the complex. 
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Fig. 5.11 SDS-PAGE analysis of 
affinity chromatography of 6-His-
tagged FliK from H. pylori. 
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6.1 INTRODUCTION 
 
A crucial step in the fast and correct protein-folding pathway is the introduction of disulfide 
bonds between cysteine residues in a process called oxidative protein folding. Many 
bacteria use an oxidative protein-folding machinery to assemble proteins that are 
essential for cell integrity and to produce virulence factors (Heras et al. 2009). Disulfide 
bonds contribute to the stability and function of many extracytoplasmic, soluble or 
membrane-bound proteins; the formation of disulfide bonds plays a key role also in 
bacterial virulence, which often depends on cysteine-rich, extracytoplasmic proteins. In 
Gram-negative bacteria, the oxidative protein folding takes place in the periplasm and is 
controlled by proteins from the disulfide bond (Dsb) family. In general, there are two, 
mostly antagonistic, metabolic pathways acting in the periplasm: an oxidation pathway 
and an isomerization/reduction 
pathway, as reported for 
Escherichia coli (Fig. 6.1). The 
first reaction (catalyzed by 
DsbA and DsbB) is responsible 
for the formation of disulfide 
bonds in the newly synthesized 
proteins, just after they cross 
the cytoplasmic membrane. As 
this process occurs in a non-
selective way, a second reaction (driven by DsbC and DsbD) rearranges improperly 
introduced disulfide bonds 
(Denoncin and Collet 2012; 
Bocian-Ostrzycka et al. 2015). 
In the highly oxidizing environment of the periplasm, there is also a need for selected 
proteins to be kept in a reduced form. In the assembly of c-type cytochromes, essential 
for electron transfer in a multitude of different cellular processes, energy metabolism, 
apoptosis (Barker and Ferguson 1999; Martinou, Desagher, and Antonsson 2000; 
Stevens et al. 2004; Hamel et al. 2009), among the many roles, the cytochrome c 
maturation process requires ligation of heme (iron protoporphirin IX) to reduced thiols of 
Fig. 6.1 The oxidative apthway and the isomerase pathway in E. coli. 
Adapted from Heras et al., 2009. 
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the Cys-X-X-Cys-His motif of apocytochrome (Bonnard et al. 2010). Biogenesis of 
cytochrome c occurs in the bacterial periplasm, besides the mitochondrial intermembrane 
space and thylakoid lumen. It consists of the following steps: synthesis and transport 
across at least one biological membrane of apocytochrome c and heme, reduction and 
maintenance under a reduced form of the heme ferrous iron and the CXXCH sulfhydryls, 
formation of thioether bonds between the heme and apocytochrome c (Hamel et al. 2009). 
To date, three distinct pathways for cytochrome-c biogenesis have been reported, named 
system I, II, and III, respectively. Specifically, bacteria predominantly use systems I and 
II, whereas eukaryotes exclusively adopt system III. They comprise two kinds of proteins 
acting in a coordinated fashion: those involved in heme handling and heme ligation to the 
apocytochrome, and those contributing to reduction of a disulfide bond of the CXXCH 
heme-binding motifs (Sanders et al. 2010). 
The cytochrome c maturation machinery of the system I operating in many Gram-negative 
bacteria (including Escherichia coli), archaea and plant mitochondria, consists of up to 
ten proteins, named Ccm ABCDEFGHI and DsbD or its shorter version CcdA (Fig. 6.2). 
The apocytochrome reduction is accomplished by the action of a specific periplasmic 
thioredoxin-like protein named CcmG (also known as DsbE), as well as of CcmH, and 
DsbD or CcdA. DsbD/CcdA transfers electrons from cytoplasmic thioredoxin to CcmG. 
Then CcmG is reoxidized by shuttling its electrons to CcmH, which finally transfers them 
to apocytochrome c. The remaining proteins play a role in heme transport and its ligation 
to the apocytochrome (Ferguson et al. 2008; Roszczenko et al. 2015). 
 
Fig. 6.2 The Ccm (System I) system for c-type cytochrome assembly as exemplified by E. coli. Adapted from Ferguson et al., 
2008. 
System II, referred to as the cytochrome c synthesis pathway, is simpler and more 
widespread; it is present in some Gram-negative bacteria (including H. pylori), Gram-
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positive bacteria (including Bacillus subtilis), cyanobacteria and chloroplasts. System II is 
comprised of four (sometimes three) membrane-bound proteins: ResA (also named CcsX 
or HelX), ResB (also named CcsB), ResC (also named CcsA) and CcdA, among which 
ResA is a functional counterpart of CcmG, and CcdA is a functional counterpart of the 
transmembrane domain of DsbD (Fig. 6.3). CcsA (ResC) and CcsB (ResB) are the 
components of the cytochrome c synthase, whereas CcdA and CcsX (ResA) function in 
the generation of a reduced heme-binding motif. The CcdA protein is required for reducing 
CcsX (ResA) and receives its reducing equivalents from thioredoxin in the cytoplasm. In 
a few bacterial species, such as Helicobacter, Bacteroides and Wolinella, the genes 
encoding the CcsB and CcsA proteins are naturally fused into one large open reading 
frame (called ccsBA). The integral membrane protein CcsBA acts as a heme exporter 
and attaches heme to apocytochrome c (Simon and Hederstedt 2011; Yoon et al. 2013). 
 
Fig. 6. 3Fig. Overview of the membrane-bound System II machinery for cytochrome c biogenesis. Adapted from Simon and 
Hederstedt, 2011. 
Many studies have been carried out to decipher the cooperation among periplasmic Dsb 
proteins in cytochrome c biogenesis, mainly in the maintenance of the proper oxidative 
status of the CXXC motif of the apocytochrome c, showing some peculiarities as regards 
H. pylori. Analysis of its genome nucleotide sequence revealed that H. pylori possesses 
a rather simple respiratory chain consisting of three enzymes: quinol-cytochrome c 
reductase, cytochrome bc1 complex, cytochrome c553 and cb-type cytochrome c oxidase 
(Koyanagi et al. 2000). Little is known about the cytochrome c maturation system of this 
pathogen. In the genome of H. pylori 26695 149 proteins containing CXXC motifs 
characteristic of thiol:disulfide oxidoreductases have been identified to date. Only four of 
these proteins have a thioredoxin-like (TRX) fold and are periplasm-located, among them 
HP0377 (HPG27_1020 in strain G27). Additionally, the H. pylori genome lacks classical 
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DsbA and DsbB proteins, members of the Dsb oxidative pathway, as well as classical 
DsbC and DsbD proteins, members of the Dsb isomerization pathway (Bocian-Ostrzycka 
et al. 2015). Interestingly, in the genome of H. pylori 26695 homologues of the four 
proteins of system II, namely the cytochrome c maturation system, have been identified. 
HP0265 is homologous to the CcdA protein. HP0378 contains homologues of two system 
II components, namely CcsB and CcsA proteins, in a single open reading frame. Finally, 
HP0377, located directly upstream of HP0378 in a single operon, is homologous to the 
ResA protein. Specifically, HP0377 shows 15% overall sequence identity compared to 
ResA of Bacillus subtilis, which is required to keep the cysteine residues in the heme-
binding CXXCH motif of apocytochrome c reduced before heme attachment (Yoon et al. 
2013). Although HP0377 was originally described as DsbC homologue, since it was 
identified as a homologue of the E. coli disulfide-bond isomerase DsbC (12% overall 
sequence identity; Kaakoush et al. 2007), its x-ray crystallographic structure has been 
determined (Roszczenko et al. 2015; PDB accession codes: 4FYB, 4FYC) and indicates 
that HP0377 can be characterized as a ResA homologue and, thus, counterpart of CcmG 
protein. H. pylori utilizes the system II pathway for the synthesis of cytochrome c. Before 
covalent attachment of the heme group, the active-site cysteines of apocytochrome c553 
must be kept reduced by a component of the H. pylori system II. HP0377 is a thioredoxin-
Fig. 6.4 Models representing the role of H. pylori HP0377 in cytochrome c biogenesis and in 
oxidized protein folding. Adapted from Roszczenko et al., 2015. 
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fold protein containing the CSYC motif, which indicates that it functions as a disulfide 
oxidoreductase (Fig. 6.4; Roszczenko et al. 2015). HP0377 has a classic thioredoxin-fold 
composed of [β1–(α1a–α1b)–β2]–α2–(β5–β6–α3), with three major modifications. The 
modifications are the distinct insertion of a two-stranded β-sheet (β3 and β4) between β2 
and α2, and extensions at both the N- and C-termini (310-helix η1 and β0; α4). The CXXC 
motif and the cis-proline loop are conserved active-site features among the redox-active 
proteins of the thioredoxin-fold and are important in the activity, substrate recognition and 
stabilization of these proteins. The CXXC motif of HP0377 is located at the N-terminus of 
the first helix, namely α1, and includes a tyrosine and a serine residues among two 
cysteine residues (Fig. 6.5; Yoon et al. 2013). Although there is no evidence that HP0377 
is involved in cytochrome c assembly in vivo, that is the likely case because its resolved 
structure is similar to that of other CcmG proteins and suggests that HP0377 may function 
as a reductase towards H. pylori apocytochrome c553. Confirming this evidence, in the 
genome of H. pylori 26695 the hp0377 gene is located between hemH (hp0376), a gene 
for heme biosynthesis, and ccsBA (hp0378), a gene for heme export and the attachment 
of heme to apocytochrome c (Frawley and Kranz 2009; Roszczenko et al. 2015). 
Moreover, HP0377 has been demonstrated to reduce a putative L,D-transpeptidase 
(HP0518), which contains a single cysteine residue in the active site, and form a covalent 
complex via the expected disulfide bond, similarly to E. coli DsbC, which plays a role as 
a backup for DsbG in protecting the catalytic cysteine of the YbiS L,D-transpeptidase from 
oxidation (Yoon et al. 2013). HP0377 and E. coli DsbC share a remarkably similar active 
site, but differ in the oligomerization, since HP0377 exists as a monomer, as well as other 
Fig. 6.5 Overall monomer structure and topology of HP0377. (a) Stereoview of an HP0377 monomer in cartoon 
representation, with the secondary-structure elements labelled. α-helices are depicted in green and β-strands in red. 
S atoms of Cys89 and Cys92 in the CXXC motif are shown as red and green spheres, respectively; the cis-Pro156 is 
shown as a green stick model. (b) A topology diagram of HP0377 (chain B, oxidized state) is shown with the same 
colour scheme as in (a). The classic thioredoxin fold is encircled by a red dotted box. Residue numbers for each 
secondary-structure element are indicated. α-helices, 310-helices, β-strands and loops are shown as cylinders (green), 
flat cylinders (green), arrows (graded red) and solid lines, respectively. Adapted from Yoon et al., 2013. 
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periplasmic thioredoxin-like proteins (B. subtilis ResA, Bradyrhizobium japonicum CcmG 
and TlpA, and E. coli CcmG), whereas E. coli DsbC is a V-shaped dimeric proteins. The 
structural determination has confirmed that HP0377 possesses a classic thioredoxin-fold 
with a distinct insertion between α2 and β2 and extensions at both the N- and C-termini 
(Fig. 6.5). Additionally, in contrast to B. subtilis ResA, HP0377 shows no substantial 
difference between the reduced and partially 
oxidized structures (Fig. 6.6; Yoon et al. 2013). 
HP0377 is present in vivo in the reduced form, 
which is a characteristic feature of thiol 
oxidoreductases being reductants, and its 
redox state is influenced by a further 
thioredoxin-like protein, namely HP0231, 
creating a redox pair playing a role in 
introduction of disulfide bonds (Roszczenko et 
al. 2015). A model of their interaction is shown 
in Fig. 6.4. The picture evidences how HP0377 
seems to be a membrane-anchored lipoprotein, 
differently than reported by Yoon et al., 
containing a putative signal sequence with a 
lipobox that can potentially be processed by 
signal peptidase II (Paetzel et al. 2002); 
nevertheless, understanding the role of the HP0377 lipobox requires more investigation. 
Additionally, the pKa of the N-terminal cysteine of the CXXC motif of HP0377 appears to 
be similar to those observed for E. coli DsbC or DsbA, but not to those determined for 
most CcmGs. This observation suggests that the activity of HP0377 in H. pylori is distinct 
from that described for the classical CcmGs. Therefore, HP0377, in contrast to most 
CcmGs that are involved in only the cytochrome c biogenesis process, is at least a 
bifunctional reductase, also showing a Dsb-related isomerization function. 
Given the importance of disulfide bond formation to achieve native protein structures and 
the role of the Dsb proteins in the correct folding of several bacterial virulence factors 
(Heras et al. 2009), including those from H. pylori, this family of proteins represents a 
possible new drug target. In this regard, HP0377, namely HPG27_1020 in H. pylori strain 
examined, has been considered an attractive target for structural investigations in this 
research project. To date few crystal structures of bacterial thiol:disulfide oxidoreductase 
Fig. 6.6 Structural comparisons of reduced HP0377 
with partially oxidized HP0377 and reduced E. coli 
DsbC. Adapted from Yoon et al., 2013. 
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have been determined, among them ResA from Bacillus subtilis (Crow et al. 2004; PDB 
accession codes: 1ST9, 1SU9), ResA from Bacillus anthracis (data not published yet; 
PDB accession code: 4NMU), DsbC from Escherichia coli (McCarthy et al. 2000; PDB 
accession code: 1EEJ), DsbC from Salmonella enterica (Jiao et al. 2013; PDB accession 
code: 4ILF), DsbC from Haemophilus influenzae (Zhang et al. 2004; PDB accession code: 
1T3B) and the previously described HP0377 from H. pylori  26695 (Yoon et al. 2013; PDB 
accession codes: 4FYB, 4FYC). Therefore, further structural investigations of these 
family of proteins could corroborate their use as potential pharmacological target. 
 
 
6.2 SEQUENCE ANALYSIS 
 
 
 
Property Value 
Aminoacid 223 
Cysteines 3 
Molecular weight (kDa) 25,552.0 
Theoretical pI 8.18 
Abs280nm (c=1mg/mL; b=1cm) 0.816 (all Cys reduced) 
Signal peptide Yes 
 
 
HP0377 from H. pylori G27, namely HPG27_1020, is composed of 223 aminoacids, 
including 3 cysteine residues, two of which are included in the CXXC motif characteristic 
of the thioredoxin-fold proteins. The alignment of the aminoacid sequences of 
HPG27_1020 from H. pylori and other bacterial thiol:disulfide oxidoreductases, from B. 
subtilis, E. coli and the related Helicobacter hepaticus,  reports an overall high variability, 
10 20 30 40 50 60
MFSLSYVSKK FLSVLLLISL FLSACKSNNK DKLDENLLSS GSQSSKELND ERDNIDKKSY 
70 80 90 100 110 120
AGLEDVFLDN KSISPNDKYM LLVFGRNGCS YCERFKKDLK NVKELRDYVK EHFSAYYVNI 
130 140 150 160 170 180
SYSKEHDFKV GDKDKNDEKE IKMSTEELAQ IYAIQSTPTI VLSDKTGKTI YELPGYMPST 
190 200 210 220
QFLAVLEFIG DGKYQDAKND EDLTKKLKAY IKYKTNLSKS KSS 
Tab. 6.1 Some properties of HPG27_1020 protein from H. pylori. 
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but the CXXC motif of the active site is conserved (Fig. 6.7). The secondary structure 
expected include a core of β-strands (11%) surrounded by α-helices (55%), in accordance 
to the general structure of the thioredoxin-fold proteins (Phyre2; Kelley et al. 2015; 
http://www.sbg.bio.ic.ac.uk/phyre2/). As reported by Yoon et al. 2013, in the case of 
HP0377 from H. pylori 26695, and confirmed by SignalP 4.1 Server prediction (Petersen 
et al. 2011; http://www.cbs.dtu.dk/services/SignalP), the N-terminal domain includes a 24 
aa signal peptide (Fig. 6.8). In order to confirm the thioredoxin-fold, a putative structure 
of the thiol:disulfide oxidoreductase HPG27_1020 from H. pylori G27 has been predicted, 
using the SWISS-MODEL bioinformatics homology modelling tool (Biasini et al. 2014, 
http://swissmodel.expasy.org/) and HP0377 from H. pylori 26695 as template, which 
shares 96% sequence identity (PDB accession code: 4FYB); the model has evidenced 
the typical thioredoxin-fold composed of four-stranded antiparallel β-sheet and three 
flanking α-helices, added of two two-stranded β-sheet, as reported for the template (Fig. 
6.9). 
 
 
Fig. 6.7  Sequence alignment of thiol:disulfide oxidoreductases HPG27_1020 from H. pylori strain G27, B. 
subtilis, E. coli and H. hepaticus; in shades of blue the identity above 50% is shown (ClustalW and Jalview 
ver. 2.9.0b2). 
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6.3 MATERIALS AND METHODS 
 
6.3.1 MOLECULAR CLONING 
The coding sequence for FliK (HPG27_857) was PCR-amplified from genomic DNA of H. 
pylori strain G27, using Q5® High-Fidelity DNA Polymerase (New England Biolabs) and 
primers 5’- GAAGGAGATATACATATGTGCAAGTCCAACAATAAAGAC-3’ (fw) and 5’- 
GTGATGGTGGTGATGATGGCTGGATTTGCTTTTAGAAAG-3’ (rv). Since the full-length 
protein is toxic to E. coli, the 24 aa N-terminal export signal sequence was excluded and 
C-terminal 6-His tag was included. The reverse primer provided a 18 nt-sequence that 
recognizes the pETite C-His Kan vector (Lucigen) and encodes the C-terminal 6-His tag; 
it did not include a Stop anticodon. The forward primer included a Start codon. It was 
decided to not introduce a TEV proteolysis site between the 6-His-tag and the C-terminal 
end of the target protein. The PCR product, purified by 1% agarose gel, was cloned by 
thermal shock into the pETite C-His Kan vector (Lucigen) using E. coli XL1-Blue 
competent cells (Agilent), grown overnight on selective LB medium supplemented with 
30 μg/ml of kanamycin. The colonies were checked by colony-PCR using EconoTaq DNA 
Polymerase (Lucigen) and T7 primers. Purified plasmid of positive colonies was double-
digested by NdeI (New England Biolabs) and NotI (New England Biolabs) restriction 
Fig. 6.8 HPG27_1020 from H. pylori signal peptide 
prediction (SignalP 4.1 Server). 
Fig. 6.9 Homology modelling structure of 
thiol:disulfide oxidoreductases HPG27_1020 
from H. pylori G27, monomer predicted 
(SWISS-MODEL; template:  thiol:disulfide 
oxidoreductases HP0377 from H. pylori 26695, 
PDB accession code: 4FYB). 
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enzyme, for 1 h at 37 °C. Positive samples were finally checked by DNA sequencing to 
evaluate the quality. 
The following sequence corresponds to the final recombinant construct lacking the 24 aa 
N-terminal export signal and flanked by a C-terminal 6-His tag. 
 
 
 
Property Value 
Aminoacid 205 
Cysteines 3 
Molecular weight (kDa) 23,685.5 
Theoretical pI 7.23 
Abs280nm (C=1mg/mL; b=1cm) 0.818 (all Cys reduced) 
Signal peptide No 
 
 
 
 
6.3.2 EXPRESSION 
The pETite plasmid carrying the HPG27_1020 gene was transformed into E. coli BL21 
(DE3) competent cells (Lucigen). The E. coli BL21 (DE3) harboring the pETite plasmid 
were grown in small scale in a selective LB medium supplemented with 30 µg/mL of 
kanamycin, in order to control and optimize level and quality of protein expression. 
Multiple 50 mL cultures were grown under mild shaking (180 rpm) at 37 °C until an OD 
value (optical dispersion, at 600 nm) of about 0.6; then 0.5 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) was added to the medium to induce protein expression and 
the cultures were incubated at 37 °C for 3 h, at 30°C overnight, at 20 °C overnight, 
respectively. The cultured cells were harvested from each small scale culture and medium 
10 20 30 40 50 60
CKSNNKDKLD ENLLSSGSQS SKELNDERDN IDKKSYAGLE DVFLDNKSIS PNDKYMLLVF 
70 80 90 100 110 120
GRNGCSYCER FKKDLKNVKE LRDYVKEHFS AYYVNISYSK EHDFKVGDKD KNDEKEIKMS 
130 140 150 160 170 180
TEELAQIYAI QSTPTIVLSD KTGKTIYELP GYMPSTQFLA VLEFIGDGKY QDAKNDEDLT 
190 200
KKLKAYIKYK TNLSKSKSSH HHHHH
Tab. 6.2 Some properties of HPG27_1020 from H. pylori referred to the recombinant 
construct lacking of 24 aa N-terminal export signal and added of C-terminal 6-His-
tag. 
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eliminated by centrifugation at 5,000 rpm for 30 min at 4 °C. The pellet was resuspended 
in a lysis buffer containing 50 mM Tris-HCl pH 8.1, 150 mM NaCl, supplemented with a  
protease inhibitor cocktail (1 mM phenylmethanesulfonyl fluoride (PMSF), 15 µM 
aprotinin, 1 µM leupeptin, 0.5 mM 4-(2-Aminoethyl)-benzenesulfonylfluoride 
hydrochloride (AEBSF)), and lysed by mechanical pressure using a One Shot Cell 
disruption system (Constant Systems Ltd) at pressure 1.35 kBar. After vacuum 
centrifugation at 18,000 rpm for 30 min at 4°C, pellet and supernatant were loaded on 
SDS-PAGE and Wester blotting, in order to evaluate the expression level and the 
solubility of the expressed protein. The highest yield of soluble recombinant protein was 
obtained under incubation overnight at 30 °C, as reported by SDS-PAGE (Fig. 6.10). 
 
 
6.3.3 WESTERN BLOTTING 
The samples from expression trials of the recombinant HPG27_1020 were investigated 
for the presence of the His-tag, to ensure the identity of the protein and the yield of soluble 
fraction. After loading of the sample into a SDS-PAGE, the proteins were transferred on 
a Hybond-ECL nitrocellulose membrane (GE Healthcare) by electrophoresis. After 
blocking of the membrane using BSA 3% solution in TBS for 1 h and incubation of the 
Anti-polyHistidine primary antibody (Sigma-Aldrich) at 4 °C overnight, three washing 
steps using TTBS and a final one with TBS were performed. The peroxidase-conjugated 
secondary antibody (Promega) was incubated for 1 h at room temperature in TBS and 
washed for three times with TTBS and finally with TBS.  Subsequently, the membrane 
was developed using the Pierce ECL Western Blotting Substrate (ThermoFischer) for 
detection of peroxidase activity, at Image Station 4000 MM PRO (Kodak). Western 
Fig. 6.10 SDS-PAGE analysis of expression and solubilization of 
6-His-tag HPG27_1020 from H. pylori. 
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blotting analysis confirmed the identity of the recombinant protein and the highest yield of 
soluble protein under incubation overnight at 30 °C (Fig. 6.11). 
 
 
6.4 RESULTS AND DISCUSSION 
 
The thiol:disulfide oxidoreductase HPG27_1020 was previously cloned as full-length 
protein, but it resulted toxic for the growth of different engineered E. coli strains. 
Therefore, it was decided to exclude the N-terminal signal peptide, as reported in the 
structural investigation of HP0377 from H. pylori 26695 (Yoon et al. 2013). The 
recombinant protein lacking 24 aminoacids at the N-terminus demonstrated a high 
expression level and an optimal solubility; incubation overnight at 30 °C under mild 
shaking (180 rpm) was identified as the best expression condition for E. coli BL21 (DE3) 
harboring the pETite plasmid carrying the recombinant HPG27_1020 and the soluble 
fraction of recombinant protein was estimates 60% from SDS-PAGE analysis. On 
SDS_PAGE analysis the recombinant HPG27_1020 demonstrated a molecular weight 
lower than expected; but Western blotting analysis confirmed the identity and the 
molecular weight of the protein of interest. Despite this initial promising results, the 
investigations were forcedly interrupted since meantime the x-ray structure of the 
thiol:disulfide oxidoreductase from H. pylori 26695, namely HP0377, has been 
determined and published. The aminoacid sequences from two H. pylori strains show a 
high degree of identity (96%), therefore the investigation has not longer been considered 
innovative.
Fig. 6.11 Western blotting analysis of expression and 
solubilization of 6-His-tag HPG27_1020 from H. pylori. 
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7.1 INTRODUCTION 
 
H. pylori possesses a relatively small genome of less than 1600 genes compared to other 
Gram-negative bacteria; specifically, the well-characterized strain 26695 contains 1590 
open reading frames (ORFs) (Tomb et al. 1997), whereas strain G27, examined in this 
research project, 1515 (Baltrus et al. 2009), respectively. Interestingly, H. pylori 
possesses several genes that are uncharacterized since: the gene sequences are quite 
new; the function of genes have not been characterized in any other bacterial systems; 
sometimes, the protein that is classified into a known protein based on the sequence 
homology shows some functional ambiguity, which raises questions about the function of 
the protein produced in H. pylori (Park, Son, and Lee 2012). A relevant fraction of these 
proteins are annotated as “hypothetical proteins”, possibly from 30% to 40% (Fig. 7.1). 
The function of some of the latter can be hypothesized based on a weak homology with 
proteins of other organisms, while that of others is completely unknown (Zanotti and 
Cendron 2014). In order to understand the whole picture of gene functions in H. pylori 
and how this bacterium works as human pathogen, knowledge on the three-dimensional 
structure of a protein, especially unknown or hypothetical proteins, is frequently useful to 
elucidate the structure-function relationship of the uncharacterized gene product. 
Because of its importance as a human pathogen, understanding the mechanism of H. 
pylori colonization and inflammation is the most important part in order to discover 
effective and specific therapies for H. pylori. In this regard, the structural and functional 
study of H. pylori proteins should be the most important point for developing antibiotics 
and can provide clues to help cope with new antibiotic-resistant bacteria (Kang, Kim, and 
Lee 2013). 
Most of these “hypothetical proteins” are encoded by strain-specific genes and clustered 
into one locus called hypervariable plasticity zone, which has a lower G+C content, 
indicating that this region contains fragments acquired by horizontal gene transfer, 
enriching the pathogen with virulence and survival factors. One of the major challenges 
is to assign function to and characterize these unclassified proteins, many of which are 
likely to be novel determinants important in survival and stomach colonization. An initial 
approach consists in using the genome sequence to perform in silico structural and 
functional prediction. The structure determination can provide detailed insights about the 
function of these “hypothetical proteins”. In this regard, in this research project it has been 
considered attractive to include structural studies on these proteins of unknown functions; 
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specifically, the selected candidates are HPG27_1030 and HPG27_1117, from H. pylori 
strain G27, appointed as “hypothetical proteins”.  Their homologues in H. pylori 26695, 
namely HP0367 and HP1173, respectively, were identified by proteomic analysis of the 
secretome of the pathogen (Bumann et al. 2002); as secreted proteins, they could 
mediate important pathogen-host interactions and, thus, they represent interesting target 
for antibiotics and vaccine development. 
  
Fig. 7.1 Genome sequence and proteins of H. pylori. In the phylogenetic tree, a total of 36 sub-species 
are branched with a total of about 60,000 genes (A); and among the translated proteins, the biological 
functions of 40% of the proteins are unidentified (B). Adapted from Park et al., 2012. 
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7.2 HYPOTHETICAL PROTEIN HPG27_1030 
 
7.2.1 SEQUENCE ANALYSIS 
 
 
Property Value 
Aminoacid 202 
Cysteines 0 
Molecular weight (kDa) 23183.8 
Theoretical pI 7.85 
Abs280nm (c=1mg/mL; b=1cm) 0.494 
Signal peptide No 
 
 
HPG27_1030 from H. pylori G27 is a small protein and is composed of 202 aminoacids. 
There is no evidence of export signals at N- or C- terminal ends, as confirmed by SignalP 
4.1 Server prediction (Petersen et al. 2011; http://www.cbs.dtu.dk/services/SignalP). By 
means of Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov) the 
aminoacid sequence shows no similarity compared to proteins from organisms different 
from Helicobacter species; it shares 41% and 68% identity with two hypothetical proteins 
from Helicobacter cetorum, respectively, and 80% identity with a hypothetical protein from 
Helicobacter acinonychis (Fig. 7.2). Interestingly, the aminoacid sequence of 
HPG27_1030 shows complete identity compared to a protein denoted as laminin subunit 
α2 precursor from a different strain of H. pylori (Fig. 7.2). These evidences confirm as this 
hypothetical protein is a species-specific protein, likely involved in peculiar mechanisms 
of the pathogen microorganism. 
The secondary structure content has been predicted by Phyre2 Server (Kelley et al. 2015; 
http://www.sbg.bio.ic.ac.uk/phyre2/) and includes 84% α-helices and no presence of β-
10 20 30 40 50 60
MSKISNNYNP SLMVRDYHTQ RVGSHTKNGE KEENKEIQNL SENDEKIKLA KQAKQDNLAI 
70 80 90 100 110 120
GDLESRLKSL KGMDKDAKEL VGISKAYAHN NEKDRSDFEH FKSRLDKAID SFNQKSGNDG 
130 140 150 160 170 180
LKLPSNIDID DTKALEKFSK SLESEKENIQ NSLHQWKKQL AETNHLNKEY NTLDKTRLNA 
190 200
QKFQDVHDTS KITPSRLQDL LA 
Tab. 7.1 Some properties of HPG27_1030 protein from H. pylori. 
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structure; therefore, it is plausible to expect a globular structure. To confirm that, a model 
of HPG27_1030 has been predicted using RaptorX (Källberg et al. 2012; 
http://raptorx.uchicago.edu/), a web server for protein secondary structure prediction, 
template-based tertiary structure modeling, alignment quality assessment and 
sophisticated probabilistic alignment sampling. The model was predicted based on the 
template 4HPQ_C (transport protein 
Atg17 from Lachancea 
thermotolerans, chain C) and 
evidenced an elongated organization, 
differently from previously announced, 
and an high solvent accessibility, in 
accordance with the nature of secreted 
protein (Fig. 7.3).  
 
 
 
 
 
7.2.2 MATERIALS AND METHODS 
 
7.2.2.1 MOLECULAR CLONING 
The coding sequence for HPG27_1030 protein was PCR-amplified from genomic DNA of 
H. pylori strain G27, using Phusion® High-Fidelity DNA Polymerase (New England 
Fig. 7.2  Sequence alignment of HPG27_1030 from H. pylori strain G27, hypothetical protein A from Helicobacter 
cetorum, hypothetical protein B from Helicobacter cetorum, hypothetical protein from Helicobacter acinonychis, and 
laminin α2 subunit precursor from Helicobacter pylori; in shades of blue the identity above 50% is shown (ClustalW 
and Jalview ver. 2.9.0b2). 
 
Fig. 7.3 Homology modelling structure of HPG27_1030 protein 
from H. pylori G27, monomer predicted (RaptorX web server). 
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Biolabs) and primers 5’ 
CATCATCACCACCATCACGAAAACCTGTATTTTCAGGGATCTAAGATTTCAAATAAT
TATAACC-3’ (fw) and 5’-GTGGCGGCCGCTCTATTAAGCGAGCAAGTCTTGCAA-3’ 
(rv). The forward primer provided a 18 nt-sequence that recognizes the pETite N-His Kan 
vector (Lucigen) and encodes the N-terminal 6-His tag, and a TEV proteolysis site. The 
reverse primer included a Stop anticodon. The PCR product, purified by 1% agarose gel, 
was cloned by thermal shock into the pETite N-His Kan vector (Lucigen) using E. coli 10G 
competent cells (Lucigen), grown overnight on selective LB medium supplemented with 
30 μg/ml of kanamycin. The colonies were checked by colony-PCR using EconoTaq DNA 
Polymerase (Lucigen) and T7 primers. Purified plasmid of positive colonies was digested 
by EcoRV restriction enzyme (New England Biolabs), for 1 h at 37 °C. Positive samples 
were finally checked by DNA sequencing to evaluate the quality. 
The following sequence corresponds to the final recombinant construct with the addition 
of a N-terminal 6-His tag flanked by a TEV recognition site. 
 
 
// corresponds to the cleavage site for TEV protease 
 
Property Value 
Aminoacid 214 
Cysteines 0 
Molecular weight (kDa) 24727.3 
Theoretical pI 7.39 
Abs280nm (c=1mg/mL; b=1cm) 0.524 
Signal peptide No 
 
 
  
10 20 30 40 50 60
HHHHHHENLY FQ//GSKISNNY NPSLMVRDYH TQRVGSHTKN GEKEENKEIQ NLSENDEKIK 
70 80 90 100 110 120
LAKQAKQDNL AIGDLESRLK SLKGMDKDAK ELVGISKAYA HNNEKDRSDF EHFKSRLDKA 
130 140 150 160 170 180
IDSFNQKSGN DGLKLPSNID IDDTKALEKF SKSLESEKEN IQNSLHQWKK QLAETNHLNK 
190 200 210
EYNTLDKTRL NAQKFQDVHD TSKITPSRLQ DLLA 
Tab. 7.2 Some properties of HPG27_1030 protein from H. pylori referred to the 
recombinant construct with the addition of a N-terminal 6-His-tag flanked by a TEV 
recognition site. 
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7.2.2.2 EXPRESSION 
The pETite plasmid carrying the HPG27_1030 gene was transformed into E. coli BL21 
(DE3) competent cells (Lucigen). The E. coli BL21 (DE3) harboring the pETite plasmid 
were grown in a selective LB medium supplemented with 30 µg/mL of kanamycin. A 2 L 
culture was grown under mild shaking (180 rpm) at 37 °C until an OD value (optical 
dispersion, at 600 nm) of about 0.6; then 0.5 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) was added to the medium to induce protein expression and the culture was 
incubated at 20 °C overnight. The cultured cells were harvested and medium eliminated 
by centrifugation at 5,000 rpm for 30 min at 4 °C. The pellet was resuspended in a 
selected lysis buffer consisting of 50 mM MOPS pH 6.8, 150 mM NaCl, 5 mM imidazole, 
supplemented with a protease inhibitor cocktail (1 mM phenylmethanesulfonyl fluoride 
(PMSF), 15 µM aprotinin, 1 µM leupeptin, 0.5 mM 4-(2-Aminoethyl)-
benzenesulfonylfluoride hydrochloride (AEBSF)), and lysed by mechanical pressure 
using a One Shot Cell disruption system (Constant Systems Ltd) at pressure 1.35 kBar. 
The lysis procedure was repeated twice to be more effective.  The lysed cell suspension 
was cleared of debris by vacuum centrifugation at 18,000 rpm for 30 min at 4°C. Pellet 
and supernatant were loaded on SDS-PAGE and Wester blotting, in order to evaluate the 
expression level and the solubility of the expressed protein. The recombinant 
HPG27_1030 protein exhibited an optimal profile of expression and a high yield of soluble 
fraction, approximately 80%, as estimated from SDS-PAGE analysis and in accordance 
with its nature of secreted protein (data not shown).  
 
 
7.2.2.3 PURIFICATION 
The HPG27_1030 protein was firstly purified by immobilized metal ion affinity 
chromatography (IMAC). The cleared supernatant was loaded onto a 1 mL His-Trap HP 
Ni–NTA column (GE Healthcare), previously equilibrated with the lysis buffer, at a flow 
rate of approximately 1 mL/min. The column was extensively washed with the lysis buffer 
and subsequently with a buffer supplemented with 5% elution buffer (50 mM MOPS pH 
6.8, 150 mM NaCl, 500 mM imidazole), in order to eliminate unspecifically bound species. 
The 6-His-tagged protein was eluted at approximately 250 mM imidazole, by applying a 
linear gradient from 5% to 100% elution buffer. The HPG27_1030 protein elution profile 
showed a shoulder peak (Fig. 7.3, left) ascribed to degradation processes, as confirmed 
by SDS-PAGE analysis (Fig. 7.3, right). The 6-His-tagged HPG27_1030 protein ran on 
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SDS-PAGE with an apparent molecular weight of approximately 26 kDa, in agreement 
with its calculated molecular mass (24727.3 kDa). 
The fractions containing the 6-His-tagged HPG27_1030 showing a profile of lower 
degradation, corresponding to the peak, were pooled and concentrated by ultrafiltration 
using a Vivaspin 20 5,000 MWCO centrifugal concentrator (Sartorius). Subsequently, the 
concentrated sample was further purified by gel-filtration chromatography using a HiLoad 
16/60 Superdex 75 preparative grade column (GE Healthcare), equilibrated with a buffer 
containing 50 mM MOPS pH 6.8, 150 mM NaCl. The recombinant protein was eluted as 
single peak, with a good profile and a retention volume of 62 mL, corresponding to the 
molecular weight of the monomer (Fig. 7.4, left). 
The fractions collected from the peak at 62 mL volume were checked on SDS-PAGE (Fig. 
7.4, right), which still showed a degradation profile, although the protein of interest was 
the major species, and concentrated by ultrafiltration using a Vivaspin 20 5,000 MWCO 
centrifugal concentrator (Sartorius), for crystallization trials. After purification 
approximately 39 mg of whole purified protein were obtained starting from 1 L E. coli 
culture; nevertheless, the concentration of purified sample for crystallization trials was 
limited, since the protein started to precipitate above 3 mg/mL. The final protein 
concentration was verified by UV-Vis absorption spectrum (250-340 nm; NanoDrop 2000 
UV-Vis Spectrophotometer). Additionally, it was decided to not perform the 6-His-tag 
removal for initial crystallization test.  
 
     
 
 
0
20
40
60
80
100
120
0
200
400
600
800
1000
1200
1400
1600
1800
105 107 109 111 113 115 117 119 121 123 125 127 129 131 133 135 137 139 141
A
b
s
2
8
0
n
m
(m
A
U
)
 mAU  %B
Volume (mL)
250.0
70.0
55.0
35.0
25.0
15.0
10.0
130.0
100.0
FTS WS P
MW (kDa)
Fig. 7.3 6-His-tagged HPG27_1030 affinity chromatography; left: sbsorption profile; right: SDS-PAGE analysis of the 
fractions collected (S: shoulder; P: peak; FT: flow-throw; W: wash). 
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7.2.2.4 CRYSTALLIZATION TRIALS 
Purified 6-his-tagged HPG27_1030 protein samples were used for crystallization tests, at 
a limited concentration (~3 mg/mL). Crystallization trials with sitting-drop vapor-diffusion 
technique were carried out using an Oryx8 crystallization robot (Douglas Instruments). 
Several standard crystal screening kits were explored, including Structure Screen I and 
II (Molecular Dimensions), Crystal Screen I and II (Hampton Research), PACT Suite 
(Qiagen), JCSG Suite (Qiagen), PEGs II (Qiagen). Hanging-drop vapor-diffusion 
experiments were also performed, using the previous crystal screening kits. Despite the 
limited protein concentration, several conditions showed precipitation even immediately 
after drop deposition, most likely due to the inhomogeneity of the protein sample, prone 
to degradation. Microcrystalline species were observed only in few crystallization 
conditions, not suitable for x-ray diffraction measurement. Several crystallization attempts 
were performed, but suitable crystals were not obtained. 
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Fig. 7.4 6-His-tagged HPG27_1030 gel-filtration chromatography (HiLoad 16/60 Superdex 75 pg); left: absorption profile; 
right: SDS-PAGE analysis of the fractions collected from the peak at 62 mL volume. 
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7.3 HYPOTHETICAL PROTEIN HPG27_1117 
 
7.3.1 SEQUENCE ANALYSIS 
 
 
 
Property Value 
Aminoacid 183 
Cysteines 3 
Molecular weight (kDa) 20643.8 
Theoretical pI 8.79 
Abs280nm (c=1mg/mL; b=1cm) 0.650 (all Cys reduced) 
 
 
HPG27_1117 from H. pylori G27 is a small protein composed of 183 aminoacids. By 
means of Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov) the 
aminoacid sequence of HPG27_1117 exhibits no similarity compared to proteins from 
organisms different from Helicobacter species; on the contrary, it shares 83% and 51% 
identity with two hypothetical proteins from Helicobacter cetorum, respectively, and 87% 
identity with a hypothetical protein from Helicobacter acinonychis, in the aligned regions 
(Fig. 7.5). Additionally, the aminoacid sequence of HPG27_1117 shows 31% identity 
compared to a hypothetical protein from Hirsutella minnesotensis, a fungal species (Fig. 
). As reported for the hypothetical protein HPG27_1030, also HPG27_1117 is most likely 
a species-specific protein, involved in survival and pathogenicity mechanisms peculiar of 
the microorganism. 
The secondary structure content has been predicted by Phyre2 Server (Kelley et al. 2015; 
http://www.sbg.bio.ic.ac.uk/phyre2/) and includes 17% α-helices and 48% β-strands, and 
a limited grade of disordered structure. A model of the hypothetical protein HPG27_1117 
has been predicted using RaptorX (Källberg et al. 2012; http://raptorx.uchicago.edu/), a 
10 20 30 40 50 60
MSYFYKHCLK FSLVGLLGLL SVQLDARSFV DGDLDIQKFS YEDSLLKKGD PNGVHKVQVR 
70 80 90 100 110 120
DYKGKMQEAE IHSEIRIALK PGVKKEVKKG KIYSAQINDG MCYAFRMLQT GDNTTGLDSK 
130 140 150 160 170 180
EFPKQSREKK GRVITLIGKD EVPYLILETD CQVGDIAKIS LVGNFDGTGF LTEYKFKDAK 
PIY 
Tab. 7.3 Some properties of HPG27_1117 protein from H. pylori. 
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web server for protein secondary structure prediction, template-based tertiary structure 
modeling, alignment quality assessment and sophisticated probabilistic alignment 
sampling. The model was predicted based on the template 2GE8_A (β-mannosidase 
Btman2A from Bacteroides thetaiotaomicron, chain A) and evidenced a prevalence of β-
structure, similar to a β-barrel organization, and a N-terminal elongated α-helix region 
(Fig. 7.6).  
 
 
 
 
 
Fig. 7.5 Sequence alignment of HPG27_1117 from H. pylori strain G27, hypothetical protein A from Helicobacter cetorum, 
hypothetical protein B from Helicobacter cetorum, hypothetical protein from Helicobacter acinonychis, and hypothetical 
protein from Hirsutella minnesotensis; in shades of blue the identity above 50% is shown (ClustalW and Jalview ver. 
2.9.0b2). 
 
Fig. 7.6 Homology modelling structure of HPG27_1117 protein 
from H. pylori G27 (RaptorX web server). 
 
Chapter VII 
193 
 
7.3.2 MATERIALS AND METHODS 
 
7.3.2.1 MOLECULAR CLONING 
The coding sequence for HPG27_1117 protein was PCR-amplified from genomic DNA of 
H. pylori strain G27, using Phusion® High-Fidelity DNA Polymerase (New England 
Biolabs) and primers 5’-
CATCATCACCACCATCACGAAAACCTGTATTTTCAGGGAAGTTATTTTTATAAGCAC
TGTTTG-3’ (fw) and 5’-GTGGCGGCCGCTCTATTAGTAAATGGGTTTAGCGTCTTT-3’ 
(rv). The forward primer provided a 18 nt-sequence that recognizes the pETite N-His Kan 
vector (Lucigen) and encodes the N-terminal 6-His tag, and a TEV proteolysis site. The 
reverse primer included a Stop anticodon. The PCR product, purified by 1% agarose gel, 
was cloned by thermal shock into the pETite N-His Kan vector (Lucigen) using E. coli 10G 
competent cells (Lucigen), grown overnight on selective LB medium supplemented with 
30 μg/ml of kanamycin. The colonies were checked by colony-PCR using EconoTaq DNA 
Polymerase (Lucigen) and T7 primers. Purified plasmid of positive colonies was digested 
by EcoRV restriction enzyme (New England Biolabs), for 1 h at 37 °C. Positive samples 
were finally checked by DNA sequencing to evaluate the quality. 
The following sequence corresponds to the final recombinant construct with the addition 
of a N-terminal 6-His tag flanked by a TEV recognition site. 
 
 
// corresponds to the cleavage site for TEV protease 
 
 
 
 
 
 
10 20 30 40 50 60
HHHHHHENLY FQ//GSYFYKHC LKFSLVGLLG LLSVQLDARS FVDGDLDIQK FSYEDSLLKK 
70 80 90 100 110 120
GDPNGVHKVQ VRDYKGKMQE AEIHSEIRIA LKPGVKKEVK KGKIYSAQIN DGMCYAFRML 
130 140 150 160 170 180
QTGDNTTGLD SKEFPKQSRE KKGRVITLIG KDEVPYLILE TDCQVGDIAK ISLVGNFDGT 
190
GFLTEYKFKD AKPIY
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Property Value 
Aminoacid 195 
Cysteines 3 
Molecular weight (kDa) 22187.4 
Theoretical pI 8.59 
Abs280nm (c=1mg/mL; b=1cm) 0.672 (all Cys reduced) 
 
 
 
 
7.3.2.2 EXPRESSION 
The pETite plasmid carrying the HPG27_1117 gene was transformed into E. coli BL21 
(DE3) competent cells (Lucigen). The E. coli BL21 (DE3) harboring the pETite plasmid 
were grown in a selective LB medium supplemented with 30 µg/mL of kanamycin. A 2 L 
culture was grown under mild shaking (180 rpm) at 37 °C until an OD value (optical 
dispersion, at 600 nm) of about 0.6; then 0.5 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) was added to the medium to induce protein expression and the culture was 
incubated at 37 °C for 3 h. The cultured cells were harvested and medium eliminated by 
centrifugation at 5,000 rpm for 30 min at 4 °C. The pellet was resuspended in a selected 
lysis buffer consisting of 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM imidazole, 1 mM 
DTT, supplemented with a protease inhibitor cocktail (1 mM phenylmethanesulfonyl 
fluoride (PMSF), 15 µM aprotinin, 1 µM leupeptin, 0.5 mM 4-(2-Aminoethyl)-
benzenesulfonylfluoride hydrochloride (AEBSF)), and lysed by mechanical pressure 
using a One Shot Cell disruption system (Constant Systems Ltd) at pressure 1.35 kBar. 
The lysis procedure was repeated twice to be more effective.  The lysed cell suspension 
was cleared of debris by vacuum centrifugation at 18,000 rpm for 30 min at 4°C. Pellet 
and supernatant were loaded on SDS-PAGE and Wester blotting, in order to evaluate the 
expression level and the solubility of the expressed protein. The recombinant 
HPG27_1117 protein exhibited a limited expression level; on the contrary, the yield of 
soluble protein was significant, approximately 80%, as estimated by SDA-PAGE analysis 
and in accordance with its nature of secreted protein. Additionally, the 6-His-tagged 
HPG27_1117 protein ran on SDS-PAGE with an apparent molecular weight of 
approximately 27 kDa, not in full agreement with its calculated molecular mass (22187.4 
Tab. 7.4 Some properties of HPG27_1117 protein from H. pylori referred to the 
recombinant construct with the addition of a N-terminal 6-His tag flanked by a TEV 
recognition site. 
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kDa). To confirm the identity of the protein of interest, a Western blotting analysis was 
performed to investigate the presence of the 6-His-tag. 
 
 
7.3.2.3 WESTERN BLOTTING 
Samples from expression and solubility test of the recombinant HPG27_1117 protein 
were investigated for the presence of the His-tag. After loading of the sample into a SDS-
PAGE, the proteins were transferred on a Hybond-ECL nitrocellulose membrane (GE 
Healthcare) by electrophoresis. After blocking of the membrane using BSA 3% solution 
in TBS for 1 h and incubation of the Anti-polyHistidine primary antibody (Sigma-Aldrich) 
at 4 °C overnight, three washing steps using TTBS and a final one with TBS were 
performed. The peroxidase-conjugated secondary antibody (Promega) was incubated for 
1 h at room temperature in TBS and washed for three times with TTBS and finally with 
TBS.  Subsequently, the membrane was developed using the Pierce ECL Western 
Blotting Substrate (ThermoFischer) for detection of peroxidase activity, at Image Station 
4000 MM PRO (Kodak). The Western blotting analysis confirmed the identity of the 
recombinant protein, despite of its apparent molecular weight of approximately 27 kDa 
(Fig. 7.7).  
 
 
 
 
 
7.3.2.4 PURIFICATION 
The HPG27_1117 protein was firstly purified by immobilized metal ion affinity 
chromatography (IMAC). The cleared supernatant was loaded onto a 1 mL His-Trap HP 
70.0
55.0
35.0
25.0
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10.0
100.0
MW (kDa)
SUR INDNI P
Fig. 7.7 Western blotting analysis 
of 6-His-tagged HPG27_1117 (NI: 
not induced E. coli culture; P: lysed 
pellet; SUR: supernatant; IND: 
induced E. coli culture). 
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Ni–NTA column (GE Healthcare), previously equilibrated with the lysis buffer, at a flow 
rate of approximately 1 mL/min. The column was extensively washed firstly with the lysis 
buffer, following with a buffer consisting of 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM 
imidazole, 1 mM DTT, and finally with lysis buffer supplemented with 5% elution buffer 
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 500 mM imidazole, 1 mM DTT), in order to 
eliminate unspecifically bound species. The 6-His-tagged HPG27_1117 was eluted at 
approximately 150 mM imidazole, by applying a linear gradient from 5% to 100% elution 
buffer. The HPG27_1117 protein was eluted as single peak (Fig. 7.8, left); however, the 
SDS-PAGE analysis of the fractions related to the elution peak showed several species 
of lower molecular weight, ascribed to degradation processes (Fig. 7.8, right).  
The fractions containing the 6-His-tagged HPG27_1117 as clearly predominant species 
were pooled and concentrated by ultrafiltration using a Vivaspin 20 5,000 MWCO 
centrifugal concentrator (Sartorius). Subsequently, the concentrated sample was further 
purified by gel-filtration chromatography using a HiLoad 16/60 Superdex 75 preparative 
grade column (GE Healthcare), equilibrated with a buffer containing 50 mM Tris-HCl pH 
7.5, 150 mM NaCl, 1mM DTT. The recombinant protein was eluted as single peak, with 
a clear profile, although not very intense, and a retention volume of 63 mL, corresponding 
to the molecular weight of the monomer (Fig. 7.9). 
The fractions collected from the peak at 63 mL volume were checked on SDS-PAGE, 
which showed a limited degradation profile (data not shown), and concentrated by 
ultrafiltration using a Vivaspin 20 5,000 MWCO centrifugal concentrator (Sartorius), for 
crystallization trials. After purification a limited amount of whole purified protein, 
approximately 7 mg, was obtained starting from 1 L E. coli culture, owing to the low level 
of expression. The recombinant protein purified was concentrated till 18 mg/mL, verified 
by UV-Vis absorption spectrum (250-340 nm; NanoDrop 2000 UV-Vis 
Spectrophotometer). Additionally, it was decided to not perform the 6-His-tag removal for 
initial crystallization test.  
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7.3.2.5 CRYSTALLIZATION TRIALS 
Purified 6-his-tagged HPG27_1117 protein concentrated to 18 mg/mL was used for 
crystallization tests. Crystallization trials were carried out using the sitting-drop vapor-
diffusion technique with an Oryx8 crystallization robot (Douglas Instruments). Several 
standard crystal screening kits were explored, including Structure Screen I and II 
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Fig. 7.8 6-His-tagged HPG27_1117 affinity chromatography; left: absorption profile; right: SDS-PAGE analysis of 
the fractions collected from the peak. 
 
 
Fig. 7.9 6-His-tagged HPG27_1117 gel-filtration chromatography (HiLoad 
16/60 Superdex 75 pg): absorption profile. 
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(Molecular Dimensions), Crystal Screen I and II (Hampton Research), PACT Suite 
(Qiagen), JCSG Suite (Qiagen), PEGs II (Qiagen). Crystallization 96-well plates (Douglas 
Instrument) were performed at 20 °C and testing various dilutions of the precipitant 
solutions and drop dimensions. Preliminary crystals were obtained in the following 
screening conditions: n. 56 from Crystal Screen (1.5 M NaCl, 10% (v/v) EtOH), n. 23 from 
Structure Screen I (0.2 M CaCl2, 0.1 M Na HEPES pH 7.5, 28% (v/v) PEG 400), n. 27 
from Structure Screen I (0.1 M Na Hepes pH 7.5, 1.5 M LiSO4). The crystals obtained 
were thin and needlelike or exhibited agglomeration (Fig. 7.10). The x-ray diffraction data 
were measured at synchrotron, but the crystals diffracted at a limited resolution. Further 
crystallization trials were performed, varying the dilution of the precipitant solutions, the 
drop size, the protein concentration, and the temperature condition, but suitable crystals 
were not obtained.  
 
 
 
 
 
 
7.4 RESULTS AND DISCUSSION 
 
Despite their small size, these secreted hypothetical proteins were not demonstrated 
easy to handle and the lacking information did not support. First of all, as clearly observed, 
they have in common the tendency to degradation. 
HPG27_1030 exhibited an easy and high yielding expression, with the majority of the 
protein of interest in the soluble fraction (approximately 80%). Despite its propensity to 
Fig. 7.10 Crystals of 6-His-tag HPG27_1117 
grown at 18 mg/mL protein concentration, in 0.2 M 
CaCl2, 0.1 M Na HEPES pH 7.5, 28% (v/v) PEG 
400, at 20 °C. 
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degradation during purification procedures, the amount of whole purified protein obtained 
starting from 1 L E. coli culture was significant (about 39 mg). Nevertheless, the final 
concentration of purified protein was limited, since the protein started to aggregate and 
precipitate above 3 mg/mL concentration. Therefore, to overcome the reported problems 
of degradation, variations of the buffer composition and the use of additives could 
enhance the stability of the protein in solution and improve the purification. Increasing the 
concentration of protease inhibitors and using them over all the purification steps could 
limit the degradation processes, as well as adding detergents could decrease the 
aggregation during the final concentration procedure. However, the presence of 
detergents can affect the crystallization process. 
Besides the instability in solution, the second major bottleneck of the purification of 
HPG27_1117 was the limited expression level. It is possible to assume that the protein 
of interest is toxic for E. coli and prevents its growth. The pETite plasmid carrying the 
HPG27_1117 gene was transformed in further E. coli engineered strains, namely BL21 
(DE3) pLysS cells (Invitrogen), C41 (DE3) cells (Lucigen), C43 (DE3) cells (Lucigen), and 
several overexpression trials were performed, varying the conditions of temperature, 
duration, isopropyl-β-D-thiogalactopyranoside (IPTG) concentration. Nevertheless, it has 
not been possible to obtain a significant increase in expression yield in the case of all of 
the E. coli strain used (data not shown). As suggested for HPG27_1030, to overcome the 
degradation problem, changings in the buffer composition could improve the stability of 
the protein in solution and, thus, the purification profile, leading to a greater final amount 
of purified protein. Since the protein of interest contains 3 cysteine residue in its 
sequence, dithiothreitol (DTT) was added to the buffer composition, to ensure the proper 
reduced state of the cysteine residues. Moreover, the apparent molecular weight on SDS-
PAGE higher than the calculated one could be due to an altered amount of bound sodium 
dodecyl sulfate (SDS) to the protein, consequent to hydrophobic properties of its surface. 
SDS is employed in SDS-PAGE to disrupt secondary structure and give all proteins a 
constant charge/mass ratio, which is assumed to be 1.4 g SDS/1 g protein. This condition 
is achieved by the aggregation of SDS molecules at hydrophobic protein sites to induce 
“reconstructive denaturation”. It can be assumed that a lower amount of SDS is bound to 
HPG27_1117, due to intrinsic properties of the protein; therefore, its mobility would 
decrease, since the protein presents a lower net negative charge. 
Finally, despite several attempts and reasonable protein concentrations, it was not 
possible to obtain quality crystals. HPG27_1030 showed precipitation in most of the 
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conditions, most likely due to degradation processes and not homogeneous samples; 
only few crystallization conditions showed microcrystalline species. On the other hand, it 
has been possible to obtain preliminary crystal of HPG27_1117; however, despite several 
attempts to improve their quality, crystals suitable to x-ray diffraction measurement have 
not been obtained yet, possibly owing to the limited amount of protein sample achieved 
from each expression and purification event. Improving the stability of these hypothetical 
proteins could lead to an enhancement of the crystallization possibility.   
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CONCLUSIONS 
 
 
This research project, whose results are summarized in this thesis, is focused on the 
identification and structural characterization of new potential pharmacological targets of 
the pathogen H. pylori. Although its infection rate has globally decreased, as result of 
gradual improvements in socio-economic status and hygienic practice, the acquisition of 
H. pylori still remains a worldwide emergency. The clinical outcomes, when present, 
associated to its infection include severe gastroduodenal diseases and the effectiveness 
of the eradication treatment is often compromised by a widespread antibiotic resistance. 
Therefore, identification of new pharmacological targets and new treatments is a crucial 
challenge in managing H. pylori infections and related diseases.  
This research project provided some additional insights into the overall comprehension 
about H. pylori proteome and the identification of attractive proteins as future subjects 
aimed to therapy and vaccine development. Colonization factors and putative proteins 
mediating host-pathogen interactions were considered for the structural characterization, 
which might allow to develop new potential therapeutic molecules. 
Among these subjects, great interest was converged on two of the main players of the 
intricate network aimed to balance of urea and bicarbonate and to buffer the pH of the 
microorganism fluids in the extremely acid conditions, namely α-carbonic anhydrase and 
β-carbonic anhydrase, located in periplasm and cytoplasm, respectively. Both enzymes 
catalyze the reversible conversion of the carbon dioxide into bicarbonate and cooperate 
with the crucial enzyme urease; the latter hydrolyzes urea into carbon dioxide and 
ammonia in the cytoplasm, providing both acid-neutralizing and acid-buffering capacity. 
Subsequently, carbon dioxide molecules freely diffused out of the inner membrane are 
substrates of α-carbonic anhydrase; on the contrary, carbon dioxide remaining into 
cytoplasm is hydrolyzed by β-carbonic anhydrase. From these evidences it is possible to 
deduce the key role of these enzymes in H. pylori survival and colonization, thus making 
them attractive targets of investigations and promising drug targets. The structural 
peculiarities of α-carbonic anhydrase have been successfully determined, highlighting the 
overall structure shared with many other members of the α-carbonic anhydrase family, 
the elegant expedient to solve the problem of the absence of a negatively charged side 
chain at position 127 through the use of an anion from the external medium, the 
localization close to the inner membrane of the bacterium. Taking all these findings 
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together, the definition of the details of shape and organization of the active site may 
constitute a basis for the design of inhibitors specific against H. pylori. On the contrary, 
the experimental procedures concerning β-carbonic anhydrase revealed how this enzyme 
possesses a different handling characteristics compared to α-carbonic anhydrase, 
confirming how these enzymes present several structural differences. It was not possible 
to define the molecular details of the three-dimensional structure of β-carbonic 
anhydrase, since several limits were encountered in its expression and purification 
running. Consequently, crystallization attempts were sacrificed in the number owing to 
the limited amount of purified protein and crystals obtained were not adequately suitable 
to x-ray diffraction measurement. 
In this research project further disparate proteins, responsible of various bacterial 
functions, were subjects of structural investigations, in order to widen the overall 
comprehension on H. pylori and to characterize new pharmacological targets. 
Specifically, effectors responsible of flagellar motility, oxidative metabolic processes, 
host-pathogen interactions were considered. From the related investigations only partial 
findings were achieved, since various issues were encountered. Commonly, these 
proteins were successfully cloned as 6-His-tag recombinant product; however, 
improvements can be provided at the level of expression or purification, depending on 
the subject considered. Crystals of one of these proteins, namely HPG27_1117, were 
obtained, but not adequately suitable to x-ray diffraction measurement. These partial 
findings constitute the basis for future improvements of the procedures and structural 
investigations. 
This project thesis contributes to a deeper overall comprehension of the molecular 
specifications and the physiopathological mechanisms of some features of the human 
pathogen H. pylori; moreover, it sets the experimental basis for future investigations, 
which may lead to the development of new therapies and vaccines, aimed to limit the 
diffusion and the related gastric damages of H. pylori. Despite the mass of information 
accumulated to date on H. pylori, much work and further researches are still required to 
achieve a full comprehension of the physiology of the bacterium, the molecular 
mechanisms, the host-pathogen interactions and related clinical outcomes.  
  
 205 
 
 
 
 
REFERENCES 
  
 206 
 
  
References 
207 
 
REFERENCES 
 
Abdollahi, Hamid and Omid Tadjrobehkar. 2012. “The Role of Different Sugars, Amino Acids and Few 
Other Substances in Chemotaxis Directed Motility of Helicobacter Pylori.” Iranian Journal of Basic 
Medical Sciences 15(3):787–94. 
Adams, Paul D. et al. 2010. “PHENIX: A Comprehensive Python-Based System for Macromolecular 
Structure Solution.” Acta crystallographica. Section D, Biological crystallography 66(Pt 2):213–21. 
Agarwal, K. and S. Agarwal. 2008. “Helicobacter Pylori Vaccine : From Past to Future.” Mayo Clinic 
Proceedings 83(2):169–75. 
Aggarwal, Mayank et al. 2014. “Structural Insight into Activity Enhancement and Inhibition of H64A 
Carbonic Anhydrase II by Imidazoles.” IUCrJ 1(1):129–35. 
Aggarwal, Mayank, Teck Khiang Chua, Melissa A. Pinard, Doletha M. Szebenyi, and Robert McKenna. 
2015. “Carbon Dioxide ‘Trapped’ in a β-Carbonic Anhydrase.” Biochemistry 151016144023009. 
Ahmed, Niyaz, Shivendra Tenguria, and Nishant Nandanwar. 2009. “Helicobacter Pylori--a Seasoned 
Pathogen by Any Other Name.” Gut pathogens 1:24. 
Akada, Junko K., Mutsunori Shirai, Hiroaki Takeuchi, Masataka Tsuda, and Teruko Nakazawa. 2000. 
“Identification of the Urease Operon in Helicobacter Pylori and Its Control by mRNA Decay in 
Response to pH.” Molecular Microbiology 36:1071–84. 
Akhiani, Ali a et al. 2002. “Protection against Helicobacter Pylori Infection Following Immunization Is IL-
12-Dependent and Mediated by Th1 Cells.” Journal of immunology (Baltimore, Md. : 1950) 
169(12):6977–84. 
Algood, H. M. S. and T. L. Cover. 2006. “Helicobacter Pylori Persistence: An Overview of Interactions 
between H. Pylori and Host Immune Defenses.” Clinical Microbiology Reviews 19(4):597–613.  
Alm, R. A. et al. 1998. “Genomic-Sequence Comparison of Two Unrelated Isolates of the Human Gastric 
Pathogen Helicobacter Pylori.” Nature 395(2):863–69. 
Alm, R. A. and T. J. Trust. 1999. “Analysis of the Genetic Diversity of Helicobacter Pylori: The Tale of Two 
Genomes.” Journal of molecular medicine (Berlin, Germany) 77(12):834–46. 
Amieva, Manuel R. et al. 2003. “Disruption of the Epithelial Apical-Junctional Complex by Helicobacter 
Pylori CagA.” Science (New York, N.Y.) 300(5624):1430–34. 
Amieva, Manuel R. and Emad M. El-Omar. 2008. “Host-Bacterial Interactions in Helicobacter Pylori 
Infection.” Gastroenterology 134(1):306–23. 
Andersen, Leif Percival. 2007. “Colonization and Infection by Helicobacter Pylori in Humans.” 
Helicobacter 12 Suppl 2:12–15. 
Andersen, Leif Percival and Lone Rasmussen. 2009. “Helicobacter Pylori - Coccoid Forms and Biofilm 
Formation.” FEMS Immunology and Medical Microbiology 56(2):112–15. 
Aras, R. A. 2002. “Helicobacter Pylori Interstrain Restriction-Modification Diversity Prevents Genome 
Subversion by Chromosomal DNA from Competing Strains.” Nucleic Acids Research 30(24):5391–
97. 
Aras, Rahul a, Josephine Kang, Ariane I. Tschumi, Yasuaki Harasaki, and Martin J. Blaser. 2003. 
“Extensive Repetitive DNA Facilitates Prokaryotic Genome Plasticity.” Proceedings of the National 
References 
208 
 
Academy of Sciences of the United States of America 100(23):13579–84.  
Aspholm, Marina et al. 2006. “SabA Is the H. Pylori Hemagglutinin and Is Polymorphic in Binding to 
Sialylated Glycans.” PLoS pathogens 2(10):e110. 
Aspinall, G. O. and M. A. Monteiro. 1996. “Lipopolysaccharides of Helicobacter Pylori Strains P466 and 
MO19: Structures of the O Antigen and Core Oligosaccharide Regions.” Biochemistry 35(7):2498–
2504. 
Atherton, J. C., R. M. Jr Peek, K. T. Tham, T. L. Cover, and M. J. Blaser. 1997. “Clinical and Pathological 
Importance of Heterogeneity in vacA, the Vacuolating Cytotoxin Gene of Helicobacter Pylori.” 
Gastroenterology 112(1):92–99. 
Atherton, J. C., K. T. Tham, R. M. Peek, T. L. Cover, and M. J. Blaser. 1996. “Density of Helicobacter 
Pylori Infection in Vivo as Assessed by Quantitative Culture and Histology.” The Journal of infectious 
diseases 174(3):552–56. 
Atherton, JC et al. 1995. “Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter Pylori. Association 
of Specific VacA Types with Cytotoxin Production and Peptic Ulcerataion.” Journal of Biological 
Chemistry 270(30):17771–77. 
Ayala, Guadalupe, Wendy Itzel Escobedo-Hinojosa, Carlos Felipe de la Cruz-Herrera, and Irma Romero. 
2014. “Exploring Alternative Treatments for Helicobacter Pylori Infection.” World journal of 
gastroenterology : WJG 20(6):1450–69. 
Backert, Steffen and Matthias Selbach. 2008. “Role of Type IV Secretion in Helicobacter Pylori 
Pathogenesis.” Cellular Microbiology 10(8):1573–81. 
Baidya, Amit K., Saurabh Bhattacharya, and Rukhsana Chowdhury. 2015. “Role of the Flagellar Hook-
Length Control Protein FliK and σ28 in cagA Expression in Gastric Cell–Adhered Helicobacter 
Pylori.” Journal of Infectious Diseases 211:1779–89. 
Baltrus, David a. et al. 2009. “The Complete Genome Sequence of Helicobacter Pylori Strain G27.” 
Journal of Bacteriology 91(1):447–48. 
Bamford, K. B. et al. 1998. “Lymphocytes in the Human Gastric Mucosa during Helicobacter Pylori Have 
a T Helper Cell 1 Phenotype.” Gastroenterology 114(3):482–92. 
Bardhan, Pradip K. 1997. “Epidemiological Features of Helicobacter Pylori Infection in Developing 
Countries.” Clinical Infectious Diseases 973–78. 
Barker, P. D. and S. J. Ferguson. 1999. “Still a Puzzle: Why Is Haem Covalently Attached in c-Type 
Cytochromes?” Structure (London, England : 1993) 7(12):R281–90. 
Basso, Daniela et al. 2008. “Clinical Relevance of Helicobacter Pylori cagA and vacA Gene 
Polymorphisms.” Gastroenterology 135(1):91–99. 
Becker, Holger M., Michael Klier, and Joachim W. Deitmer. 2014. Carbonic Anhydrase: Mechanism, 
Regulation, Links to Disease, and Industrial Applications. 
Bellack, N. R., M. W. Koehoorn, Y. C. MacNab, and M. G. Morshed. 2006. “A Conceptual Model of 
Water’s Role as a Reservoir in Helicobacter Pylori Transmission: A Review of the Evidence.” 
Epidemiology and infection 134(3):439–49. 
de Bernard, M. et al. 1995. “Low pH Activates the Vacuolating Toxin of Helicobacter Pylori, Which 
Becomes Acid and Pepsin Resistant.” The Journal of Biological Chemistry 270(41):23937–40. 
References 
209 
 
de Bernard, Marina and Mario M. D’Elios. 2010. “The Immune Modulating Activity of the Helicobacter 
Pylori HP-NAP: Friend or Foe?” Toxicon 56(7):1186–92. 
Biasini, Marco et al. 2014. “SWISS-MODEL: Modelling Protein Tertiary and Quaternary Structure Using 
Evolutionary Information.” Nucleic acids research 42(Web Server issue):W252–58. 
Björkholm, B. et al. 2001. “Mutation Frequency and Biological Cost of Antibiotic Resistance in 
Helicobacter Pylori.” Proceedings of the National Academy of Sciences of the United States of 
America 98(25):14607–12. 
Blaser, Martin J. and John C. Atherton. 2004. “Helicobacter Pylori Persistence: Biology and Disease.” 
Journal of Clinical Investigation 113(3):321–33. 
Blaser, Martin J., Yu Chen, and Joan Reibman. 2008. “Does Helicobacter Pylori Protect against Asthma 
and Allergy?” Gut 57(5):561–67. 
Bocian-Ostrzycka, Katarzyna M., Magdalena J. Grzeszczuk, Lukasz Dziewit, and Elżbieta K. Jagusztyn-
Krynicka. 2015. “Diversity of the Epsilonproteobacteria Dsb (disulfide Bond) Systems.” Frontiers in 
microbiology 6(June):570. 
Bode, G., F. Mauch, and P. Malfertheiner. 1993. “The Coccoid Forms of Helicobacter Pylori. Criteria for 
Their Viability.” Epidemiology and infection 111(3):483–90.  
Bonnard, Geraldine, Vincent Corvest, Etienne H. Meyer, and Patrice P. Hamel. 2010. “Redox Processes 
Controlling the Biogenesis of c-Type Cytochromes.” Antioxidants & redox signaling 13(9):1385–
1401. 
Boone, Christopher D., Melissa Pinard, Rob McKenna, and David Silverman. 2014. “Catalytic Mechanism 
of Alpha-Class Carbonic Anhydrases: CO2 Hydration and Proton  Transfer.” Sub-cellular 
biochemistry 75:31–52. 
Boren, T., P. Falk, K. A. Roth, G. Larson, and S. Normark. 1993. “Attachment of Helicobacter Pylori to 
Human Gastric Epithelium Mediated by Blood Group Antigens.” Science (New York, N.Y.) 
262(5141):1892–95. 
Van de Bovenkamp, Jeroen H. B. et al. 2003. “The MUC5AC Glycoprotein Is the Primary Receptor for 
Helicobacter Pylori in the Human Stomach.” Helicobacter 8(5):521–32. 
Bridge, Dacie R. and D. Scott Merrell. 2013. “Polymorphism in the Helicobacter Pylori CagA and VacA 
Toxins and Disease.” Gut Microbes 4(April):101–17. 
Brown, L. M. 2000. “Helicobacter Pylori: Epidemiology and Routes of Transmission.” Epidemiologic 
Reviews 22(2):283–97. 
Bukanov, N. O. and D. E. Berg. 1994. “Ordered Cosmid Library and High-Resolution Physical-Genetic 
Map of Helicobacter Pylori Strain NCTC11638.” Molecular microbiology 11(3):509–23. 
Bumann, D. et al. 2002. “Proteome Analysis of Secreted Proteins of the Gastric Pathogen Helicobacter 
Pylori.” Infect Immun 70(7):3396–3403. 
Bury-Moné, Stéphanie et al. 2003. “Presence of Active Aliphatic Amidases in Helicobacter Species Able 
to Colonize the Stomach.” Infection and immunity 71(10):5613–22. 
Bury-Moné, Stéphanie et al. 2004. “Responsiveness to Acidity via Metal Ion Regulators Mediates 
Virulence in the Gastric Pathogen Helicobacter Pylori.” Molecular microbiology 53(2):623–38.  
Bury-Moné, Stéphanie et al. 2008. “Roles of Alpha and Beta Carbonic Anhydrases of Helicobacter Pylori 
References 
210 
 
in the Urease-Dependent Response to Acidity and in Colonization of the Murine Gastric Mucosa.” 
Infection and immunity 76(2):497–509. 
Busler, V. J. et al. 2006. “Protein-Protein Interactions among Helicobacter Pylori Cag Proteins.” Journal of 
Bacteriology 188(13):4787–4800. 
Byrd, J. C., C. K. Yunker, Q. S. Xu, L. R. Sternberg, and R. S. Bresalier. 2000. “Inhibition of Gastric Mucin 
Synthesis by Helicobacter Pylori.” Gastroenterology 118(6):1072–79. 
Capasso, Clemente and Claudiu T. Supuran. 2015. “An Overview of the Alpha-, Beta- and Gamma-
Carbonic Anhydrases from Bacteria: Can Bacterial Carbonic Anhydrases Shed New Light on 
Evolution of Bacteria?” Journal of enzyme inhibition and medicinal chemistry 30(2):325–32. 
Carlsohn, Elisabet, Johanna Nyström, Ingrid Bölin, Carol L. Nilsson, and Ann-Mari Svennerholm. 2006. 
“HpaA Is Essential for Helicobacter Pylori Colonization in Mice.” Infection and immunity 74(2):920–
26. 
Carraway, K. L. and S. R. Hull. 1991. “Cell Surface Mucin-Type Glycoproteins and Mucin-like Domains.” 
Glycobiology 1(2):131–38. 
Cascales, E. and P. J. Christie. 2003. “The Versatile Bacterial Type IV Secretion Systems.” Nature 
reviews. Microbiology 18(9):1199–1216. 
Ceci, Pierpaolo, Laura Mangiarotti, Claudio Rivetti, and Emilia Chiancone. 2007. “The Neutrophil-
Activating Dps Protein of Helicobacter Pylori, HP-NAP, Adopts a Mechanism Different from 
Escherichia Coli Dps to Bind and Condense DNA.” Nucleic acids research 35(7):2247–56. 
Cendron, Laura and Giuseppe Zanotti. 2011. “Structural and Functional Aspects of Unique Type IV 
Secretory Components in the Helicobacter Pylori Cag-Pathogenicity Island.” FEBS Journal 
278(8):1223–31. 
Censini, S. et al. 1996. “Cag , a Pathogenicity Island of Helicobacter Pylori , Encodes Type I-Specific and 
Disease-Associated Virulence Factors.” Proceedings of the National Academy of Sciences of the 
United States of America 93(December):14648–53. 
Cerda, Oscar A. et al. 2011. “tlpA Gene Expression Is Required for Arginine and Bicarbonate Chemotaxis 
in Helicobacter Pylori.” Biological research 44(3):277–82. 
Ceruso, Mariangela et al. 2015. “Inhibition Studies of Bacterial, Fungal and Protozoan β-Class Carbonic 
Anhydrases with Schiff Bases Incorporating Sulfonamide Moieties.” Bioorganic & Medicinal 
Chemistry 23(15):4181–87. 
Chevance, Fabienne F. V and Kelly T. Hughes. 2008. “Coordinating Assembly of a Bacterial 
Macromolecular Machine.” Nat Rev Micro 6(6):455–65. 
Chirica, L. C., B. Elleby, and S. Lindskog. 2001. “Cloning, Expression and Some Properties of Alpha-
Carbonic Anhydrase from Helicobacter Pylori.” Biochimica et biophysica acta 1544(1-2):55–63. 
Chiurillo, Miguel Angel et al. 2013. “Genotyping of Helicobacter Pylori Virulence-Associated Genes 
Shows High Diversity of Strains Infecting Patients in Western Venezuela.” International Journal of 
Infectious Diseases 17(9):750–56. 
Choli-Papadopoulou, Theodora. 2011. “Helicobacter Pylori Neutrophil Activating Protein as Target for 
New Drugs against H. Pylori Inflammation.” World Journal of Gastroenterology 17(21):2585.  
Cid, Trinidad Parra, Miryam Calvino Fernández, Selma Benito Martínez, and Nicola L. Jones. 2013. 
References 
211 
 
“Pathogenesis of Helicobacter Pylori Infection.” Helicobacter 18:12–17. 
Colland, F. et al. 2001. “Identification of the Helicobacter Pylori Anti-sigma28 Factor.” Molecular 
microbiology 41(2):477–87. 
Contreras, Monica, Jean Michel Thiberge, M. a. Mandrand-Berthelot, and Agnès Labigne. 2003. 
“Characterization of the Roles of NikR, a Nickel-Responsive Pleiotropic Autoregulator of 
Helicobacter Pylori.” Molecular Microbiology 49(4):947–63. 
Covacci, a, J. L. Telford, G. Del Giudice, J. Parsonnet, and R. Rappuoli. 1999. “Helicobacter Pylori 
Virulence and Genetic Geography.” Science (New York, N.Y.) 284(5418):1328–33. 
Covacci, Antonello, Stanley Falkow, Douglas E. Berg, and Rino Rappuoli. 1997. “Did the Inheritance of a 
Pathogenicity Island Modify the Virulence of Helicobacter Priori?” TRENDS in Microbiology 
5(5):205–8. 
Covarrubias, Adrian Suarez et al. 2005. “Structure and Function of Carbonic Anhydrases from 
Mycobacterium Tuberculosis.” Journal of Biological Chemistry 280(19):18782–89. 
Cover, T. L., L. Y. Reddy, and M. J. Blaser. 1993. “Effects of ATPase Inhibitors on the Response of HeLa 
Cells to Helicobacter Pylori Vacuolating Toxin.” Infect Immun 61(4):1427–31. 
Cover, T. L., M. K. Tummuru, P. Cao, S. A. Thompson, and M. J. Blaser. 1994. “Divergence of Genetic 
Sequences for the Vacuolating Cytotoxin among Helicobacter  Pylori Strains.” The Journal of 
biological chemistry 269(14):10566–73. 
Cover, Timothy L. and Steven R. Blanke. 2005. “Helicobacter Pylori VacA, a Paradigm for Toxin 
Multifunctionality.” Nat Rev Micro 3(4):320–32. 
Cover, Timothy L. and Martin J. Blaser. 2009. “Helicobacter Pylori in Health and Disease.” 
Gastroenterology 18(9):1199–1216. 
Cover, Timothy L., Phyllis I. Hanson, and John E. Heuser. 1997. “Acid-Induced Dissociation of VacA, the 
Helicobacter Pylori Vacuolating Cytotoxin, Reveals Its Pattern of Assembly.” Journal of Cell Biology 
138(4):759–69. 
Cronk, Jeff D. et al. 2006. “Identification of a Novel Noncatalytic Bicarbonate Binding Site in Eubacterial 
Beta-Carbonic Anhydrase.” Biochemistry 45(14):4351–61. 
Cronk, Jeff D., James a Endrizzi, Michelle R. Cronk, and Jason W. O. Neill. 2001. “Crystal Structure of E. 
Coli B-Carbonic Anhydrase, an Enzyme with an Unusual pH-Dependent Activity.” Protein Science 
10:911–22. 
Crow, Allister, Richard M. Acheson, Nick E. Le Brun, and Arthur Oubrie. 2004. “Structural Basis of Redox-
Coupled Protein Substrate Selection by the Cytochrome c Biosynthesis Protein ResA.” Journal of 
Biological Chemistry 279(22):23654–60. 
Croxen, Matthew A., Gary Sisson, Roberto Melano, and Paul S. Hoffman. 2006. “The Helicobacter Pylori 
Chemotaxis Receptor TlpB (HP0103) Is Required for pH Taxis and for Colonization of the Gastric 
Mucosa.” Journal of bacteriology 188(7):2656–65.  
Cullen, Thomas W. et al. 2011. “Helicobacter Pylori versus the Host: Remodeling of the Bacterial Outer 
Membrane Is Required for Survival in the Gastric Mucosa.” PLoS Pathogens 7(12):e1002454. 
D’Elios, Mario Milco and Leif P. Andersen. 2007. “Helicobacter Pylori Inflammation, Immunity, and 
Vaccines.” Helicobacter 12 Suppl 1:15–19. 
References 
212 
 
D’Elios, Mario Milco, Cesare Montecucco, and Marina de Bernard. 2007. “VacA and HP-NAP, Ying and 
Yang of Helicobacter Pylori-Associated Gastric Inflammation.” Clinica chimica acta; international 
journal of clinical chemistry 381(1):32–38. 
Dabiri, Hossein et al. 2009. “Distribution of Helicobacter Pylori cagA, cagE, oipA and vacA in Different 
Major Ethnic Groups in Tehran, Iran.” Journal Gastroenterology Hepatology 18(9):1199–1216. 
Danielli, Alberto et al. 2009. “Growth Phase and Metal-Dependent Transcriptional Regulation of the fecA 
Genes in Helicobacter Pylori.” Journal of Bacteriology 191(11):3717–25. 
Delany, Isabel, A. N. A. Beatriz F. Pacheco, Gunther Spohn, and Rino Rappuoli. 2001. “Iron-Dependent 
Transcription of the frpB Gene of Helicobacter Pylori Is Controlled by the Fur Repressor Protein.” 
Journal of Bacteriology 183(16):4932–37. 
Denoncin, Katleen and Jean-François Collet. 2012. “Disulfide Bond Formation in the Bacterial Periplasm: 
Major Achievements and Challenges Ahead.” Antioxidants & Redox Signaling 
19(1):121002061152001. 
Dian, Cyril et al. 2011. “The Structure of the Helicobacter Pylori Ferric Uptake Regulator Fur Reveals 
Three Functional Metal Binding Sites.” Molecular Microbiology 79(5):1260–75. 
Donczew, Rafał, Christoph Weigel, Rudi Lurz, Jolanta Zakrzewska-Czerwinska, and Anna Zawilak-
Pawlik. 2012. “Helicobacter Pylori oriC--the First Bipartite Origin of Chromosome Replication in 
Gram-Negative Bacteria.” Nucleic acids research 40(19):9647–60. 
Dong, Quan-Jiang, Qing Wang, Ying-Nin Xin, Ni Li, and Shi-Ying Xuan. 2009. “Comparative Genomics of 
Helicobacter Pylori.” World journal of gastroenterology : WJG 15:3984–91. 
Dore, Maria P., Antonia R. Sepulveda, Michael S. Osato, Giuseppe Realdi, and David Y. Graham. 1999. 
“Helicobacter Pylori in Sheep Milk.” The Lancet 354(9173):132. 
Dore, MariaP. et al. 1999. “High Prevalence of Helicobacter Pylori Infection in Shepherds.” Digestive 
Diseases and Sciences 44(6):1161–64. 
Dorer, Marion S., Sarah Talarico, and Nina R. Salama. 2009. “Helicobacter Pylori’s Unconventional Role 
in Health and Disease.” PLoS pathogens 5(10):1–6. 
Dosanjh, Nuvjeevan S. and Sarah L. J. Michel. 2006. “Microbial Nickel Metalloregulation: NikRs for Nickel 
Ions.” Current Opinion in Chemical Biology 10(2):123–30. 
Dossumbekova, Anar et al. 2006. “Helicobacter Pylori HopH (OipA) and Bacterial Pathogenicity: Genetic 
and Functional Genomic Analysis of hopH Gene Polymorphisms.” The Journal of infectious 
diseases 194(10):1346–55. 
Douillard, Francois P., Kieran A. Ryan, Jason Hinds, and Paul W. O. Toole. 2009. “Effect of FliK Mutation 
on the Transcriptional Activity of the σ 54 Sigma Factor RpoN in Helicobacter Pylori.” Microbiology 
155(Pt 6):1901–11. 
Dubois, Andre and Thomas Borén. 2007. “Helicobacter Pylori Is Invasive and It May Be a Facultative 
Intracellular Organism.” Cellular Microbiology 9(5):1108–16. 
Dundon, W. G., D. G. Marshall, C. A. O’Morain, and C. J. Smyth. 2000. “Population Characteristics of 
Irish Helicobacter Pylori Isolates: A tRNA-Associated Locus.” Irish journal of medical science 
169(2):137–40. 
Dunn, B. E., G. P. Campbell, G. I. Perez-Perez, and Blaser M.J. 1990. “Purification and Characterization 
References 
213 
 
of Urease from Helicobacter Pylori.” The Journal of Biological Chemistry 265(5):9464–69. 
Dunn, BE, H. Cohen, and MJ Blaser. 1997. “Helicobacter Pylori.” Clinical Microbiology Reviews 4:720–
41. 
Dunn, Bruce E. and Suhas H. Phadnis. 1998. “Structure , Function and Localization of Helicobacter 
Pyloni Urease.” Yale Journal of Biology and Medicine 71(1998):63–73. 
Dunne, Ciara. 2014. “Factors That Mediate Colonization of the Human Stomach by Helicobacter Pylori.” 
World Journal of Gastroenterology 20(19):5610. 
Duś, Irena et al. 2013. “Role of PCR in Helicobacter Pylori Diagnostics and Research – New Approaches 
for Study of Coccoid and Spiral Forms of the Bacteria Rola Metody PCR W Diagnostyce I 
Badaniach Naukowych Helicobacter Pylori – Nowe Możliwości Poznawcze Formy Kokoidalnej I 
Spir.” Postepy Higieni i Medycyny Doswiadczalnej 261–68. 
Eaton, K. a., C. L. Brooks, D. R. Morgan, and S. Krakowka. 1991. “Essential Role of Urease in 
Pathogenesis of Gastritis Induced by Helicobacter Pylori in Gnotobiotic Piglets.” Infection and 
Immunity 59(7):2470–75. 
Eaton, K. A., S. Suerbaum, C. Josenhans, and S. Krakowka. 1996. “Colonization of Gnotobiotic Piglets by 
Helicobacter Pylori Deficient in Two Flagellin Genes.” Infection and immunity 64(7):2445–48. 
Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2010. “Features and Development of Coot.” Acta 
crystallographica. Section D, Biological crystallography 66(Pt 4):486–501. 
Ernst, Florian D. et al. 2005. “Transcriptional Profiling of Helicobacter Pylori Fur- and Iron-Regulated 
Gene Expression.” Microbiology (Reading, England) 151(Pt 2):533–46. 
Evans, D. G., D. J. Evans, J. J. Moulds, and D. Y. Graham. 1988. “N-Acetylneuraminyllactose-Binding 
Fibrillar Hemagglutinin of Campylobacter Pylori: A Putative Colonization Factor Antigen.” Infection 
and immunity 56(11):2896–2906.  
Evans, D. J. Jr and D. G. Evans. 2000. “Helicobacter Pylori Adhesins: Review and Perspectives.” 
Helicobacter 5(4):183–95. 
Evans, D., T. Karjalainen, D. Evans, D. Graham, and C. H. Lee. 1993. “Cloning, Nucleotide Sequence, 
and Expression of an Adhesin Subunit Protein of Helicobacter Pylori.” J.Bacteriol. 175(3):674–83. 
Evans, Doyle J., Dolores G. Evans, Stacy S. Kirkpatrick, and David Y. Graham. 1991. “Characterization 
of the Helicobacter Pylori Urease and Purification of Its Subunits.” Microbial Pathogenesis 10(1):15–
26. 
Evans, Philip. 2006. “Scaling and Assessment of Data Quality.” Acta crystallographica. Section D, 
Biological crystallography 62(Pt 1):72–82. 
Fabre, Nicolas, Ilja M. Reiter, Noelle Becuwe-Linka, Bernard Genty, and Dominique Rumeau. 2007. 
“Characterization and Expression Analysis of Genes Encoding Alpha and Beta Carbonic 
Anhydrases in Arabidopsis.” Plant, cell & environment 30:617–29. 
Falke, J. J. and G. L. Hazelbauer. 2001. “Transmembrane Signaling in Bacterial Chemoreceptors.” 
Trends in biochemical sciences 26(4):257–65. 
Falush, D. et al. 2001. “Recombination and Mutation during Long-Term Gastric Colonization by 
Helicobacter Pylori: Estimates of Clock Rates, Recombination Size, and Minimal Age.” Proceedings 
of the National Academy of Sciences of the United States of America 98(26):15056–61. 
References 
214 
 
Falush, Daniel et al. 2003. “Traces of Human Migrations in Helicobacter Pylori Populations.” Science 
(New York, N.Y.) 299(5612):1582–85. 
Farzi, Nastaran, Tannaz Malekian, Masoud Alebouyeh, Farzam Vaziri, and Mohammad Reza Zali. 2015. 
“Genotype Diversity and Quasispecies Development of Helicobacter Pylori in a Single Host.” 
Japanese Journal of Infectious Diseases 68(3):176–80. 
Ferguson, Stuart J., Julie M. Stevens, James W. A. Allen, and Ian B. Robertson. 2008. “Cytochrome c 
Assembly: A Tale of Ever Increasing Variation and Mystery?” Biochimica et Biophysica Acta - 
Bioenergetics 1777:980–84. 
Fernandez-Gonzalez, Esther and Steffen Backert. 2014. “DNA Transfer in the Gastric Pathogen 
Helicobacter Pylori.” Journal of Gastroenterology 49(4):594–604. 
Ferraroni, Marta, Sonia Del Prete, Daniela Vullo, Clemente Capasso, and Claudiu T. Supuran. 2015. 
“Crystal Structure and Kinetic Studies of a Tetrameric Type II β-Carbonic Anhydrase from the 
Pathogenic Bacterium Vibrio Cholerae.” Acta Crystallographica Section D Biological Crystallography 
71(12):2449–56. 
Ferrero, R. L. and A. Labigne. 2001. “Helicobacter Pylori Vaccine Development in the Post-Genomic Era : 
Can In Silico Translate to In Vivo ?” Scandinavian Journal of Immunology 443–48. 
Figura, N. et al. 1989. “Cytotoxin Production by Campylobacter Pylori Strains Isolated from Patients with 
Peptic Ulcers and from Patients with Chronic Gastritis Only.” Journal of Clinical Microbiology 225–
26. 
Di Fiore, Anna et al. 2013. “X-Ray Structure of the First `extremo-Alpha-Carbonic Anhydrase’, a Dimeric 
Enzyme from the Thermophilic Bacterium Sulfurihydrogenibium Yellowstonense YO3AOP1.” Acta 
crystallographica. Section D, Biological crystallography 69(Pt 6):1150–59. 
Fischer, Wolfgang. 2011. “Assembly and Molecular Mode of Action of the Helicobacter Pylori Cag Type 
IV Secretion Apparatus.” FEBS Journal 278(8):1203–12. 
Fischer, Wolfgang et al. 2014. “A Comprehensive Analysis of Helicobacter Pylori Plasticity Zones Reveals 
That They Are Integrating Conjugative Elements with Intermediate Integration Specificity.” BMC 
genomics 15(1):310. 
Fischer, Wolfgang, Dirk Hofreuter, and Rainer Haas. 2001. “Natural Transformation, Recombination, and 
Repair.” edited by H. L. T. Mobley, G. L. Mendz, and S. L. Hazell. Washington (DC). 
Fraser, A. G., R. Scragg, P. Metcalf, S. McCullough, and N. J. Yeates. 1996. “Prevalence of Helicobacter 
Pylori Infection in Different Ethnic Groups in New Zealand Children and Adults.” Australian and New 
Zealand journal of medicine 26(5):646–51. 
Frawley, Elaine R. and Robert G. Kranz. 2009. “CcsBA Is a Cytochrome c Synthetase That Also 
Functions in Heme Transport.” Proceedings of the National Academy of Sciences of the United 
States of America 106(25):10201–6. 
Frenck, Robert W. and John Clemens. 2003. “Helicobacter in the Developing World.” Microbes and 
Infection 5(8):705–13. 
Fulkerson, John F. and Harry L. T. Mobley. 2000. “Membrane Topology of the nixA Nickel Transporter of 
Helicobacter Priori: Two Nickel Transport-Specific Motifs within Transmembrane Helices II and III.” 
Journal of Bacteriology 182(6):1722–30. 
References 
215 
 
Gangwer, Kelly A. et al. 2007. “Crystal Structure of the Helicobacter Pylori Vacuolating Toxin p55 
Domain.” Proceedings of the National Academy of Sciences of the United States of America 
104(41):16293–98. 
Garner, Juli a. 1996. “Binding and Internalization of the Helicobacter Pylori Vacuolating Cytotoxin by 
Epithelial Cells . Binding and Internalization of the Helicobacter Pylori Vacuolating Cytotoxin by 
Epithelial Cells.” Microbiology 64(10):4197–4203. 
Gebert, Bettina, Wolfgang Fischer, Evelyn Weiss, Reinhard Hoffmann, and Rainer Haas. 2003. 
“Helicobacter Pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation.” Science 
301(5636):1099–1102. 
Geis, Gabriele, Hermann Leying, Sebastian Suerbaum, U. W. E. Mai, and Wolfgang Opferkuch. 1989. 
“Ultrastructure and Chemical Analysis of Campylobacter Pylori Flagella.” Journal of clinical 
microbiology 27(3):436–41. 
Geis, Gabriele, Sebastian Suerbaum, B. Forsthoff, H. Leying, and W. Opferkuch. 1993. “Ultrastructure 
and Biochemical Studies of the Flagellar Sheath of Helicobacter Pylori.” Journal of Medical 
Microbiology 38(5):371–77. 
Gewirtz, Andrew T. et al. 2004. “Helicobacter Pylori Flagellin Evades Toll-like Receptor 5-Mediated Innate 
Immunity.” The Journal of infectious diseases 189(10):1914–20. 
Gilmour, K. M. 2010. “Perspectives on Carbonic Anhydrase.” Comparative biochemistry and physiology. 
Part A, Molecular & integrative physiology 157(3):193–97. 
Goh, Khean Lee. 1997. “Prevalence of and Risk Factors for Helicobacter Pylori Infection in a Multi-Racial 
Dyspeptic Malaysian Population Undergoing Endoscopy.” Journal of Gastroenterology and 
Hepatology 12(6):S29–35. 
González-Rivera, Christian, Holly M. Scott Algood, Jana N. Radin, Mark S. McClain, and Timothy L. 
Cover. 2012. “The Intermediate Region of Helicobacter Pylori Vaca Is a Determinant of Toxin 
Potency in a Jurkat T Cell Assay.” Infection and Immunity 80(8):2578–88. 
Goodman, K. J. et al. 1996. “Helicobacter Pylori Infection in the Colombian Andes: A Population-Based 
Study of Transmission Pathways.” American journal of epidemiology 144(3):290–99. 
Goosen, C. et al. 2002. “Evaluation of a Novel Heminested PCR Assay Based on the 
Phosphoglucosamine Mutase Gene for Detection of Helicobacter Pylori in Saliva and Dental Plaque 
Evaluation of a Novel Heminested PCR Assay Based on the Phosphoglucosamine Mutase Gene for 
Detection of.” Journal of clinical microbiology 40(1):205–9. 
Gorden, J. E. D. and P. L. C. Small. 1993. “Acid Resistance in Enteric Bacteria.” Survival 61(1):364–67. 
Grasso, G. M., G. Ripabelli, M. L. Sammarco, A. Ruberto, and G. Iannitto. 1996. “Prevalence of 
Helicobacter-like Organisms in Porcine Gastric Mucosa: A Study of Swine Slaughtered in Italy.” 
Comparative Immunology, Microbiology and Infectious Diseases 19(3):213–17. 
Grebowska, Aneta et al. 2008. “Anti-Phagocytic Activity of Helicobacter Pylori Lipopolysaccharide (LPS)--
Possible Modulation of the Innate Immune Response to These Bacteria.” Polish journal of 
microbiology / Polskie Towarzystwo Mikrobiologow = The Polish Society of Microbiologists 
57(3):185–92. 
Grübel, Peter et al. 1997. “Vector Potential of Houseflies (Musca Domestica) for Helicobacter Pylori.” 
References 
216 
 
Journal of Clinical Microbiology 35(6):1300–1303. 
Gunaletchumy, Selva Perumal et al. 2014. “Helicobacter Pylori Genetic Diversity and Gastro-Duodenal 
Diseases in Malaysia.” Scientific Reports 4:7431. 
Guruge, J. L. et al. 1998. “Epithelial Attachment Alters the Outcome of Helicobacter Pylori Infection.” 
Proceedings of the National Academy of Sciences of the United States of America 95(7):3925–30.  
Ha, Nam-chul et al. 2001. “Supramolecular Assembly and Acid Resistance of Helicobacter Pylori 
Urease.” Nature structural Biology 8(6):505–9. 
Hage, Naim et al. 2015. “Structural Basis of Lewis B Antigen Binding by the Helicobacter Pylori Adhesin 
BabA.” Science advances (August):1–9. 
Hamel, Patrice, Vincent Corvest, Philippe Giege, and Geraldine Bonnard. 2009. “Biochemical 
Requirements for the Maturation of Mitochondrial c-Type Cytochromes.” Biochimica et biophysica 
acta 1793(1):125–38. 
Handt, L. K. et al. 1994. “Helicobacter Pylori Isolated from the Domestic Cat: Public Health Implications.” 
Infection and immunity 62(6):2367–74. 
Handt, L. K. et al. 1997. “Diagnosis of Helicobacter Pylori Infection in a Colony of Rhesus Monkeys 
(Macaca Mulatta).” Journal of clinical microbiology 35(1):165–68. 
Hatakeyama, Masanori. 2004. “Oncogenic Mechanisms of the Helicobacter Pylori CagA Protein.” Nature 
reviews. Cancer 4(9):688–94. 
He, S. et al. 2015. “The IS200/IS605 Family and ‘Peel and Paste’ Single-Strand Transposition 
Mechanism.” Microbiology spectrum 3(4). 
Hennig, Ewa E., Ray Mernaugh, Jennifer Edl, Ping Cao, and Timothy L. Cover. 2004. “Heterogeneity 
among Helicobacter Pylori Strains in Expression of the Outer Membrane Protein BabA 
Heterogeneity among Helicobacter Pylori Strains in Expression of the Outer Membrane Protein 
BabA.” Infection and immunity 72(6):3429–35. 
Heras, Begona et al. 2009. “DSB Proteins and Bacterial Pathogenicity.” Nature reviews. Microbiology 
7(3):215–25. 
Hessey, S. J. et al. 1990. “Bacterial Adhesion and Disease Activity in Helicobacter Associated Chronic 
Gastritis.” Gut 31(2):134–38. 
Hirano, Takanori, Satoshi Shibata, Kouhei Ohnishi, Tomomi Tani, and Shin-Ichi Aizawa. 2005. “N-
Terminal Signal Region of FliK Is Dispensable for Length Control of the Flagellar Hook.” Molecular 
Microbiology 56(2):346–60. 
Hopkins, R. J. et al. 1993. “Seroprevalence of Helicobacter Pylori in Chile: Vegetables May Serve as One 
Route of Transmission.” The Journal of infectious diseases 168(1):222–26. 
Huang, S. et al. 1998. “Crystal Structure of Carbonic Anhydrase from Neisseria Gonorrhoeae and Its 
Complex with the Inhibitor Acetazolamide.” Journal of molecular biology 283(1):301–10. 
Huang, Shenghua et al. 2011. “Structural Studies of β-Carbonic Anhydrase from the Green Alga 
Coccomyxa: Inhibitor Complexes with Anions and Acetazolamide.” PLoS ONE 6(12):e28458.  
Ilver, D. et al. 1998. “Helicobacter Pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens 
Revealed by Retagging.” Science 279(5349):373–77. 
Ilver, Dag, Silvia Barone, David Mercati, Pietro Lupetti, and John L. Telford. 2004. “Helicobacter Pylori 
References 
217 
 
 Toxin VacA Is Transferred to Host Cells via a Novel Contact-Dependent Mechanism.” Cellular 
Microbiology 6(2):167–74. 
Israel, I. D. a and R. M. Peek. 2001. “Review Article : Pathogenesis of Helicobacter Pylori-Induced Gastric 
Inflammation.” Alimentary pharmacology & therapeutics (15):1271–90. 
James, Paul et al. 2014. “The Structure of a Tetrameric Alpha-Carbonic Anhydrase from Thermovibrio 
Ammonificans Reveals a Core Formed around Intermolecular Disulfides That Contribute to Its 
Thermostability.” Acta crystallographica. Section D, Biological crystallography 70(Pt 10):2607–18. 
Jiao, Li et al. 2013. “Crystal Structure of the Periplasmic Disulfide-Bond Isomerase DsbC from Salmonella 
Enterica Serovar Typhimurium and the Mechanistic Implications.” Journal of structural biology 
183(1):1–10. 
Johnson, Elizabeth M., Jennifer a Gaddy, and Timothy L. Cover. 2012. “Alterations in Helicobacter Pylori 
Triggered by Contact with Gastric Epithelial Cells.” Frontiers in cellular and infection microbiology 
2(February):17. 
Jones, A. C. et al. 1997. “A Flagellar Sheath Protein of Helicobacter Pylori Is Identical to HpaA, a Putative 
N-Acetylneuraminyllactose-Binding Hemagglutinin, but Is Not an Adhesin for AGS Cells.” Journal of 
bacteriology 179(17):5643–47. 
Jones, B. D. and H. L. T. Mobley. 1988. “Proteus-Mirabilis Urease - Genetic Organization, Regulation, 
and Expression of Structural Genes.” Journal of Bacteriology 170(8):3342–49. 
Jones, C. J., M. Homma, and R. M. Macnab. 1989. “L-, P-, and M-Ring Proteins of the Flagellar Basal 
Body of Salmonella Typhimurium: Gene Sequences and Deduced Protein Sequences.” Journal of 
bacteriology 171(7):3890–3900. 
Jones, K. R. et al. 2009. “Polymorphism in the CagA EPIYA Motif Impacts Development of Gastric 
Cancer.” Journal of Clinical Microbiology 47(4):959–68. 
De Jonge, Ramon et al. 2004. “Role of the Helicobacter Pylori Outer-Membrane Proteins AlpA and AlpB 
in Colonization of the Guinea Pig Stomach.” Journal of Medical Microbiology 53(5):375–79. 
Josenhans, C., A. Labigne, and S. Suerbaum. 1995. “Comparative Ultrastructural and Functional Studies 
of Helicobacter Pylori and Helicobacter Mustelae Flagellin Mutants: Both Flagellin Subunits, FlaA 
and FlaB, Are Necessary for Full Motility in Helicobacter Species.” Journal of bacteriology 
177(11):3010–20. 
Kaakoush, Nadeem O., Torsten Sterzenbach, William G. Miller, Sebastian Suerbaum, and George Louis 
Mendz. 2007. “Identification of Disulfide Reductases in Campylobacterales: A Bioinformatics 
Investigation.” Antonie van Leeuwenhoek 92(4):429–41. 
Kabsch, Wolfgang. 2010. “XDS.” Acta crystallographica. Section D, Biological crystallography 66(Pt 
2):125–32. 
Källberg, Morten et al. 2012. “Template-Based Protein Structure Modeling Using the RaptorX Web 
Server.” Nat. Protocols 7(8):1511–22. 
Kang, Su-Jin, Do-Hee Kim, and Bong-Jin Lee. 2013. “NMR Study on Small Proteins from Helicobacter 
Pylori for Antibiotic Target Discovery: A Review.” Molecules 18(11):13410–24. 
Kao, Cheng-Yen, Shew-Meei Sheu, Bor-Shyang Sheu, and Jiunn-Jong Wu. 2012. “Length of Thymidine 
Homopolymeric Repeats Modulates Promoter Activity of sabA in  Helicobacter Pylori.” Helicobacter 
References 
218 
 
17(3):203–9. 
Karnholz, Arno et al. 2006. “Functional and Topological Characterization of Novel Components of the 
comB DNA Transformation Competence System in Helicobacter Pylori.” Journal of Bacteriology 
188(3):882–93. 
Kauser, Farhana et al. 2004. “The Cag Pathogenicity Island of Helicobacter Pylori Is Disrupted in the 
Majority of Patient Isolates from Different Human Populations.” Journal of clinical microbiology 
42(11):5302–8. 
Kawagishi, I., M. Homma, a W. Williams, and R. M. Macnab. 1996. “Characterization of the Flagellar 
Hook Length Control Protein fliK of Salmonella Typhimurium and Escherichia Coli.” Journal of 
bacteriology 178(10):2954–59. 
Kawahara, T. et al. 2001. “Helicobacter Pylori Lipopolysaccharide from Type I, but Not Type II Strains, 
Stimulates Apoptosis of Cultured Gastric Mucosal Cells.” The journal of medical investigation : JMI 
48(3-4):167–74. 
Kelley, Lawrence A., Stefans Mezulis, Christopher M. Yates, Mark N. Wass, and Michael J. E. Sternberg. 
2015. “The Phyre2 Web Portal for Protein Modeling, Prediction and Analysis.” Nat. Protocols 
10(6):845–58. 
Kennemann, Lynn et al. 2012. “In Vivo Sequence Variation in HopZ, a Phase-Variable Outer Membrane 
Protein of Helicobacter Pylori.” Infection and immunity 80(12):4364–73. 
Kersulyte, D., H. Chalkauskas, and D. E. Berg. 1999. “Emergence of Recombinant Strains of 
Helicobacter Pylori during Human Infection.” Molecular microbiology 31(1):31–43. 
Kersulyte, Dangeruta et al. 2004. “Sequence Organization and Insertion Specificity of the Novel Chimeric 
IS Hp609 Transposable Element of Helicobacter Pylori Sequence Organization and Insertion 
Specificity of the Novel Chimeric ISHp609 Transposable Element of Helicobacter Pylori †.” Journal 
of Bacteriology of Bacteriology 186(22):7521–28. 
Kersulyte, Dangeruta, Natalia S. Akopyants, Sandra W. Clifton, Bruce A. Roe, and Douglas E. Berg. 
1998. “Novel Sequence Organization and Insertion Specificity of IS605 and IS606: Chimaeric 
Transposable Elements of Helicobacter Pylori.” Gene 223(1-2):175–86. 
Kersulyte, Dangeruta, Henrikas Chalkauskas, and Douglas Berg. 1999. “Emergence of Recombinant 
Strains of Helicobacter Pylori during Human Infection.” Molecular Microbiology 31(1):31–43. 
Khalifa, Mohammed Mahdy, Radwa Raed Sharaf, and Ramy Karam Aziz. 2010. “Helicobacter Pylori: A 
Poor Man’s Gut Pathogen?” Gut pathogens 2(1):2. 
Kidd, M., J. C. Atherton, A. J. Lastovica, and J. A. Louw. 2001. “Clustering of South African Helicobacter 
Pylori Isolates from Peptic Ulcer Disease Patients Is Demonstrated by Repetitive Extragenic 
Palindromic-PCR Fingerprinting.” J Clin Microbiol 39(5):1833–39. 
Kim, Byeong Gwan et al. 2007. “Comparison of 7-Day and 14-Day Proton Pump Inhibitor-Containing 
Triple Therapy for Helicobacter Pylori Eradication: Neither Treatment Duration Provides Acceptable 
Eradication Rate in Korea.” Helicobacter 12(1):31–35. 
Kim, J. S., J. H. Chang, S. I. Chung, and J. S. Yum. 1999. “Molecular Cloning and Characterization of the 
Helicobacter Pylori fliD Gene, an Essential Factor in Flagellar Structure and Motility.” Journal of 
bacteriology 181(22):6969–76. 
References 
219 
 
Kim, Kyung-Mi et al. 2007. “γ-Glutamyltranspeptidase of Helicobacter Pylori Induces Mitochondria-
Mediated Apoptosis in AGS Cells.” Biochemical and Biophysical Research Communications 
355(2):562–67. 
Kim, Nayoung et al. 2004. “Genes of Helicobacter Pylori Regulated by Attachment to AGS Cells.” 
Infection and immunity 72(4):2358–68. 
Kim, Sa-Hyun et al. 2014. “Cyanidin 3-O-Glucoside Reduces Helicobacter Pylori VacA-Induced Cell 
Death of Gastric KATO III Cells through Inhibition of the SecA Pathway.” International journal of 
medical sciences 11(7):742–47. 
Kimber, M. S. and E. F. Pai. 2000. “The Active Site Architecture of Pisum Sativum Beta-Carbonic 
Anhydrase Is a Mirror Image of that of Alpha-Carbonic Anhydrases.” EMBO Journal 19(7):1407–18.  
Kivi, M., a L. V Johansson, M. Reilly, and Y. Tindberg. 2005. “Helicobacter Pylori Status in Family 
Members as Risk Factors for Infection in Children.” Epidemiology and infection 133:645–52. 
Klein, P. D. et al. 1991. “Originally Published as Volume 1, Issue 8756Water Source as Risk Factor for 
Helicobacter Pylori Infection in Peruvian Children.” The Lancet 337(8756):1503–6. 
De Koning-Ward, T. F., A. .. C. Ward, and R. M. Robins-Browne. 1994. “Characterisation of the Urease-
Encoding Gene Complex of Yersinia Enterocolitica.” Gene 145(1):25–32. 
Konno, Mutsuko et al. 2008. “Predominance of Mother-to-Child Transmission of Helicobacter Pylori 
Infection Detected by Random Amplified Polymorphic DNA Fingerprinting Analysis in Japanese 
Families.” The Pediatric infectious disease journal 27(11):999–1003. 
Konturek, J. W. 2003. “Discovery by Jaworski of Helicobacter Pylori and Its Pathogenetic Role in Peptic 
Ulcer, Gastritis and Gastric Cancer.” Journal of Physiology and Pharmacology 54(SUPPL. 3):23–41. 
Kostrzynska, M., J. D. Betts, J. W. Austin, and T. J. Trust. 1991. “Identification, Characterization, and 
Spatial Localization of Two Flagellin Species in Helicobacter Pylori Flagella.” Journal of Bacteriology 
173(3):937–46. 
Koyanagi, S., K. Nagata, T. Tamura, S. Tsukita, and N. Sone. 2000. “Purification and Characterization of 
Cytochrome c-553 from Helicobacter Pylori.” Journal of biochemistry 128(3):371–75. 
Kraft, Christian and Sebastian Suerbaum. 2005. “Mutation and Recombination in Helicobacter Pylori: 
Mechanisms and Role in Generating Strain Diversity.” International journal of medical microbiology : 
IJMM 295(5):299–305. 
Krauss, Irene Russo, Antonello Merlino, Alessandro Vergara, and Filomena Sica. 2013. “An Overview of 
Biological Macromolecule Crystallization.” International Journal of Molecular Sciences 14(6):11643–
91. 
Krissinel, Evgeny and Kim Henrick. 2007. “Inference of Macromolecular Assemblies from Crystalline 
State.” Journal of molecular biology 372(3):774–97. 
Krokan, H. E., R. Standal, and G. Slupphaug. 1997. “DNA Glycosylases in the Base Excision Repair of 
DNA.” Biochem J 325 ( Pt 1:1–16. 
Kuipers, Ernst J. et al. 2000. “Quasispecies Development of Helicobacter Pylori Observed in Paired 
Isolates Obtained Years Apart from the Same Host.” The Journal of Infectious Diseases 
181(1):273–82. 
Kusters, J. G., A. H. M. van Vliet, and E. J. Kuipers. 2006. “Pathogenesis of Helicobacter Pylori Infection.” 
References 
220 
 
Clinical Microbiology Reviews 19(3):449–90. 
Kuzminov, A. 1999. “Recombinational Repair of DNA Damage in Escherichia Coli and Bacteriophage 
Lambda.” Microbiology and molecular biology reviews : MMBR 63(4):751–813, table of contents. 
Kwok, Terry et al. 2007. “Helicobacter Exploits Integrin for Type IV Secretion and Kinase Activation.” 
Nature 449(7164):862–66. 
Kwok, Terry, Steffen Backert, Heinz Schwarz, Jürgen Berger, and Thomas F. Meyer. 2002. “Specific 
Entry of Helicobacter Pylori into Cultured Gastric Epithelial Cells via a Zipper-Like Mechanism 
Specific Entry of Helicobacter Pylori into Cultured Gastric Epithelial Cells via a Zipper-Like 
Mechanism.” Infection and immunity 70(4):2108–20. 
Lambert, J. R. et al. 1995. “High Prevalence of Helicobacter Pylori Antibodies in an Institutionalized 
Population: Evidence for Person-to-Person Transmission.” The American journal of 
gastroenterology 90(12):2167–71. 
Lara-Ramírez, Edgar Eduardo et al. 2011. “New Implications on Genomic Adaptation Derived from the 
Helicobacter Pylori Genome Comparison.” PloS one 6(2):e17300. 
Larussa, Tiziana, Isabella Leone, Evelina Suraci, Maria Imeneo, and Francesco Luzza. 2015. 
“Helicobacter Pylori and T Helper Cells : Mechanisms of Immune Escape and Tolerance.” Journalof 
Immunology Research 2015. 
Lee, Mann Hyung, Scott B. Mulrooney, Michael J. Renner, Yves Markowicz, and Robert P. Hausinger. 
1992. “Klebsiella Aerogenes Urease Gene Cluster: Sequence of ureD and Demonstration That Four 
Accessory Genes (ureD, ureE, ureF, and ureG) Are Involved in Nickel Metallocenter Biosynthesis.” 
Journal of bacteriology 174(13):4324–30. 
Lehneck, Ronny et al. 2014. “Crystal Structures of Two Tetrameric β-Carbonic Anhydrases from the 
Filamentous Ascomycete Sordaria Macrospora.” FEBS Journal 281:1759–72. 
Leung, Wai-Keung et al. 1999. “Isolation of Helicobacter Pylori from Vomitus in Children and Its 
Implication in Gastro-Oral Transmission.” Am J Gastroenterol 94(10):2881–84. 
Leunk, R. D., P. T. Johnson, B. C. David, W. G. Kraft, and D. R. Morgan. 1988. “Cytotoxic Activity in 
Broth-Culture Filtrates of Campylobacter Pylori.” Journal of medical microbiology 26(2):93–99. 
Liljas, A. and M. Laurberg. 2000. “A Wheel Invented Three Times. The Molecular Structures of the Three 
Carbonic Anhydrases.” EMBO reports 1(1):16–17. 
Lina, Taslima T. et al. 2014. “Immune Evasion Strategies Used by Helicobacter Pylori.” World Journal of 
Gastroenterology 20(36):12753. 
Lindskog, S. 1997. “Structure and Mechanism of Carbonic Anhydrase.” Pharmacology & therapeutics 
74(1):1–20. 
Lindskog, S. and J. E. Coleman. 1973. “The Catalytic Mechanism of Carbonic Anhydrase.” Proceedings 
of the National Academy of Sciences of the United States of America 70(9):2505–8. 
Loh, John T., Shobhana S. Gupta, David B. Friedman, Andrzej M. Krezel, and Timothy L. Cover. 2010. 
“Analysis of Protein Expression Regulated by the Helicobacter Pylori ArsRS Two-Component Signal 
Transduction System.” Journal of bacteriology 192(8):2034–43. 
Luo, Miao, Siqiang Niu, Yibing Yin, Ailong Huang, and Deqiang Wang. 2009. “Cloning, Purification, 
Crystallization and Preliminary X-Ray Studies of Flagellar Hook Scaffolding Protein FlgD from 
References 
221 
 
Pseudomonas Aeruginosa PAO1.” Acta Crystallographica Section F: Structural Biology and 
Crystallization Communications 65(8):795–97. 
Lupetti, P. et al. 1996. “Oligomeric and Subunit Structure of the Helicobacter Pylori Vacuolating 
Cytotoxin.” Journal of Cell Biology 1994(4):801–7. 
Macauley, Sheridan R. et al. 2009. “The Archetype Gamma-Class Carbonic Anhydrase (Cam) Contains 
Iron When Synthesized in Vivo.” Biochemistry 48(5):817–19. 
Magalhaes, Ana et al. 2009. “Fut2-Null Mice Display an Altered Glycosylation Profile and Impaired BabA-
Mediated Helicobacter Pylori Adhesion to Gastric Mucosa.” Glycobiology 19(12):1525–36. 
Magariyama, Yukio and Seishi Kudo. 2002. “A Mathematical Explanation of an Increase in Bacterial 
Swimming Speed with Viscosity in Linear-Polymer Solutions.” Biophysical Journal 83(2):733–39.  
Mahdavi, Jafar et al. 2002. “Helicobacter Pylori SabA Adhesin in Persistent Infection and Chronic 
Inflammation.” Science 297(5581):573–78. 
Makrides, SC. 1996. “Strategies for Achieving High-Level Expression of Genes in Escherichia Coli.” 
Microbiol. Rev. 60(3):512–38. 
Malaty, H. M., L. Engstrand, N. L. Pedersen, and D. Y. Graham. 1994. “Helicobacter Pylori Infection: 
Genetic and Environmental Influences. A Study of Twins.” Annals of internal medicine 120(12):982–
86. 
Malfertheiner, P. et al. 2007. “Current Concepts in the Management of Helicobacter Pylori Infection : The 
Maastricht III Consensus Report.” Gut 56(6):772–81. 
Malnick, Stephen David Howard, Ehud Melzer, Malka Attali, Gabriel Duek, and Jacob Yahav. 2014. 
“Helicobacter Pylori: Friend or Foe?” World journal of gastroenterology : WJG 20(27):8979–85.  
Mapstone, N. P. et al. 1993. “PCR Identification of Helicobacter Pylori in Faeces from Gastritis Patients.” 
The Lancet 341(8842):447. 
Marcus, Elizabeth a, George Sachs, Yi Wen, Jing Feng, and David R. Scott. 2012. “Role of the 
Helicobacter Pylori Sensor Kinase ArsS in Protein Trafficking and Acid Acclimation.” Journal of 
bacteriology 194(20):5545–51. 
Marcus, Elizabeth A., Amiel P. Moshfegh, George Sachs, and David R. Scott. 2005a. “The Periplasmic 
Alpha-Carbonic Anhydrase Activity of Helicobacter Pylori Is Essential for Acid Acclimation.” Journal 
of bacteriology 187(2):729–38. 
Marcus, Elizabeth A., Amiel P. Moshfegh, George Sachs, and David R. Scott. 2005b. “The Periplasmic α-
Carbonic Anhydrase Activity of Helicobacter Pylori Is Essential for Acid Acclimation.” Journal of 
Bacteriology 187(2):729–38. 
Maresca, Alfonso, Daniela Vullo, Andrea Scozzafava, and Claudiu T. Supuran. 2013. “Inhibition of the 
Alpha- and Beta-Carbonic Anhydrases from the Gastric Pathogen Helycobacter Pylori with Anions.” 
Journal of enzyme inhibition and medicinal chemistry 28(2):388–91. 
Maria, Ruth et al. 2011. “Determination of Strain of Helicobacter Pylori and of Polymorphism in the 
Interleukin-8 Gene in Patients with Stomach Cancer.” Arquivos de Gastroeneterologia Journal 
(1):46–51. 
Marshall, BarryJ and J. Robi. Warren. 1984. “Unidentified Curved Bacilli in the Stomach of Patients with 
Gastritis and Peptic Ulceration.” The Lancet 323(8390):1311–15. 
References 
222 
 
Marsin, Stéphanie, Aurélie Mathieu, Thierry Kortulewski, Raphaël Guérois, and J. Pablo Radicella. 2008. 
“Unveiling Novel RecO Distant Orthologues Involved in Homologous Recombination.” PLoS 
genetics 4(8):e1000146. 
De Martel, Catherine and Julie Parsonnet. 2006. “Helicobacter Pylori Infection and Gender: A Meta-
Analysis of Population-Based Prevalence Surveys.” Digestive Diseases and Sciences 51(12):2292–
2301. 
Martin, Miriam E. and Jay V. Solnick. 2014. “The Gastric Microbial Community, Helicobacter Pylori 
Colonization, and Disease.” Gut Microbes 5(3):345–50. 
Martinou, J. C., S. Desagher, and B. Antonsson. 2000. “Cytochrome c Release from Mitochondria: All or 
Nothing.” Nature cell biology 2(3):E41–43. 
McCarthy, A. A. et al. 2000. “Crystal Structure of the Protein Disulfide Bond Isomerase, DsbC, from 
Escherichia Coli.” Nature structural biology 7(3):196–99. 
McClain, Mark S. et al. 2003. “Essential Role of a GXXXG Motif for Membrane Channel Formation by 
Helicobacter Pylori Vacuolating Toxin.” Journal of Biological Chemistry 278(14):12101–8. 
McClain, Mark S., Carrie L. Shaffer, Dawn a Israel, Richard M. Peek, and Timothy L. Cover. 2009. 
“Genome Sequence Analysis of Helicobacter Pylori Strains Associated with Gastric Ulceration and 
Gastric Cancer.” BMC genomics 10:3. 
McGee, D. J. and H. L. Mobley. 2000. “Pathogenesis of Helicobacter Pylori Infection.” Current opinion in 
gastroenterology 16(1):24–31. 
McGee, David J. et al. 2004. “Purification and Characterization of Helicobacter Pylori Arginase, RocF: 
Unique Features among the Arginase Superfamily.” European journal of biochemistry / FEBS 
271(10):1952–62. 
McGee, David J., Fiona J. Radcliff, George L. Mendz, Richard L. Ferrero, and Harry L. T. Mobley. 1999. 
“Helicobacter Pylori rocF Is Required for Arginase Activity and Acid Protection in Vitro but Is Not 
Essential for Colonization of Mice or for Urease Activity.” Journal of Bacteriology 181(23):7314–22. 
Mégraud, F. and N. Broutet. 2000. “Review Article: Have We Found the Source of Helicobacter Pylori?” 
Alimentary pharmacology & therapeutics 14 Suppl 3:7–12. 
Megraud, F., Trimoulet pascale, H. Lamouliatte, and L. Boyanova. 1991. “Bactericidal Effect of Amoxicillin 
on Helicobacter Pylori in an in Vitro Model Using Epithelial Cells.” Antimicrobial agents and 
chemotherapy 35(5):869–72. 
Meyer-Rosberg, K., David R. Scott, David Rex, Klaus Melchers, and George Sachs. 1996. “The Effect of 
Environmental pH on the Proton Motive Force of Helicobacter Pylori.” Gastroenterology 111(5):886–
900. 
Miller, Erica F. and Robert J. Maier. 2014. “Ammonium Metabolism Enzymes Aid Helicobacter Pylori Acid 
Resistance.” Journal of bacteriology 196(17):3074–81. 
Miller-Podraza, H. et al. 1999. “Helicobacter Pylori and Neutrophils: Sialic Acid-Dependent Binding to 
Various Isolated Glycoconjugates.” Infection and immunity 67(12):6309–13. 
Minamino, Tohru et al. 2004. “Domain Organization and Function of Salmonella FliK, a Flagellar Hook-
Length Control Protein.” Journal of Molecular Biology 341(2):491–502. 
Minamino, Tohru and Anthony P. Pugsley. 2005. “Measure for Measure in the Control of Type III 
References 
223 
 
Secretion Hook and Needle Length.” Molecular Microbiology 56(2):303–8. 
Mitchell, H. M. et al. 1992. “Epidemiology of Helicobacter Pylori in Southern China: Identification of Early 
Childhood as the Critical Period for Acquisition.” The Journal of infectious diseases 166(1):149–53. 
Mitchell, H. M. 1999. “The Epidemiology of Helicobacter Pylori.” Current topics in microbiology and 
immunology 241:11–30. 
Mitsuhashi, Satoshi et al. 2000. “X-Ray Structure of Beta Carbonic Anhydrase from the Red 
Alga,Porphyridium Purpureum, Reveals a Novel Catalytic Site for CO2 Hydration.” Journal of 
Biological Chemistry 275(8):5521–26. 
Miyaji, H. et al. 2000. “Helicobacter Pylori Infection Occurs via Close Contact with Infected Individuals  in 
Early Childhood.” Journal of gastroenterology and hepatology 15(3):257–62. 
Mizote, T., H. Yoshiyama, and T. Nakazawa. 1997. “Urease-Independent Chemotactic Responses of 
Helicobacter Pylori to Urea, Urease Inhibitors, and Sodium Bicarbonate.” Infection and immunity 
65(4):1519–21. 
Mizuno, Shino, Hirokazu Amida, Naohiro Kobayashi, Shin-Ichi Aizawa, and Shin-ichi Tate. 2011. “The 
NMR Structure of FliK, the Trigger for the Switch of Substrate Specificity in the Flagellar Type III 
Secretion Apparatus.” Journal of Molecular Biology 409(4):558–73. 
Mobley, H. L., M. D. Island, and R. P. Hausinger. 1995. “Molecular Biology of Microbial Ureases.” 
Microbiological reviews 59(3):451–80. 
Mobley, Harry L. T., George L. Mendz, and Stuart L. Hazell, eds. 2001. Helicobacter Pylori: Physiology 
and Genetics. Washington (DC). 
Modak, Joyanta K., Yu C. Liu, Mayra A. Machuca, Claudiu T. Supuran, and Anna Roujeinikova. 2015. 
“Structural Basis for the Inhibition of Helicobacter Pylori Alpha-Carbonic Anhydrase by 
Sulfonamides.” PloS one 10(5):e0127149. 
Modak, Joyanta K., Sarah A. Revitt-Mills, and Anna Roujeinikova. 2013. “Cloning, Purification and 
Preliminary Crystallographic Analysis of the Complex of Helicobacter Pylori Alpha-Carbonic 
Anhydrase with Acetazolamide.” Acta crystallographica. Section F, Structural biology and 
crystallization communications 69(Pt 11):1252–55. 
Molinari, M. et al. 1998. “Selective Inhibition of Ii-Dependent Antigen Presentation by Helicobacter Pylori 
Toxin VacA.” The Journal of experimental medicine 187(1):135–40. 
Momtaz, Hassan, Hossein Dabiri, Negar Souod, and Mohsen Gholami. 2014. “Study of Helicobacter 
Pylori Genotype Status in Cows, Sheep, Goats and Human Beings.” BMC gastroenterology 
14(1):61. 
Montecucco, Cesare and Rino Rappuoli. 2001. “Living Dangerously: How Helicobacter Pylori Survives in 
the Human Stomach.” Nat Rev Mol Cell Biol 2(6):457–66. 
Morishita, Saori et al. 2008. “Cloning, Polymorphism, and Inhibition of Beta-Carbonic Anhydrase of 
Helicobacter  Pylori.” Journal of gastroenterology 43(11):849–57. 
Moriya, Nao, Tohru Minamino, Kelly T. Hughes, Robert M. Macnab, and Keiichi Namba. 2006. “The Type 
III Flagellar Export Specificity Switch Is Dependent on FliK Ruler and a Molecular Clock.” Journal of 
molecular biology 359(2):466–77. 
Muotiala, A., I. M. Helander, L. Pyhala, T. U. Kosunen, and A. P. Moran. 1992. “Low Biological Activity of 
References 
224 
 
Helicobacter Pylori Lipopolysaccharide.” Infection and Immunity 60(4):1714–16. 
Muramoto, K., S. Makishima, S. I. Aizawa, and R. M. Macnab. 1998. “Effect of Cellular Level of FliK on 
Flagellar Hook and Filament Assembly in Salmonella Typhimurium.” Journal of molecular biology 
277(4):871–82. 
Naughton, J., G. Duggan, B. Bourke, and M. Clyne. 2014. “Interaction of Microbes with Mucus and 
Mucins.” Gut Microbes 5(1):48–52. 
Neiši, Dragana, Marshall C. Miller, Zachary T. Quinkert, Markus Stein, and Brian T. Chait. 2010. 
“Helicobacter Pylori CagA Inhibits PAR1/MARK Family Kinases by Mimicking Host Substrates.” 
Nature Structural & Molecular Biology 17(1):130–32. 
Niehus, Eike et al. 2004. “Genome-Wide Analysis of Transcriptional Hierarchy and Feedback Regulation 
in the Flagellar System of Helicobacter Pylori.” Molecular microbiology 52(4):947–61. 
Nishimori, Isao, Daniela Vullo, et al. 2006. “Carbonic Anhydrase Inhibitors: Cloning and Sulfonamide 
Inhibition Studies of a Carboxyterminal Truncated Alpha-Carbonic Anhydrase from Helicobacter 
Pylori.” Bioorganic & medicinal chemistry letters 16(8):2182–88. 
Nishimori, Isao, Tomoko Minakuchi, et al. 2006. “Carbonic Anhydrase Inhibitors: DNA Cloning and 
Inhibition Studies of the Alpha-Carbonic Anhydrase from Helicobacter Pylori, a New Target for 
Developing Sulfonamide and Sulfamate Gastric Drugs.” Journal of medicinal chemistry 49(6):2117–
26. 
Nishimori, Isao, Tomoko Minakuchi, Takuhiro Kohsaki, Saburo Onishi, Hiroaki Takeuchi, Daniela Vullo, 
Andrea Scozzafava, and Claudiu T. Supuran. 2007. “Carbonic Anhydrase Inhibitors: The Beta-
Carbonic Anhydrase from Helicobacter Pylori Is a New Target for Sulfonamide and Sulfamate 
Inhibitors.” Bioorganic & medicinal chemistry letters 17(13):3585–94. 
Nishimori, Isao, Tomoko Minakuchi, Takuhiro Kohsaki, Saburo Onishi, Hiroaki Takeuchi, Daniela Vullo, 
Andrea Scozzafava, and Claudiu T. Supuran. 2007. “Carbonic Anhydrase Inhibitors: The β-Carbonic 
Anhydrase from Helicobacter Pylori Is a New Target for Sulfonamide and Sulfamate Inhibitors.” 
Bioorganic and Medicinal Chemistry Letters 17:3585–94. 
Nishimori, Isao et al. 2010. “The β-Carbonic Anhydrases from Mycobacterium Tuberculosis as Drug 
Targets.” Current Pharmaceutical Design 3300–3309. 
Nishimori, Isao, Saburo Onishi, Hiroaki Takeuchi, and Claudiu T. Supuran. 2008. “The Alpha and Beta 
Classes Carbonic Anhydrases from Helicobacter Pylori as Novel Drug Targets.” Current 
Pharmaceutical Design 14(7):622–30. 
Nitharwal, Ram Gopal, Vijay Verma, Santanu Dasgupta, and Suman Kumar Dhar. 2011. “Helicobacter 
Pylori Chromosomal DNA Replication: Current Status and Future Perspectives.” FEBS Letters 
585(1):7–17. 
Nolan, K. J. et al. 2002. “In Vivo Behavior of a Helicobacter Pylori SS1 nixA Mutant with Reduced Urease 
Activity.” Infection and Immunity 70(2):685–91. 
Nowak, Martin A. 1992. “What Is a Quasispecies?” Trends in ecology & evolution. 
O’Toole, P. W., M. Kostrzynska, and T. J. Trust. 1994. “Non-Motile Mutants of Helicobacter Pylori and 
Helicobacter Mustelae Defective in  Flagellar Hook Production.” Molecular microbiology 14(4):691–
703. 
References 
225 
 
O′Toole, Paul W., Michael C. Lane, and Steffen Porwollik. 2000. “Helicobacter Pylori Motility.” Microbes 
and Infection 2(10):1207–14. 
Odenbreit, S. et al. 2000. “Translocation of Helicobacter Pylori CagA into Gastric Epithelial Cells by Type 
IV Secretion.” Science (New York, N.Y.) 287(5457):1497–1500. 
Odenbreit, Stefan et al. 2009. “Outer Membrane Protein Expression Profile in Helicobacter Pylori Clinical 
Isolates.” Infection and immunity 77(9):3782–90. 
Odenbreit, Stefan, Gerhard Faller, and Rainer Haas. 2002. “Role of the alpAB Proteins and 
Lipopolysaccharide in Adhesion of Helicobacter Pylori to Human Gastric Tissue.” International 
journal of medical microbiology : IJMM 292(3-4):247–56. 
Odenbreit, Stefan, Markus Till, Dirk Hofreuter, Gerhard Faller, and Rainer Haas. 1999. “Genetic and 
Functional Characterization of the alpAB Gene Locus Essential for the Adhesion of Helicobacter 
Pylori to Human Gastric Tissue.” Molecular Microbiology 31(5):1537–48. 
Oganesyan, Natalia, Sung-hou Kim, and Rosalind Kim. 2004. “On-Column Chemical Refolding of 
Proteins.” PharmaGenomics (September). 
Ogiwara, Hiroaki et al. 2009. “Role of Deletion Located between the Intermediate and Middle Regions of 
the Helicobacter Pylori vacA Gene in Cases of Gastroduodenal Diseases.” Journal of clinical 
microbiology 47(11):3493–3500. 
Olson, J. W., N. S. Mehta, and R. J. Maier. 2001. “Requirement of Nickel Metabolism Proteins HypA and 
HypB for Full Activity of Both Hydrogenase and Urease in Helicobacter Pylori.” Molecular 
Microbiology 39:176–82. 
Orillard, Emilie, J. Pablo Radicella, and Stéphanie Marsin. 2011. “Biochemical and Cellular 
Characterization of Helicobacter Pylori RecA, a Protein with High-Level Constitutive Expression.” 
Journal of Bacteriology 193(23):6490–97. 
Orodovsky Mark, Rppuoli Rino, and Covacci Antonello. 1996. “Cag , a Pathogenicity Island of 
Helicobacter Pylori , Encodes Type I-Specific and Disease-Associated Virulence Factors.” 
Proceedings of the National Academy of Sciences of the United States of America 
93(December):14648–53. 
Osato MS, Ayub K, Le HH, Reddy R, Graham DY. 1998. “House Flies Are Unlike Reservoir of Vector for 
Helicobacter Pylori.” J Clin Microbiol 36(9):2786–88. 
Paetzel, Mark, Andrew Karla, Natalie C. J. Strynadka, and Ross E. Dalbey. 2002. “Signal Peptidases.” 
Chemical reviews 102(12):4549–80. 
Pang, Siew Siew et al. 2014. “The Three-Dimensional Structure of the Extracellular Adhesion Domain of 
the Sialic Acid-Binding Adhesin SabA from Helicobacter Pylori.” The Journal of biological chemistry 
289(10):6332–40. 
Panthel, K., P. Dietz, R. Haas, and D. Beier. 2003. “Two-Component Systems of Helicobacter Pylori 
Contribute to Virulence in a Mouse Infection Model.” Infect Immun 71(9):5381–85. 
Park, Haewon, Bongkeun Song, and Francois M. M. Morel. 2007. “Diversity of the Cadmium-Containing 
Carbonic Anhydrase in Marine Diatoms and Natural Waters.” Environmental microbiology 9(2):403–
13. 
Park, Sung Jean, Woo Sung Son, and Bong-Jin Lee. 2012. “Structural Analysis of Hypothetical Proteins 
References 
226 
 
from Helicobacter Pylori: An Approach to Estimate Functions of Unknown or Hypothetical Proteins.” 
International journal of molecular sciences 13(6):7109–37. 
Peck, B., M. Ortkamp, K. D. Diehl, E. Hundt, and B. Knapp. 1999. “Conservation, Localization and 
Expression of HopZ, a Protein Involved in Adhesion of Helicobacter Pylori.” Nucleic acids research 
27(16):3325–33. 
Petersen, Andreas Munk and Karen Angeliki Krogfelt. 2003. “Helicobacter Pylori: An Invading 
Microorganism? A Review.” FEMS Immunology and Medical Microbiology 36(3):117–26. 
Petersen, Thomas Nordahl, Soren Brunak, Gunnar von Heijne, and Henrik Nielsen. 2011. “SignalP 4.0: 
Discriminating Signal Peptides from Transmembrane Regions.” Nature methods 8(10):785–86. 
Pflock, Michael et al. 2006. “Characterization of the ArsRS Regulon of Helicobacter Pylori, Involved in 
Acid Adaptation.” Journal of Bacteriology 188(10):3449–62. 
Pich, Oscar Q. and Douglas Scott Merrell. 2013. “The Ferric Uptake Regulator of Helicobacter Pylori: A 
Critical Player in the Battle for Iron and Colonization of the Stomach.” Future microbiology 
18(9):1199–1216. 
Pinard, Melissa A. et al. 2015. “Structure and Inhibition Studies of a Type II Beta-Carbonic Anhydrase 
psCA3 from  Pseudomonas Aeruginosa.” Bioorganic & medicinal chemistry 23(15):4831–38. 
Portal-Celhay, Cynthia and Guillermo I. Perez-Perez. 2006. “Immune Responses to Helicobacter Pylori 
Colonization: Mechanisms and Clinical Outcomes.” Clinical science (London, England : 1979) 
110(3):305–14. 
Pounder, R. E. and D. Ng. 1995. “The Prevalence of Helicobacter Pylori Infection in Different Countries.” 
Alimentary pharmacology & therapeutics 9 Suppl 2:33–39. 
Del Prete, Sonia et al. 2014. “Discovery of a New Family of Carbonic Anhydrases in the Malaria Pathogen 
Plasmodium Falciparum--the Eta-Carbonic Anhydrases.” Bioorganic & medicinal chemistry letters 
24(18):4389–96. 
Prinz, Christian et al. 2001. “Key Importance of the Helicobacter Pylori Adherence Factor Blood Group 
Antigen Binding Adhesin during Chronic Gastric Inflammation 1.” Cancer Research 1903–9. 
Queiroz, Dulciene M. M. et al. 2009. “IL2-330G Polymorphic Allele Is Associated with Decreased Risk of 
Helicobacter Pylori Infection in Adulthood.” Microbes and infection / Institut Pasteur 11(12):980–87. 
Raghavan, S., M. Fredriksson, A. M. Svennerholm, J. Holmgren, and E. Suri-payer. 2003. “Absence of 
CD4+CD25+ Regulatory T Cells Is Associated with a Loss of Regulation Leading to Increased 
Pathology in Helicobacter Pylori-Infected Mice.” Clinical & Experimental Immunology 132(3):393–
400. 
Raghavan, Sukanya and Jan Holmgren. 2005. “CD4+CD25+ Suppressor T Cells Regulate Pathogen 
Induced Inflammation and Disease.” FEMS immunology and medical microbiology 44(2):121–27. 
Raju, D. et al. 2012. “Vacuolating Cytotoxin and Variants in Atg16L1 That Disrupt Autophagy Promote 
Helicobacter Pylori Infection in Humans.” Gastroenterology 18(9):1199–1216. 
De Reuse, Hilde and Stefan Bereswill. 2007. “Ten Years after the First Helicobacter Pylori Genome: 
Comparative and Functional Genomics Provide New Insights in the Variability and Adaptability of a 
Persistent Pathogen.” FEMS Immunology and Medical Microbiology 50(2):165–76. 
Reyrat, J. M. et al. 1999. “3D Imaging of the 58 kDa Cell Binding Subunit of the Helicobacter Pylori 
References 
227 
 
Cytotoxin.” Journal of molecular biology 290(2):459–70. 
Robinson, Karen, Michael F. Loughlin, Rebecca Potter, and Peter J. Jenks. 2005. “Host Adaptation and 
Immune Modulation Are Mediated by Homologous Recombination in Helicobacter Pylori.” The 
Journal of infectious diseases 191(4):579–87. 
Ronning, Donald R. et al. 2005. “Active Site Sharing and Subterminal Hairpin Recognition in a New Class 
of DNA Transposases.” Molecular Cell 20(1):143–54. 
Roszczenko, Paula et al. 2015. “Helicobacter Pylori HP0377, a Member of the Dsb Family, Is an 
Untypical Multifunctional CcmG That Cooperates with Dimeric Thioldisulfide Oxidase HP0231.” 
BMC Microbiology 15(1):135. 
Rothenbacher, D., M. J. Blaser, G. Bode, and H. Brenner. 2000. “Inverse Relationship between Gastric 
Colonization of Helicobacter Pylori and Diarrheal Illnesses in Children: Results of a Population-
Based Cross-Sectional Study.” The Journal of infectious diseases 182(5):1446–49. 
Rothenbacher, Dietrich and Hermann Brenner. 2003. “Burden of Helicobacter Pylori and H. Pylori-
Related Diseases in Developed Countries: Recent Developments and Future Implications.” 
Microbes and Infection 5(8):693–703. 
Rowlett, Roger S. 2010. “Structure and Catalytic Mechanism of the Beta-Carbonic Anhydrases.” 
Biochimica et biophysica acta 1804(2):362–73. 
Russo, Maria Elena et al. 2013. “Kinetic Study of a Novel Thermo-Stable Alpha-Carbonic Anhydrase for 
Biomimetic CO2 Capture.” Enzyme and microbial technology 53(4):271–77. 
Ryan, Kieran A., Najma Karim, Mulugeta Worku, Charles W. Penn, and Paul W. O’Toole. 2005. “Hook-
Filament Transition Is Controlled by a FliK Functional Homolog Encoded by the Gene HP0906.” 
Journal of bacteriology 187(16):5742–50. 
Sachs, G. 2005. “Acid Acclimation by Helicobacter Pylori.” Physiology 20(6):429–38. 
Sachs, George, David L. Weeks, Klaus Melchers, and David R. Scott. 2003. “The Gastric Biology of 
Helicobacter Pylori.” Annual review of physiology 65:349–69. 
Sachs, George, Yi Wen, and David R. Scott. 2009. “Gastric Infection by Helicobacter Pylori.” Current 
Gastroenterology reports 11(6):455–61. 
Salama, N. et al. 2000. “A Whole-Genome Microarray Reveals Genetic Diversity among Helicobacter 
Pylori Strains.” Proceedings of the National Academy of Sciences of the United States of America 
97(26):14668–73. 
Salama, Nina R., Mara L. Hartung, and Anne Muller. 2013. “Life in the Human Stomach: Persistence 
Strategies of the Bacterial Pathogen Helicobacter Pylori.” Nat Rev Micro 11(6):385–99. 
Salih, Barik A. 2009. “Helicobacter Pylori Infection in Developing Countries: The Burden for How Long?” 
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association 
15(3):201–7. 
Sanders, Carsten, Serdar Turkarslan, Dong-Woo Lee, and Fevzi Daldal. 2010. “Cytochrome c 
Biogenesis: The Ccm System.” Trends in microbiology 18(6):266–74. 
Satin, B. et al. 1997. “Effect of Helicobacter Pylori Vacuolating Toxin on Maturation and Extracellular 
Release of Procathepsin D and on Epidermal Growth Factor Degradation.” Journal of Biological 
Chemistry 272(40):25022–28.  
References 
228 
 
Saunders, N. J., J. F. Peden, D. W. Hood, and E. R. Moxon. 1998. “Simple Sequence Repeats in the 
Helicobacter Pylori Genome.” Molecular Microbiology 27(6):1091–98.  
Sawaya, Michael R. et al. 2006. “The Structure of β-Carbonic Anhydrase from the Carboxysomal Shell 
Reveals a Distinct Subclass with One Active Site for the Price of Two.” Journal of Biological 
Chemistry 281(11):7546–55. 
Schär, Jennifer, Albert Sickmann, and Dagmar Beier. 2005. “Phosphorylation-Independent Activity of 
Atypical Response Regulators of Helicobacter Pylori.” Journal of Bacteriology 187(9):3100–3109. 
Schmees, C. et al. 2007. “Inhibition of T-Cell Proliferation by Helicobacter Pylori Gamma-Glutamyl 
Transpeptidase.” Gastroenterology 132(5):1820–33. 
Schreiber, S. et al. 2004. “The Spatial Orientation of Helicobacter Pylori in the Gastric Mucus.” 
Proceedings of the National Academy of Sciences of the United States of America 101(14):5024–
29.  
Schreiber, Sören et al. 2005. “Rapid Loss of Motility of Helicobacter Pylori in the Gastric Lumen In Vivo 
Rapid Loss of Motility of Helicobacter Pylori in the Gastric Lumen In Vivo So.” Infection and 
immunity 73(3):1–7. 
Scott, D., D. Weeks, K. Melchers, and G. Sachs. 1998. “The Life and Death of Helicobacter Pylori.” Gut 
1998;43(Suppl 1):S56–60. 43(supplem(suppl 1):S56–60. 
Scott, David R. et al. 2000. “Expression of the Helicobacter Pylori ureI Gene Is Required for Acidic pH 
Activation of Cytoplasmic Urease.” Infection and Immunity 68(2):470–77. 
Scotti, Claudia et al. 2010. “Cell-Cycle Inhibition by Helicobacter Pylori L-Asparaginase.” PloS one 
5(11):e13892. 
Selbach, Matthias, Stefan Moese, Christof R. Hauck, Thomas F. Meyer, and Steffen Backert. 2002. “Src 
Is the Kinase of the Helicobacter Pylori CagA Protein in Vitro and in Vivo.” The Journal of biological 
chemistry 277(9):6775–78. 
Senkovich, Olga a. et al. 2011. “Helicobacter Pylori AlpA and AlpB Bind Host Laminin and Influence 
Gastric Inflammation in Gerbils.” Infection and Immunity 79(8):3106–16. 
Sgouras, Dionyssios N., Tran Thi Huyen Trang, and Yoshio Yamaoka. 2015. “Pathogenesis of 
Helicobacter Pylori Infection.” Helicobacter 20:8–16. 
She, Fei-fei, Jian-yin Lin, Jun-yan Liu, Cheng Huang, and Dong-hui Su. 2003. “Virulence of Water-
Induced Coccoid Helicobacter Pylori and Its Experimental Infection in Mice.” World Journal of 
Gastroenterology 9(3):516–20. 
Shibayama, Keigo, Hiroaki Takeuchi, Jun-Ichi Wachino, Shigetarou Mori, and Yoshichika Arakawa. 2011. 
“Biochemical and Pathophysiological Characterization of Helicobacter Pylori Asparaginase.” 
Microbiology and immunology 55(6):408–17. 
Simon, Jörg and Lars Hederstedt. 2011. “Composition and Function of Cytochrome c Biogenesis System 
II.” The FEBS journal 278(22):4179–88.  
De Simone, Giuseppina, Vincenzo Alterio, and Claudiu T. Supuran. 2013. “Exploiting the Hydrophobic 
and Hydrophilic Binding Sites for Designing Carbonic Anhydrase Inhibitors.” Expert opinion on drug 
discovery 8(7):793–810. 
Sipponen, P. 1995. “Helicobacter Pylori: A Cohort Phenomenon.” The American journal of surgical 
References 
229 
 
pathology 19 Suppl 1:S30–36. 
Skouloubris, S., a Labigne, and H. De Reuse. 1997. “Identification and Characterization of an Aliphatic 
Amidase in Helicobacter Pylori.” Molecular microbiology 25(5):989–98. 
Skouloubris, Stéphane, Agnès Labigne, and Hilde De Reuse. 2001. “The AmiE Aliphatic Amidase and 
AmiF Formamidase of Helicobacter Pylori: Natural Evolution of Two Enzyme Paralogues.” Molecular 
Microbiology 40(3):596–609. 
Sly, W. S. and P. Y. Hu. 1995. “Human Carbonic Anhydrases and Carbonic Anhydrase Deficiencies.” 
Annual review of biochemistry 64:375–401. 
Smith, K. S. and J. G. Ferry. 1999. “A Plant-Type (beta-Class) Carbonic Anhydrase in the Thermophilic 
Methanoarchaeon Methanobacterium Thermoautotrophicum.” Journal of bacteriology 
181(20):6247–53. 
Smith, K. S., C. Ingram-Smith, and J. G. Ferry. 2002. “Roles of the Conserved Aspartate and Arginine in 
the Catalytic Mechanism of an Archaeal  -Class Carbonic Anhydrase.” Journal of Bacteriology 
184(15):4240–45. 
Smith, Kerry S., Nathaniel J. Cosper, Christina Stalhandske, and Robert A. Scott. 2000. “Structural and 
Kinetic Characterization of an Archaeal β-Class Carbonic Anhydrase.” Journal of Bacteriology 
182(23):6605–13. 
Smith, S. I., S. Miehlke, K. S. Oyedeji, A. A. Arigbabu, and A. O. Coker. 2002. “Fingerprinting of Nigerian 
Helicobacter Pylori Isolates by Plasmid Profile and PCR.” Journal of basic microbiology 42(1):45–
53. 
Smith, Sinéad M. 2014. “Role of Toll-like Receptors in Helicobacter Pylori Infection and Immunity.” World 
journal of gastrointestinal pathophysiology 5(3):133–46. 
Solnick, Jay V, Lori M. Hansen, Nina R. Salama, Jenni K. Boonjakuakul, and Michael Syvanen. 2004. 
“Modification of Helicobacter Pylori Outer Membrane Protein Expression during Experimental 
Infection of Rhesus Macaques.” Proceedings of the National Academy of Sciences of the United 
States of America 101(7):2106–11. 
Sorensen, Hans Peter and Kim Kusk Mortensen. 2005. “Advanced Genetic Strategies for Recombinant 
Protein Expression in Escherichia Coli.” Journal of biotechnology 115(2):113–28. 
Sørensen, Hans Peter and Kim Kusk Mortensen. 2005. “Soluble Expression of Recombinant Proteins in 
the Cytoplasm of Escherichia Coli.” Microbial cell factories 4(Figure 1):1. 
Steiner, H. and S. Lindskog. 1972. “Effects of High Concentrations of Salt on the Esterase Activity of 
Human Carbonic Anhydrase.” FEBS letters 24(1):85–88. 
Stevens, Julie M., Oliver Daltrop, James W. A. Allen, and Stuart J. Ferguson. 2004. “C-Type Cytochrome 
Formation: Chemical and Biological Enigmas.” Accounts of chemical research 37(12):999–1007. 
Strop, Pavel, Kerry S. Smith, Tina M. Iverson, James G. Ferry, and Douglas C. Rees. 2001. “Crystal 
Structure of the ‘Cab’-Type β Class Carbonic Anhydrase from the Archaeon Methanobacterium 
Thermoautotrophicum.” Journal of Biological Chemistry 276(13):10299–305. 
Su, B. et al. 1998. “Type I Helicobacter Pylori Shows Lewis(b)-Independent Adherence to Gastric Cells 
Requiring de Novo Protein Synthesis in Both Host and Bacteria.” Journal of Infectious Diseases 
178(5):1379–90. 
References 
230 
 
Suerbaum, S. 2000. “Genetic Variability within Helicobacter Pylori.” International journal of medical 
microbiology : IJMM 290(2):175–81.  
Suerbaum, S. and C. Josenhans. 1999. “Virulence Factors of Helicobacter Pylori: Implications for Vaccine 
Development.” Molecular medicine today 5(1):32–39. 
Suerbaum, Sebastian and Mark Achtman. 2004. “Helicobacter Pylori: Recombination, Population 
Structure and Human Migrations.” International journal of medical microbiology : IJMM 294(2-
3):133–39. 
Suerbaum, Sebastian and Christine Josenhans. 2007. “Helicobacter Pylori Evolution and Phenotypic 
Diversification in a Changing Host.” Nature reviews. Microbiology 5(6):441–52. 
Supuran, Claudiu T. 2011. “Carbonic Anhydrase Inhibitors and Activators for Novel Therapeutic 
Applications.” Future medicinal chemistry 3(9):1165–80. 
Supuran, Claudiu T. and Andrea Scozzafava. 2007. “Carbonic Anhydrases as Targets for Medicinal 
Chemistry.” Bioorganic & medicinal chemistry 15(13):4336–50. 
Suzuki, Masato et al. 2009. “Helicobacter Pylori CagA Phosphorylation-Independent Function in Epithelial 
Proliferation and Inflammation.” Cell host & microbe 5(1):23–34. 
Sycuro, Laura K. et al. 2010. “Peptidoglycan Crosslinking Relaxation Promotes Helicobacter Pylori’s 
Helical Shape and Stomach Colonization.” Cell 141(5):822–33. 
Sycuro, Laura K. et al. 2012. “Multiple Peptidoglycan Modification Networks Modulate Helicobacter 
Pylori’s Cell Shape, Motility, and Colonization Potential.” PLoS Pathogens 8(3):e1002603. 
Syrjänen, Leo et al. 2010. “Characterization of the First Beta-Class Carbonic Anhydrase from an 
Arthropod (Drosophila Melanogaster) and Phylogenetic Analysis of Beta-Class Carbonic 
Anhydrases in Invertebrates.” BMC biochemistry 11:28. 
Tanc, Muhammet, Fabrizio Carta, Andrea Scozzafava, and Claudiu T. Supuran. 2015. “Alpha-Carbonic 
Anhydrases Possess Thioesterase Activity.” ACS medicinal chemistry letters 6(3):292–95. 
Taylor, Diane E. 1999. “Helicobacter Pylori and Its Genome: Lessons from the Treasure Map.” 13(3):218–
23. 
Tegtmeyer, N., S. Wessler, and S. Backert. 2013. “Role of the Cag Pathogenicity Island Encoded Type IV 
Secretion System in Helicobacter Pylori Pathogenesis.” FEBS Journal 18(9):1199–1216. 
Terebiznik, M. R. et al. 2006. “Helicobacter Pylori VacA Toxin Promotes Bacterial Intracellular Survival in 
Gastric Epithelial Cells.” Infection and Immunity 74(12):6599–6614. 
Terradot, Laurent and Gabriel Waksman. 2011. “Architecture of the Helicobacter Pylori Cag-Type IV 
Secretion System.” FEBS Journal 278(8):1213–22. 
Terry, Karianne, Susan M. Williams, Lynn Connolly, and Karen M. Ottemann. 2005. “Chemotaxis Plays 
Multiple Roles during Helicobacter Pylori Animal Infection Chemotaxis Plays Multiple Roles during 
Helicobacter Pylori Animal Infection.” Infection and Immunity 73(2):803–11. 
Tomb, J. F. et al. 1997. “The Complete Genome Sequence of the Gastric Pathogen Helicobacter Pylori.” 
Nature 388(6642):539–47. 
Tonello, F. et al. 1999. “The Helicobacter Pylori Neutrophil-Activating Protein Is an Iron-Binding Protein 
with Dodecameric Structure.” Molecular microbiology 34(2):238–46. 
Torres, Victor J., Susan E. Ivie, Mark S. McClain, and Timothy L. Cover. 2005. “Functional Properties of 
References 
231 
 
the p33 and p55 Domains of the Helicobacter Pylori Vacuolating Cytotoxin.” Journal of Biological 
Chemistry 280(22):21107–14. 
Touati, Danièle. 2000. “Iron and Oxidative Stress in Bacteria.” Archives of Biochemistry and Biophysics 
373(1):1–6. 
Trinchieri, Giorgio. 2003. “Interleukin-12 and the Regulation of Innate Resistance and Adaptive Immunity.” 
Nature reviews. Immunology 3(2):133–46. 
Tripp, Brian C., Kerry Smith, and James G. Ferry. 2001. “Carbonic Anhydrase: New Insights for an 
Ancient Enzyme.” Journal of Biological Chemistry 276(52):48615–18. 
Tytgat, G. N. 1995. “Endoscopic Transmission of Helicobacter Pylori.” Alimentary pharmacology & 
therapeutics 9 Suppl 2:105–10. 
Vagin, Alexei and Alexei Teplyakov. 2010. “Molecular Replacement with MOLREP.” Acta 
crystallographica. Section D, Biological crystallography 66(Pt 1):22–25. 
Vaira, D. et al. 1988. “CAMPYLOBACTER PYLORI IN ABATTOIR WORKERS: IS IT A ZOONOSIS?” The 
Lancet 332(8613):725–26. 
Van Vliet, Arnoud H. M. et al. 2002. “The Role of the Ferric Uptake Regulator (Fur) in Regulation of 
Helicobacter Pylori Iron Uptake.” Helicobacter 7(4):237–44. 
Van Vliet, Arnoud H. M., Florian D. Ernst, and Johannes G. Kusters. 2004. “NikR-Mediated Regulation of 
Helicobacter Pylori Acid Adaptation.” Trends in Microbiology 12(11):489–94. 
Van Vliet, Arnoud H. M., Ernst J. Kuipers, Jeroen Stoof, Sophie W. Poppelaars, and Johannes G. 
Kusters. 2004. “Acid-Responsive Gene Induction of Ammonia-Producing Enzymes in Helicobacter 
Pylori Is Mediated via a Metal-Responsive Repressor Cascade.” Infection and Immunity 72(2):766–
73. 
Vullo, Daniela et al. 2013. “The Alpha-Carbonic Anhydrase from the Thermophilic Bacterium 
Sulfurihydrogenibium Yellowstonense YO3AOP1 Is Highly Susceptible to Inhibition by 
Sulfonamides.” Bioorganic & medicinal chemistry 21(6):1534–38. 
Wang, Ge, Praveen Alamuri, M. Zafri Humayun, Diane E. Taylor, and Robert J. Maier. 2005. “The 
Helicobacter Pylori MutS Protein Confers Protection from Oxidative DNA Damage.” Molecular 
microbiology 58(1):166–76. 
Wang, Ge, F. Lo Leja, and Robert J. Maier. 2011. “NIH Public Access.” DNA Repair 18(9):1199–1216. 
Waters, Richard C., Paul W. O’Toole, and Kieran a Ryan. 2007. “The FliK Protein and Flagellar Hook-
Length Control.” Protein science : a publication of the Protein Society 16(5):769–80. 
Weeks, D. L., S. Eskandari, D. R. Scott, and G. Sachs. 2000. “A H+-Gated Urea Channel: The Link 
between Helicobacter Pylori Urease and Gastric  Colonization.” Science (New York, N.Y.) 
287(5452):482–85. 
Wen, Yi, Jing Feng, David R. Scott, Elizabeth A. Marcus, and George Sachs. 2007. “The HP0165-
HP0166 Two-Component System (ArsRS) Regulates Acid-Induced Expression  of HP1186 Alpha-
Carbonic Anhydrase in Helicobacter Pylori by Activating the pH-Dependent Promoter.” Journal of 
bacteriology 189(6):2426–34. 
Wen, Yi, Jing Feng, David R. Scott, Elizabeth a. Marcus, and George Sachs. 2011. “A Cis-Encoded 
Antisense Small RNA Regulated by the HP0165-HP0166 Two-Component System Controls 
References 
232 
 
Expression of ureB in Helicobacter Pylori.” Journal of Bacteriology 193(1):40–51. 
WHO-IARC. 1994. “Schistosomes, Liver Flukes and Helicobacter Pylori. IARC Working Group on the 
Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994.” IARC monographs on the 
evaluation of carcinogenic risks to humans / World Health Organization, International Agency for 
Research on Cancer 61:1–241. 
Willey, Joanne M., Linda. Sherwood, Christopher J. Woolverton, Lansing M. Prescott, and Joanne M. 
Willey. 2011. Prescott’s Microbiology. New York: McGraw-Hill. 
Wilson, Keith T. and Jean E. Crabtree. 2007. “Immunology of Helicobacter Pylori: Insights Into the Failure 
of the Immune Response and Perspectives on Vaccine Studies.” Gastroenterology 133(1):288–308. 
Windle, H. J., A. Fox, D. Ni Eidhin, and D. Kelleher. 2000. “The Thioredoxin System of Helicobacter 
Pylori.” The Journal of biological chemistry 275(7):5081–89. 
Winn, Martyn D. et al. 2011. “Overview of the CCP4 Suite and Current Developments.” Acta 
crystallographica. Section D, Biological crystallography 67(Pt 4):235–42. 
Wyle, F. A., A. Tarnawski, D. Schulman, and W. Dabros. 1990. “Evidence for Gastric Mucosal Cell 
Invasion by C. Pylori: An Ultrastructural Study.” Journal of clinical gastroenterology 12 Suppl 1:S92–
98. 
Xia, H. H. and N. J. Talley. 1997. “Natural Acquisition and Spontaneous Elimination of Helicobacter Pylori 
Infection: Clinical Implications.” The American journal of gastroenterology 92(10):1780–87. 
Xu, Yan, Liang Feng, Philip D. Jeffrey, Yigong Shi, and Francois M. M. Morel. 2008. “Structure and Metal 
Exchange in the Cadmium Carbonic Anhydrase of Marine Diatoms.” Nature 452(7183):56–61. 
Yahiro, K. et al. 1999. “Activation of Helicobacter Pylori VacA Toxin by Alkaline or Acid Conditions 
Increases Its Binding to a 250-kDa Receptor Protein-Tyrosine Phosphatase.” Journal of Biological 
Chemistry 274(51):36693–99. 
Yamaoka, Y. 2006. “Helicobacter Pylori Outer Membrane Proteins and Gastroduodenal Disease.” Gut 
55(6):775–81. 
Yamaoka, Y. 2009. “Helicobacter Pylori Typing as a Tool for Tracking Human Migration.” Clinical 
microbiology and infection : the official publication of the European Society of Clinical Microbiology 
and Infectious Diseases 15(9):829–34. 
Yamaoka, Y., D. H. Kwon, and D. Y. Graham. 2000. “A M(r) 34,000 Proinflammatory Outer Membrane 
Protein (oipA) of Helicobacter Pylori.” Proceedings of the National Academy of Sciences of the 
United States of America 97(13):7533–38. 
Yoon, Ji Young et al. 2013. “Structural and Functional Characterization of HP0377, a Thioredoxin-Fold 
Protein from Helicobacter Pylori.” Acta Crystallographica Section D Biological Crystallography 
69(5):735–46. 
Zabaleta, Eduardo, M. Victoria Martin, and Hans-Peter Braun. 2012. “A Basal Carbon Concentrating 
Mechanism in Plants?” Plant science : an international journal of experimental plant biology 187:97–
104. 
Zabaleta, Jovanny et al. 2004. “Helicobacter Pylori Arginase Inhibits T Cell Proliferation and Reduces the 
Expression of the TCR Zeta-Chain (CD3zeta).” Journal of immunology (Baltimore, Md. : 1950) 
173(1):586–93. 
References 
233 
 
Zambon, Carlo-F. et al. 2005. “Pro- and Anti-Inflammatory Cytokines Gene Polymorphisms and 
Helicobacter Pylori Infection: Interactions Influence Outcome.” Cytokine 29(4):141–52. 
Zanotti, Giuseppe et al. 2002. “Structure of the Neutrophil-Activating Protein from Helicobacter Pylori.” 
Journal of molecular biology 323(1):125–30. 
Zanotti, Giuseppe and Laura Cendron. 2014. “Structural and Functional Aspects of the Helicobacter 
Pylori Secretome.” World Journal of Gastroenterology 20(6):1402. 
Zawilak, a et al. 2001. “Identification of a Putative Chromosomal Replication Origin from Helicobacter 
Pylori and Its Interaction with the Initiator Protein DnaA.” Nucleic acids research 29(11):2251–59. 
Zeevaart, Jacob G. et al. 2009. “Structural Analysis of the Oligomeric States of Helicobacter Pylori VacA 
Toxin.” Journal of Molecular Biology 130(29):9492–99. 
Zhang, Man, Arthur F. Monzingo, Laura Segatori, George Georgiou, and Jon D. Robertus. 2004. 
“Structure of DsbC from Haemophilus Influenzae.” Acta crystallographica. Section D, Biological 
crystallography 60(Pt 9):1512–18. 
Zhang, Mei. 2015. “High Antibiotic Resistance Rate: A Difficult Issue for Helicobacter Pylori Eradication 
Treatment.” World Journal of Gastroenterology 21(48):13432. 
Zolfaghari Emameh, Reza, Harlan Barker, Martti E. E. Tolvanen, Csaba Ortutay, and Seppo Parkkila. 
2014. “Bioinformatic Analysis of Beta Carbonic Anhydrase Sequences from Protozoans and 
Metazoans.” Parasites & vectors 7(1):38. 
 
